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Complete absorption
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Should a bandage roll
accommodate swelling
like this...

...or like this?

The answer is obvious...Conform Stretch Bandage

When you dress an injury with associated
swelling—whether it be for limbs, moving joints
or difficult-to-bandage areas.. .you require a
bandage that provides a secure hold yet allows
for optimum freedom of movement.
Unlike ordinary gauze bandages, Conform
Stretch Bandage provides a consistent, even
stretch which reduces the chance of constriction.

Comfort and conformability—the two things
your patients need.
• more stretch with less ©sturdier weave
chance of constriction slighter—yet stronger
# softer—more
• better hold
comfortable
• lint-free
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Enteral nutrition begins in the
recovery r o o m ...

Vivonex Jejunostomy Kit
All you need to perform a
needle-catheter jejunostomy in one
complete, economical kit.
Each kit contains:
- hinged easy access tray
- 90 cm (36”) 5 Fr radiopaque polyurethane catheter
- 100 cm ‘soft tip’, stainless steel, flexible guidewire
- No. 14 gauge, thin-wall, non-coring needles (2)
- No. 20 gauge, needle cannula with female adapter hub
- catheter/adapter sleeve for nonshearing, leak- and
kink-proof connection
- specially designed anchoring catheter retainer to
prevent accidental dislodgement
- instruction sheet

And continues on the ward
New Formula

Vivonex HN
- New formulation containing molybdenum,
selenium, and chromium; less sodium and
chloride; added potassium
- Unique amino acid formula is absorbed with
minimal digestion
- Less than half the cost of TPN
- Virtually eliminates the risk of sepsis associated
with parenteral feedings
- Safe and effective
“Nutritional benefits are realized early when the
needs are greatest. Although the present study did
not compare intrajejunal feeding with total paren
teral nutrition, the nutritional benefits appear to
be equal or better, and almost all the hazards of
total parenteral nutrition are avoided.”
~ Hoover, HC Jr., Ryan, JA, Anderson, EJ, and Fischer, JE: Nutritional
benefits of immediate postoperative jejunal feeding of an elemental diet.
Am J Surg 139:153 (Jan) 1980.
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Surgexsmooths
Surgex
Hair Rem over Cream
No nicks, no cuts, less chance of infection when you
rely on SURGEX to help you get him back in the game
safely and comfortably.
Proven today’s most effective prepping method,
SURGEX is indispensible in eliminating the pro
blems associated with shaving the irregular,
bony areas of the body.
If razor prepping is performed more than a
few hours before surgery, the minor abra
sions produced provide a culture medium
from which infection may spread. With
SURGEX, the preps can be done one day
pre-operatively because there are no
abrasions.
SURGEX removes hair below the skin
line. It eliminates the patients appre
hension of a razor; SURGEX patients
are more relaxed. In some cases
they can apply it themselves.
For orthopedic procedures, as
for general medical and surgical
use, choose SURGEX - (MVP)
Most Valuable Prep of today’s
medical team.

Yes, I’d like to try SURGEX.
Please send me a free sample and additional information.
N a m e _______________________ —-----------------------------------Address
C ity .
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Telephone
Have your local Sparta representative call me.
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QUILL ON SCALPEL

This section provides a medium through which Canadian surgeons can declare themselves, briefly
and informally, on the day-to-day affairs of surgery.

Avascular Osteonecrosis
Death of osteocytes and medullary
elements results from interruption of
blood supply to a given portion of
bone. This entity of osteonecrosis can
be diagnosed histologically and clinic
ally. These histologic changes alone
are clinically silent. Symptoms, cli
nical signs and radiologic changes be
come evident when dead bone is
replaced by new tissue. At this stage,
there is pain, and radiolucent zones
and even collapse of the articular
surface can be seen on the roent
genogram.
The incidence of necrosis of bone
has increased greatly over the past
20 years. A better understanding of
the disease process resulting in im
proved treatment has partly compen
sated for the increased incidence of
avascular necrosis. Surgical procedures
have been developed and refined.
They offer the patient satisfactory
relief of symptoms and increased
mobility, particularly when there is
advanced involvement of the joint.
Moreover, it seems that this advanced
joint deformation can be prevented
by surgical intervention during the
early stages. Certain types of arthro
plasty are firmly established in ad
vanced cases, but the prevention of
joint incongruity needs further re
finement. Such is the expectation for
the future. The lack of established
preventive measures is due to insuffi
cient knowledge of the pathogenesis
of osteonecrosis.
The division of orthopedic surgery
at the University of Ottawa devoted
its 1980 annual course on the clinical
application of basic sciences to the
topic of osteonecrosis. In the current
issue (pages 567-590), three papers
reflect the present state of the art.

Avascular osteonecrosis occurs in
some cases after subcapital fracture
of the femur. Since major vessels are
involved, the osteonecrosis is termed
macrovascular. Osteonecrosis can also
occur following occlusion of smaller
vessels due either to intravascular
obstruction or to extravascular com
pression. This type of osteonecrosis is
called microvascular.
Localized death of bone cannot be
diagnosed radiologically. Radiologic
signs of osteonecrosis will only be
come evident when the dead tissue
is replaced by living tissue. During
this stage of repair, bone is mechanic
ally weak and deformation at the
joint level may occur causing joint
incongruity which results in pain and
impaired function.
Etiologic factors responsible for
osteonecrosis are well identified. The
pathogenesis, however, is still contro
versial. Cruess (page 567) postulates
that osteonecrosis results from intra
vascular occlusion of small arteries
by fat droplets.1Hungerford (page 583)
and Solomon (page 573) believe that
it is the result of an increase in size
of medullary fat cells. This causes
increased pressure in a closed space,
leading to extravascular occlusion of
small veins and impaired arterial
supply.
No therapeutic regimens are pre
sently known to prevent or to treat
intra-arterial occlusion effectively.
Extravascular compression can be
relieved by decompression and Hun
gerford and Solomon show that if
performed during the early stages,
decompression can prevent articular
collapse.
Having made the step from the
satisfactory treatment of fully es
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tablished osteonecrosis by arthro
plasty to the prevention of collapse
through early decompression, we hope
that further research will help not
only to diagnose but also to prevent
the initiating event of vascular
occlusion.
H ans

K.

U h t h o f f , m d , f r c s [c ]

Division of orthopedic surgery,
Ottawa General Hospital,
Ottawa, Ont.
Reference
R L , R o s s D, C r a w s h a w E : The
etiology of steroid-induced av ascu lar necrosis
of bone. A la b o ra to ry and clinical study.
Clin O rthop 1975; 113: 178-83

1. C r u ess

NOTICES
Pan-Pacific International Symposium
on Biomaterials

The Japanese and Canadian societies
for biomaterials invite participation
in a joint conference session to be
held at the University of British Co
lumbia, Vancouver, July 28-30, 1982.
Invited are papers on orthopedic, car
diovascular and dental materials and
tissue mechanics. All papers must be
received by Apr. 2, 1982. Commer
cial exhibitors and sponsors are wel
come to take a complementary role
in the conference; exhibit space is
available. Further information can be
obtained from: Dr. R.H. Roydhouse,
Conference chairman, Secretariat Bio
materials ’82, #1704, 1200 Alberni
St., Vancouver, BC V6E 1A6.
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CORRESPONDENCE

Colorectal Anastomosis
with a Surgical Stapler
To the editors.—We found the article
“Colorectal Anastomosis by Transanal
End-to-End Stapling” by Stoller and
colleagues (Can J Surg 1980; 23:
461-4) most interesting. We recently
reported our experience with colo
rectal anastomosis1 and esophagogas
tric anastomoses2 using the EEA stapler
(EEA Auto Stapler; Auto Suture Com
pany, Division of United States Sur
gical Corp., Stamford, Conn.). Since
our initial report of 20 patients who
had low anterior resection, we have
used the stapler in 20 more patients
requiring colorectal anastomoses fol
lowing resection for carcinoma of the
middle third of the rectum. Ten pa
tients in our initial series had clinically
serious anastomotic leaks; in 3 a loop
transverse colostomy was created and
7 were managed conservatively. All of
the colostomies were subsequently
closed. There have been no serious
anastomotic leaks in our more recent
series. These improved results relate
to our meticulous attention to the
preparation of the bowel wall at the
anastomotic site — excess fat and soft
tissue are completely removed from
the anastomotic site. The importance
of this maneuver cannot be over-em
phasized. Each metal staple is 4 mm
deep; in its grasping or holding posi
tion it is 2 mm deep. Therefore, if the
tissue thickness at the anastomotic site
is greater than 4 mm, the anastomosis
may be unstable.
We disagree with Stoller that “it is
not advisable to 'test' the anastomosis
with air or water”. In four of the
patients from our initial series, ana
stomotic problems were detected at
the time of operation by air insufflation
with the anastomosis under water in
the pelvic cavity. Experiments nearing
completion in the laboratory suggest
that a bowel anastomosis (hand-sewn
or stapled) can be air- and watertight

immediately after construction. In
addition to inspecting the two doughnut-shaped rings of tissue from the
stapling instrument, we continue to
use air insufflation through the rectum
with the anastomosis under normal
saline in the pelvic cavity as a method
of testing the integrity of the ana
stomosis.
We agree with Stoller and associates
that the stapling technique, when
properly used, appears to be safer
than low-level standard suturing tech
niques.
J.S. D o r s e y ,
R.M. S t o n e ,

md
m d

, f r c s [ c ], f a c s

Department of surgery,
The Hospital for Sick Children,
Toronto, Ont.
References
1. D o rsey JS , S t o n e RM: L ow anterior ana
stom osis w ith surgical stapler (C). A rch Surg
1979; 114: 639
2. D orsey JS, E sses S, G oldberg M, S t o n e R:
Esophagogastrectom y using the Auto Suture
EE A surgical stapling
instrument. A n n
Thorac Surg 1980; 30: 308-12

Mediocrity of Surgical Education
To the editors.— I was pleased to
see that my editorial (Can J Surg
1981; 24: 337—8) produced such in
terest from senior surgeons in Canada.
I had no wish to reopen the bitter
arguments about certification and
fellowship, but surely when the can
didate has been certified to act as
a consultant, is it not assumed at the
same time, by the public if by no one
else, that the candidate possesses a
high level of excellence in his or her
specialty?
The statement “the Canadian-train
ed graduate receives favoured treat
ment” refers to the fact that in the
written examination, a certain per
centage (85% to 90%) will pass as
the “reference group” each year,
whatever the level of that particular
year. I was relieved to see that there

Contributions of the Correspondence sec
tion are welcomed. They should be type
written and double spaced.

was considerable discussion by the
Royal College committee on examina
tions concerning the adoption of an
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absolute standard based on the average
cutting scores prevailing over the
previous 5-year period, which would
allow for higher pass rates, conceiv
ably to a level of 100%, but would
place an arbitrary limit of 10% to
15% on the failure rate.1
I agree that the oral examination
is an artificial and stressful encounter,
but it is the only currently available
method of independently assessing a
candidate’s ability to perform a cli
nical examination, certainly not al
ways assessed during training, and it
does represent an attempt to assess
clinical judgement, a quality certainly
not assessed by multiple-choice exa
mination. I note, with regret, that
examination of a patient has recently
been omitted from the clinical portion
of the general surgery examination.
Are we allowed to ask why?
Even the task force set up by the
committee on examinations to evalu
ate the report on examinations by the
Canadian Association of Interns and
Residents agreed that "a high level
of validity, dependability, and uni
formity of the ITE [in-training evalu
ation] process will need to be achieved
before the orals can safely be eli
minated”.2 Over a 5-year period, in
the orthopedic certification examina
tion, the ITE ratings were compared
with the written and oral results; there
was little correlation between the
ratings and the eventual result (Ash
worth MA: personal communication,
1981). In a problem situation, whom
are we to believe? A computer, the
first-hand experience of an inde
pendent external group of six exa
miners over a 3'A-hour period, or a
favourable ITE report? I wonder if
those individuals completing a Royal
College ITE report for a “nonrefer
ence” candidate really understand the
importance that the examiners place
on this report.
Professor Inglis refers to certain
weaknesses in all undergraduate sur
gical programs and at the University
of Toronto we are attempting to
provide the student at each stage
with more exposure to surgery and
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To reduce the risk
of stroke

with reduced risk
of stomach upset

N o w , E N T R O P H E N * is
indicated for reducing the risk
of recurrent transient ischem ic
attacks or stroke in m en w h o
have had transient ischemia
o f the brain due to fibrin
platelet emboli. A t present
there is no evid en ce that
A S A is effective in reducing
transient ischemic attacks
in w om en, or is of
b en efit in the treatment
of com pleted strokes
in m en or women.
Inhibition of platelet
m
cyclooxygen ase activity
b y a single dose of
E N T R O P H E N * -10
w as comparable to
JH
that of plain A S A ,
r l
although the effe ct was
delayed, reflecting the
d elayed appearance of
A S A in the plasma.1

W hen you prescribe
A S A for long-term use,
it is important not to create
additional problem s for
your patients.
While they may benefit
from the therapeutic
effect of A S A , there is
still a potential for
gastric irritation and
upset, particularly
w hen the regim en calls
for continuous daily
dosage.
Clinical experience
has shown that
E N T R O P H E N *, coated
with P O L Y M E R 37*
reduces gastric distress
in long-term treatment
with high doses of A S A .

itylsalicylic acid ta W fc . USP)
ric-coated with POMPER 37'

L with reduced risk
of stomach upset
1. Ali, M. et al.: Plasma acetylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin,
Stroke 77777:9-13, Jan/Feb 1980.
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TABLETS

entrophen*
(acetylsalicylic acid tablets, USP)
Enteric-coated with POLYMER 37*
Anti-inflammatory—Analgesic Agent
Platelet Aggregation Inhibitor
DESCRIPTION

ENTROPHEN* is an enteric-coated tablet contain
ing acetylsalicylic acid coated with POLYMER 37*.
a partially esterified polyvinyl alcohol.
ACTION

Acetylsalicylic acid (ASA) has analgesic, anti
pyretic and anti-inflammatory properties.
In rheumatic diseases, although the analgesic and
antipyretic effects are useful, the major purpose
for which ASA is used is to reduce the intensity of
the inflammatory process. Inhibition of prosta
glandin synthesis may be involved in the anti
inflammatory action of ASA.
ASA also alters platelet aggregation and release
reaction by inhibiting prostaglandin synthesis.
Thromboxane A2 is an essential step in platelet
aggregation. ASA prevents Thromboxane A2 for
mation by acetylation of platelet cyclooxygenase.
This inhibition of prostaglandin synthesis is
irreversible and affects platelet function for the
life of the platelet.
The POLYMER 37* coating substantially resists
disintegration in aqueous fluids having a pH lower
than 3.5 for a period of at least 2 hours and is
capable of disintegrating in aqueous fluids having
a pH of at least 5.5 in from 10 to 30 minutes. Thus,
POLYMER 37* coating effectively inhibits the
release of ASA in the stomach, whilst allowing the
tablet to dissolve in the upper portion of the small
intestine for absorption from the duodenal area.
Clinical experience has shown that POLYM ER 37*
coated acetylsalicylic acid diminishes or eliminates
gastric distress during long-term treatment with
high doses of ASA.

Patients have recovered upon cessation of
therapy.
Use in Pregnancy

ASA does not appear to have any teratogenic
effects. ASA has been found to delay parturition
in rats. This effect has also been described with
non-steroidal anti-inflammatory agents which
inhibit prostaglandin synthesis.
High doses (3 g daily) of ASA during pregnancy
may lengthen the gestation and parturition time.
Because of possible adverse effects on the
neonate and the potential for increased maternal
blood loss, ASA should be avoided during the last
three months of pregnancy.
Drug Interactions

Caution is necessary when ENTROPHEN*
and anticoagulants are prescribed concurrently, as
ASA may potentiate the action of anticoagulants.
Salicylates may potentiate sulfonylurea hypo
glycemic agents. Large doses of salicylates may
have a hypoglycemic action, and thus, affect the
insulin requirements of diabetics.
Although salicylates in large doses are uricosuric
agents, smaller amounts may depress uric acid
clearance and thus decrease the uricosuric
effects of probenecid, sulfinpyrazone and
phenylbutazone.
Sodium excretion produced by spironolactone
may be decreased in the presence of salicylates.
Salicylates also retard the renal elimination of
methotrexate.
ADVERSE REACTIONS

Gastrointestinal reactions: nausea, vomiting,
diarrhea, gastrointestinal bleeding and/or ulcera
tion. Ear reactions: tinnitus, vertigo, hearing loss.
Hematologic reactions: leukopenia, throm bo
cytopenia, purpura. Dermatologic and Hypersen
sitivity reactions: urticaria, angioedema, pruritus,
various skin eruptions, asthma and anaphylaxis.
Miscellaneous reactions: acute reversible hepatotoxicity, mental confusion, drowsiness, sweating
and thirst.
SYMPTOMS AND TREATMENT
OF OVERDOSAGE

INDICATIONS

Symptoms

ENTROPHEN* is indicated whenever gastric
intolerance to ASA is of concern.
ENTROPHEN* is indicated for the relief of signs
and symptoms of the following:
Osteoarthritis
Rheumatoid arthritis
Spondylitis
Bursitis
and other forms of rheumatism
Musculoskeletal disorders
Rheumatic fever, however, penicillin and other
appropriate therapy should be administered
concomitantly.
ASA is generally considered to be the primary
therapy for most forms of arthritis.
ENTROPHEN* is also indicated for reducing the
risk of recurrent transient ischemic attacks or
stroke in men who have had transient ischemia of
the brain due to fibrin platelet emboli. At present
there is no evidence that ASA is effective in
reducing transient ischemic attacks in women, or
is of benefit in the treatment of completed strokes
in men or women.

In mild overdosage these may include rapid and
deep breathing, nausea, vomiting (leading to
alkalosis), hyperpnea, vertigo, tinnitus, flushing,
sweating, thirst and tachycardia. (High blood
levels of ASA lead to acidosis.) Severe cases may
show fever, hemorrhage, excitement, confusion,
convulsions or coma, and respiratory failure.

CONTRAINDICATIONS

Sensitivity to the ingredients
Active peptic ulcer
Patients who had a bronchospastic reaction to
ASA or non-steroidal anti-inflammatory drugs.
W ARNINGS
ASA is one of the most frequent causes of
accidental poisoning in toddlers and infants.
ENTROPHEN* should, therefore, be kept well out
of the reach of all children.
PRECAUTIONS

Salicylates should be administered with caution
to patients with asthma and other allergic condi
tions, with a history of gastrointestinal ulcerations,
with bleeding tendencies, with significant anemia
or with hypoprothrombinemia.
Salicylates can produce changes in thyroid
function tests.
Acute hepatitis has been reported rarely in
patients with systemic lupus erythematosus and
juvenile rheumatoid arthritis with plasma sali
cylate concentrations above 25 mg/100 mL.

Treatment

Treatment is essentially symptomatic and sup
portive. Administer water, universal antidote and
remove by gastric lavage or emesis. Force fluids
(e.g., salty broth) to replace sodium loss. If the
patient is unable to retain fluids orally, the alkalosis
can be treated by hypertonic saline intravenously.
If salicylism acidosis is present, sodium bicar
bonate intravenously is preferred because it
increases the renal excretion of salicylates.
Vitamin K is indicated if there is evidence of
hemorrhage. Hemodialysis has been used with
success.
Respiratory depression may require artificial
ventilation with oxygen. Convulsions may best be
treated by the administration of succinylcholine
and artificial ventilation with oxygen. Central
nervous system depressant agents should not
be used.
Hyperthermia and dehydration are immediate
threats to life and initial therapy must be directed
to their correction and to the maintenance of
adequate renal function. External cooling with
cool water or alcohol should be provided quickly
to any child who has a rectal temperature over
104°F.

The generally accepted way to achieve effective
anti-inflammatory salicylate blood levels of 20 to
25 mg per cent is to titrate the dosage by starting
with 2.6 to 3.9 g daily, according to the size, age
and sex of the patient. It necessary, the dosage is
then gradually adjusted by daily increments of
0.65 g until symptoms of salicylism e.g., auditory
symptoms, occur. Then, the dosage is decreased
by 0.65 g daily until these symptoms disappear
and maintained at that level as long as necessary.

In adults the median dose at which tinnitus
develops is 4.5 g per day, but the range extends
from 2.6 to 6.0 g per day.
Intermittent administration is ineffective. Patients
should be advised not to vary the dose from day
to day depending on the level of pain because
that often fluctuates independently of the intensity
of the inflammation. A continuous regimen of
0.65 g four times daily is considered to be
minimum therapy for adults. ENTROPHEN*
should be administered four times daily. For night
time and early morning benefits, the last dose
should be given at bedtime.
O nce m ainte n a n ce dose is e s ta b lis h e d ,
ENTROPHEN*-15 may be useful to encourage
patient compliance.
Optimally, salicylate therapy should be monitored
by periodic blood salicylate level determinations.
If this is not practical, the appearance of auditory
symptoms in the form of tinnitus or deafness are
acceptable as an indication of the maximum
tolerated salicylate dose.
There is an inverse relation between blood
salicylate levels at which auditory symptoms
appear and the age of the patient. In the young
adult, this is usually in the range of 20 to 30 mg
per cent. In children, however, the level may be
much higher, or the effect apparently absent.
Because salicylate toxicity may appear without
such warning in children, the usual practice is to
give ASA in a daily dose of 50 to 100 mg per
kilogram of body weight and to follow blood levels
aiming for a concentration of about 30 mg per cent.
Rheumatic Fever

A total daily dosage of 100 mg per kilogram of
body weight administered in divided doses to
allay the pain, swelling and fever.
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The recommended dosage is 1,300 mg per day
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DOSAGE AND ADMINISTRATION
Analgesic: antipyretic

Up to 2.925 g daily as necessary
Anti-inflammatory

Because the suppression of inflammation in
creases with the dose of salicylate even beyond
the point of toxicity, the therapeutic objective is
to employ as large a dose as possible short of
toxicity. Most patients will tolerate blood salicylate
levels in the range of 20 to 25 mg per cent. The
most common reason for failing to obtain a
therapeutic response to ASA is the administration
of inadequate doses.
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surgeons. However, when recently
assessing the results of an under
graduate surgical examination by
subjective methods, how do we
explain the variation in honours from
one hospital to another, between 17%
and 53 %? At the same time, it should,
of course, be pointed out that there
were no failures from 250 candi
dates! Professor Inglis refers to a
rise in the cut-off point from 58%
to 70% of the questions in the
general surgical multiple-choice exa
mination over a 9-year period. Could
this not be explained by the fact that
the student is now learning the art
of answering this type of question,
that he is now better prepared rather
than better informed? Has it ever
been conclusively proved that the
multiple-choice type of question en
courages organization of thoughts
and facts, which should result in im
proved clinical judgement?
Certainly, Dr. Monaghan has
provided facts to show that there is
tremendous interest and enthusiasm
concerning surgical education and
assessment at McGill University. One
would require more hard data, how
ever, to justify the belief that surgical
education has improved over the last
two decades.
G ordon

A.

H u n ter, m b , frcs,

F R .C S f c ]

Division of orthopedics,
Department of surgery,
Sunnybrook Medical Centre,
Toronto. Ont.
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To the editors.— Dr. Hunter's con
cern about surgical education is unfor
tunately not shared by many. Whether
this is because there really is nothing
wrong with our surgical education
or whether it is because we prefer
not to believe that we and our stu
dents are anything but excellent is
probably a matter of debate, but in
my own association with undergra
duate and postgraduate teaching at
various universities over the past 20
years I have seen changes that cause
me some anxiety.
Undergraduate examinations in
many universities are inconsistent,
performed by occasional examiners,
usually at the end of each surgical
rotation. To be an examiner is often
regarded as a chore and there is

little appreciation of the skills re
quired and of the requirement to
uphold standards. Honours are easy
to obtain, particularly when a ward
assessment is used in calculating the
student’s final mark. Most of us be
come more kind hearted when faced
across our desks by an anxious
medical student for assessment of his
or her abilities on the wards and this
in itself usually adds 10 marks. In
common with other aspects of societal
life, keeping standards high is re
garded as old fashioned or as a form
of punishment for the less success
ful. But by being kind we debase the
currency of the surgical mark. Some
universities do not even have an
examination but rely solely upon their
assessment of the student on the wards
as evidence of his or her ability. It is
hard for this to be objective and the
well mannered student who is punc
tual in attendance and laughs at the
surgeon’s jokes tends to do well.
There is much to be said for going
back to a system in which a small
number of examiners test, in a final
examination at the end of the aca
demic year, often with the assistance
of external examiners from other
universities. An examiners’ meeting at
the end of each day will enable fail
ures and honours to be discussed and
will raise the standard of examining.
Experienced examiners working re
gularly with less experienced ones
will also help to raise and perpetuate
the standard of examining.
The use of the multiple-choice
examination encourages students to
remember but not to think. The art
of medicine requires much thought
and assessment of data and in this
we, as teachers, fail. Indeed, to be a
medical school teacher is no longer
regarded as the honour it used to be
and many of our so-called university
teachers do their best to avoid exam
ining duties. Thus, the load is often
left to the junior staff members, who
are inexperienced but who are un
able to avoid this task. While many
young university appointees are ex
cellent teachers, their experience and
their closeness to the student often
make their assessment of student re
quirements less objective, leading to
a further lowering of standards.
A vicious circle thus exists. We
appoint good students, we give them
an easy examination and they obtain
high marks. This confirms in our
opinion that we chose good students
and taught them well, and absolves
us from the responsibility of looking
objectively at what we are doing. This
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REVIEW ARTICLE

Antibiotic Prophylaxis in Surgery
R .T. L e w is ,

This review examines the principles
and practice of antibiotic prophylaxis
in surgery. Such prophylaxis is required
to decrease the frequency of
postoperative infection in most
patients with clean-contaminated
and contaminated wounds, to prevent
infrequent but devastating infection
of prostheses in cardiovascular and
orthopedic surgery and to prevent
endocarditis in noncardiac surgery in
patients who have valvular heart
disease. Prophylaxis should begin
before operation; it is usually
unnecessary afterwards. The antibiotic
may be given topically or parenterally.
The latter is more certain, but oral
prophylaxis in bowel surgery may offer
additional protection by reducing
colonic flora, and topical wound and
peritoneal antibiotics may augment
protective antibiotic levels at those
sites. Antibiotics, such as the
cephalosporin cefazolin (but not
cephalothin), which penetrate blood
and tissues rapidly and for prolonged
periods, afford excellent prophylaxis
at most sites. But for prophylaxis
in colonic surgery, antibiotics directed
against Bacteroides fragilis may be
superior, and to prevent endocarditis
in noncardiac surgery, vancomycin
or a combination of penicillin and an
aminoglycoside is best.
Cette revue de question se penche
sur les principes et sur I'usage
des antibiotiques en prophylaxie. Une
telle prophylaxie s'avere necessaire
pour diminuer la frequence des
From the departments o f surgery,
Queen Elizabeth Hospital and
M c G ill University, M ontreal, PQ

m b , m sc , frcs [ c ], f a c s *

infections postoperatoires chez la
plupart des patients qui subissent
la contamination d'une plaie propre
ou qui ont une plaie contaminee, pour
prevenir I’infection peu frequente
mais devastatrice des protheses en
chirurgie cardiovasculaire et
orthopedique, et pour prevenir
I'endocardite en chirurgie non
cardiaque chez les patients qui ont
une maladie valvulaire. La prophylaxie
doit debuter avant I'operation;
elle n'est habituellement pas necessaire
par la suite. L’antibiotique peut etre
administre localement ou par voie
parenterale. Cette derniere voie est
plus sure, mais la prophylaxie par
voie orale dans la chirurgie intestinale
peut offrir une protection supplementaire en reduisant la flore colique,
et les antibiotiques en application
locale sur la plaie ou dans la cavite
peritoneale peuvent augmenter
les niveaux protecteurs dans ces sites.
Les antibiotiques, tels que la
cephalosporine cefazoline (mais non
la cephalothine), qui diffusent
rapidement dans le sang et les tissus
et pendant une periode prolongee,
offrent une excellente protection pour
la plupart des sites. Mais pour la
prophylaxie en chirurgie du colon des
antibiotiques efficaces contre
Bacteroides fragilis peuvent etre
superieurs, et pour prevenir
I’endocardite en chirurgie non
cardiaque la vancomycine ou une
association de penicilline et d’un
aminoglycoside represented le meilleur
choix.

creasing the bacterial load by using
good surgical technique, by asepsis
and Listerian antisepsis and by the
use of antibiotics.
The rational use o f antibiotic pro
phylaxis in surgery is critical and of
concern to all surgeons. In the 40
years since Howard Florey and Ernst
Chain reported the clinical efficacy
of penicillin, antibiotic therapy has
come to be accepted fully, but the
use o f antibiotics for prophylaxis is
still controversial. This is because the
principles o f antibiotic prophylaxis
are different from those o f antibiotic
therapy. This review examines those
principles and surveys the literature
supporting their practical application,
by reference to four questions: (a)
Who should receive antibiotic pro
phylaxis? (b) When should antibiotic
prophylaxis begin and end? (c) H ow
should the antibiotic be given? (d)
Which antibiotic should be used?

W ho N eeds A ntibiotic P rop h y lax is?
Good surgical technique, asepsis
and Listerian antisepsis do not always
prevent postoperative infection. This
is well illustrated in the approach to
prevention o f postoperative infection
in patients who undergo elective sur
gery o f the colon. Does mechanical
bowel preparation or delayed primary
closure o f the wound eliminate the
need to give antibiotics prophylactically?
Double-blind studies, using anti
biotics both systemically1,2 and orally3,4
have shown repeatedly that patients
given antibiotics fare better than con
trols having only mechanical prepara
tion, provided the choice o f antibiotic
is appropriate. Even patients on
whole-gut irrigation, which effects
better mechanical cleansing o f the
bowel than does conventional bowel
preparation,5 benefit from antibiotic
prophylaxis.6

Reprint requests to: D r. R .T . Lewis,
Department o f surgery, Queen Elizabeth
Hospital, 2100 M arlow e Ave.,
Montreal, PQ H4A 3L6

Infection associated with surgical pro
cedures results from an increased
challenge by bacteria or decreased
host resistance to bacterial contamina
tion. The means o f improving host
resistance to infection are nonspeci
fic and rudimentary; for prophylaxis,
therefore, we rely mainly upon de

V O L U M E 24, N O . 6, N O V E M B E R 1981

/ THE CANADIAN JOURNAL OF SURGERY

* Associate professor o f surgery,
M c G ill University
Accepted fo r publication Jan. 16, 1981

561

We do not know if antibiotics
administered prophylactically in elec
tive surgery of the colon enhance
the benefits of delayed wound closure.
But in the studies of Paul and asso
ciates7 in which 4.4% of wounds
treated by delayed closure became
infected, two-thirds of the patients
studied received oral or systemic anti
biotic prophylaxis. Moreover, Stone
and Hester8 have suggested that in pa
tients with a colostomy near the
abdominal wound, delayed primary
closure of the wound is associated
with an increased frequency of
wound infection, due to contamina
tion of the susceptible open wound
by coliform organisms from the
stoma. Antibiotic prophylaxis may be
preferable.
Granted, then, that some patients
do need antibiotic prophylaxis, how
do we establish the need for such
prophylaxis in a group of patients?
The general criteria are: (a) anti
cipated increased frequency of infec
tion; (b) infrequent but potentially
catastrophic infection and (c) de
creased host resistance to infection.9
Anticipated Increased Frequency
of Infection
This is expressed by the National
Academy of Sciences-National Re
search Council classification of
wounds10 as “clean”, “clean—conta
minated”, “contaminated” or “dirty”,
with anticipated or actual infection
rates of less than 5%, 10%, 20%
and 30% to 40% respectively.11 It
is recommended that patients with
clean—contaminated or contaminated
wounds by this classification receive
antibiotics for prophylaxis only and
those with dirty wounds receive anti
biotics for prophylaxis and therapy.
With further discrimination, one
may recognize subsets of patients
within these classes who benefit from
antibiotic prophylaxis and others who
do not. Thus, in biliary surgery, Chetlin and Elliott12 identified four sub
groups of patients — those with acute
cholecystitis, with common bile duct
stones, with jaundice and those older
than 70 years — who need antibiotic
prophylaxis, whereas other patients
who undergo elective cholecystectomy
do not. Further, the risk of infection
correlates closely with “bactibilia”, so
that intraoperative immediate gramstaining of the bile may help identify
patients who need antibiotic prophy
laxis.13
Similarly, with respect to gastro
duodenal procedures, patients in four
subgroups of procedures benefit from
antibiotic prophylaxis14 — patients
562

operated on for gastric ulcer, gastric
cancer, gastric outlet obstruction and
those who have emergency gastric
operations for bleeding or perfora
tion — but patients who have elective
surgery for intractable duodenal ulcer
do not require prophylaxis. Gatehouse
and associates15 have shown that
these different susceptibilities to in
fection relate to the degree of bac
terial colonization of the stomach.
Those at high risk of infection have
bacterial counts of 10s to 107/m l and
a high intragastric pH. whereas pa
tients at low risk of infection have
bacterial counts of less than 103/ml
and a low intragastric pH.
Infrequent but Potentially
Catastrophic Infection
When postoperative infection is
infrequent, but devastating, as in
cardiovascular or orthopedic opera
tions in which prostheses are im
planted, prophylactic administration
of antibiotics may be indicated even
for patients with clean wounds. In
peripheral vascular surgery, the main
risk is of aortofemoral wound and
graft infection. Antibiotics given pro
phylactically reduce the frequency of
these infections but are unnecessary
for brachiocephalic procedures.10
In cardiac surgery, we all fear
endocarditis following cardiac valve
replacement. The only trial reported,
comparing placebo with antibiotic
prophylaxis in cardiac surgery,17 was
abandoned when endocarditis due to
Streptococcus pneumoniae developed
in 2 of 15 patients in the placebo
group; both died. Four of 57 patients
who received antibiotics prophylac
tically died of endocarditis. Today,
with the routine prophylactic use of
antibiotics for cardiac valve replace
ment endocarditis is uncommon, but
no further placebo-controlled studies
have been reported. Although there
are occasional reports of decreased
sternal wound infection with anti
biotic prophylaxis,18 these infections
are generally uncommon even with
out antibiotics.19 There is little evi
dence to support the widespread use
of antibiotics prophylactically in coro
nary artery bypass surgery without
valve replacement.
The incidence of endocarditis in
noncardiac surgery is too low to
permit clinical testing of the efficacy
of antibiotic prophylaxis. Recent stu
dies, using the New Zealand white
rabbit model, of subacute bacterial
endocarditis20 have prompted revision
of ineffective conventional regimens
of antibiotic prophylaxis in patients
with valvular heart disease who under
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go noncardiac surgery,21 particularly
surgery of the oral and upper respira
tory tracts and in genitourinary and
abdominal operations and "instru
mentation”.
While some decrease in the fre
quency of wound infections occurs
with antibiotic prophylaxis in clean
orthopedic procedures,22 the advan
tage is minimal and antibiotic pro
phylaxis does not appear justifiable.
Benefit is similarly equivocal in sur
gery for hip fractures,23 but in patients
who have total hip replacement the
value of antibiotic prophylaxis in
reducing both deep and superficial
wound infections is undeniable. While
similar gains have been made with
greater attention to aseptic technique
and by using laminar flow operating
rooms,24 the methods required are
cumbersome, expensive and of limited
availability.
Decreased Host Resistance
to Infection
Antibiotics have also been recom
mended to protect “the patient who
is debilitated or immuno-suppressed
or both”.9 However, there is little
evidence to support the prophylactic
use of antibiotics in this situation.
Indeed one would not expect benefit
in such patients; studies in granulo
cytopenic patients with acute leuke
mia25'20 suggest that a protected envi
ronment is likely to be of greater
value than prophylactic use of anti
biotics.
When Should Antibiotic Prophylaxis
Begin and End?

The experiments of Miles and as
sociates27 and Burke28 and clinical
studies of Polk and Lopez-Mayor1
have established the importance of
starting antibiotic prophylaxis before
operation. In Burke’s report,28 peni
cillin used for prophylaxis of subcu
taneous infections in dermal wounds
contaminated by staphylococci had
its greatest effect when given before
wounding and contamination and was
completely ineffective when given
after the “decisive” 3-hour period
following wounding. During this pe
riod, the fibrin coagulum in the wound
traps bacteria, thereby protecting
them from the antibiotics. It is there
fore possible to prolong the “deci
sive” period by dissolving the coagu
lum with proteolytic enzymes such
as Travase (Flint Laboratories) placed
in the wound;29 this is now being done
experimentally.
Less well understood is how long
before operation the antibiotics should
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be administered. Since Polk and
Lopez-Mayor’s study many surgeons
start antibiotic prophylaxis 1 hour
before operation, others at the time
of induction of anesthesia. Since
optimal benefit depends on adequate
antibiotic penetration of the tissues
as well as blood, prophylaxis with
antibiotics such as gentamicin that
penetrate the tissues slowly30 should
probably be started earlier than cepha
losporins, which do so rapidly. Stone
and associates2 found that, even with
cefazolin, visceral tissue and subcuta
neous fat antibiotic levels were con
sistently higher when the drug was
given 8 to 12 hours before operation
than when it was given merely 1 hour
preoperatively, but the incidence of
infection postoperatively was the
same in both groups of patients.
Also, it now seems that antibiotic
prophylaxis need only be maintained
for the duration of the operation.
Stone and associates31 and others32
found no advantage in extending the
duration of prophylactic antibiotic
coverage beyond the day of surgery.
Indeed, when compared directly,
single-dose antibiotic prophylaxis has
consistently been as effective as mul
tiple-dose prophylaxis.33'35
More prolonged prophylactic use
of antibiotics may sometimes be in
dicated. Polk and Lopez-Mayor1 noted
that cephaloridine given prophylactically, which was successful in re
ducing the frequency of wound and
intra-abdominal infections in gastro
intestinal operations, failed to abort
drain site infections probably acquired
well after antibiotic prophylaxis had
been completed. In surgery for car
diac valve replacement, when intra
cardiac monitoring catheters remain
in place postoperatively, an antibiotic
regimen should be continued for 2
days after operation;30 in extensive
head and neck surgery, continued sa
livary leak through an incontinent
suture line after antibiotic levels have
decreased may account for the rel
atively high residual infection rate
when antibiotics are given only on the
day of operation.37 Further studies are
warranted to determine how long anti
biotic prophylaxis should continue in
these situations.
How Should the Antibiotic Be Given?

Prophylactic antibiotics may be
administered topically or parenterally.
The former includes oral prophylaxis
as well as topical wound and peri
toneal administration; the latter in
cludes intravenous and intramuscular
administration. Three topics deserve
VOLUME 24, NO. 6, NOVEMBER 1981

special discussion: the relative merits
of oral and systemic antibiotic pro
phylaxis in elective surgery of the
colon, the place of topical wound and
peritoneal antibiotics in prophylaxis
and the special advantages of the
intravenous and intramuscular sys
temic routes of administration.
Oral Versus Systemically Administered
Antibiotics in Elective Surgery
of Colon
Antibiotics given orally have now
been shown unequivocally to decrease
the frequency of infection after elec
tive colonic surgery.3,4 Do they act
by reducing the residual flora of the
colon operation to such a low level
that minor spillage does not produce
clinical infection? Or are they only
effective when absorbed and produc
ing adequate drug levels in the blood
and tissues at the time of operation?
The former is the conventional be
lief38,39 and still enjoys considerable
support.40 But recent studies suggest
that bowel preparation with orally
administered antibiotics is effective
mainly by absorption of the antibiotic
from the bowel. In the study by
Keighley and associates41 absorption
of oral metronidazole was inadequate,
resulting in a low mean serum level
of metronidazole (0.4 ± 0.6 ytzg/ml)
and a postoperative wound sepsis rate
of 32%, despite significant reduction
in the bacterial flora of the colon.
The patients who received systemic
metronidazole had a mean blood level
of 13.2 ± 5.7 /xg/ml, with no re
duction in the bacterial counts of the
colon and a wound infection rate of
only 6.5%. But Dion and associates42
showed excellent absorption of the
orally administered metronidazole
from the bowel. The mean blood
levels with oral and systemic admin
istration of metronidazole were 15.2
± 9.4 /ug/ml and 16.4 ± 8.1 /j,g/ml
respectively and the wound infection
rate was less than 8% in each group.
These results do not, however, explain
the success of the neomycin-eryth
romycin oral regimen of bowel pre
paration, for neomycin is absorbed
poorly and erythromycin may not
be absorbed sufficiently to provide
satisfactory blood and tissue levels
consistently at the time of operation.43
Reduction of residual colonic flora
probably plays some part in reducing
postoperative infections.
Topical Wound and Peritoneal
Antibiotics
The special roles of antibiotics
I

applied topically to the wound and
intraperitoneally at operation remain
uncertain. Topically applied antibi
otics are certainly effective in reduc
ing wound infection rates,44 but they
offer protection only to the wound
and may be generally less effective
than antibiotics given parenterally.45
Whether an antibiotic given topically
can amplify the effectiveness of intra
venously administered antibiotics in
protecting the wound in high-risk
situations is unknown. Pitt and asso
ciates46 found no additional benefit
in patients having vascular surgery,
but in contaminated wounds added
value has been implied.8
An antibiotic placed in the peri
toneal cavity at operation and given
time for absorption may act like a
single dose of antibiotic administered
parenterally.47 Thus, intraperitoneally
administered antibiotics can reduce
the frequency of wound and intra
abdominal sepsis.48’49 Besides, the
studies of Fowler50 and Stephen and
Loewenthal51 suggest that in the treat
ment of high-risk patients with peri
tonitis, peritoneal antibiotics may
penetrate intraperitoneal loculations
better than parenteral antibiotics
and thereby decrease mortality as
well as the formation of residual
abscesses. Careful monitoring of
serum levels of aminoglycosides is
necessary to avoid ototoxicity and
toxic respiratory and renal effects.47,51
But to date no strictly prophylactic
role has been defined for intraperi
toneal antibiotics.
The Intramuscular Versus
Intravenous Route
The differences between intramus
cular and intravenous routes of ad
ministration of antibiotics given prophylactically are interesting. Polk and
Lopez-Mayor1 noted that 12% of
patients receiving cephaloridine intra
muscularly before operation had
wound levels below the 4 ptg/m l
required for protection against coliform organisms. They reported that
cephaloridine given intravenously
fared better but they gave no sup
porting data. Alexander and Alexan
der52 have shown that while the high
est blood and wound levels follow
drug administration by intravenous
bolus, levels are better sustained when
the intramuscular route is used.
Hence, when an antibiotic is given
by both routes before operation, high
blood levels are maintained for pro
longed periods and intraoperative
administration of the antibiotic is
unnecessary.
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Which Antibiotic Should Be Given?

Antibiotic Spectrum

An antibiotic given for prophy
laxis may fail because penetration of
the blood and tissues is inadequate
or because the spectrum of effective
ness is inadequate for dealing with
the contaminating bacterial flora.
Appropriate antibiotic usage therefore
demands not only proper timing and
dosage but also a knowledge of the
drug kinetics and of the spectrum of
antibacterial activity desired.

It is convenient to consider three
bands of the antibacterial spectrum
for which antibiotic prophylaxis may
be required in patients who undergo
operation. The first includes patients
having cardiovascular, orthopedic
and head and neck procedures, where
the main offending bacteria are
gram-positive cocci or anaerobic bac
teria sensitive to penicillin; gram
negative bacilli are uncommon. A
cephalosporin such as cefazolin af
fords adequate prophylaxis. We may
also include, in the same band,
patients with valvular heart disease
who undergo noncardiac surgery but
require antibiotic prophylaxis to pre
vent endocarditis. To prevent endo
carditis due to Streptococcus viridans
in oral and upper respiratory tract
surgery, three doses of penicillin are
now recommended orally in patients
without artificial heart valves; intra
venously administered penicillin and
streptomycin or gentamicin are re
commended for those with prosthetic
valves. In patients allergic to peni
cillin, vancomycin is substituted.
Similarly, ampicillin and gentamicin
are recommended to prevent enterococcal endocarditis in patients who
undergo genitourinary and abdominal
operations.21
In the second band are patients
who undergo gastroduodenal, biliary
tract and contaminated pulmonary
and urologic operations. The conta
minating bacteria are gram-positive
cocci and gram-negative bacilli, ex
cluding B. fragilis. Here a cephalo
sporin such as cefazolin affords excel
lent prophylaxis. Although the secondgeneration cephalosporins such as
cefamandole provide a broader spec
trum of activity against gram-negative
organisms than their predecessors, it
seems unlikely that they will give
better results than the excellent ones
reported with the first-generation
drugs.
The real controversy with respect
to antibiotic effectiveness concerns the
final band of the antibacterial spec
trum, in which the offending bacteria
include not only gram-positive cocci
and aerobic gram-negative bacilli but
also B. fragilis, in surgery of the
terminal ileum, colon and vagina.
Several controversial issues must be
discussed.
Principles of prophylaxis.—Are the
principles of prophylaxis, well tested
at other sites, ineffective for oper
ations on the colon?9 Before and
since the Veterans’ Administration
cooperative study,57 in which orally

Penetration of the Blood and Tissues
Antibiotics such as erythromycin
that penetrate the tissues poorly after
intravenous administration30 are clear
ly less suitable for preventing wound
infections than cephalosporins, which
penetrate the tissues well. But even
among the cephalosporins, differen
ces in pharmacokinetics exist. Thus,
cephaloridine and cefazolin have a
long half-life in the blood (about 90
minutes); the mean serum levels of
these agents 1 hour after intravenous
administration of 1 g are about 25
/xg/ml and 75 /xg/ml respectively.53
They are therefore better suited to
perioperative prophylaxis than cephalothin and cephradine, whose half-life
is about 40 minutes and for which
the blood levels 1 hour following 1
g given intravenously are only 6
/xg/ml and 12 /xg/ml respectively.53
Moreover, as peak levels of antibiotics
in the wound are, at best, half of
those in the blood and peak levels
of antibiotics in the bones are only
one quarter of the blood levels, cephalothin may afford protection for
wounds for only 1 hour after intra
venous administration, whereas cefa
zolin will do so for much longer.54
Some55 have suggested that the
unsuitable kinetics of cephalothin may
account for some of its failures. This
was not, however, found to be the
case by Burdon and associates.56 In
their initial study, patients who under
went elective colonic operations re
ceived 1 g of cephalothin or a place
bo intravenously at the start of opera
tion and 1 hour later an additional
1 g. Five of 18 patients who received
cephalothin had wound infections,
compared with 11 of 24 patients who
received the placebo. When each dose
of cephalothin was increased to 2 g,
wound infections occurred in 13 of
28 recipients of the antibiotic and
in 13 of 22 patients who got the
placebo. Since Burdon and his col
leagues did not actually measure the
blood levels of antibiotic, the evi
dence is circumstantial.
564
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administered neomycin and erythro
mycin succeeded and intravenous
cephalothin failed to prevent infection
in colonic surgery, much has been
written denying the usefulness of
antibiotics given parenterally, espe
cially cephalosporins, in this situation.56,58'60 Yet, whenever the principles
governing timing, dosage and antibio
tic selection to achieve adequate blood
levels have been applied rigorously,
prophylaxis by the parenteral route
has been successful in elective colonic
surgery, whether cephalosporins1*61 or
antibiotics of broader spectrum41*42
have been used. Further studies on
the efficacy of cephalosporins inef
fective against B. fragilis are indi
cated, as are studies to determine
whether the benefits of oral antibiotic
prophylaxis are extended by con
current administration of systemic
antibiotics.
Roles of bacteria: experimental
studies of peritonitis.—-What are the
relative roles of aerobic and anaero
bic bacteria in producing infections
in colonic and vaginal surgery?
Explicit information on this subject
is provided by studies using Gorbach’s
model of experimental peritonitis.02
In that model, pooled rat stool in
gelatine capsules is dropped into the
peritoneal cavity of meat-fed Wistar
rats. The capsules dissolve and the
stool produces peritonitis. The animals
become toxic and about 40% die of
peritonitis by the seventh day. All
the animals that survive this stage
have peritoneal abscesses. The bac
teria grown from the peritoneal cavity
at the stage of peritonitis are pre
dominantly aerobic, Escherichia coli
and enterococci, and E. coli are grown
from the blood of toxic animals.
But the organisms grown from the
abscesses are mainly anaerobic —
B. fragilis and Fusobacterium varium.B3 Onderdonk and associates64
have studied the ability of these in
dividual bacteria to cause death or
abscess. They found that: (a) aerobic
bacteria alone caused death, but no
abscesses and (b) anaerobic bacteria
alone caused neither death nor
abscesses, but in the presence of
aerobic bacteria, they produced abs
cesses and when the aerobe was
E. coli, they caused death as well.
Thus, these workers demonstrated
synergy between the aerobic and
anaerobic bacteria.
Weinstein and associates65 have also
examined the ability of specific anti
biotics to prevent mortality or the
formation of abscesses in the rat
model. Gentamicin, an antibiotic
specifically active against aerobic bac-
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teria, prevented death but not ab
scess formation. The cephalosporins
cefazolin and cefamandole gave simi
lar results.*6 Clindamycin, an anti
biotic specifically active against anae
robic bacteria but not against coliforms, prevented abscess formation
but not death. To prevent both ab
scess formation and death a com
bination of gentamicin and clindamy
cin was necessary. On the basis of
these findings, Gorbach67 concluded
that antibiotic treatment of intra
abdominal infections should incor
porate drugs to manage both aerobic
and anaerobic organisms.
Roles of bacteria: clinical studies of
peritonitis.-—-For several reasons, one
may question whether these experi
mental findings apply to clinical peri
tonitis; the infections are produced by
pooled stool under highly artificial
circumstances and although the find
ings noted above suggest these conclu
sions, other findings in the same
model do not.68 Besides, no surgical
treatment is included in the model.
Surgery is considered important in
handling anaerobic infection,69,70 tak
ing advantage of the synergy between
the aerobic and anaerobic bacteria,
and other studies have reported suc
cessful clinical treatment with cephalothin and surgical treatment.69
But the experiments and conclu
sions reached are well supported by
the clinical work of Thadepalli and
associates71 in penetrating abdominal
trauma. In that study, in addition to
surgical management, the combination
of kanamycin and clindamycin ■
— ac
tive against both aerobic and anae
robic bacteria — was more effective
in preventing postoperative infection
than kanamycin and cephalothin, a
combination effective against aerobic
bacteria, but inactive against B. fragilis. The former combination per
mitted 5 septic complications, only
1 due to anaerobic or mixed bacteria,
among 48 patients, whereas the latter
allowed 14 septic complications, 11
caused by anaerobic or mixed bac
teria, in 52 patients.
Application of experimental find
ings to prophylaxis.—Do these con
clusions with respect to antibiotic
treatment of established intra-abdo
minal infection apply also to prophy
laxis? Perhaps lesser degrees of bac
terial contamination in patients re
quiring prophylaxis allow one to take
greater advantage of bacterial syner
gy. This is suggested by the findings
in recent animal experiments and
several carefully done clinical studies,
which are inconsistent with Gorbach’s
conclusions.

Kelly12 has recently attempted to
produce wound infections in guinea
pigs with subinfective doses of 9 X
104 colonies of either B. fragilis or
E. coli. After 1 week the wounds
were clinically and histologically
normal. But when half the number
of each bacterial type was given in
combination, the animals became
listless, unwell and pyrexial by the
second day and severe wound infec
tion developed. These findings sug
gest that if one or other organism
was eliminated by prophylactic ad
ministration of antibiotics, wound
infection could be prevented. This
may also be the corollary of the
finding that in animal experiments,
even in established peritonitis, high
doses of cephalothin, penicillin and
carbenicillin prevent the formation of
intra-abdominal abscess, whereas low
doses of the same antibiotics do not.66
No doubt Kelly will soon report
studies on antibiotic prophylaxis in
his experimental model of wound in
fection and clarify the issue.
The clinical studies published to
date indicate that both aerobic and
anaerobic bacteria are important in
producing postoperative infection,
but do not show consistently whether
prophylaxis need be directed against
both groups of bacteria. Thus, the
Veterans’ Administration study,57
which showed that the combination
of neomycin and erythromycin given
orally was superior to cephalothin
given intravenously for prophylaxis
in elective colonic surgery, may be
interpreted as supporting the applica
tion of Gorbach’s conclusions to
prophylaxis as well as to treatment.
Cephalothin may have failed in that
study because its kinetics are unsuit
able, rather than because its spectrum
is inadequate. How else can we
explain the success of cephaloridine
in the study of Polk and LopezMayor,1 or the equivalence of prophy
laxis by parenterally administered
cephaloridine and neomycin and
erythromycin given orally in the re
port by Lewis and associates?61 Si
milarly, although E. coli and Bacteroides sp. are both prominent in
vaginal flora73 and in pelvic infec
tions,71 Vaughan75 found that metro
nidazole and cephradine given intra
venously were equally successful in
reducing significant infection after
cesarean section. On the other hand,
orally administered erythromycin and
metronidazole were more successful
than intravenously administered ce
phradine in reducing postoperative in
fection in elective colonic surgery.76
Whether this result relates to a failure
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of the spectrum or to the kinetics of
cephradine is the subject of a further
study now in progress.
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Steroid-Induced Osteonecrosis: a Review
R ichard L. C r u e ss ,

Between 1963 and 1980 cortisoneinduced osteonecrosis has been seen
in 122 patients at the Royal Victoria
Hospital, Montreal. Of these, 68 had had
renal homotransplants; the others
suffered from a variety of conditions.
The femoral head was most commonly
affected; the humeral head, distal
femur, proximal tibia, talus and
capitellum were also involved.
There were two patterns of
involvement, similar in all locations.
The more common is subchondral
osteolysis, which may heal without
operation. The other is similar to
osteochondritis dissecans and requires
operation.
Alteration in fat metabolism is the
most likely cause of the condition.
Vascular occlusion and bone death may
result from an increase in fat cell
size or from fat embolization.
Treatment should be conservative
as often as possible, but gratifying
results have been obtained in those
patients requiring surgical procedures.
Entre 1963 et 1980 une osteonecrose
provoquee par la cortisone a ete
observee chez 122 patients a I'hopital
Royal Victoria de Montreal. Parmi
ceux-ci, 68 avaient re?u une homogreffe
renale; les autres souffraient de
diverses affections. La tete du femur
fut le plus souvent affectee; la tete
Presented at the 7th annual course on
clinical application of basic sciences,
University of Ottawa, Ottawa, Ont.
May 15-17, 1980
Supported by grant MA-1571 from the
Medical Research Council of Canada

m d , fr c s [ c ]*

de I'humerus, la partie distale du femur,
la partie proximate du tibia, I’astragale
et le condyle de I'humerus furent
aussi touches.
On a note deux types d'atteintes,
semblables pour toutes les
localisations. Le plus frequent est
une osteolyse sous-chondrale, qui
peut guerir sans operation. L'autre
est semblable a une osteochondrite
dissequante et exige une operation.
La cause la plus probable de cette
affection est une alteration du
metabolisme lipidique. L'occlusion
vasculaire et la destruction osseuse
peuvent resulter d'une augmentation
de la taille des cellules adipeuses
ou d’une embolie graisseuse.
Le traitement doit etre conservateur
le plus souvent possible, mais des
resultats interessants ont ete obtenus
chez les patients qui ont besoin
d'une intervention chirurgicale.

Natural History

It is one of the ironies of modern
medicine that drugs which have been
of great benefit to patients have
created new diseases and problems
for those same patients. Cortisoneinduced osteonecrosis is such a con
dition and it has posed serious pro
blems for the orthopedic profession
since its first description in 1957.1
In this review I shall describe the
current status of this condition and
outline the natural history and patho
genesis and my approach to man
agement.
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Rm. S9.20, Royal Victoria Hospital,
687 Pine Ave. W, Montreal, PQ
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The F em oral H ead

Two major patterns of involvement
of the femoral head were seen. The
most common was subchondral osteo
lysis (Fig. 1) in which case the head
would either heal or collapse, de-

Patients

Between 1963 and 1981, I managed
122 patients with steroid-induced os
teonecrosis. Of these, 68 were patients
who had had renal homotransplants,
18 were suffering from lupus erythe
matosus, 8 were being treated for asth
ma, 8 for the management or sequelae
of glomerulonephritis and 20 had a
variety of conditions including peri
pheral neuritis, sinusitis, pemphigus,

*Professor and chairman, division of
orthopedic surgery, McGill University
and orthopedic surgeon-in-charge,
Royal Victoria Hospital, Montreal, PQ

Guillain—Barre syndrome, head injury
or postoperative conditions. Data in
the literature2'4 indicate that this is a
reasonably representative series but,
of course, each hospital’s patient load
will reflect the activities within that
hospital. Thus the post-transplanta
tion group is the largest in this series
because the Royal Victoria Hospital
has an active transplant program.
The sites involved in these 122 pa
tients were the femoral head in 118,
humeral head in 22, knee (distal
femur or proximal tibia) in 20, talus
in 6 and capitellum in 3. Only four
patients failed to demonstrate even
tual involvement of the femoral head
if other bones were involved. Thus
the femoral head is the bone most
at risk, at least clinically and roentgenologically, as noted in other re
ports.2'4

F1G. 1— Early subchondral lesion in
patient treated with steroids for ophthal
mologic condition.
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pending on the extent of the lesion.
Of the 118 patients with subchondral
osteolysis, 49 demonstrated little or
no collapse and healing occurred by
production of sclerotic new bone fill
ing in the lesion. As reported pre
viously,5 microscopic sections long
after the event have confirmed the
presence of extensive areas of bone
necrosis with reparative new bone on
their surfaces. If the subchondral le
sion is large, it apparently either ex
ceeds the reparative capacity of the
body and collapse occurs or collapse
occurs before repair can be effected,
as in 69 of the 118 patients seen. This
collapse is always associated with
symptoms and starts in the superior
weight-bearing area of the femoral
head. It may progress to almost total
separation of articular cartilage from
the underlying bone. It conforms to
Solomon’s description6 in which arti
cular cartilage and necrotic subchon
dral bone lies immediately above an
empty space. There is, then, necrotic
and collapsed bone immediately overlying an area of very active bone
resorption and formation. Of great
importance is the fact that the mar
row immediately beneath this repara
tive area is completely normal. This
is not total necrosis of the femoral
head but represents subchondral
bone necrosis; most of the femoral
neck and a large part of the femoral
head are normal. There are obviously
some exceptions to this rule in which
the necrotic area extends down to
the central part of the head but this
is less common than the localized
subchondral lesion. Probably the sub
chondral necrosis is present in other
areas of the femoral head and col
lapse occurs in the weight-bearing
area because of the stress to which
that area is subjected (Fig. 2).
The articular cartilage can become
almost completely separated from the
underlying bone and occasionally
comes to lie as a cup of cartilage
over the femoral neck. This is im
portant because it acts as a buffer
to protect the cartilage of the aceta
bulum. Thus, inspection of acetabular
cartilage during the early phases of
the process reveals what appears to
be normal cartilage. The separated
articular cartilage can fragment and
produce free-floating bits of cartilage
within the joint or it can become
reattached to the underlying bone of
the femoral head. In either instance,
there are degenerative changes of the
acetabular cartilage (Fig. 3) and, in
fact, degenerative arthritis occurs
with narrowing, sclerosis and produc
tion of osteophytes.
568

The role of the lateral edge of the
acetabulum in producing the de
formity is important. In many patients,
collapse appears to be concentric be
cause the head is well covered. But
in others most of the deformity re-

suits from lateral subluxation of the
separated cartilage and pressure by
the lateral edge of the acetabulum
leads to gross joint incongruity. This
has some implications for manage
ment as will be seen later.
The second major pattern of hip
involvement was a lesion of the
femoral head similar to osteochondri
tis dissecans (Fig. 4) which was seen
in five patients; a small area of the
femoral head (less than 25% of the
total circumference) sequestrates from
the underlying bone. In all instances,
the articular cartilage is intact but is
easily indented. In our experience
this lesion has been intensely symp
tomatic and has required operation.

FIG. 2— Typical collapse of underlying
bone; lateral edge of acetabulum has
deformed head.

O ther B o n es

FIG. 3— Degenerative arthritis many
years after onset of steroid-induced osteo
necrosis of femoral head in transplant
patient.

The femoral head is the commonest
site of osteonecrosis and more mate
rial is available for study from this
region. However, it must be stressed
that the lesion seen in other bones
appears to be identical, both in ap
pearance and on microscopic examin
ation. In the humeral head subchon
dral osteolysis (Fig. 5) is associated

FIG. 5— Early subchondral osteolysis
in humeral head.

FIG. 4— Microscopic picture of “osteochondritis dissecans” of femoral head
showing sequestrated area of subchondral bone with normal cartilage overlying it.
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been reported by any investigator and
it was not seen in this series. The
There is speculation as to the etio same is true of hypercoagulability.
Interest has therefore centred
logy of steroid-induced osteonecrosis.
Any theory must explain several around alterations in fat metabolism.
observations. In the first place the Two hypotheses have been proposed
importance of the subchondral loca and both have some experimental
lization of the initial lesion must be support. It has been suggested that
stressed. This is not total bone ne there is an increase in fat cell size
crosis as is seen in the hip region within the marrow cavity of the
following fracture or dislocation. It femoral head. This increase in size
is a well localized subchondral lesion results in a greater intraosseous pres
with normal structures immediately sure and leads to vascular occlusion
beneath it. Second, the involvement causing marrow and bone death with
of bones that have a tenuous blood the series of events already described.
supply or relatively small collateral Solomon16 has measured this increase
vessels must be considered.10 The in fat cell size in steroid-treated pa
femoral head, humeral head, talus tients and in alcoholics and the in
and capitellum are well known for creased intravascular pressure has
their involvement with other forms been well documented (Hungerford
of aseptic necrosis. In addition, DS: personal communication, 1980).
osteonecrosis of the distal femoral Presumably localization to the sub
condyles is a well described le chondral region of bone occurs be
sion.11 Third, the variable occurrence cause of the microanatomy of the
of the lesion must be explained. While circulation in which small arterioles
I have found some correlation with approach the subchondral region,
total steroid dose,5 this cannot be a dilate into small sinusoids and then
primary factor because others have turn 180° to return to the intraos
failed to corroborate the finding.12 seous circulation. This is the most
Finally, it is important to stress the vulnerable area and the one that
roentgenologic and pathologic simi initially becomes avascular. The pro
larities of osteonecrosis seen in the ponents of the second theory believe
cortisone-treated patient, and those that fat embolization of vulnerable
with Gaucher’s disease, decompres subchondral vessels represents the
most likely etiology.17 It is an estab
sion sickness and sickle cell anemia.
These similarities have been insuffi lished experimental and clinical fact
that cortisone and its derivatives
ciently stressed.
Interest through the years has cause a fatty liver.18 Hyperlipidemia
centred on steroid-induced osteoporo is also well documented in research
sis with stress fracture,13 hypercoagu animals19 and in steroid-treated pa
lability,14 steroid-induced vasculitis tients, and death from fat emboliza
and alterations in fat metabolism as tion has been documented.19 Injected
etiologic agents. Steroid-induced oste exogenous fat localizes in the sub
oporosis is an unlikely factor. In chondral region of bone.18 Steroidalmost all instances osteonecrosis treated animals have been studied in
manifests itself within 6 to 8 months, three independent laboratories and
and often earlier, following the insti both subchondral fat embolization and
tution of steroid therapy. Steroid- bone and marrow death have been
induced osteoporosis, a generalized documented.20-22 The subchondral oste
metabolic bone disease, in my expe olytic lesion and collapse have been
rience takes 2 to 3 years to become seen in one experimental animal.23 The
clinically apparent and then resembles increased intraosseous pressure could
classic osteoporosis with compression also be the result of a blockage of
fractures of the spine and hip frac the subchondral vascular system.
tures. This picture is not seen in Moreover, Gregg and associates,23
osteonecrosis. Steroid-induced vas using labelled microspheres of differ
culitis or vasculitis from other causes ent sizes, have shown with great clar
has received little support in the ity that it is possible to produce sub
literature and there is no experimental chondral lesions with one size of
evidence to support it. Vasculitis may embolic material and diaphyseal le
play a role, particularly in patients sions with larger spheres. One of the
with lupus erythematosus because principal attractions of the embolic
osteonecrosis is found in some pa theory is that it helps to explain the
tients with lupus who have not been similarity of the lesion seen in steroidtreated by steroids.15 This is probably treated patients, alcoholics and those
a contributory rather than primary with Gaucher’s disease, sickle cell
FIG. 6— Typical collapse of superior
factor since no evidence of vasculitis anemia and hyperuricemia. This
portion of humeral head following
in the region of the bone lesions has theory appears at present to have
osteolysis.

with either repair with sclerotic bone
or separation of articular cartilage
(Fig. 6). As has been reported previ
ously,7’8 if the progress of the lesion
is followed long enough the articular
cartilage becomes reattached to the
underlying bone and degenerative ar
thritis then occurs. The shoulder ap
pears to become deformed in the area
of maximal stress — the humeral head
is indented by the glenoid in a position
that corresponds to approximately
90° of glenohumeral abduction. This
has been demonstrated to be the posi
tion in which the maximum force is
transmitted across the joint.9
Both the distal femur and the
proximal tibia demonstrate subchon
dral sclerosis with separation of frag
ments of cartilage over collapsed sub
chondral bone. Moreover, small le
sions resembling osteochondritis dis
secans can be seen. These are, how
ever, characteristically seen over the
weight-bearing areas of the femoral
condyles rather than in the inter
condylar notch as is seen in sponta
neous or idiopathic osteochondritis
dissecans. In both the talus and the
capitellum the pattern is identical. A
subchondral osteolytic defect is seen.
It enlarges and then the underlying
bone collapses, followed by separa
tion of cartilage and deformity. The
opposing articular cartilage of the
radial head or tibia shows no gross
changes early but later may show
degenerative arthritis if gross incon
gruity occurs.
Radiologic evidence of typical
bone infarcts was seen in three pa
tients in this series. These bone in
farcts resemble those seen in decom
pression sickness and in other con
ditions.
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the strongest clinical and experimental
support.
Management
Steroid-induced osteonecrosis cre
ates serious problems in patients who
often have systemic illness and who
may have multiple causes of disability.
The management problems presented,
therefore, require a good deal of
thought. It is advisable to be cautious,
for several reasons. First, many pa
tients are seriously ill and will not
survive long. Second, the steroidtreated patient constitutes a more
serious operative risk and the risk of
infection is increased. Third, many
patients can function well even with
serious roentgenologic abnormalities.
Finally, the exact prognosis for each
lesion in the individual patient is un
predictable. For these reasons, almost
all patients are managed conserva
tively until the exact degree of dis
ability can be assessed and until the
patient’s personality and response to
pain and disability can be appreciated.
During the osteolytic phase and
before collapse, no surgical procedure
has been carried out. In general, all
patients have been encouraged to
decrease the stresses across the in
volved joint. Judicious use of crutches
and nonweight bearing is recommend
ed for the hip lesions, pendulum
exercises and reduced activity for the
shoulder and quadriceps exercises and
external support for the knee. In the
majority of cases symptoms subside
either spontaneously or because of
this management. Most patients pro
bably return to a reasonably normal
level of activity in spite of the warn
ings of the treating team.
The H ip

The operative approach to the hip
that has evolved with experience is
based on the principle of different
operations for different stages of the
disease. Cup arthroplasty was attempt
ed in two instances and failed in
both. This corresponds to the results
of others;4 this operation has no place
in the management of avascular
osteonecrosis. For small osteochondritic lesions and those in which the
collapse is minimal and congruity of
the femoral head has been preserved,
a varus derotation osteotomy is re
commended. This was done in two
patients with follow up of 1 and 10
years respectively. In both instances,
the patients are pain-free and have
a full range of motion. They wear a
heel lift to correct the discrepancy in
570

leg length but the operation has ap
parently prevented progression of the
disorder and seated the femoral head
in the acetabulum so that concentri
city is maintained. The operation is
not often indicated but can be gratifyingly successful.4 When collapse is
extensive and symptoms warrant, re
placement arthroplasty is the proce
dure of choice. Early in the course
of the process when the acetabulum
is both radiologically and grossly
normal, hemiarthroplasty is recom
mended. Of 24 patients who had
Austin Moore prostheses inserted and
have been followed up for 3 to 13
years, the results were excellent in
4, satisfactory in 15 and poor in 5.
Of the five patients with poor results,
three have had total hip arthroplasty
at 8 and 9 years after insertion. One
patient died before definitive therapy
could be carried out and another
patient had the hemiarthroplasty
converted to a Girdlestone resection
arthroplasty with a satisfactory end
result. Some deterioration has been
apparent after 5 years with some loss
of acetabular cartilage but no late
infections have been encountered and
no settling or stem loosening has been
found. When the acetabulum shows
degenerative changes it is not reason
able to expect a hemiarthroplasty to
offer adequate pain relief. Total hip
replacement is indicated. Eighteen
primary total hip replacements have
been carried out and three Austin
Moore arthroplasties have been con
verted to total hip arthroplasties. At
present, the results of all primary
total hip replacements rate as excel
lent and patients have a full range of
motion and no pain. Of the Austin
Moore revisions, results are rated as
excellent in two patients and as fair
in one, who has limited motion but
no pain. It must be remembered that
this series antedated the general ac
ceptance of total hip replacement and
many of the early patients initially
treated with hemiarthroplasty would
probably now be treated by total hip
replacement.
The Knee

The management of patients with
lesions about the knee has also been
conservative. Because of a suspicion
of tuberculosis, one patient had syno
vial and bone biopsy which confirmed
the diagnosis of osteonecrosis. One
tibial plateau elevation was unsuc
cessful because of a gram-negative in
fection which became apparent 6
weeks after operation. Two patients
had such severe collapse and loose
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cartilaginous body formation that
hemijoint replacement was carried
out. The first patient died 18 months
after operation but had no further
difficulty with his knee. The second
is alive and well 6 years postoperatively. Hemijoint replacement is now
our policy when symptoms become
intolerable. I have not yet seen a
patient with two compartments in
volved. One patient had a small osteochondritic defect in the major weight
bearing portion of the lateral femoral
condyle drilled. She was placed on
range-of-motion exercises without re
sistance and was not allowed to bear
weight for 4 months. She had no
further symptoms until her death \V i
years later from systemic lupus erythe
matosus. All other patients, including
some with advanced roentgenologic
changes, have been successfully man
aged conservatively.
The Shoulder

As reported previously6 patients
with shoulder involvement fall into
three groups. In about one third with
minimal incongruity of the joint, the
lesion has stabilized and they have an
acceptable level of disability. Only
one lesion has deteriorated and under
gone further collapse. Another onethird have significant roentgenologic
deformity, usually with a large depres
sion in the humeral head. They have
limitation of activity and some dis
comfort but the discomfort is not
severe enough to interfere with their
enjoyment of life or ability to per
form essential tasks. They are re
ceiving continuous steroid therapy and
no surgical intervention has been
warranted. The remaining third have
required replacement of the humeral
head. Six such procedures have been
carried out in five patients. The pa
tient with the longest follow-up had
what appeared to be a secondary
hematogenous infection in the joint
8 years after operation and the initial
excellent result deteriorated to poor.
After 1 year, she was operated upon
again with antibiotic coverage. A
Neer’s surface replacement was car
ried out. This failed due to hetero
topic ossification, probably accom
panied by a low grade infection. The
prosthesis was removed and she now
has a fibrous ankylosis which has
satisfactory function and is relatively
pain free. All other patients have had
excellent end results. All are free of
pain and have an almost full range
of motion; the longest follow-up is
7 years. Two patients died more than
1 year after operation from other
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causes. The results in both were
excellent: both could use crutches.
Other Joints
The capitellum and talus rarely
require therapy of an active nature.
One patient had excision of a loose
cartilaginous body that had arisen
from the capitellum. This gave an
excellent functional result. The other
capitellar lesions as well as the talar
lesions have responded to nonopera
tive treatment.
The management of these patients
has been cautious. Joint replacement
has been carried out when indicated
but only the anatomically abnormal
portions have been removed. All pa
tients have been operated upon with
preoperative, intraoperative and post
operative antibiotic coverage and all
have been given appropriate steroids
on a supplementary basis. No serious
complications have been encountered.
There has been one definite wound
infection in an elevated tibial plateau
and two probable wound infections,
in an Austin Moore arthroplasty and
in a hemiarthroplasty of the shoulder.
In neither instance was an organism
cultured but both patients were taking
antibiotics at the time. The cautious
approach outlined, coupled with a
knowledge of the natural history of
the lesions involved has allowed gra
tifying results to be achieved.
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SESAP III Question
436. The right ureter is divided at the pelvic brim during a right hemicolectomy for
carcinoma. The best treatment would be
(A)
(B)
(C)
(D)
(E)

nephrectomy
end-to-end ureteral anastomosis
cutaneous ureterostomy
ureteroneocystostomy
ureteroureterostomy to contralateral ureter

For the incomplete statement above select the one answer that is best of the five
given.
For the critique of Item 436 see page 614 of this issue.
(Reproduced by permission from SESAP III Syllabus: Surgical Education and Selfassessment Program No. 3. For enrolment in the Surgical Education and Self-assess
ment Program No. 3, please apply to the American College of Surgeons, 55 East Erie
St., Chicago, IL 60611.)
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Idiopathic Necrosis of the Femoral Head:
Pathogenesis and Treatment
Louis So l o m o n ,

The classic features of idiopathic
femoral head necrosis — increased
roentgenologic density, the subchondral
crescent-fracture and distortion of
the femoral head — are now known
to be late manifestations of the
disease. The early changes have been
studied prospectively in 34 patients
receiving corticosteroids in high dosage
and 11 patients with femoral head
necrosis attributed to alcohol abuse.
In five patients with unilateral femoral
head necrosis, intraosseous pressure
studies and core biopsy were carried
out on the apparently unaffected
side.
The earliest pathologic changes
were a relative increase in cancellous
bone fat at the expense of myeloid
tissue, swelling and necrosis of the
fat cells, and variable areas of cell
death in the trabeculae. All of these
were fairly widespread throughout
the proximal femur. Intraosseous
pressures were raised, suggesting the
presence of venous stasis. Fat cell size
was measured in undistorted femoral
heads with osteonecrosis and in a
comparable series with osteoarthritis.
There was a significant (P <0.001)
increase in fat cell size and a virtual
absence of vascular sinusoids in
histologic sections from those with
osteonecrosis.
It is posited that idiopathic
osteonecrosis results from the
following sequence: fatty accumulation
and replacement of myeloid tissue,
followed by compression of vascular
sinusoids, venous stasis, ischemia,
fat necrosis and then bone necrosis.
The earliest stages in this chain
of events are clinically asymptomatic
and produce no radiologic abnormality.
The results of treatment by core
decompression in 22 hips are
discussed. This is an effective

md*

prophylactic measure in all early
cases and it has a place even in the
management of more advanced
cases, especially if the patient is
considered too young for hip
arthroplasty.
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Les caracteristiques classiques
de la necrose idiopathique de la tete
du femur — densite radiologique
augmentee, fracture du croissant
sous-chondral et distorsion de la tete
du femur — sont reconnues comme
etant des manifestations tardives de
cette maladie. Les changements
precoces ont ete etudies de maniere
prospective chez 34 patients soumis
a des corticosteroi'des a fortes doses
et chez 11 patients ayant une necrose
de la tete du femur attribute a un
exces d'alcool. Chez cinq patients
souffrant d'une necrose unilaterale
de la tete du femur, des etudes
de la pression intraosseuse et une
biopsie de I'axe central ont ete
pratiquees du cote apparemment
non touche.
Les changements pathologiques
les plus precoces ont ete une
augmentation relative de la matiere
grasse du tissu spongieux aux
depens du tissu myeloide, un
gonflement et une necrose des cellules
adipeuses, et des etendues variables
de destruction cellulaire dans les
travees osseuses. Toutes ces
manifestations etaient passablement
disseminees dans la partie proximale
du femur. Les pressions intraosseuses
etaient augmentees, suggerant la
presence d'une stase veineuse. La
dimension des cellules adipeuses
a ete mesuree dans des tetes femorales
necrosees mais n’ayant pas de
distorsion et dans une serie
comparable de tetes arthrosees.
On a constate une difference
significative de la taille des cellules
adipeuses et I'absence, a toute fin
pratique, de sinusoi'des vasculaires
dans les coupes histologiques
des tetes atteintes d'osteonecrose.
On avance que I'osteonecrose
idiopathique resulte du processus
suivant: accumulation de tissus
adipeux et remplacement du tissu
myeloide, suivi d’une compression
des sinusoi'des vasculaires, d’une
stase veineuse, d'ischemie, d'une
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necrose du tissu adipeux, puis
d’une necrose du tissus osseux. Les
premiers stades de cette chaine
d'evenements demeurent cliniquement
silencieux et ne produisent pas
d'anomalies radiologiques.
On discute les resultats obtenus
dans le traitement de 22 hanches par
decompression de I'axe central. Ceci
represente une mesure prophylactique
efficace dans les cas precoces et ce
traitement a aussi sa place meme dans
les cas plus avances, surtout si le
patient est considere trop jeune pour
subir une arthroplastie de la hanche.

The term “idiopathic necrosis of the
femoral head” has become so en
trenched in our vocabulary that it
has acquired something approaching
an acronym (INFH) and has become
synonymous with “ spontaneous ”
osteonecrosis. Yet even the early re
ports of this disorder1,2 noted its fre
quent association with either corti
costeroid therapy or excessive alcohol
consumption; in a personal series of
57 patients a history of one or the
other was obtained in every case.
Because the radiologic and morbid
anatomical features of idiopathic
femoral head necrosis are similar to
those of avascular necrosis following
femoral neck fracture, the patho
genesis has been sought in possible
mechanisms of direct arterial shut
down: occlusion of small vessels due
to vasculitis (especially following cor
ticosteroid therapy for connective tis
sue disorders),3 microfracture of the
subchondral bone4 and end-arterial fat
embolism.5,6
It is now recognized that the mor
phologic and histologic changes
characteristically associated with oste
onecrosis are late manifestations of
the disorder and all the features mar
shalled in support of the several theo
ries of pathogenesis could as well be
the result as the cause of bone necro
sis. By the time the diagnosis is made
the condition has been present for
months or even years. Indeed, the very
hallmark of the clinical disorder —
increased roentgenographic density of
the femoral head — is not due to
osteonecrosis at all but is a mani
festation of repair, new bone forma
tion upon the dead trabeculae pro
ducing an increase in bone mass.4
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At its onset osteonecrosis is asymp
tomatic and produces no roentgenographic abnormality. Yet it is only at
this stage that the very early patho
physiologic changes can be studied.
This we have attempted to do by
carefully investigating the apparently
unaffected side in patients with
obvious osteonecrosis in one femoral
head. Since the physiologic changes
in patients on high dosage corticoste
roids and in alcoholics must be gen
eralized, it was reasonable to expect
that we might find early abnormalities
preceding any clinical or roentgenographic disorder at a time when one
area (the opposite hip) was already
clearly the seat of advanced bone
change.
Patients and Methods

Thirty-four patients receiving corti
costeroids in high dosage and 11 ad
mitting to alcohol abuse (i.e., intake
greater than 150 g/d) were included
in the prospective study that started
in 1974. All had unilateral necrosis
of the femoral head. Features typical
of osteonecrosis developed subse
quently on the previously “unaffect
ed” side in 15 patients of the corti
costeroid group and 2 of the alcohol
group.
In addition to routine clinical and
roentgenologic examination of all the
large joints, a complete blood count,
determination of the hemoglobin
level, serum calcium, phosphate, alka
line phosphatase and lipid levels and
liver function tests were carried out in
each patient. About half of the pa
tients underwent tomography of the
hip and radioscintigraphy with techne
tium 99m sulfur colloid (99mTc-Sc).
Intraosseous pressure studies and
core biopsy of the femoral head and
neck were performed in most of our
patients with femoral head necrosis.
Five patients, after receiving a full
explanation of the risks and potential
benefits of these procedures, agreed
to have the same investigations car
ried out on the apparently unaffected
side. Intraosseous pressure was mea
sured through a long, threaded can
nula (external diameter 4 mm, internal
diameter 3 mm) introduced into the
greater trochanter to a depth of 3 cm.
This was connected by a saline bridge
to a transducer and digital pressure
recorder. Three readings were taken:
the baseline pressure after stabiliza
tion of the system, peak pressure after
injecting 5 ml of saline into the tro
chanter and the stable “stress pres
sure” 3 minutes after this injection.
A cylinder of bone was then re
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moved from the centre of the femoral
neck and head, using a specially
hardened Mayo bone biopsy tool on
a motorized drill (external diameter
10 mm, internal diameter 7.5 mm).
The same procedure was carried out
as a method of treatment (decom
pression) in 17 hips with established
osteonecrosis but little distortion of
the femoral head. The bone speci
mens were examined by fine detail
roentgenography then fixed in 10%
buffered formalin, decalcified, sec
tioned and stained with hematoxylin
and eosin.
Fifty-two femoral heads were
examined for fat distribution and fat
cell size was measured; 25 were from
patients with idiopathic osteonecrosis
following high dosage corticosteroid
therapy or alcohol abuse, 25 from
otherwise healthy patients who under
went total hip replacement for osteo
arthritis and 2 were autopsy speci
mens obtained from patients on high
dosage corticosteroids but without
any hip disorder, who had died some
months after renal transplantation.
Thick slices cut in the coronal plane
were examined macroscopically. Thin
sections from all the specimens were
stained with hematoxylin and eosin;
in 22 cases special staining for fat by
the oil-red O technique7 was also car
ried out. With an eyepiece micro
meter, fat cells in several areas of
each section were measured across
their greatest diameter and again at
right angles to this line; the product
of the two measurements was re
garded as “fat cell size”. Mean values
were determined for the osteonecrotic
heads and for heads from the osteo
arthritis (control) group.
Results

By definition clinical and roentgenographic abnormalities were absent
in the "unaffected” hip. Nevertheless,
on careful questioning 8 of the 15
patients who had osteonecrosis in a
previously normal hip after high
dosage corticosteroid therapy admitted
to having pain in the joint some
months before the first appearance of
roentgenographic change.
Results of blood studies showed
hypertriglyceridemia in 16 of the 34
patients on corticosteroids and 3 of
the 11 patients who had a high alcohol
intake. Four of the latter group were
also investigated for pancreatic func
tion; none had any abnormality of
either endocrine or exocrine function.
99mTc-Sc Scintigraphy
Although this radionuclide is known
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to be taken up in the reticuloendo
thelial system and is said to be more
reliable than bone-seeking isotopes
in displaying vascularity of marrowcontaining bone,8 it was an inconsis
tent indicator of osteonecrosis. Indeed,
the usual finding was an increased
uptake on the obviously affected side,
which we interpreted as being due
to revascularization and bone replace
ment in the osteonecrotic femoral
head (Fig. 1).
Intraosseous Pressure
Normally the resting pressure in
the greater trochanter of the femur
is 10 to 24 mm Hg and this rises
by about 10 mm Hg after saline
injection (the stress pressure). In the
five "unaffected” femora studied, both
resting and stress pressures were
abnormally high (Table I).
An interesting finding in the ob
viously osteonecrotic femora tested
in this way was that excessively high
pressures were still present as long
as the femoral head was intact, but
once the head had fractured or col
lapsed the injection of saline no
longer increased intraosseous pres
sure. The region had, in a sense,
decompressed itself and in some cases
the saline injection actually produced
a fall in pressure.
Core Biopsy
All the core biopsy specimens were
completely intact in their proximal
two thirds and were 7 to 11 cm long.
Fine-detail roentgenograms showed
no trabecular fragmentation and no
obvious increase in bone mass in the
segment from the femoral head (Fig.
2). The trochanteric segment, however,
was always osteoporotic and, in some
cases, slightly fragmented.
Despite the normal roentgenologic
findings, the histologic appearances
told a different story. The following
features were consistently identified
and are regarded as the early mani
festations of osteonecrosis:
• A relative absence of myeloid
tissue and its replacement by fat cells.
• Patchy areas of fat cell necrosis
in the femoral head, neck and greater
trochanter (Fig. 3).
• Foamy histiocytes clustered near
the damaged fat cells (Fig. 4).
• Occasional collections of round
cells suggestive of an inflammatory
reaction.
• Intact bone trabeculae, but
several areas with absence of nuclear
staining in the osteocytic lacunae; a
few trabeculae showed osteoblastic
proliferation and delicate new bone
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formation even at this early stage
(Fig. 5).
Fat Distribution and Fat Cell Size
The specimens from patients who
received corticosteroids at high dos
age all showed a paucity of myeloid
tissue compared with a normal spe
cimen (Fig. 6a). This was especially

noticeable in the two autopsy speci
mens without osteonecrosis (Fig. 6b).
In those with established osteonecro
sis the zone of repair was always
marked by an area of increased vas
cularity, but distal to this the pro
portion of fatty marrow to red
marrow was again excessive (Fig. 6c).
Mean fat cell size was significantly

greater (P < 0.001, Student’s t-test)
in the osteonecrotic specimens than in
those from patients with osteoarthritis
(Table II). Moreover, microscopically,
there was a notable absence of vas
cular sinusoids in the fatty marrow of
the former compared with that of the
latter (Fig. 7).
Discussion
The Pathogenesis of Idiopathic
Femoral Head Necrosis
There can be little doubt that idio
pathic osteonecrosis, like tissue death
anywhere, is the result of ischemia.
However, much argument has reTable I— Intraosseous Pressures before
and afte r Injection of Saline in Five
Asymptomatic Patients w ith Suspected
Osteonecrosis
Pressures, mm Hg
Patient
no.
Resting
i
2
3
4
5

56
64
42
34
58

Maximum
stress

Stabilized
stress

98
110
88
78
94

72
89
62
56
80

Fig. l b
FIG . 1— (a) Roentgenogram and (b) technetium -99m sulfur colloid scan in
patient with obvious idiopathic necrosis of right fem oral head and apparently un
affected left hip. There appears to be decreased uptake of radionuclide on left and
slightly increased uptake in proximal fem ur on right.

F IG . 3— Sections from core biopsy spe
cim en showing necrosis of m arrow fat
cells (hem atoxylin and eosin, reduced by
52% from XlOO).

FIG . 2— Fine detail of core biopsy specimen from fem oral neck and head. A rrow indicates overlying articular cartilage.
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volved around the precise cause, in
femoral head necrosis, of the dimi
nished blood supply, which theore
tically could result from one of two
mechanisms: interruption of the arte
rial supply (as in femoral neck frac
ture) or venous occlusion with second
ary arterial stasis.
The common abnormality in hypercortisolism and alcohol abuse is the
abnormal accumulation of fat in the
liver and other tissues associated in
some cases with a hyperlipidemia.
This finding educed the hypothesis

that osteonecrosis is due to fat em
bolism and occlusion of the end
arteries of the femoral head;5,6 the
subsequent demonstration of fat in
the Haversian canals of subchondral
bone in steroid-induced femoral head
necrosis9'" seemed to clinch the mat
ter. However, other studies have
failed to show any constant relation
between the presence of fat in the
subchondral Haversian canals and
osteonecrosis and identical appear
ances occur even in normal femoral
heads.4
A striking feature in the present
study of preclinical osteonecrosis was
the fatty engorgement of the marrow
spaces (steatosis) at the expense of
myeloid tissue. This could account

Table II— Fat Cell Size (p 2) in Osteonecrotic Femoral Heads and Those of
Patients with O steoarthritis

No. of sections
Mean cell size
Standard deviation

Osteonecrosis

Osteoarthritis

64
62.8
±25.6

46
37.4
±16.0

Fig. 7a

F IG . 4— Foam y histiocytes in a re a of
fa t necrosis (hem atoxylin and eosin, re 
duced by 5 2% fro m XlOO).

F ig. 6c

F IG . 5— N ecrotic bone trab e cu la lined
by osteoblasts (hem atoxylin and eosin,
re d u ce d by 52% fro m XlOO).
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F IG . 6— C o ro n al sections th ro u g h three
fem oral heads: (a) norm al specim en fro m
70-year-old w om an show ing d istribution
of m yeloid tissue; (b) autopsy specim en
fro m patient w ho had un d erg o n e renal
tran sp la n tatio n and was taking c o rtico 
steroids in high dosage, show ing paucity
o f myeloid tissue; (c) established fem oral
head necrosis.
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Fig. 7b
F IG . 7— A ppearance o f m arro w spaces
in cancellous part of fem o ral head in (a)
o steo arth ritis (in tercellu lar sinusoids are
filled w ith red cells) and (b) idiopathic
osteonecrosis (fat cells cro w d ed together)
(hem atoxylin and eosin, reduced by 5 2%
fro m x 4 0 0 ).
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for the relative absence of patent
sinusoids in the histologic sections
and the rise in intraosseous pressure
due to venous stasis. It is postulated
that this, rather than intravascular
occlusion, causes diminished perfusion
and ischemia of the femoral head.
The same suggestion has been made
by Wang and associates12 who produc
ed similar fatty changes in the marrow
of cortisone-treated rabbits, although
it is not clear from their paper
whether this was actually accompa
nied by bone necrosis.
Excessive consumption of alcohol
may produce steatosis in two ways.
Alcohol is normally oxidized in the
liver in the presence of the coenzyme
nicotinamide-adenine
dinucleotide
(NAD); in the process NAD is re
duced (NADH2). A fall in the ratio
of NAD to NADHs reduces the redox
potential in the liver, resulting in
diminished fatty acid oxidation and
accumulation of fat in the liver.13
These changes take place even with
a normal diet and comparatively
small alcohol (e.g., 60 g/d) intake in
susceptible individuals,14 even though
the mean daily alcohol intake of
men with fatty livers is around 172
g of absolute alcohol (in Canada
about 19 ounces of 80-proof liquor
or 13 bottles of beer).15
Another effect of alcohol that
occurs only in certain individuals is
hypercortisolemia of similar degree to
that seen in Cushing’s syndrome.16
The path to femoral head necrosis
may, therefore, be the same in corti
costeroid therapy and alcohol abuse.
Staging of Osteonecrosis
Others17,18 have reported increased
intraosseous pressure or abnormal
femoral venography, or both, before

any clinical or roentgenologic sign of
osteonecrosis. All are agreed that any
proposed staging of idiopathic femoral
head necrosis should emphasize the
fact that there is an early phase of
the disorder which may last for weeks
or even months, during which there
is no architectural distortion and the
condition is potentially reversible. A
suggested staging of this kind is pre
sented in Table III.
Implications for Treatment
Initially we had reasoned that, if
the cause of progressive osteonecrosis
is increased intraosseous pressure and
circulatory stasis, the condition could
be prevented — or its progress re
tarded — by bone decompression at
an early stage before subarticular
trabecular fracture occurred and the
femoral head became distorted (stage
1). All five “unaffected” hips forming
the basis of the original study showed
histologic features of early osteone
crosis in the core biopsy specimen.
The patients have now been followed
up for 4 years or longer and there
is no clinical or roentgenologic evi
dence of abnormality in any of the
hips. (The core biopsy, of course,
served to decompress the femur as
well.)
Since then core decompression has
been carried out in 17 hips with
stage 2 or 3 osteonecrosis, either be
cause the patients were considered
too young for total hip replacement
or because of poor physical condi
tion and unacceptable risks of infec
tion with major reconstructive sur
gery. They have been followed up
for periods of 6 months to 3 years:
11 became completely asymptomatic
and have remained so, 1 of them
actually showing reconstitution of

the previously distorted trabecular
pattern (Fig. 8). One patient, a 23year-old woman with bilateral femoral
head necrosis following renal trans
plantation and corticosteroid immuno
suppression, was totally bedridden
and was considered unsuitable for
hip replacement; following bilateral
core decompression she became
asymptomatic, but when she started
to walk 4 weeks later she sustained
a subtrochanteric fracture on the left
side through the entry site of the
drill-hole. The fracture was treated
by internal fixation and she pro
gressed to full weight bearing within
6 months; 2 years later there is no
deterioration and she is asymptoma
tic.
Six of the 17 hips with stage 2 or
3 osteonecrosis failed to improve
after core decompression; 3 have
since required total replacement, 2
have been treated by intertrochanteric
varus-extension osteotomy (with a
follow-up of only 1 year) and 1 hip
has remained untreated.
Others19,20 have reported similarly
encouraging results with simple core
decompression. The procedure is
easy and carries little risk, provided
the osteoporotic bone is protected by
not allowing full weight bearing for
at least 3 months postoperatively.
Moreover, if it should fail to give
relief the procedure in no way com
promises further surgical procedures
such as osteotomy or arthroplasty. In
our own unit core decompression has,
therefore, become the first line of
treatment for all but the most ad
vanced cases, patients with severe des
truction of the femoral head, or for
those over the age of 50 years who
are otherwise suitable for total hip
replacement.

Table III—-Stages in the Development of Idiopathic Femoral Head Necrosis
Stage

Radiology

Morphology

Histology

1

Fatty congestion
Venous stasis
Marrow necrosis

Femoral head intact

Normal

2

Bone necrosis
Subchondral fracture
Reparative osteogenesis

Femoral head still spherical
? subarticular fracture

Patchy increase in density
? subarticular crescent sign

3

Established bone necrosis
Subarticular fragmentation
Increased repair by new
bone formation upon
necrotic trabeculae

Distortion of femoral head
Detachment of articular segment

Slight deformity of femoral head
Definite sclerosis

4

Disruption of articular
surface
Subarticular fragmentation
Demarcation of necrotic
segment
Sclerotic repair

Marked distortion of femoral head
Destruction of articular surface

Marked distortion of femoral head
Secondary loss of articular space
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Our present treatment protocol is
summarized in Fig. 9. Stage 1 can.
in the first instance, be only a sus
pected diagnosis in high-risk patients
who have obvious osteonecrosis of
one femoral head. At the time of
treating the affected side, pressure
measurements are routinely carried
out on the “unaffected” side; if these
are abnormally high we carry out
core biopsy under fluoroscopy and
image intensification. This serves
simultaneously to establish the diag
nosis and to decompress the femoral
head.
If there are obvious symptoms and
signs of osteonecrosis but the femoral
head is not distorted (stage 2) we

make every effort to avoid joint re
placement unless the patient is over
50 years old and fit for the operation.
The earlier the stage of osteonecrosis
the better are the chances of relieving
symptoms and preventing further de
terioration by bone decompression
alone. In patients with clear-cut roent
genologic signs, decompression is
carried out with a solid 10-mm drill;
the coring device is more difficult to
use and is unnecessary when histologic
confirmation of the diagnosis is not
required.
Contrary to our fears when we
first recognized that steroid-induced
osteonecrosis would become common
with the growth of organ transplant

Fig. 8b
FIG. 8—Roentgenograms (a) before and (b) 2 years after treatment for bilateral
femoral head necrosis. On right, core biopsy has been carried out and there is no
deterioration; on left, total hip replacement has been performed.
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FIG. 9— Flow chart showing proposed management of femoral head necrosis
at different stages.
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surgery,4 total hip replacement is re
quired in only a minority of these
patients. With improved methods of
diagnosis and the ability to recognize
very early osteonecrosis, the need for
“end-stage” procedures of this kind
should be smaller still.
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Pathogenetic Considerations in Ischemic Necrosis of Bone
D avid S. H u n g e r fo r d ,

Many factors must be considered
in the pathogenesis of ischemic
necrosis of bone. Etiologic
considerations deal with the
heterogeneous disease categories
that are associated with bone
necrosis; these may affect bone
circulation either directly or
indirectly on either the arterial or the
venous side. Moreover, the
compartmental nature of bone makes
it vulnerable to the direct effects of
pathologic processes on the cellular
elements of the intraosseous
extravascular compartment. Once
ischemia has been initiated, whether
directly through influence on the
circulatory tree or indirectly by the
elevation of bone marrow pressure,
the effects of ischemia are likely
to be further potentiated because of
the compartmental nature of bone
blood flow. Once a critical level of
ischemia is surpassed, it is
possible that the condition becomes
self perpetuating through increased
bone marrow pressure leading to
further ischemia. Interruption of this
cycle by core decompression can
be successful if extensive tissue death
has not already occurred at the time
of the intervention.

m d*

timentale de I’os le rend vulnerable
aux effets directs des processus
pathologiques s'attaquant aux elements
cellulaires du compartiment
intraosseux extravasculaire. Une fois
I'ischemie installee, soit directement
par une action sur I’arbre circulatoire,
soit indirectement par elevation de
la pression de la moelle osseuse, les
effets de I'ischemie sont susceptibles
d'etre potentialises a cause de la
nature compartimentale de la
circulation sanguine dans I'os.
Lorsqu'un niveau critique d'ischemie
est depasse, il est possible que
cet etat devienne auto-entretenu par
une augmentation de la pression
dans la moelle osseuse provoquant
encore plus d’ischemie. L’interruption
de ce cycle par decompression
de I'axe central peut reussir si une
destruction tissulaire etendue
n'est pas deja presente au moment
de (’intervention.

Reprint requests to: Dr. D.S. Hungerford,
5601 Loch Raven Blvd., Baltimore,
MD 21239, USA

Ischemic necrosis of bone, particularly
of the femoral head, appears to be
an increasing cause of musculoskeletal
disability in relatively young persons.
The disease is usually progressive,
resulting in destruction of major
weight-bearing joints and requiring
joint replacement or arthrodesis. A
decade ago the hope was that joint
replacement would solve most of
these problems. However, failure of
such arthroplasties in the young has
often resulted in a worse situation.1
The increased number of cases
reported undoubtedly stems from
multiple causes. More cases are being
correctly diagnosed. Use of exogenous
corticosteroids is increasing as are
alcohol abuse and trauma, particularly
from traffic accidents. Patients with
the diseases associated with bone ne
crosis, particularly those having organ
allografting and systemic lupus erythe
matosus, are living longer and so run
a greater risk of ischemic osteone
crosis developing. Whatever the
reason, it would be rare for any
orthopedist not to have several
patients with this condition under his
active care at any given time.
From one point of view, this con
dition is very heterogeneous. In many
different diseases there appears to be
an associated increased incidence of
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Plusieurs facteurs doivent etre
envisages dans la pathogenese de la
necrose osseuse ischemique. Les
considerations etiologiques tiennent
compte des categories heterogenes
des maladies qui sont reliees a la
necrose osseuse; celles-ci peuvent
entraver directement ou indirectement
la circulation dans le tissu osseux et
toucher le cote arteriel comme le cote
veineux. De plus, la nature compar-
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bone necrosis. However, the patterns
of necrosis and its clinical evolution
are remarkably similar for diverse
etiologic associations, suggesting a
common pathway of pathogenesis.
Pathogenetic considerations have
an important bearing on diagnosis,
etiology and treatment. Considerable
controversy continues in this field
owing to a paucity of information on
the earliest stages of bone necrosis.
The lack of a good animal model
also impedes our understanding of
the disease. I will briefly review the
limited number of hypotheses avail
able, developing in detail the hypo
thesis that best seems to fit existing
data. No single hypothesis fits all the
data. It is, therefore, probable that
several different factors operate in
the individual case.
Etiology

Etiology and pathogenesis are often
discussed together. In fact, the line
that separates the two is indistinct.
However, it is useful to examine each
area separately, since under patho
genesis one can more properly con
sider “specifically the cellular events
and reactions and other pathologic
mechanisms occurring in the develop
ment of disease" (“ Dorland’s Illustrat
ed Medical Dictionary”, 25th edition).
The list of conditions associated
with ischemic osteonecrosis is long
and the etiologic links are sometimes
tenuous. Ficat and Arlet2 have divided
the list into definite and probable
associations. Major trauma, caisson
disease, sickle cell disease, postirra
diation necrosis, necrosis of arterial
origin and Gaucher’s disease are listed
under definite etiologic associations.
In these instances, effect follows
cause in a temporal sequence that
leaves little doubt as to their linkage.
The list of probable causes is more
controversial; it includes minor
trauma, exogenous corticosteroids,
gout and hyperuricemia, venous
disease, bone dysplasia (particularly
in the hip), lipid disturbances (includ
ing that associated with alcohol
abuse), connective tissue disease,
osteoporosis and osteomalacia. The
main link between bone necrosis and
the probable cause is a greater inci-
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dence of bone necrosis under the
given conditions. In many cases, par
ticularly corticosteroid therapy and
alcohol abuse, the mechanism by
which the necrosis is produced is in
dispute.
The clinician should realize that
ischemic necrosis of bone is extremely
rare in the completely healthy indi
vidual. Therefore, an awareness of
the etiologic associations serves the
important function of heightening the
clinician’s suspicion of avascular
osteonecrosis in a patient with joint
symptoms and one of the conditions
known to be associated with bone
necrosis. Although the treatment of
the condition is also a source of con
siderable controversy, nearly all
proponents of specific treatments
agree that the earlier in the course
of the disease the diagnosis is estab
lished, the more favourable is the
outcome of treatment.3*6 This means
that a knowledge of etiology also
bears an important relation to the
outcome of treatment.
Pathogenetic H ypotheses

Theoretically there are six anato
mical areas that could be the site of
initial pathologic changes leading to
osteonecrosis. These include the two
broad categories of extraosseous and
intraosseous sites. Extraosseous arte
rial and venous, intraosseous arterial
and venous, cellular cytotoxic mecha
nisms and intraosseous extravascular
factors could all play an important
role in the development of osteone
crosis.
Extraosseous Arterial Factors
This is considered by many to be
the most important mechanism in the
development of bone necrosis, parti
cularly of the femoral head. Chandler7
likened the circulation of the femoral
head to that of the heart, suggesting
that avascular necrosis of the femoral
head results from involvement of
the posterolateral retinacular artery
with infarction of the superolateral
segment of the femoral head. Certain
ly the typical roentgenographic ap
pearance of the femoral head in
patients with advanced disease sug
gests a wedge-shaped infarction such
as is seen in the spleen or kidney
with arterial occlusion (Fig. 1). One
of the most common assumptions is
that fracture of the femoral neck
results in contusion or mechanical
interruption of the lateral retinacular
vessels and infarction of the area of
bone irrigated by that vessel. Jacque
584

line and Rabinowicz,* however, in
examining 82 femoral heads removed
at various times after femoral neck
fracture, did not find evidence of
acute infarction nor did the ischemic
lesions conform to the irrigation bed
of any single vessel. They interpreted
the histologic picture as being more
compatible with progressive ischemia
rather than acute infarction.
Several authors9,10 have reported
nonvisualization of the lateral retina
cular vessels on selective arteriography
in patients with ischemic necrosis of
the femoral head and have inter
preted this, incorrectly I believe, as
evidence that the primary cause of
the disease is obstruction. However,
it should be remembered that visua
lization of an artery by roentgeno
graphic techniques depends on blood
flow in the artery. Conditions of low
flow can exist in the presence of a
completely patent vessel. The classic
example is nonvisualization of the
anterior tibial artery in cases of
anterior compartment syndrome. Once
the compartment pressure is relieved
through fasciotomy, the vessel can
again be visualized. Although this has
not been demonstrated for the retina
cular vessels around the hip, to as
sume that nonvisualization is syno
nymous with obstruction is clearly
unwarranted.
Nevertheless, Ficat and Arlet2 have
reported 18 cases in which they be
lieved specific arterial pathology was
strongly implicated in the develop
ment of bone necrosis. Arteriography
was carried out in 17 of the patients;
13 showed typical arteriosclerotic
disease and 4 showed stenosing arteri
tis. The mean age was 51 years and
15 of the 18 patients were over 40,
making this source of bone necrosis

a more important consideration in the
older patients with avascular osteo
necrosis. Although extraosseous arte
rial involvement may be important in
the occasional patient with ischemic
necrosis of the femoral head, I do
not believe it plays a major role in
the majority particularly in cases
associated with exogenous cortico
steroid administration and alcohol
abuse.

■v

Extraosseous Venous Factors
Serre and Simon,11 in 1961, de
monstrated, by intramedullary veno
graphy, widespread intraosseous ven
ous abnormalities in patients with
ischemic osteonecrosis of the femoral
head. In many of these cases, the
extraosseous veins could not be vi
sualized. They proposed that “prim
ary” ischemic necrosis of the femoral
head had a venous pathogenetic
mechanism. Although such mecha
nisms, based on extraosseous venous
pathologic features, would be hard to
document and are not usually evident
in the majority of patients seen, Ficat
and Arlet2 have reported on 21 cases
in which there was a strong correla
tion between extraosseous venous
disease and ischemic necrosis of the
head of the femur. In six of these
patients the onset of symptoms, which
led to a diagnosis of the condition,
coincided with delivery or occurred
near the end of pregnancy. The other
15 patients had strong clinical evi
dence of venous insufficiency and a
history of thrombophlebitis. Venogra
phy of the deep venous system demon
strated serious disease in the proximal
main veins in 11 patients. Extraosse
ous venous factors do not seem to be
an important mechanism but are none

4 A
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Fig. la

Fig. lb

FIG. 1— (a) Anteroposterior and (b) lateral roentgenograms of hip with advanced
bone necrosis. Appearance and localization are those of infarct.
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the less a possible, less common
mechanism for the development of
bone necrosis.
Intraosseous Arterial Factors
The main consideration concerns
circulating microemboli that block the
microcirculation of the epiphysis.
Jones and Sakovich12 have demon
strated that Lipiodol injected into the
femoral artery will initially lodge in
the metaphyseal circulation, but after
a time will obstruct the microcircula
tion in the subchondral region. Pre
sumably in the sluggish capillary cir
culation of the epiphyseal bone the
viscous fat globules become impacted
in the terminal arterioles and capilla
ries with insufficient hydrostatic pres
sure to push them through into the
venous side of the circulation.
Several investigators claim to have
found intravascular fat emboli in
human bone involved with ischemic
necrosis.13,14 It is. however, difficult
to tell whether this was the primary
cause of the avascular necrosis or the
result of bone collapse leading to the
extrusion of intramedullary fat into
the circulation. The association of
hyperlipemia with such conditions as
gout and alcoholism and with corti
costeroid therapy has led to wide
spread acceptance of the fat emboli
theory as a primary initiating mecha
nism for avascular osteonecrosis.
Nevertheless, hyperlipemia exists in
many patients who have no evidence
of the disease, and many patients
who indisputably have osteonecrosis
have no evidence of hyperlipemia. The
argument is that the fat embolization
occurs in episodes associated with
release of fat from accumulations in
the liver and may not be evident at
the time the hyperlipemia is sought.
Experimentally, Rutishauser and
associates15 demonstrated that bone
necrosis, albeit reversible, could be
produced in the experimental animal
by the injection of microparticles that
would obstruct the intraosseous arte
rial tree. This lends laboratory support
to the implication of emboli. How
ever, the report by Hartmann16 that
no vascular complications were seen
in 5000 cases of venous infusion of
fat, as well as the failure of Schmid
and associates17 to find any evidence
of bone lesions in 3 1 patients follow
ing lymphangiography with Lipiodol
is indirect evidence against the fat
microembolism theory. There are
attractive elements to the fat micro
embolism hypothesis, but for the
moment it awaits stronger confirma
tion.
VOLUME 24, NO. 6, NOVEMBER 1981

Intraosseous Venous Factors
Many authors have demonstrated
intraosseous venous abnormalities by
venography in early cases of ischemic
osteonecrosis.4,5'111819 This has been
construed by some as evidence of an
intraosseous venous pathogenesis of
bone necrosis. There is an alternative
explanation which will be reviewed in
greater depth under intraosseous extravascular factors. However, Ruti
shauser and associates15 have experi
mentally induced widespread intra
osseous intravenous thrombosis by
injecting thrombin into the intrame
dullary space. The resulting lesions
were histologically indistinguishable
from those produced by intra-arterial
embolization with carbon particles,
but the histologic changes produced
by the venous thrombosis required
nearly twice as long to resolve as
those produced by the arterial emboli.
It is also possible that sickle cell
disease with the stronger tendency
for sickling on the venous side of the
capillary circulation could produce
bone necrosis by intravascular ob
struction on the venous side. The
same could be true for nitrogen
bubbles coming out of solution in
decompression.
Cellular Cytotoxic Factors
In radiation necrosis it is obvious
that the lesion may be the end result
of widespread cell death due to the
ionizing radiation. Kenzora and Glimcher20 have also suggested that in both
chronic alcoholics and patients receiv
ing corticosteroid therapy the disease
might be produced by direct metabolic
effects on the cells. However, they
did not provide confirmatory experi
mental or clinical evidence.
Intraosseous Extravascular Factors
Clearly the intraosseous extravas
cular compartment must be affected
by any important pathologic changes
in the circulatory system whether
inside or outside the bone, whether
on the arterial, capillary or venous
side. But it is not self-evident that
specific intraosseous extravascular
events could extensively affect that
same circulatory system. Nevertheless,
the marrow elements and the trabe
culae exist within a closed compart
ment and, therefore, primary changes
in this closed compartment will have
more serious repercussions on all
tissue elements than similar changes
would have in a soft tissue organ.
Conditions such as Gaucher’s dis
ease, involving reticuloendothelial cells
/

that accumulate abnormal amounts of
cerebroglycosides, appear to encroach
upon the lumen of the capillaries
within the bone and reduce the intra
medullary circulation. The findings
of Wang and associates21,22 that intra
medullary lipocyte size and bone
marrow pressure were increased in
steroid-treated rabbits lend support
to the hypothesis that primary intra
medullary lipocyte hypertrophy may
be an important primary pathogenetic
mechanism in steroid-associated avas
cular necrosis. More recently, Pooley
and Walder23 reported on decreased
blood flow in the bones of animals
during exposure to compressed air.
They also demonstrated that lipocytes
exposed to similar conditions increased
in size. They hypothesized that the
increase in lipocyte size is the cause
of the decreased bone blood flow
under these conditions, suggesting an
additional mechanism in caisson
disease. Therefore, there are at least
three separate etiologic associations
with avascular necrosis — steroidassociated ischemic osteonecrosis,
Gaucher’s disease and caisson disease
— in which an increase in cell size
in the intraosseous extravascular com
partment is a possible pathogenetic
mechanism in initiating the ischemia.
Hemodynamics of Bone Circulation
Michelsen’s24 initial observations,
expanded by Wilkes and Visscher,2’
have shown indisputably that bone
circulation functions as a Starling
resistor. A Starling resistor consists
of a rigid canister through which
passes a flexible thin-walled tube.
Flow in the tube is determined by
the driving pressure outside the can
ister and the pressure within the
canister outside the tube. Any in
crease in the pressure within the can
ister and outside the flexible tube will
result in a proportional decrease in
flow within the flexible tube, as long
as the driving pressure remains un
changed. Thus, bone marrow pressure
directly affects vascular resistance
and, therefore, bone blood flow. F ur
ther, this reduction in flow can be
completely independent of any prim
ary pathologic changes in the vessels.28
This is undoubtedly the mechanism
of bone infarction and sequestrum
formation in osteomyelitis. It may
also be a mechanism for bone ische
mia associated with steroid therapy,
alcohol abuse or caisson disease as
elucidated in the previous section.
Bone marrow pressure may be
directly elevated by pathologic pro
cesses affecting primarily the intra-
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osseous extravascular compartment.
However, the bone marrow tissue may
also be adversely affected by ischemia
that results from primary vascular
lesions. In this way, ischemia results
in bone marrow edema and elevation
of bone marrow pressure with further
potentiation of the ischemia due to
a secondary compartment syndrome.
This is a common phenomenon asso
ciated with acute, large vessel obstruc
tion or transection and a period of
ischemia followed by re-establishment
of flow. It frequently results in soft

tissue compartment syndromes that publications and those of others have
require fasciotomy if substantial soft shown a high frequency of elevated
tissue loss is to be prevented.
bone marrow pressure in the early
stages of bone ischemia (Figs. 2 and
3^4.5,18,19 These findings are not re
The Compartment Syndrome:
stricted to the hip but have been
a Common Pathway
demonstrated in the knee and shoulder
also. Patients who had unilateral
Evidence from Diagnostic Studies
ischemic necrosis of the femoral head
Since 1973 we have been using the also underwent measurement of bone
measurement of bone marrow pres marrow pressure on the asymptoma
sure as a method of detecting bone tic roentgenographically normal con
ischemia in the preradiologic and tralateral side. Of 27 such patients,
even preclinical stages. Our previous 17 demonstrated abnormal bone mar
row pressure and in 13 symptoms
and bone ischemia as shown in biopsy
specimens subsequently developed.
Thus, elevation of bone marrow pres
sure can be considered at least an
early if not a primary factor in the
pathogenesis of ischemic necrosis of
the femoral head.
Intramedullary venograms normally
show rapid filling of the extraosseous
medullary drainage route and rapid
clearing of the intraosseous dye (Fig.
4). In the preradiologic stages of
ischemic necrosis of the femoral head
there is evidence of outflow obstruc
tion. Five minutes after injection of
Renografin profound intramedullary
stasis is demonstrated (Fig. 5). From

F'lG. 2—Normal bone marrow pressure does not exceed 30 mm Hg and shows
pulse pressure and changes with respiration. Injection of 5 ml of saline (between
arrows) does not provoke intraosseous hypertension.
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FIG. 3—Bone marrow pressure in early avascular necrosis of femoral head
showing both elevated baseline pressure and hypertensive response to saline loading
(between arrows).
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Fig. 4b
FIG. 4— (a) Normal venogram demon
strates abundant metaphyseal drainage
without diaphyseal reflux, (b) Five min
utes after injection there is nearly com
plete clearance of intraosseous dye.
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this evidence alone it is not certain
whether the venogram shows primary
intraosseous venous disease or the
results of a compartment syndrome
with compression of the venous bed.
Evidence from Core Biopsy Material

Core biopsy specimens from pa

tients with painful hips, normal roent
genograms, abnormal scans and
elevated bone marrow pressure have
shown primarily bone marrow changes
before trabecular changes (Figs. 6
and 7).3-5 This is in agreement with
the findings of Rutishauser and col
leagues15 on the histologic manifesta
tions of progressive bone marrow

Fig. 5a

F IG . 6— N o rm a l bone m arrow show s o rd e rly p a tte rn of m ed u llary lip o cy tes and
sprinkling o f h em ato p o ietic islands. T ra b e c u la e a re alive (h em ato x v lin a n d eosin.
X 175).

Fig. 5b
F IG . 5— A v ascu lar necrosis of fe
m o ral head, (a) V enogram show s poor
filling of m etaphyseal veins and diaph
yseal reflux, (b) F ive m inutes a fte r in
jection m uch dye rem ain s intraosseously.

F IG . 7— B one m arrow changes in ischem ic n e cro sis of fe m o ra l head precede
and are usually m o re extensive th a n tra b e c u la r c h an g es. In this case ro e n tg e n o g ra m
w as n o rm al but bone m arrow pressure w as e le v ate d (h e m a to x y lin a n d eosin, X l7 5 ).
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ischemia. The first effect of ischemia
is to eliminate hematopoiesis. Marrow
edema and fibrosis appear next;
trabecular bone death is seen only in
the end stages of ischemia. The his
tologic appearance of material from
the roentgenographically normal cases
supports the compartment syndrome
theory.
Evidence from the Results
o f T reatm ent

We and others have reported on
decompression, consisting of removal
of a 1-cm core of bone from the
femoral head and neck through a
lateral trochanteric window to provide
rapid relief of symptoms and arrest
the disease.2’5 The results can be com
pared to decompressing a soft tissue
compartment such as the forearm in
Volkmann's syndrome or the anterior
tibial compartment. If the compart
ment is decompressed during the early
ischemic phase, one can expect
normal function to be restored. If the
compartment is decompressed only
after extensive tissue death has oc
curred. the condition is unlikely to
be reversed. These are exactly the
findings reported for core decom
pression.
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Percutaneous Antegrade Biliary Drainage:
a Nonoperative Approach to Biliary Obstruction
I.H. K o v e n , m d , f r c s [c ], facs ,* M .I. St e in h a r d t , md , f r c p [c ] t and B. R e ic h s t e in , m d $

in contrast to external drainage
(retrograde) by T- or U-tubes. Although
the mean survival time with this
method is sim ilar to that with insertion
of drainage tubes at the time of
laparotomy, morbidity and mortality
are reduced; this is important in view
of the poor p rogn osis of bile duct
obstruction due to malignant disease.

le tem ps m oyen de su rvie par cette
m ethode soit le m em e que celui qui est
ob serve lo rs de I’insertion de drains
a la laparotomie, la m orbidite et la
mortality son t reduites; ceci est
important, compte tenu du m auvais
pronostic rattache a une obstruction
des v o ie s biliaires due a une
maladie maligne.

Reprint requests to: Dr. I.H . Koven,
Ste. 449, 600 University A ve., Toronto,
Out. M5G 1X8

Vingt-sept m alades ont subi un
drainage biliaire anterograde par voie
percutanee pour un ictere par
retention. Le taux de la bilirubine
serique etait eleve chez tous les
patients. Un sym ptom e majeur etait
un prurit generalise. Vingt de ces
patients avaient deja eu une laparotomie
pour maladie maligne. Pour les
24 patients chez qui cette methode
s 'e s t averee efficace, la lesion
obstructive a ete decouverte au niveau
du hile du foie chez 12 et au niveau
des voies biliaires extrahepatiques
chez les 12 autres. Les m etastases
etaient la cause la plus frequente
d ’obstruction.
Suite au drainage le taux de la
bilirubine serique a chute d ’une
m oyenne de 21.4 m g/dl (366 umol/l)
a une m oyenne de 4.1 m g/dl
(70.1 u.mol/1) en m oins d'une
semaine. Le prurit a ete soulage.
Les com plications m ajeures furent
une cholangite transitoire chez
cinq patients et le deplacement
accidentel du catheter chez quatre.
Chez trois de ce s derniers un
nouveau catheter put facilement
etre reintroduit. On ne rencontra
aucune peritonite ou hemorragie non
controlee. Vingt-et-un patients
purent quitter I'hopital. Leur tem ps
moyen de survie fut de 7.3 mois.
Un catheter a perforations multiples
p asse a travers ('obstruction presente
I’avantage de permettre I'ecoulem ent
de la bile dans le duodenum
(drainage anterograde) par opposition
au drainage externe (retrograde)
par des tubes en T ou en U. Bien que

Operations for biliary obstruction
caused by malignant tum ours are dif
ficult and are associated with a high
mortality. Resection offers the only
hope for cure of prim ary tum ours but
is possible in only 10% of patients.1,2
When obstruction is caused by m e ta
static disease or an unresectable prim 
ary tum our, a palliative procedure is
all that can be offered.
The principle objective of palliation
is to provide drainage of bile from
the liver. T he relief of jaundice and
its associated pruritus com forts the
patient and forestalls the onset of
progressive hepatic failure. It is
usually obstructive liver failure rather
than disseminated carcinomatosis that
shortens survival in these patients.
A nother indication for biliary d ra in 
age is to relieve jaundice before
em barking on a m ajor surgical p ro 
cedure. T h e mortality m ay be doubled
if a m ajor surgical procedure is p e r
formed when the serum bilirubin
value is greater than 20 m g /d l (342
p,moI/l).:1
Biliary drainage can be achieved in
various ways. An indwelling T -tube
or biliary-enteric fistula is effective
when an obstruction at the lower end
of the com m on bile duct is found at
operation. O bstruction at the bifurca
tion of the hepatic ducts is more dif
ficult to manage. If resection is not
feasible, drainage may be achieved by
the use of a U-tube as described by
Terblanche and colleagues4 and Saypol and K urian.5 T he mortality asso
ciated with this technique is reported
to be less than with the use of various
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Twenty-seven patients underwent
percutaneous antegrade biliary drainage
for obstructive jaundice. The serum
bilirubin level w as elevated in all
patients. Generalized pruritus w a s a
major complaint. Twenty of the patients
had had a laparotomy for malignant
disease. Of the 24 patients in whom
this method of drainage w as
successful, the obstructing lesion
w as found at the porta hepatis in
12 and in the extrahepatic bile ducts
in 12. Metastatic d ise a se w as the
com m onest cause of obstruction.
Following drainage the serum
bilirubin level fell from a mean of
21.4 mg/dl (366 (j.mol/1) to a mean of
4 1 mg/dl (70.1 pm ol/l) within a week.
Pruritus w as relieved. The major
complications were transient cholangitis
in five patients and inadvertent
dislodgem ent of the catheter in four.
In three of these patients another
catheter w as reinserted with ease.
There w as no peritonitis or uncontrolled
bleeding. Twenty-one patients were
able to leave hospital. Their mean
survival time w as 7.3 months.
A multiperforated catheter
manipulated through the obstruction
has the advantage of permitting bile
flow into the duodenum (antegrade)
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biliary-enteric bypass procedures.6,7
Molnar and Stockum8 described the
use of a percutaneous transhepatic
catheter, fixed to the skin, to provide
external retrograde biliary drainage
without laparotomy. One drawback to
this method is that the patient must
always wear a bag to collect bile.
Other problems are the frequent acci
dental extrusion of the drainage ca
theter and replacement of bile and
electrolyte losses.
In 1978 Nakayama and colleagues9
used a multiperforated catheter intro
duced percutaneously into an acces
sible bile duct and manipulated
through the obstructing lesion. By this
method, bile can flow from above the
obstruction into the common bile duct
or the duodenum and the need for an
external collecting receptacle is eli
minated. This paper reports our
experience with that method in a
group of patients presenting with
obstruction of the extrahepatic biliary
tree.
Patients
Percutaneous transhepatic drainage
was undertaken in 27 patients (17
women, 10 men) with obstructive
jaundice. The mean age of the women
was 59 years (ranging from 19 to 92
years) and of the men 63 years (rang
ing from 55 to 77 years).
The commonest cause of obstruc
tion was metastatic cancer (12 pa
tients), followed by carcinoma of the
pancreas (6 patients) and of the bile
duct (5 patients). Benign duct stric
ture was the cause in one patient. In
three patients the cause was unknown.
Most obstructions of the common bile
duct were at the lower end and were
thought to result from direct invasion
by cancer of the pancreas. One pa
tient, previously operated on for
benign bile duct stricture, had ob
struction of the common hepatic duct.
The mean serum bilirubin level in
these 27 patients was 21.4 mg/dl (366
/xmol/l) ranging from 9.0 to 42.0
mg/dl (154 to 718 /xmol/1). Gene
ralized pruritus was a major complaint
in 50%. No patient was cachectic but
all had some degree of anorexia and
nausea. One patient was uremic
(blood urea nitrogen 170 mg/dl [urea,
60.7 mmol/l]).
Twenty of the 27 patienis had pre
viously undergone an operation for a
malignant tumour (Table I); resection
of the primary tumour was possible
in 15, a biliary-enteric anastomosis to
bypass the obstruction was done in
3 patients with cancer of the pan
creas, and an unresectable cancer of
592

the extrahepatic duct was found in 2.
One patient had two unsuccessful at
tempts at repair of a benign biliary
stricture. Six patients had neither a
history of malignant disease nor sur
gery on the biliary tract.
The indication for percutaneous
transhepatic drainage of the six pa
tients with no previous history of a
malignant condition or bile duct
surgery was to lower the serum bili
rubin level by a nonoperative method
before laparotomy. At laparotomy
cancer of the pancreas was found in
three of these patients and was not
resectable in two of them. The other
three had obstruction of the hepatic
ducts; two of them were aged 87
and 92 years respectively and one
had ascites related to malignant
disease.
Methods
The site of obstruction was first
determined by percutaneous trans
hepatic cholangiography. It was in
the porta hepatis in 12 patients, the
common bile duct in 8 and the com
mon hepatic duct in 4. Occasionally
percutaneous transhepatic biliary chol
angiography was not possible because
a suitable accessible bile duct could
not be found. Drainage was achieved
by introducing a multiperforated
catheter into a bile duct and mani
pulating it through the obstruction.
The initial radiologic examinations
and procedures were all performed
by one of us (M.I.S.). The technique
used to pass the catheter has been
described elsewhere.9,10 It consists of
a series of maneuvers: a dilated intrahepatic duct is punctured with a no.
19 French sheathed steel needle (Fig.
1) , a guide wire is inserted and mani
pulated through the obstruction (Fig.
2) , the multiperforated catheter is
advanced over the guide wire so that
its tip is below the obstruction when
confirmed by roentgenography (Fig.
3) and finally the guide wire is with
drawn and the catheter is immobilized,
usually by attaching it to the patient’s
skin. When indicated, a sample of

tissue for histologic diagnosis is
obtained during the procedure. This
is done by flexible “skinny” needle
biopsy. The patients remain in hospital
following the procedure in order to
flush debris from the catheter by
daily irrigations with normal saline.
Thereafter, the open proximal end
of the catheter is clamped to provide
internal drainage. Broad-spectrum
antibiotics effective against gram
positive ard gram-negative organisms
are given intravenously during this
time.
Results
The procedure was successful in 24
of the 27 patients; in 3 patients the
procedure failed because a suitable
accessible bile duct could not be
located.
After the drainage procedure, the
serum bilirubin level of all patients
decreased greatly from a mean of
21.4 mg/dl (366.9 yu.mol/1) to a mean
of 4.1 mg/dl (70 /zmol/1) (ranging
from 10.5 to 1.2 mg/dl [179.5 to
20.5 yumol/l]) in a relatively short
time (mean 8 days). Concomitantly,

Fig. la

Table 1— Initial O perative Findings
Site of m alignant tumour

No. of patients

Stomach
Colon
Pancreas
Bile duct
Gallbladder
Breast
Kidney
Total

5
4
3
3
2
2
1

Fig. lb
FIG. 1— (a) Site of obstruction deter
mined by cholangiography, (b) Diagrams
showing penetration of dilated duct by
sheathed needle.
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generalized pruritus either disappeared
or diminished.
After the relief of jaundice, 5 pa
tients received a course of chemo
therapy or radiotherapy, or both; 3
patients had decompression before
laparotomy and the remaining 16
received only supportive care.
Complications
There was one death attributable
to the procedure; the patient had liver
failure at the time the drainage pro
cedure was performed. She removed
the tube 24 hours later. Attempts to
replace it were unsuccessful and she
died shortly thereafter. Transient chol
angitis occurred in five patients. It
was managed easily in four by broadspectrum antibiotics given intraven
ously but one patient with septicemia
and shock required intensive sup
port.
The catheter was inadvertently
pulled out or spontaneously dislodged

in four patients. In three of these
another catheter was inserted with
ease. This could not be done in one
patient, who required a laparotomy
the following day at which time
retrograde drainage was achieved by
inserting a T-tube into the common
bile duct.
There was no instance of peritonitis
or uncontrollable bleeding.
Follow-Up
Twenty-one patients were able to
leave hospital after relief of their
jaundice by this method. In addition
to the death already referred to, two
other patients died in hospital from
terminal carcinoma of the stomach
and of the breast, respectively. Ten
patients died following discharge
from hospital. Their mean survival
was 7.3 months.
Discussion
In patients with obstructive jaun
dice, percutaneous transhepatic chol
angiography has become an invalu
able means of identifying the site of

b

» =

obstruction. By passing a perforated
catheter through the obstructing
lesion, we can now provide adequate
biliary decompression without an
operation.
In one reported series9 this method
of preoperative biliary decompression
gave a lower mortality (8.2% ) than
decompression performed at the time
of operation (28.3%). No operative
death occurred in the patients who
had a subsequent laparotom y after
biliary decompression in our study.
This method of drainage was found
to be most valuable in those with
known metastatic disease in whom
resection was impossible. M ost of the
patients were able to leave hospital
and resume some degree of activity
at home. The relief of pruritus and
jaundice made it possible for five
of the patients to undergo a course
of chemotherapy or radiotherapy, or
both.
The mean survival time after this
method of nonoperative drainage
does not differ from the method of
T- or U-tube insertion at the time of
operation.2 However, because of the
poor prognosis and survival after
surgical bypass, percutaneous trans
hepatic antegrade biliary drainage
offers a viable alternative in the m ana
gement of bile duct obstruction due
to malignant tumours. It is also use
ful preoperatively for decompression
of the liver in patients with severe
hyperbilirubinemia.
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Aneurysms of the Descending Thoracic Aorta:
Treatment with the Gott Shunt
A lain

G.

V erdant, md, frcs[c ],* C laude H. M ercier, md, m sc,* A rthur A. Page, md, FRCs[c],t
Robert G. Cossette , md, frcs[c] and L eon D ontigny, md, frcs[c]*

In the repair of aneurysms of the
descending thoracic aorta, interruption
of aortic flow has usually been
accomplished by cardiopulmonary
bypass, which has been associated
with excessive bleeding due to the
system ic heparinization required.
To avoid this problem, the authors have
used an external (Gott aneurysm)
shunt, which does not require
system ic heparinization.
In 50 patients with an aneurysm
of the descending thoracic aorta
a Gott aneurysm shunt was used as an
external bypass. The shunt is a
flexible, transparent, polyvinyl chloride
tube and its heparin-coated wall
prevents clotting. Forty-two (8 4 % )
patients survived the operation.
Thirty-tw o patients had surgical repair
of a traumatic rupture of the
descending aorta; 29 (9 1 % ) survived.
Of 18 patients operated on for an
arteriosclerotic aneurysm or a DeBakey
type III dissection 13 (7 2 % ) survived.
Most of the deaths occurred early
in the series; among the last
14 patients treated for an
arteriosclerotic aneurysm or
dissection 13 (9 3 % ) survived.
Paraplegia occurred once (2 % )
because a shunt was accidentally
introduced outside the lumen of the
descending aorta and therefore did not
function. Another patient with an
acutely transected aorta and bleeding
had rapid cross-clamping of the aorta
without a shunt but suffered a cardiac
arrest due to postclamping acidosis.
He was successfully resuscitated.
No heart failure, paraplegia or renal
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failure occurred in the 48 patients
properly protected with the Gott
aneurysm shunt. Regardless of their
etiology, thoracic aneurysms are
unpredictable and the authors
recommend surgical treatment in
most patients, using this external
bypass technique as a method of organ
protection.
Malgre les progres techniques
recents, la chirurgie de I'aorte
thoracique descendante comporte
encore un defi et son succes est
directement relie au respect de
deux principes durant le clampage
aortique; a) line decompression
proximate adequate evitant a la fois
la surcharge du coeur gauche et
I'hypertension cerebrale. b) line
perfusion distale suffisante de tous
les organes mais surtout des reins
et de la moelie epiniere afin de
prevenir I’insuffisance renale et la
paraplegie.
La circulation extra-corporeale
a ete la methode la plus utilisee
par plusieurs pour atteindre ce
double but. Elle necessite cependant
I'heparinisation totale avec le risque
inherent d'hemorragie per- et
postoperatoire. Depuis le debut de
notre experience, nous avons opte
pour une technique de derivation
externe: le shunt de Gott est
un tube de chlorure de polyvinyl dont
la paroi enduite d'un complexe
heparine empeche toute coagulation
a I'interieur de sa lumiere. Insere
entre I'aorte ascendante proximalement
et I’aorte descendante distalement,
il repond aux exigences de protection
organique et ne necessite pas I'emploi
d'heparine systemique. Durant les
6 dernieres annees, 50 malades
porteurs d'un anevrysme de I’aorte
thoracique descendante ont ete operes
avec le “ Gott aneurysm shunt” comme
systeme de derivation externe. La
survie globale des malades a ete de
84% (42/50). Les meilleurs resultats
ont ete obtenus chez 32 malades
operes pour une rupture traumatique
de I’aorte thoracique dont la survie
fut de 91% (29/32). Dix-huit malades,
avec comme lesion soit un anevrysme
arteriosclerotique soit un anevrysme
dissequant type III, ont egalement
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ete operes. Treize malades ont survecu
(7 2 % ). La plupart des mortalites
de ce second groupe ont ete
enregistrees au tout debut de notre
experience. Des raffinements apportes
a la technique ont permis d'ameliorer
la survie de ce groupe de malades
plus risques. En effet parmi les
14 derniers malades traites pour un
anevrysme arteriosclerotique ou une
dissection aortique, 13 malades ont
survecu a ['operation (9 3 % ). Aucune
defaillance cardiaque ni aucune
insuffisance renale ne fut notee. Nous
deplorons un cas de paraplegie (2 % )
sur ces 50 malades. Elle fut attribute
a une mauvaise insertion de shunt
dans I'aorte thoracique descendante
avec comme consequence I'absence
de perfusion durant tout le temps
du clampage aortique. Un autre cas
non perfuse durant le clampage
aortique (shunt non utilise a cause
de I'urgence de la situation) a souffert
d'un arret cardiaque au moment du
declampage aortique fort heureusement
temporaire et avec recuperation
sans sequelle. Par ailleurs, tous les
malades adequatement proteges avec
ce shunt et qui ont survecu a
■'intervention n’ont eu aucune
complication ni cardiaque ni renale
ni spinale.

The management of aneurysms of
the descending thoracic aorta conti
nues to challenge the surgeon despite
advances in operative techniques.
Temporary interruption of aortic flow
is required to effect the repair and,
during the period of aortic cross
clamping, acute left heart failure and
ischemic injury to the spinal cord and
kidneys must be avoided. To accom
plish these goals, cardiopulmonary
bypass has been widely used but ex
cessive bleeding has been common
because total body heparinization is
necessary. We have used an external
shunt, which does not require systemic
heparinization, placed between the
ascending and descending aorta to
provide proximal decompression and
distal body perfusion.
Patients

During the 6-year period ending
Apr. 30, 1981, 50 patients with an
aneurysm of the descending thoracic
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aorta underwent surgical treatment at
the Hopital du Sacre-Coeur in Mont
real. Their ages ranged from 18 to 75
years. They were divided into three
groups according to etiology.
Group 1

Thirty-two patients were treated
for a traumatic rupture of the des
cending thoracic aorta resulting from
a motor-vehicle accident.1 Twenty
patients seen in the first few hours
after their admission to the emer
gency department were operated on
in the acute phase. Twelve had sur
gical repair in the chronic phase
(more than 3 months after the acci
dent). Chest symptoms predominated;
in five patients progressive dilatation
of the aneurysm was evident radiologically.

through the bed of the resected fourth
or fifth left rib. The right radial
artery is cannulated for continuous
monitoring of blood pressure and
gases. A standard endotracheal tube
is used for inflation of both lungs
and to obtain maximal oxygenation,
and an autotransfusion system is
available for rapid reinfusion if blood
loss is extensive. During aortic cross
clamping, acute left heart failure
and ischemic injury to the spinal cord
must be avoided.
The Gott aneurysm shunt (Sher
wood Medical Industries, St. Louis,
Mo.), used as an external bypass from
the ascending to the descending aorta,
has been our method of choice to
prevent these lethal complications

Group 2

Nine patients had an arteriosclero
tic aneurysm distal to the left sub
clavian artery. Saccular and fusiform
aneurysms involving the thoracic
aorta have an unpredictable course
when left untreated. In this group
one patient with a thoracic aneurysm
(4 cm in diameter), which was found
at the time of investigation of an
abdominal aortic aneurysm but was
not treated, was readmitted 6 years
later when the thoracic aneurysm
ruptured. Aortography was repeated
and showed a 9-cm enlargement.

/

Group 3

There were nine patients with a
dissecting aneurysm (five acute and
four chronic). Indications for opera
tion were impending rupture, uncon
trollable severe hypertension, chest
pain or formation of a saccular aneu
rysm.

0

F IG . 2— G ott aneurysm shunt. R ubber
ring is added at each end fo r better con
trol of aortic cannulation.

(Fig. 1). It is a flexible, transparent,
polyvinyl chloride tube and its hepa
rin-coated wall prevents clotting so
that systemic heparinization is not
required. The central portion of the
shunt has an inner diameter of 12.5
mm and each end is tapered to an
inner diameter of 8 mm, thus reduc
ing the overall resistance to flow. The
tapered ends, which have an outer
diameter of 9 mm, facilitate cannulation. A rubber ring added to the tip
of the shunt (Fig. 2) avoids excessive
penetration of the aorta. The shunt is
secured in the ascending and descend
ing aorta with two purse-string su
tures. The aorta is cross-clamped
proximally between the left carotid
and left subclavian arteries and the
repair effected by interposing a D a
cron prosthesis. Sometimes alterna
tive techniques of aortic shunting
must be used. These are easily carried
out with the Gott aneurysm shunt.2
In DeBakey type III dissecting aneur
ysms it would be hazardous to cannulate the descending aorta because
of the danger of rupturing the dis
sected aorta. In this situation we pre
fer to assure the distal perfusion by
retrograde cannulation of the femoral
artery (Fig. 3). This can be achieved
by cannulating the femoral artery it
self or, if too small, by introducing
the distal tip of the shunt through a
10-mm side branch Dacron prosthesis
sewed end-to-side to the femoral ar
tery. When the aneurysm involves
only the midthoracic portion, prox
imal cannulation of the aorta can be
done distal to the left subclavian ar
tery and distal cannulation is then

Technique

A

standard

approach

is

made

STANDARD
AORTA-AORTIC BYPASS

FIG . 1— G ott aneurysm shunt is placed
between ascending and descending aorta.

F IG . 3— Two alternative techniques o f ao rtic shunting easily achieved with G o tt
aneurysm shunt.
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easily carried out through the left fe
moral artery (Fig. 3). In one of our
cases, because there was extreme cal
cification of the ascending aorta, the
proximal end of the shunt was in
serted in the apex of the left ventricle
(Fig. 4).
To assess the performance of the
shunt, pressure and flow variations
were recorded in a number of pa
tients. When both the aorta and the
shunt were cross-clamped, a proximal
pressure of 240/90 mm Hg and a
distal pressure of 30 mm Hg were
observed. After opening the shunt,
the proximal and distal pressures
returned to more physiologic levels,
125/60 and 65 mm Hg respectively.
In most of our patients, the mean
aortic pressures obtained were 150/75
in the ascending aorta and 70 mm
Hg in the distal aorta with a pulsatile
wave at times. With a flowmeter
adapted to the Gott aneurysm shunt
we observed an average flow rate of
1300 to 1500 ml/min with a proximal
pressure of 125/65 mm Hg. By
increasing the proximal pressure to
150/75 mm Hg, a mean flow of
1800 to 2000 ml/min was reached.
Substantial elevation of the left atrial
pressure was recorded when the
proximal systolic pressure was main
tained above 160 mm Hg, suggesting
that any pressure above this results
in left ventricular overloading without
improvement in distal body perfusion.
In some older patients with long
standing severe hypertension, and
especially in patients with dissection,
an intravenous drip of nitroglycerin
or Nipride was added to lower the
pressure and to decompress the left
heart completely.

FIG. 4— Left ventricle to left femoral
artery bypass used only when both as
cending and descending aorta are not
suitable for cannulation.
596

Results
Group 1
In this group 29 (91%) of the 32
patients survived. Of the 12 operated
on in the chronic phase, all survived
and of the 20 treated in the acute
phase, 17 (85%) survived. There
were three deaths in the acute cases,
two from severe coexisting brain
damage and the other from profuse
intrathoracic hemorrhage that oc
curred before proximal aortic control
could be obtained. A 3-hour delay
in obtaining the patient’s consent for
thoracotomy was the reason for this
death.
Group 2
Eight of the nine patients in this
group with arteriosclerotic aneurysms
had an elective operation and seven
(87%) survived. One patient died of
pulmonary embolism 7 days after the
procedure. The only patient operated
upon for a ruptured aneurysm suf
fered a cardiac arrest before the pro
cedure and died while the chest was
being opened.
Group 3
Five of the nine patients with a
dissecting aneurysm were operated
on for acute dissection; four survived.
Only one patient died — of peri
operative hypoxia and cardiac arrest
secondary to the use of a Carlen’s
tube. Four patients were treated for
a chronic dissection early in the series
and two survived. The two deaths
were due to postoperative hemor
rhage.
Discussion

The best results were obtained in
patients with traumatic rupture of the
aorta. In this group of young patients,
even better surgical results could be
obtained by postponing the operation
in those with severe brain damage.
This coexisting lesion was the leading
cause of death in our patients. In the
patients with arteriosclerotic and dis
secting aneurysms, most of the opera
tive deaths occurred early in our
surgical experience. With refinements
of surgical technique, the survival
rate substantially improved. Excluding
the patient with the ruptured thoracic
aneurysm, 13 (93%) of the last 14
patients treated for arteriosclerotic
and dissecting aneurysms survived.
Regardless of etiology, thoracic aneu
rysms tend to dilate and rupture.
Therefore, even in the more difficult
cases of aortic dissection we re
commend operation for most patients.
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We have found acute dissection easier
to repair than chronic dissection be
cause the site of rupture is better
visualized and the dissecting process
more limited.
With this shunting procedure no
heart failure or renal shutdown oc
curred. In two unshunted patients
with ruptured aortas, major complica
tions occurred. The first patient was
admitted in shock and was hurried
to the operating room. Once the
aorta had been cross-clamped, the
blood pressure stabilized and it was
decided to carry on the procedure
without a shunt. Secondary metabolic
acidosis developed during the 35minute period of aortic cross-clamp
ing and when the aorta was un
damped, the heart arrested. Fortu
nately, the patient was successfully
resuscitated. In the second patient
the Gott aneurysm shunt was acci
dentally placed in hematoma sur
rounding all of the descending aorta.
During the 54 minutes of aortic cross
clamping, there was no distal per
fusion; paraplegia resulted. In our
series, the mean aortic cross-clamping
time was 39 minutes. In nine com
plicated cases, the aorta was crossclamped for 60 to 135 minutes. The
shunt procedure was successful in all
and no complications occurred. We
do believe that a shunting procedure
should be used to protect the heart
and cerebral vessels proximally and
to assure good distal perfusion of
the spinal cord and kidneys.3
Conclusion

Regardless of cause, most descend
ing thoracic aortic aneurysms should
be surgically treated because of the
constant threat of rupture. We be
lieve that a shunting procedure should
be used to protect the heart and
distal organs. In our experience the
Gott aneurysm shunt is an excellent
shunting device for this purpose.
Addendum

Since this paper was written, two more
patients have successfully undergone re
section of a chronic traumatic aneurysm
using the Gott aneurysm shunt to provide
external bypass.
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Effectiveness of the Adriamycin-DNA Complex in
Kidney Allograft Immunosuppression
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The chem otherapeutic effectiveness
of the lysosom otropic A d ria m yc in -D N A
complex has been dem onstrated
experimentally. This study evaluated
the im m unosuppressive activity of
the complex on renal allografts in rats
of the B u ffa lo-Le w is strain. S ix rats
receiving no treatment served as a
control. Five rats received D N A alone
(at a dose equivalent to that in the
complex), seven received the
A d ria m yc in -D N A com plex (molar
ratio of D N A mononucleotide to
Adriamycin, 20:1) and five were given
free Adriamycin. Adriamycin, free
or linked to D N A, w as injected as
follows: 2 m g/kg on days 2, 6 and 9
and 1 m g/kg on day 13 after
transplantation.
The A d ria m y c in -D N A complex
prevented renal allograft rejection
in the early postoperative period, by
delaying for more than a week, the
increase in serum creatinine levels in
anim als receiving transplants.
Histologic examination of renal grafts
in these rats confirm ed the reduced
severity of acute cellular rejection.
There w as also functional and
m orphologic evidence of reduced
toxicity of Adriam ycin when linked
to DNA. The beneficial effect of
such a drug should be attributed to
its lysosom otropic m echanism of
activity.
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L'efficacite chimiotherapeutique
du com plexe A d ria m ycin e -A D N
possedant un tropism e pour les
lyso so m e s a ete experimentalement
demontre. Cette etude a evalue
le pouvoir im m unosuppresseur de ce
com plexe sur I'allogreffe renale
chez des rats de le lignee BuffaloLewis. Six rats tem oins n ’ont repu
aucun traitement. Cinq rats ont recu de
I'A D N seul (a une dose equivalente
a celle contenue dans le complexe),
sept ont recu le complexe
A d ria m y c in e -A D N (a un rapport molaire
d 'A D N m ononucleotide/Adriam ycine
de 20:1) et cinq ont regu de
I’Adriam ycine libre. L’Adriamycine,
libre ou liee a I'A D N , a ete administree
de la facon suivante: 2 m g/kg
aux jours 2, 6 et 9 et 1 m g/kg au
13e jour apres la greffe.
Le com plexe A d ria m yc in e -A D N
a em peche le rejet de I'allogreffe
renale dans la periode postoperatoire
immediate, en retardant par plus
d'une sem aine I'augmentation du taux
de la creatinine serique chez les
animaux greffes. L'exam en histologique
des greffons chez ce s rats a confirme
la moindre intensity du rejet cellulaire
aigue. On a a u ssi constate des
sig n e s fonctionnels et m orphologiques
d'une toxicite dim inuee de
I’Adriam ycine lorsqu'elle etait liee
a I'A D N . Les effets benefiques
d ’un tel m edicament doivent etre
attribues a son m ecanism e de
tropism e pour les lysosom es.

G uy J ean ,*

attack selectively the cells that have
both a high endocytic and mitotic
rate, mostly tum our cells and also
stimulated lymphocytes.
The complex formed between A dri
amycin and DNA possesses the phy
sicochemical and in-vitro biological
characteristics of such a lysosomotro
pic drug.3 Moreover, the imm unosup
pressive action of Adriamycin relates
to its influence on the proliferation
and the blast transform ation of sti
mulated lymphocytes4 that characte
rize the cell-mediated immunologic
acute rejection of transplanted organs.
The chemotherapeutic effectiveness
of the lysosomotropic A driam ycinDNA complex has been successfully
demonstrated experimentally.3 The
present study was undertaken to eva
luate its potential immunosuppressive
activity on kidney allografts in rats.
E xperim ental A nim als

Male adult rats of the Buffalo
(Bu) and Lewis (Le) inbred strains
were used. They were obtained from
Microbiological Associates, W alkersville, Md. and Canadian Breeding,
Charles River Breeding Laboratories
Inc., W ilmington, Mass., respectively.
They weighed between 300 and 400 g.
M ethods

Orthotopic right kidney grafts were
implanted using ether anesthesia, in
the Bu—^Le rat strain combination,
according to already published tech
niques.5 Total duration of cold ische
mia averaged 30 minutes. The recip
ient’s own kidneys were removed at
the time of transplantation.
Doxorubicin (Adriamycin, Adria
Laboratories of Canada Ltd., Missis
sauga, Ont.) was dissolved in sterile
distilled water to a concentration of
20 m g/m l. Herring sperm DNA
(highly polymerized, type VII; Sigma
Chemical Co., St. Louis, M o.) was
dissolved in sterile 0.15 M N aC l to
a concentration of 2.34 mg/ ml, auto
claved for 15 minutes at 120°C and
cooled slowly. At the time of injec
tion, one volume of Adriamycin was

The concept of "lysosomotropic”
drugs' has led to new therapeutic
considerations, particularly in cancer
chemotherapy.2 An active drug is
bonded to a macromolecular carrier
to form an inactive complex, whose
intracellular penetration will be re
stricted to the endocytic route. Fol
lowing digestion of the carrier by the
lysosomal enzymes, free active drug
will appear first within lysosomes.
From these organelles it may diffuse
into the other parts of the cell, such
as the nucleus, to reach its target.
Obviously a drug that interferes with
DNA replication would be particu
larly advantageous, since it would
I THE CANADIAN JOURNAL OF SURGERY
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mixed with 100 volumes of DNA to
form a solution of complex with a
molar ratio of DNA mononucleotide
to Adriamycin of 20 to l.3
Rats were divided into four groups:
six untreated rats served as a control
(group 1), five rats were given DNA
alone (group 2), seven rats received
the Adriamycin—DNA complex (group
3) and five received free Adriamycin
(group 4). Adriamycin, free or linked
to DNA (molar ratio of DNA mono
nucleotide to Adriamycin of 20 to
1), was given intravenously under
light ether anesthesia as follows: 2
mg/kg on days 2, 6 and 9 and 1
mg/kg on day 13 after transplanta
tion. DNA was injected according to
this schedule, at a dose equivalent to
that present in the Adriamycin-DNA
complex, and rats in the control group
also were injected according to this
schedule with an equivalent amount
of 0.9% saline. On drug injection
days and twice a week thereafter,
blood samples were taken for mea
surement of serum creatinine levels
and complete blood count. When the
animals died, an autopsy including
microscopic examination of the trans
planted kidneys was performed.
Statistical analysis of the serum
creatinine levels was carried out using
Fisher's exact test with analysis of
variance.

Survival time in both groups was
similar, ranging from 15 to 96 days
in group 1 and from 13 to 54 days
in group 2.
G roup 3

Renal function in the early post
operative period was markedly im
proved, since graft failure became
evident only on day 16. Unfortuna
tely, from then on until the animals
died, deterioration of renal function
was rapid (Fig. 2). Compared with
the control group, the beneficial effect
of the lysosomotropic drug was statis
tically significant (P < 0.05) from
days 6 to 13 (Table I), but there was
no significant change in the duration
of survival.
G roup 4

In contrast to group 3, studies of
graft function in rats treated with
free Adriamycin revealed an early
progressive increase in serum crea
tinine levels, from a mean of 1.4 mg/
dl (123.8 /i.mol/1) on day 6 to 4
mg/dl (354 yu.mol/1) on day 20 after
transplantation (Fig. 2). In spite of
this, rat survival time was not sig
nificantly altered (Table I).
H isto lo g ic F in d in g s

of the transplanted kidneys in groups
1 and 2 were comparable. Rejection
was evident in all grafts except for
one that had to be excluded because
of advanced autolysis. When rats died
early after transplantation (13 to 19
days) there were morphologic signs
of massive or marked acute cellular
rejection, whereas later (24 to 30
days), rejection was of the mixed,
acute and chronic types. In long-term
survivors (more than 1 month), the
histologic picture was one of chronic
rejection.
In group 3 rats treated with the
Adriamycin-DNA complex, no florid
acute rejection was observed. In
three renal transplants, the lympho
cytic infiltration was either discrete
or clearly focal and, in two instances,
there was no histologic evidence of
graft rejection. In most cases, how
ever, other renal lesions, such as ne
crotizing papillitis and infectious pro
cesses, were detected.
Similar results were obtained in
group 4, but signs of acute rejection
were always present. In contrast to
group 3. additional lesions such as
glomerular sclerosis with large epi
thelial vacuoles were observed in rats
surviving more than 1 week after the
end of the treatment.

Findings on histologic examination

Results
G ro u p s 1 and 2

Immunologic deterioration of renal
function in the control group started
at day 6 after transplantation with a
serum creatinine level reaching a
mean of 2 mg/dl (177 ^m ol/l), in
creasing to 3 mg/dl (265 yu.mol/1) on
day 9, to oscillate thereafter between
the two levels until the animal died.
DNA treatment did not change signif
icantly the alteration in the renal
function after transplantation (Fig. 1).

T a b le

FIG. 1— Renal function after trans
plantation in group 1 (control) and
group 2 (DNA-treated) rats. Arrows indi
cate injection times.

FIG. 2— Renal function after trans
plantation in groups 1, 3 and 4. Arrows
indicate drug injection days with corres
ponding free or DNA-linked Adriamycin
dose (mg/kg).
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*D N A (group 2) did not change s ig n ific a n tly th e a lte re d renal fu n c tio n .
NS = not significant.
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this dose it is possible to prevent
weight loss and systemic toxicity and
to obtain long-term survivors, parti
cularly when the drug is used as a
DNA complex. Since kidney rejec
tion becomes obvious 6 days after
transplantation in untreated rats (Fig.
1), we decided to test a dosage of
2 mg/kg of Adriamycin on days 2,
6 and 9 and 1 mg/kg on day 13
after surgery, as either free or DNAlinked Adriamycin.
The B u ^ L e inbred strain of rats
was used for this study because the
transplantation genetics, microvascular operative techniques and allo
graft survival are firmly established
in this experimental model.5,21'23
Our results show clearly that the
Adriamycin-DN A complex reduces
significantly the severity of renal
allograft rejection in the early post
operative period, as evidenced by graft
function after transplantation (Fig. 2,
Table I) and by histologic examina
tion of the transplanted kidneys after
death of the animals (Table II). In
deed, the increase in serum creatinine
levels is delayed for at least a week
and histologic evidence of cellular
rejection is reduced, if not completely
absent, in the complex-treated group
compared with the control group. This
beneficial effect is not due to DNA,
which itself does not modify the re
jection and functional deterioration of
the kidney (Fig. 1, Table II). Rather,
it should be attributed to the lyso
somotropic mechanism of activity of
the Adriamycin-DNA complex on the
cell-mediated response to kidney allo
graft, because free Adriamycin does
not appear to be as effective (Fig. 2,
Table I).

Discussion

The physicochemical properties and
the biological characteristics of the
Adriamycin-DNA
complex
have
clearly established it as a lysosomo
tropic drug.3,6 Plasma clearance and
tissue distribution of free and DNAlinked Adriamycin show reduced up
take of the complex by such tissues
as kidney, heart and gastrointestinal
tract.7'9 Moreover, serum desoxyribonuclease activity has been shown to
be very low in rats (as in humans)
compared with that in other spe
cies,1011 thus preventing rapid plasma
tic dissociation of the complex after
intravenous injection.
Experiments have shown that the
Adriamycin—DN A complex, while
overall only half as toxic as free
Adriamycin, possessed greater chemo
therapeutic effectiveness against Lmo
leukemia in DBA2 mice.2,3'12'14 In clin
ical trials with this lysosomotropic
drug some success has also been re
ported, mainly in hematologic neo
plasms.14'17
The toxicity of Adriamycin for
most tissues is appreciably reduced
after intravenous injection as a DNA
complex, especially with respect to rat
cardiac18 and mouse hematopoietic
and gastrointestinal toxicity.19,20 How
ever, comparative studies of the po
tential nephrotoxic effects of these
agents in rats have not been reported.
To avoid systemic toxic effects in
our experimental model, we have
established, in preliminary experi
ments, that the cumulative dose of
Adriamycin, given intravenously in
normal rats, should not exceed 8
mg/kg during a 4-week period. At

T a b le I I — T y p e a n d S e v e r i t y o f R e je c t io n a f t e r R e n a l T r a n s p l a n t a t io n
T i m e o f d e a th a f t e r t r a n s p la n t a t i o n , d
G ro u p
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3
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M o d e ra te
A b s e n t*
2

The differences observed in the
curves of postoperative renal func
tion between the control and Adriamycin-treated groups (Fig. 2), and the
morphologic evidence of glomerular
epithelial vacuoles, never seen in
groups 1 and 2, suggest a nephrotoxic
effect of free Adriamycin. This ne
phrotoxicity is considerably less
evident, both from our functional
and morphologic studies, when the
drug is linked to DNA. However,
the toxic effect of Adriamycin on
the kidneys, together with the higher
susceptibility of immunosuppressed
animals to infectious complications,
may account for the lack of long
term survival in groups 3 and 4.
These preliminary results indicate
that the lysosomotropic AdriamycinDNA complex possesses an immuno
suppressive effect on rat renal allo
graft rejection, at least as beneficial
and potentially less toxic than the
free drug. Efforts should therefore
be made to find other drugs without
nephrotoxicity and perhaps new car
riers to increase the specificity of
lysosomotropic agents to the cells
responsible for the immunologic at
tack on transplanted organs.
We are indebted to Danielle Deprez-De
Campeneere and Roger Baurain for their
collaboration.
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LIPOSYN* 10% Injection
Intravenous Fat Emulsion 10%
Intravenous Nutrient Supplement

Use in Renal Disease:
Lipid infusion should be used with caution in patients with acute renal disorders
and in those with coagulation disturbances or blood dyscrasias. The serum of
such patients should be examined regularly lor the presence of lipids.
Extreme care should be used in administering fat infusions to diabetics control
led with insulin and to patients with liver disease (See CONTRAINDICA
TIONS).

PRESCRIBING INFORMATION
DESCRIPTION
LIPOSYN* 10% (Intravenous Fat Emulsion 10%) is a sterile, nonpyrogenic fat
emulsion prepared for intravenous administration. It contains 10% safflower oil,
1.2% egg phosphatides and 2.5% glycerin in Water for Injection. Sodium hy
droxide has been added to adjust the pH to approximately 8.0.
The safflower oil is a mixture of neutral triglycerides of predominantly unsatura
ted fatty acids. The fatty acids forming the major component of the emulsion are
linoleic (77%), oleic (13%), palmitic (7%), and stearic acid (2.5%).
LIPOSYN* 10% Injection has an osmolarity of approximately 300 mOsm/litre
and contains emulsified fat particles of approximately 0.4 micron in diameter,
similar to naturally-occurring chylomicrons. The total caloric value of
LIPOSYN* 10% including fat, phospholipid and glycerol is 1.1 kcal/mL. Of this
total, 0.7 kcal/mL is supplied by linoleic acid.
ACTIONS
LIPOSYN* 10% (Intravenous Fat Emulsion 10%) provides the patient requiring
parenteral nutrition with a source of calories and the essential fatty acids nor
mally obtained from a nutritionally complete oral diet. The supplemental polyun
saturated fat prevents biochemical changes of essential fatty acid deficiency
(EFAD) and prevents and reverses EFAD clinical manifestations (scaliness of
skin, growth retardation, poor wound healing, sparse hair growth). The infused
fat particles are cleared from the bloodstream in a manner thought to be similar
to the clearing of chylomicrons.
INDICATIONS AND CLINICAL USE
LIPOSYN* 10% (Intravenous Fat Emulsion 10%) is indicated as a source of
calories for patients requiring parenteral nutrition. This includes pre- and post
operative nutritional disorders and nutritive disorders resulting from decreased
or inhibited intestinal absorption, as with tumours of the digestive tract, or in
ulcerative colitis and terminal ileitis.
LIPOSYN 10% Injection is also indicated in burn cases, where nitrogen loss
can be excessive, in prolonged states of unconciousness if tube feeding is
inadvisable and in cachexia due to serious diseases other than of the alimenta
ry tract.
Where such nutrition is required for extended periods of time (more than five
days), LIPOSYN* 10% Injection is also indicated as a source of essential fatty
acids to prevent biochemical changes in fatty acid composition of plasma lipids
(elevated triene/tetraene ratio) and the clinical manifestations of EFAD.
CONTRAINDICATIONS
Intravenous fat administration is contraindicated when normal fat metabolism is
disturbed, such as in certain forms of liver disease, metabolic disturbance, or
uncompensated diabetes. Since intravenously administered fat is removed
from the bloodstream by the liver, patients with severe liver disease should not
be given fat infusions until further experience has shown this to be without risk.
Caution is required when LIPOSYN* 10% is administered to patients with
moderately severe liver disease.
Infusion of fat emulsion is contraindicated in patients demonstrating distur
bances in normal fat metabolism, such as hyperlipidemia, lipoid nephrosis, or
acute pancreatitis if accompanied by hyperlipidemia. The use of fat emulsion
with heparin is contraindicated in patients with coronary artery disease.
Because of the risk of acidosis, fat emulsion should not be used in diabetics
who are not receiving insulin. The safety of fat infusions in diabetics treated with
oral hypoglycemic agents is not known.
WARNINGS
Caution should be exercised in administering Intravenous Fat Emulsion 10% to
patients with severe liver damage, pulmonary disease, anemia or blood dis
orders or when there is danger of fat embolism.
In very low-birth weight infants, the adverse effects of fat emulsion infusion on
pulmonary function and bacterial defences may outweigh the benefits (Fischer,
et al. 1980; Leven, et al. 1980). See special precautions for use in premature
and small-for-gestational age infants under DOSAGE AND ADMINISTRATION
- pediatric patients.
The consequences of long-term infusion of fat emulsion with a high linoleic acid
content are not known.
PRECAUTIONS
Use in Pregnancy:
The safety of fat emulsion for intravenous use during pregnancy or lactation
has not yet been established; therefore, it should not be given to pregnant
women or to women of child-bearing age unless its use is deemed essential to
the welfare of the patient.
Use in Patients with Liver Disease:
Liver function should be monitored frequently if fat emulsion is given to patients
with moderately severe liver disease. In long-term administration, liver function
tests should also be performed. Because free fatty acids displace bilirubin
bound to albumin, the use of lipid infusions in jaundiced or premature infants
should be undertaken with caution. Should not be used in jaundiced prema
tures.
General:
During fat emulsion therapy, the patient’s hemogram, blood coagulation, liver
function, platelet count and plasma lipid profile must be closely monitored.
Lipemia (as determined from observation of a centrifuged sample of plasma)
must clear daily between infusions. LIPOSYN* 10% Injection should be dis
continued should a significant abnormality in any one of these parameters be
attributed to therapy.
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ADVERSE REACTIONS
Adverse reactions reported to occur during or following infusion of fat emul
sions include: fever, chills, nausea, vomiting, headache, anemia, fatty throm
bus, thrombophlebitis, "colloid reaction", which is characterized by back or
chest pain with dyspnea and cyanosis and "overloading syndrome", which is
generally characterized by fever, headache and/or hyperirritability, often in the
presence of persisting hyperlipidemia.
SYMPTOMS AND TREATMENT OF OVERDOSAGE
Overdosage of LIPOSYN* 10% Injection is most likely to result in the
"overloading syndrome" (See under ADVERSE REACTIONS). The infusion
should be stopped immediately and sodium chloride 0.9%, or balanced salt
solution given. When symptoms have abated, the plasma is clear and other
blood lipid measurements have returned to normal, LIPOSYN* 10% Injection
may be restarted, cautiously.
DOSAGE AND ADMINISTRATION
LIPOSYN* 10% Injection (Intravenous Fat Emulsion) should be administered
as part of an intravenous total nutrition program via peripheral vein or central
venous catheter.
LIPOSYN* 10% Injection should not be mixed with electrolytes, nutrients or
other additive solutions. However, Heparin has been shown to be stable when
added to the emulsion at a concentration of 1-2 Units/mL. Filters should not be
used for administration of the emulsion.
LIPOSYN* 10% Injection is supplied in 100 mL and 500 mL single-dose
containers. Partially used bottles must be discarded and should not be stored
or re-sterilized for later use. Do not administer the contents of any container in
which the emulsion appears to be oiling out.
LIPOSYN* 10% Injection can be infused into the same central or peripheral
vein as the carbohydrate/amino acid solutions by means of a short, Yconnector near the infusion site. This allows for mixing of the solutions imme
diately before entering the vein or for alternation of each solution. Flow rates of
each solution should be controlled separately by infusion pumps if these are
used. Fat emulsion may also be infused through a separate peripheral site. If
desired, Heparin may be added to LIPOSYN* 10% Injection at a concentration
of 1-2 Units/mL prior to administration,
LIPOSYN* containing fluids have a propensity to extract phthalates from
phthalate-plasticized polyvinyl chloride (PVC), Although the amount is very
small and no adverse clinical effects have been reported from administration of
such amounts of phthalate, it may be advisable to consider administration of
LIPOSYN 10% Injection through a non-phthalate infusion set.

The amount of intravenously administered fat normally should not exceed 2 g of
fat (corresponding to 20 mL of LIPOSYN* 10%) per kg body weight.
LIPOSYN* 10% Injection has a caloric value of 1.1 kcal/mL. Of this total, 0.7
kcal/mL is supplied by linoleic acid.
Adult Patients:
LIPOSYN* 10% Injection can provide up to 2 g fat/kg body weight per day. The
remaining calories should be provided by carbohydrate and amino acids.
For the prevention of essential fatty acid deficiency, the recommended daily
requirement is approximately 4% of the caloric intake as linoleate. In most adult
patients, this can be supplied as 500 mL of LIPOSYN* 10% Injection adminis
tered twice weekly.
The infusion should be started at a rate of 1 mL/minute for the first 15 minutes.
If no adverse effects are observed during this initial infusion, the rate can be
increased to allow no more than 500 mL to be given over a period of four to six
hours.
Pediatric Patients:
LIPOSYN* 10% Injection can provide up to 60% of daily calories at a dose not
to exceed 4 g/kg of body weight per day. The other 40% should be provided by
carbohydrate and amino acids. For the prevention of essential fatty acid defi
ciency, the recommended daily requirement is approximately 4% of the caloric
intake as linoleate. The daily dosage ranges from 5 mL to 10 mL per kg,
depending on the size and maturity of the patient.
The infusion should be started at a rate of 0.1 mL/minute for the first 15 min
utes. If no adverse effects are observed during this initial infusion, the rate can
be increased to allow no more than 100 mL per hour.
Premature and Small-for-Gestational-Age Infants:
Sick infants, premature and small-for-gestational-age infants are at greater risk
of developing hyperlipidemia. Lipidemia has the potential for lowering oxygen
tension, especially in infants with pulmonary insufficiency. Small babies tolerate
fat infusion better if it is given by continuous infusion at a rate of 0.2 g fat/kg
body weight per hour over a 20-24 hour period.
AVAILABILITY
LIPOSYN* 10% Injection (No. 4335; DIN 503401) is supplied in 100 mL and
500 mL single-dose containers.
Product monograph available on request.
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LIPOSYN supplies concentrated nutritional support in a
clinically proven isotonic formula.1 And since LIPOSYN is
based on safflower oil, it contains 77% linoleic acid — a
high percentage when compared to soybean oil lipids
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To lower
blood pressure
during
anesthesia

Nipride

reduces excessive
blood loss

Precautions

for controlled hypotension during anesthesia
Rx Summary
‘Nipride' is only to be used as an infusion with sterile 5% dextrose
in water without preservatives. Not for direct injection.
Indications
'Nipride' is indicated for producing controlled hypotension during
anesthesia to reduce bleeding in surgical procedures where deemed
appropriate. Benefit-risk ratio should be carefully considered on an
individual basis.
Contraindications
In the treatment of compensatory hypertension, e.g. arteriovenous
shunt or coarctation of the aorta. It is also contraindicated in physically
poor-risk patients (A.S.A. Risk 5), in patients with uncorrected anemia
or hypovolemia or in those with known inadequate cerebral circulation.
In patients with liver disease, severe renal disease, Leber’s optic
atrophy and disease states associated with vitamin B 12 deficiency.
Warnings
‘Nipride’ is only to be used as an infusion with sterile 5% dextrose
in water without preservatives. Not for direct injection. Infusion rates
greater than 8 jig/kg/minute are virtually never required. If at this
rate an adequate reduction in blood pressure is not obtained within
10 minutes, administration of ‘Nipride’ should be stopped.
Fatalities due to cyanide poisoning have occurred following sodium
nitroprusside administration. One factor is common to all known
cases, namely that large amounts of nitroprusside were infused at
high rates. Since detoxification relies upon enzymatic action, the
rare possibility of deficient or atypical enzymes occurring in humans
should always be considered. Patients most apt to run into difficul
ties are those who are resistant to the hypotensive effect or those
in whom maintenance at the selected blood pressure level is difficult
or impossible.
Constant attention to the patient’s dose-response characteristics
is mandatory. If infusion rates are in excess of 8 jig/kg/minute deter
mine the nature of the response (effective constant response at
higher dose; tachyphylactic; resistant - none or less than expected).
As soon as either tachyphylaxis or resistance is determined the infu
sion of ‘Nipride’ should be discontinued immediately. In abnormal
responders it has been noted that metabolic acidosis may occur
at higher doses.
Caution should be exercised in using ‘Nipride’ in patients with hypo
thyroidism or severe renal impairment.
Blood levels of thiocyanate should be determined if treatment is to
be extended especially in patients with severe renal dysfunction.
As long as blood thiocyanate levels do not exceed 10 m g /100 ml, it is
probably safe to continue with the infusion. Peritoneal dialysis can
be helpful if too high levels of thiocyanate are found.
Hypertensive patients are more sensitive to the intravenous effect
of sodium nitroprusside than are normotensive subjects. Patients
receiving concomitant antihypertensive medications (especially
hydralazine or hexamethonium) are more sensitive to the hypotensive
effect of sodium nitroprusside and the dosage of 'Nipride' should
be adjusted downward accordingly.
The following Warnings apply to the use of 'Nipride’ for controlled
hypotension during anesthesia:
1. Extreme caution should be exercised in patients who are especially
poor surgical risks (A.S.A. class 4 and 4E).
2. Tolerance to blood loss, anemia and hypovolemia may be dimin
ished. If possible, preexisting anemia and hypovolemia should be
corrected prior to employing controlled hypotension.
3. Hypotensive anesthetic techniques may alter pulmonary ventilation
perfusion ratio. Patients intolerant of additional dead air space
at ordinary oxygen partial pressure may benefit from higher oxygen
partial pressure.
4. Resistance and tachyphylaxis occur more frequently in normoten
sive patients infused with sodium nitroprusside. Induction of delib
erate hypotension in healthy young individuals may prove to be
more difficult than in other segments of the population.
5. Upon discontinuance of the sodium nitroprusside infusion for the
purpose of controlled hypotension during anesthesia a rebound
hypertension has been observed on rare occasions.

Adequate facilities, equipment and personnel should be available
for frequent and vigilant monitoring of blood pressure. When the infu
sion is slowed or stopped, blood pressure usually begins to rise imme
diately and returns to pretreatment levels within one to ten minutes.
It should be used with caution and initially in low doses in elderly
patients, since they may be more sensitive to the hypotensive effects
of the drug.
If, in the clinical situation, stress induced by pain or manipulation
is reduced or eliminated during 'Nipride' infusion, the patient could
experience a greater than expected reduction in blood pressure
unless the rate of infusion is adjusted downward as required.
'Nipride' tends to deteriorate in the presence of light. Therefore, the
infusion bottle should be wrapped with aluminum foil or other opaque
material. Solutions of ‘Nipride’ should not be kept or used longer
than four hours. 'Nipride' in aqueous solution yields the nitroprusside
ion, which reacts with even minute quantities of a wide variety of
organic and inorganic substances to form usually highly coloured
reaction products (blue, green or dark red). If this occurs, the infusion
should be replaced as quickly as possible.
Adverse reactions
Nausea, retching, emesis, diaphoresis, apprehension, headache,
restlessness, agitation, muscle twitching, retrosternal discomfort and
chest pain, palpitations, dizziness, faintness, weakness, rash, abdo
minal pain, confusion and somnolence have been noted with too
rapid reduction in blood pressure. These symptoms rapidly disap
peared with slowing of the rate of infusion or temporary discontinua
tion of infusion and did not reappear with continued slower rate
of administration.
Irritation of the injection site may occur. Methemoglobinemia and
one case of hypothyroidism following prolonged therapy have been
reported.
Dosage and administration (for controlled hypotension)
Use of ‘Nipride’ in anesthetized normotensive patients undergoing
deliberate hypotensive surgery must be restricted to carefully
selected cases. There is a possibility of an abnormal response
occurring in normotensive patients. In this event, the infusion of
‘Nipride’ should be discontinued immediately. (See Warnings).
The contents of a 50 mg ’Nipride’ vial should be dissolved in 3 ml
of sterile dextrose in water without preservatives. No other diluent
should be used. Depending on the desired concentration, all of the
prepared stock solution should be diluted in 500 or 1000 ml of 5 per
cent sterile dextrose in water and promptly wrapped in aluminum
foil or other opaque material. Both stock solution and infusion solu
tion should be freshly prepared and any unused portion discarded.
The freshly prepared solution for infusion has a very faint brownish
tint. If it is highly coloured, it should be discarded. (See Precautions).
The solution should not be kept or used longer than four hours from
initial reconstitution. The infusion fluid used for the administration
of ’Nipride’ should not be employed as a vehicle for simultaneous
administration of any other drug.
'Nipride' dosage varies considerably from patient to patient, hence
the need for individual titration. The infusion should be started at
the lower dosage range, 0.5 ^g /kg /m in u te and increased by
0.2 ^g/kg/m inute every 5 minutes until the desired reduction in
blood pressure is obtained. The blood pressure usually starts to drop
immediately or at least within a few minutes. Continuous monitoring
of the blood pressure is necessary. Blood pressure should not be
allowed to drop at too rapid a rate and systolic pressure should not
be lowered below 60 mm Hg.
Infusion rates greater than 8 /xg/kg/m inute should rarely be used.
The maximum recommended dose is 800 jxg/minute.
‘Nipride’ should be administered by an infusion pump, micro-drip
regulator or any similar device that will allow precise measurement
of the flow rate. Avoid extravasation. The rate should be adjusted
to maintain the desired hypotensive effect, as determined by frequent
blood pressure determinations.
For the use of ’Nipride’ in the treatment of hypertensive crises please
refer to the Product Monograph.
Supply
‘Nipride’ is supplied in 5 ml amber-coloured vials containing the
equivalent of 50 mg sodium nitroprusside for dilution with 5 percent
sterile dextrose in water (available in packages of 10).
Product Monograph available on request.
* Reg. Trade Mark for sodium nitroprusside 'Roche'
®Reg. Trade Mark

Can. 8042

(sodium nitroprusside)

Usage in pregnancy
The safety of ’Nipride’ in women who are or who may become preg
nant has not been established; hence, it should be given only when
the potential benefits have been weighed against possible hazard
to mother and fetus.
Usage in children
The safety of 'Nipride' in children has not been established. Clinical
experience is limited.
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Myocardial Glycolytic and Gluconeogenic Enzyme Activity
during Cardiopulmonary Bypass in Humans
S.F.G. W r e n ,

m d , f r c s [c ],

T.A. Salerno ,

Through a study of the activity of
the regulatory enzyme of glycolysis
phosphofructokinase and the regulatory
enzyme of gluconeogenesis fructose-1,6diphosphatase, myocardial metabolism
has been evaluated in the human
heart during cardiopulmonary bypass.
Three ventricular transmural biopsy
specimens were obtained at open-heart
surgery before cardiopulmonary
bypass was instituted and three
similar specimens were taken
30 minutes after cardiopulmonary
bypass was started. The enzyme
assays were performed on the
supernatant obtained from myocardial
cells disrupted by sonication.
The activity of both enzymes increased
during the anoxic conditions of
cardiopulmonary arrest. The increase in
phosphofructokinase activity is likely
due to an overall increase in glycolytic
activity, but the presence and
increased activity of fructose-1,6diphosphatase was unexpected.
Le metabolisme myocardique du coeur
humain en circulation extracorporelle
a ete evalue par I'etude de I'activite
de I’enzyme regulateur de la
glycolyse, la phosphofructokinase, et
de celle de I'enzyme regulateur
de la gluconeogenese, la fructose-1,
6-biphosphatase. Trois biopsies
transmurales ventriculaires ont ete
obtenues lors d'une operation
a coeur ouvert avant le debut de la
circulation extracorporelle, et trois
echantillons similaires ont ete pris
30 minutes apres I’instauration de
la circulation extracorporelle. Les
determinations enzymatiques ont ete
pratiquees sur le surnageant d'une
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preparation de cellules myocardiques
brisees par ultrasons. L’activite des
deux enzymes etait augmentee durant
la periode d'anoxie de I'arret
cardiopulmonaire. L'augmentation
d’activite de la phosphofructokinase
est possiblement due a une
augmentation generate de I'activite
glycolytique, mais la presence et
I’activite accrues de la fructose-1,6biphosphatase n'etaient pas prevues.

Morphologic1 and histochemical2 in
vestigations using transmural myocar
dial biopsy specimens from human
hearts during cardiopulmonary bypass
have proved valuable in adding to
our understanding of myocardial
metabolism under these conditions.
We have extended the evaluation
of human ventricular myocardium
during cardiopulmonary bypass by
studying the activity of the regulatory
enzyme of glycolysis phosphofructo
kinase and the regulatory enzyme of
gluconeogenesis fructose-1,6-diphos
phatase.
Patient Selection

Patients who underwent aortocoro
nary bypass and who did not have
substantial myocardial fibrosis or
dysfuction were chosen. Specimens
were obtained with a Tru-cut biopsy
needle3 (Travenol Laboratories Inc.,
Deerfield, 111.). Only one biopsy could
be taken from each patient. Six biopsy
specimens were taken and divided
into two groups: group 1 in which
three were obtained before cardiopul
monary bypass and group 2 in which
three were taken 30 minutes after car
diopulmonary bypass was started. As
says for phosphofructokinase and
fructose-1,6-diphosphatase were per
formed on all specimens.
Method

Preparation of Biopsy Specimens
Transmural left ventricular biopsy
specimens were placed in an ice-cold
buffer solution (50 mM TRIS hydro
chloride, 1 mM ethylene diamine
tetra-acetate [EDTA] and 5 mM
magnesium sulfate, pH 8.2). The
sample was finely chopped, washed
and resuspended in 1 ml of buffer.
The heart suspension was then soni
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cated at 30% power in a sonic 300
W Dismembrator (Fisher Scientific
Co. Ltd., Toronto, Ont.) for 6
minutes. The resulting homogenate
was centrifuged at 800 X g for 5
minutes and the supernatant was used
for the enzyme assay.
Enzyme Assays
Phosphofructokinase was assayed
by a modification of methods pre
viously described,4*5 using a threestage reaction in which the fructose1,6-diphosphate generated from fructose-6-phosphate was converted to
glyceraldehyde-3-phosphate and dihy
droxy acetone phosphate in the pre
sence of excess aldolase; these in
turn were converted to 1,3-diphosphoglycerate in the presence of excess
glycerol-3 -phosphate dehydrogenase
and triose phosphate isomerase. The
oxidation of nicotinamide adenine
dinucleotide (reduced) (NADH) was
measured in a Beckman ratio re
cording spectrophotometer (Beckman
Instruments, Fullerton, Calif.) at
37°C and 340 nm. The assay medium
was 50 mM TRIS hydrochloride con
taining 5 mM magnesium sulfate,
200 mM potassium chloride, 1 mM
adenosine triphosphate, 2 mM ade
nosine monophosphate, 0.1 mM
NADH and 0.3 mM potassium cya
nide, pH 8.2.
Aldolase (1.53 U), triose phosphate
isomerase (20 U), glycerol phosphate
dehydrogenase (0.68 U) with 0.03
ml of the enzyme-containing super
natant were added to 1 ml of medium
containing one of the following con
centrations (in mM) of fructose-6phosphate: 0.05, 0.1, 0.2, 0.3, 0.4,
0.6, 1 and 2.
Fructose-1,6-diphosphatase was as
sayed also by a modification of pre
viously described methods.4,5 The
fructose-6-phosphate generated from
fructose-1,6-diphosphate was convert
ed to glucose-6-phosphate in the pre
sence of excess phosphoglucoisomerase and this in turn was converted to
6-phosphogluconate in the presence
of excess glucose-6-phosphate dehy
drogenase. The reduction of nicotin
amide adenine dinucleotide phosphate
(NADP) at 340 nm was followed in
the spectrophotometer. The assay
medium (1.03 ml) consisted of 50
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mM TRIS hydrochloride, pH 8.2, 5
mM magnesium sulfate, 20 mM mercaptoethanol, 0.05 mM EDTA and
0.5 mM NADP. Phosphoglucoisomerase (2.1 U) and glucose-6-phosphate
dehydrogenase suspension (0.35 U)
with 0.03 ml of the enzyme sample
were added to the medium using the
following concentrations (in mM) of
fructose-1,6-diphosphate in the cu
vette: 0.5, 1, 1.5, 2, 5, 10, 15, 20,
25, 30 and 35. Sample aliquots were
assayed for protein according to the
method of Lowry and colleagues,
and enzyme activity was expressed
as units of activity per milligram of
tissue protein. Enzyme activity was
then plotted against the amount of
substrate to obtain activity curves.
Results
In Fig. 1 the phosphofructokinase
activity plotted against increasing sub
strate (fructose-6-phosphate) concen
tration for groups 1 and 2 shows that
myocardial phosphofructokinase ac
tivity is increased at all substrate con
centrations during cardiopulmonary
bypass. Similarly, Fig. 2, in which
fructose-1,6-diphosphatase activity is
plotted against increasing substrate
(fructose-1,6-diphosphate) concentra
tions shows increased activity of this
enzyme during cardiopulmonary by
pass except at high concentrations of
fructose-1,6-diphosphate when the
activity is inhibited.

increasing activity following cardio
plegic arrest, is puzzling. Activity of
this enzyme has not been detected
previously in heart muscle, but has
been demonstrated in some types of
skeletal muscle4 and has been demon
strated histochemically in rat hearts13
and chick embryo hearts.14 Since
fructose-1,6-diphosphatase
activity
has been demonstrated in those mus
cles having a capacity for anaerobic
performance,4 it is tempting to specu
late that the chronically ischemic
myocardium and the anoxic myocar
dium create conditions whereby low,
unmeasurable activity becomes ap
parent, as in our experiments. On the
other hand, anoxia is associated with
increasing glycolytic activity and
would be expected to inhibit gluconeogenesis and hence the activity of
fructose-1,6-diphosphatase.la
Another possible explanation is
that the presence of fructose-1,6-

diphosphatase is necessary to provide
control of glycolysis through the
mechanism of substrate cycling.16 Our
own unpublished observations on the
leukocytes of patients receiving pa
renteral nutrition during which very
large amounts of glucose are adminis
tered, show that glycolytic activity is
increased, as evidenced by increased
activity of phosphofructokinase and
pyruvate kinase; however, the activity
of fructose-1,6-diphosphatase is not
inhibited but tends to increase. This
would lend support to the need for
substantial fructose-1,6-diphosphatase
activity in tissues in which glycolytic
activity is increased.
The chemicals used in the enzyme
assays were supplied by Boehringer
Mannheim Canada. Dorval, PQ.
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Early Gastric Cancer at the Hotel-Dieu de Montreal:
a 30-Year Review
M arcel J. R h e a u l t , m d , m sc , fr c s [c], facs , R ichard L eandri, m d , A lain L a p o in t e , d sc a and
C laude P o tv in , m d , f r c s [c ], facs

Early gastric cancer is usually defined
as a lesion involving the mucosa
alone or the mucosa and submucosa,
regardless of whether lymph-node
metastases are present.
Between 1948 and 1978, 1295 gastric
cancers were diagnosed at the
Hotel-Dieu de Montreal. Of these,
64 ( 5 % ) were early gastric cancers.
Sixty of the 64 patients underwent
gastric resection for cure. The other
four cancers were found incidentally
at autopsy. One patient (1.7%)
died following operation. Ten patients
were followed up for less than
5 years and therefore were excluded
from survival analysis, as were
6 patients who died of unrelated
causes. Forty-one of 43 patients
survived, free of disease, for more
than 5 years following operation,
a survival rate of 95.3%.
The annual yield of early gastric
cancers has remained relatively
constant since 1948, even with a
decreasing number of gastric cancers
treated at the hospital. The advent
of fiberoptic endoscopy significantly
(P < 0.005) increased the number
of early gastric cancers detected.
Further improvements will depend
on a more vigorous approach to
endoscopy, especially in high-risk
patients. A refined radiologic technique,
including double-contrast roentgeno
graphy after a barium meal, was
diagnostic in all patients who underwent
operation in this study.
Le cancer gastrique precoce se definit
comme une lesion qui envahit
la muqueuse seule, ou la muqueuse
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et la sous-muqueuse, sans egard a la
presence de ganglions lymphatiques
metastatiques.
Soixante-quatre patients ont
repondu a ces criteres pour representer
5 % des 1295 cas de cancers
gastriques diagnostiques a I’Hotel-Dieu
de Montreal de 1948 a 1978. Soixante
de ces 64 patients ont subi une
resection gastrique a visee curative,
alors que 4 ont ete des decouvertes
d'autopsie. Un patient (1.7%) est
decede apres I’intervention chirurgicale.
Dix patients ont ete suivis pour
moins de 5 ans et ont done ete exclus
des analyses de survie, de meme
que 6 patients qui sont decedes de
causes independantes a leur cancer.
Quarante et un des 43 patients ont
survecu plus de 5 ans a leur operation
pour un taux de survie de 95.3%.
Dans cette etude I'incidence annuelle
des cancers gastriques precoces
est demeuree relativement constante
depuis 1948, malgre une diminution des
cancers gastriques a I’Hotel-Dieu
de Montreal pendant la meme periode.
L'endoscopie a fibre optique couplee
a une technique radiologique precise
depuis 1965 a augmente de facon
significative la proportion de detection
precoce du cancer gastrique
(P < 0.005).
Les progres futurs dans la detection
reposent sur une approche
endoscopique plus agressive en
particulier chez les patients a haut
risque. Dans notre serie, une
technique radiologique rigoureuse,
incluant I’etude double contraste,
a permis la diagnostic precis chez tous
les patients soum is a la chirurgie.

Recent improvement in the diagnosis
of early gastric cancer was stimulated
by the abundant Japanese medical
literature. In 1962 the Japan Gastro
enterological Endoscopic Society de
fined and classified early gastric
cancer. The universally accepted
definition of early gastric cancer is
now carcinoma confined to the mu
cosa, or mucosa and submucosa, re
gardless of the presence of lymphnode metastasis.1 We used this defini
tion in reviewing the experience with
early gastric cancer at the Hotel-Dieu
de Montreal.
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Method

This retrospective study covers the
30-year period from 1948 to 1978.
It includes all cases of gastric cancer
diagnosed at the Hotel-Dieu de Mont
real. In 1948 the tumour registry of
the hospital was organized and fol
low-up of all cases of gastric cancer
was obtained. In 1979 all the data
on gastric cancer were computerized.
The diagnosis of early gastric can
cer is made with the collaboration of
a multidisciplinary group and is based
on the findings from clinical examina
tion, fiberoptic gastroscopy and a re
fined radiologic technique that in
cludes double-contrast
roentgeno
graphy after a barium meal and on
meticulous anatomopathologic observ
ation.
The findings were analysed by the
Student’s t-test for unpaired data and
the y2 test when needed. All P values
correspond to two-tailed statistical
tests.
Findings
Number of Patients

From 1948 to 1978, 1295 gastric
cancers were diagnosed; 64 (5%) met
the criteria of early gastric cancer.
All 64 patients were followed up for
more than 5 years or until their death.
Age and Sex

There was no significant difference
in age between patients with early
gastric cancer and those with other
types of gastric cancer. The mean
age of the entire group was 62.1
years and of those with early gastric
cancer, 59.7 years.
Gastric cancer is more frequent in
men. The ratio in our study was 2
to 1. In our patients with early gas
tric cancer there was a slightly higher
incidence in women but the difference
was not significant.
Diagnosis

The department of radiology at the
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Hotel-Dieu de Montreal2,3 uses a stan
dard three-step technique to identify
early gastric lesions. It consists of
roentgenography after the ingestion
of concentrated barium solution,
followed by filling of the stomach
with dilute barium and completed by
a double-contrast technique. Abdo
minal compression during these three
steps is essential.
In our group of patients no spe
cific symptoms suggestive of early
gastric cancer were found. The endo
scopic and radiologic studies were
performed on the basis of nonspecific
gastrointestinal symptoms.
Sixty of the early gastric cancers
were correctly diagnosed preoperatively, either by the radiologist or by
the endoscopist. Four were found
incidentally at autopsy.
The advent of fiberoptic gastro
scopy in 1965 increased the number
of gastric examinations from 200 to
2000 annually in our institution.
Since 1965 a statistically significant
(P < 0.005) increase was noticed in
the incidence of early gastric cancer,
even though the annual incidence of
the gastric carcinomas treated in our
hospital decreased. This represents an
increase from 3.5% to 7.5% of early
gastric cancer through the combined
diagnostic approach of refined radiologic techniques and the use of fiber
optic endoscopy (Table I).
Treatment
All 60 patients whose cancers were
diagnosed radiologically or endoscopically underwent curative subtotal
gastric resection. One of the 60 pa
tients (1.7%) died after the opera
tion. Before 1977 no patient received
chemotherapy or radiotherapy.
Lymph-Node Involvement
The incidence of lymph-node in
volvement in all gastric cancers in
our series was 77.7%. Ten of the
60 patients who underwent gastrec
tomy for early gastric cancer were

found to have lymph-node metastases
in the resected specimen. This re
presents a 16.7% incidence.
5-Year Survival
The 5-year-survival rate for all
gastric cancers diagnosed in our
institution was 12.2%. Among the
patients with early gastric cancer, 41
(95.3%) of the 43 available for 5-year
follow-up were alive. Excluded from
the 5-year survival figures are the 4
patients whose cancer was diagnosed
at autopsy, 1 patient who died postoperatively, 10 patients in whom the
follow-up was less than 5 years and
6 others who died of unrelated causes.
Discussion
Our experience parallels that of
the Japanese.4 The 5-year survival
rate for early gastric cancer in Japan
is 92.0% compared with 95.3% at
our hospital. Lymph-node metastasis
is encountered in 11% of early gas
tric cancers in the national registry
for stomach cancer in Japan com
pared with 15% in our series. The
only major difference is the incidence
of early gastric cancer, which accounts
for 14% of all gastric cancers in
Japan compared with only 5% in
our institution.
Do our results justify a mass
screening program to identify early
gastric cancer in Canadians and
specifically those in the province of
Quebec? The age-adjusted death rate
from gastric cancer in the United
States from 1930 to 1973 showed
a sharp and constant decrease, from
30 to 8.5 deaths per 100 000 pop
ulation.5
In Canada we had a similar, but
not as sharp, decrease during the same
period. In the province of Quebec6
in 1976, 643 patients died of gastric
cancer in a population of over 6
million — a rate of 10 per 100 000
population. Comparison of the Japa
nese experience with that in Quebec

1948 19 64
1965 1978

No. of
g a s t r ic c a n c e r s

N o . o f e a r ly
g a s t r ic c a n c e r s

%

85 2
44 3

30
34

3 .5
7 .5 *

12 95

64

5 .0

*P < 0 .0 0 5 .
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and the rest of Canada reveals no
similarity between the two. The in
cidence of gastric cancer in Japan
is four times higher. Even with an
increase to 35% of the proportion
of early gastric cancer, as found in
some regions of Japan,7 it does not
appear that in our country a mass
screening program would be a judi
cious use of our medical resources.
Further improvements in early diag
nosis must depend on a more vi
gorous endoscopic approach and a
refined, standardized, radiologic tech
nique, including double-contrast roent
genography after a barium meal, espe
cially in high-risk patients — a group
that would include those with hypochlorhydria, gastric polyps, atrophic
gastritis, gastric ulcer, pernicious ane
mia and a gastric stump following
operation for peptic ulcer or gastric
cancer.
In summary, early gastric cancer is
curable. The rate of diagnosis of
early gastric cancer rises significantly
with the use of a refined radiologic
technique, thorough fiberoptic gastroscopic examination and a meti
culous anatomopathologic examina
tion. At present, because of the low
number of gastric cancers in this
country, we do not feel justified in
proposing a mass screening program
here.
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Umbilical Vein Grafts for Vascular Access in
Patients on Long-Term Dialysis
J.L. W e l l in g t o n , m d , c m , fr cs [c ], facs
Easy access to the vascular system
is vital to any long-term dialysis
program. The author's standard
technique is an end-to-side radiocephalic
arteriovenous fistula; grafts are
reserved for situations in which a
direct fistula is either impossible
to construct or has failed. Although
bovine and, more recently, expanded
Teflon heterografts were successful
initially, late failures from thrombosis
or sepsis were not infrequent.
Since February 1979, modified human
umbilical vein has been used in
patients needing a graft. It was used
on 23 occasions in 21 patients.
There were no early (within 30 days)
failures. The overall patency rate
from 2 to 26 months was 57%. Three
infected grafts required removal,
which was complicated by dense
adhesion between the supporting
Dacron mesh and adjacent tissues.
No true aneurysms developed. After
1 year there was no obvious superiority
of umbilical vein over expanded
Teflon grafts. Longer follow-up is
necessary to determine the ultimate
role of umbilical vein grafts in
patients on dialysis.
Dans tout systeme de dialyse
a long terme une voie facile d'acces
au systeme vasculaire est vitale.
La technique couramment utilisee
par I’auteur consiste a construire
une fistule arterio-veineuse
radio-cephalique termino-laterale;
ces greffons sont reserves pour
les situations ou une fistule directe
est soit impossible a construire
ou qu'elle a deja echoue. Bien que
les heterogreffes bovines ou, plus
recemment, les heterogreffes en
Teflon expanse aient connu du succes
au debut, leur echec tardif par
thrombose ou infection n’a pas ete rare.
Depuis fevrier 1979, une veine
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ombilicale humaine modifiee a ete
utilisee chez les patients necessitant
une greffe. Elle a ete utilisee en
23 occasions chez 21 patients. On n’a
pas connu d'echecs dans les premiers
30 jours. Pour I’ensemble, la frequence
des greffons fonctionnels entre
le 2e et le 26e mois a ete de 57%.
Trois greffons infectes ont dO etre
enleves, operation qui fut compliquee
par la presence d’adherences denses
entre la tulle de Dacron utilisee
comme support et les tissus adjacents.
Aucun anevrysme vrai n'est apparu.
Apres 1 an d'utilisation on n’a note
aucune superiority evidente des
greffons de veines ombilicales sur
ceux de Teflon expanse. Des
etudes complimentaires plus prolongees
sont necessaires pour determiner
le role definitif des greffes de veines
ombilicales chez les patients
soumis a la dialyse.

The success of long-term maintenance
dialysis depends on the ability to
gain ready access to the vascular sys
tem. The absence of suitable blood
vessels occurs particularly in obese
or diabetic patients and those who
have undergone multiple procedures.
As in most centres, the end-to-side
radiocephalic fistula is our standard
method for access; we reserve the
use of grafts for situations in which
the standard fistula cannot be con
structed or has failed.
Although we experienced some
early success with bovine heterografts
and, more recently, with expanded
Teflon,1 late failures from thrombosis
or sepsis were not uncommon. There
fore, since February 1979 a modified
human umbilical vein graft has been
used for patients in whom a graft is
indicated.
Patients and Methods

Meadox Dardik Biografts (Meadox
Medicals, Inc., Oakland, NJ) were
used. They are obtained from the
human umbilical cord under sterile
conditions,2 and are tanned with glutaraldehyde and stored in 70%
ethanol. The tanning process doubles
the tensile strength of the graft and
improves its suture-holding capability.
The current product is supported in
a sleeve of polyester mesh to prevent
dilatation.

The proposed advantages of this
graft are the lower surface clotting
time, the persistence of a smooth intima without vascular invasion or
formation of a pseudointima and the
absence of any immune response in
the recipient.3
Over the past 26 months, modified
human umbilical vein grafts have
been used to create arteriovenous
fistulas on 23 occasions in 21 patients
(9 men, 12 women). The patients
ranged in age from 22 to 69 years
(mean 50 years). All were given 1 g
of a cephalosporin intravenously 1
hour before the procedure; this was
repeated at 6-hour intervals for 48
hours.
Grafts were thoroughly rinsed be
fore insertion with 6 litres of saline
containing 10 000 U /l of heparin
with a final rinse of 30 000 U of
undiluted heparin.4
Operations were performed under
local, regional or general anesthesia
with systemic heparinization. All ana
stomoses were performed with con
tinuous 6-0 Prolene suture using a
2.5 X magnifying loop.
The preferred position for graft
placement was a subcutaneous fore
arm loop between brachial artery and
cephalic vein. Other sites were in the
upper arm using a straight graft be
tween brachial artery and distal axil
lary vein or in the proximal thigh
using a loop between superficial fe
moral artery and saphenous vein. The
thigh is the least desirable site be
cause of the risk of sepsis but has
proven successful in children with
expanded Teflon grafts where the
larger vessels provide higher flow
rates.1
During anastomosis care is taken
to include a portion of the supporting
polyester mesh and the full thickness
of the umbilical vein wall. Initially,
several short forearm incisions were
used in constructing the subcutaneous
tunnel to minimize the diameter and
reduce the chances of kinking or
twisting. Erosion of the prosthesis
occurred on two occasions, when the
graft lay immediately beneath an in
cision. Therefore, only two trans
verse incisions are now made; a
proximal one just distal to the elbow
crease and a distal one for com
pletion of the tunnel. The distal inci-
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sion is undermined so that the graft
does not lie immediately beneath it
(Fig. 1). Grafts are not used for
dialysis for 3 weeks to allow time
for adequate fixation and obliteration
of any dead space in the subcu
taneous tunnel.

of needle puncture rather than to any
inherent weakness of the graft itself.
Four patients have died since
operation from a variety of causes,
but in no instance was death related
to the operative procedure; three had
patent grafts at the time of death.
The patency rate at 1 year was ap
proximately 60% (Fig. 3). This is
the same as for expanded Teflon
grafts.

Results

There were no early (within 30
days) failures and all grafts were ul
timately used for dialysis. In the fol
low-up period of 2 to 26 months, 9
of the 23 grafts failed. Six throm
bosed, three of them following suc
cessful renal transplantation. Com
plete thrombosis was frequently pre
ceded by either downstream venous
stenosis or pannus formation at the
venous anastomosis. Fogarty catheter
thrombectomy was attempted in three
cases of thrombosis but was success
ful only once.
Three grafts were lost through in
fection at 1, 2 and 4 months. In two
patients, infection was preceded by
partial extrusion of the prosthesis at
the site of an overlying forearm in
cision. In no instance could the in
fection be controlled with antibiotics
and all infected grafts had to be
removed.
Limb ischemia, a steal syndrome,
true aneurysm formation or conges
tive heart failure have not occurred.
In one patient two small false aneu
rysms developed approximately 6
months after graft insertion (Fig. 2).
These have not changed in size in 2
years. These aneurysms are probably
related to graft laceration or tearing
of the supporting mesh at the time

Discussion

Extensive laboratory and clinical
studies with modified human umbi
lical vein grafts have shown success
ful results when the graft is used as
a simple vascular conduit.3'7 Repeated
needling in patients on dialysis ex
poses the graft to thrombosis and in
fection and is therefore a demanding
test. Results can be expected to be ad
versely affected by other factors, such
as parallel transplantation or home
dialysis programs.
Six grafts were lost because of
thrombosis; three grafts thrombosed
after successful renal transplantation.
This loss of vascular access after
transplantation is common and is
probably related to disappearance of
the qualitative platelet defect that
exists in uremic patients.
Graft thrombosis is frequently pre
ceded by downstream stenosis either
at or distal to the anastomotic site
(Fig. 4). Such a stenosis should be
suspected when a progressive increase
in venous pressure occurs in the fis
tula. If this is recognized, the graft

may be salvaged by a short interposi
tion segment or local angioplasty.8
After thrombosis occurred, opera
tive thrombectomy was rarely suc
cessful. Reoperation was complicated
by dense adhesion between the sup
porting mesh and soft tissues, which
made mobilization of an adequate
length difficult. Occasionally, the
graft seemed more friable than in
its original state and did not hold
sutures well.
Infection of the umbilical vein
graft is uncommon and in two of
three instances was related to im
proper placement of the graft imme
diately beneath a forearm incision,
leading to partial extrusion of the
prosthesis. One of these patients was
undergoing dialysis at home, where
an increased tendency to infection
might be expected. All infected grafts
required removal. As with thrombec
tomy, this was a difficult undertaking
because of adherence of the support
ing polyester, requiring tedious sharp
dissection for complete removal.
Conclusions

The early results with the umbilical
vein graft suggest that it is a satis
factory prosthesis for patients on
long-term dialysis.
There was no obvious superiority
of umbilical vein grafts over ex
panded Teflon at 1 year follow-up.
The greatest difficulty with these
grafts was encountered at reoperation
either for thrombectomy or graft
removal due to dense fixation to
soft tissues.
Longer follow-up is necessary to
determine the value of this prosthesis
for patients on long-term dialysis.
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1S0CAL*
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The Case for Tube Feeding
The enteral route should always be considered
first, because it is simple, economical, and
well tolerated in most patients.15'6

' '

Why ISOCAL* First

“Because it is nutritionally complete, lactose-free
and with an osmolality of only 300 m Osm /kg H20 , 4 we have been able to use this product full
strength, straight from the can, without the
j
necessity for dilution or progressive adaptation,
v
and without the induction of abdominal
cramps and diarrhea’.’4
\
Isotonic, ISOCAL* is low in osmolality:
'
With a low osmolality (300 mOsm/kg H O),
1
patients adapt rapidly and absorption occurs
j

r

r
y.

**
i

•

’

with few side effects.12'3'56
ISOCAL* has a readily absorbed fat blend:
A combination of 20% Medium Chain
Triglycerides Oil: 80% soy oil, provides efficient
fat absorption.

W h en to U se ISOCAL*
ISOCAL* is indicated for patients requiring
nasogastric, naso-jejunal and jejunal tube
feeding including:
• patients with head and neck injury or disease
• debilitated patients
• comatose patients
• surgery patients
• cancer patients
• cachectic patients
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Arteriography and Pancreatic Disease
P ierre B. Ghosn , md , A ndre F ontaine , md , P aul R oy , md , frcp [ c] and D enis B ourbeau, md , frcs[ c]

In the last 10 years, 605 celiomesenteric
arteriographic examinations were
done at Hotel-Dieu de Montreal,
including 236 for suspected pancreatic
disease. Sixty patients with histologic
proof of malignant neoplasm had a
positive arteriographic examination
while 136 had benign disease of the
pancreas and 40 others had extrapancreatic disease.
In this series, the sensitivity of
arteriography was 88.3% and the
specificity 92.6%. In the last 5 years
the sensitivity of superselective
arteriography was 100%. These results
were better than those obtained
with noninvasive techniques such as
computerized axial tomography,
ultrasonography and duodenography.
The authors conclude that
arteriography and particularly superselective arteriography is an excellent
method for evaluating patients with
suspected pancreatic cancer.

I'echographie et la duodenographie
hypotonique. Aucune de ces methodes
ne permet d'obtenir des valeurs
semblables.
II ressort de I’etude que
I’arteriographie, et specialement
la superselective, est la methode
de choix pour revaluation de malades
chez qui Ton suspecte une neoplasie
du pancreas.

Dans un intervalle de 10 ans,
605 examens arteriographiques
coeliomesenteriques ont ete effectuees
a I'Hotel-Dieu de Montreal, dont
236 pour une suspicion de pathologie
pancreatique. Soixante patients ont eu
un examen arteriographique avec
confirmation histologique de neoplasie
maligne, alors que 136 avaient une
maladie benigne du pancreas et 40 une
maladie extra-pancreatique.
Dans le groupe de neoplasie
maligne pancreatique, les resultats
etaient les suivants: sensibilite
a 88.3% et specificite a 92.6%. Au
cours des 5 dernieres annees,
■’utilisation de I'arteriographie superselective a permis de hausser la
sensibilite a 100%. Les auteurs
ont compare ces resultats avec ceux
obtenus par des moyens non invasifs
tel que la tomographie axiale,

Method

Pancreatic carcinoma ranks fourth
among the causes of death from neo
plastic disease. The frequency of pan
creatic carcinoma is increasing gradu
ally and still there is no specific diag
nostic test. Many examinations have
been devised for evaluating the pan
creas.1-3 Some are noninvasive but
inaccurate while others are very
reliable but are invasive.
We present in this report our ex
perience with arteriography in diag
nosing pancreatic disease.

At the Hotel-Dieu de Montreal,
between Jan. 1, 1970 and Sept. 30,
1980, 605 celiomesenteric arterio-

graphic examinations were done; 236
of these were for suspected pancrea
tic disease and 369 were done for
extrapancreatic problems.
Ninety
superselective angiograms were ob
tained; 32 were for pancreatic disease
and 58 were for other diseases. Most
of the angiographic studies were car
ried out between 1973 and 1977;
there was an appreciable drop in the
number of studies, especially for
pancreatic disease, in the last 2 years
(Fig. 1), due to the introduction of
noninvasive techniques.
Superselective arteriography has
been available only since 1975. Again
there was a substantial decrease in
the number of studies done for pan
creatic disease in 1979 and 1980,
while the number done for other
diseases remains practically the same
(Fig. 2). .
In the superselective technique, the
injection may be made into the
splenic, hepatic or gastroduodenal
artery. To obtain even greater detail,
most injections are made into pan
creatic branches such as the dorsal
pancreatic artery and the inferior
pancreaticoduodenal artery (Fig. 3).
The advantage of this technique is
that better definition of the intrapancreatic network is obtained,4’5
with optimal concentration of the
contrast medium without any vascular
superimposition. In extensive lesions,
the tumour may encase the vessels
around the pancreas (Fig. 4). The
splenic vein may be completely oc
cluded (Fig. 5) with hepatopetal
venous collaterals and left-sided portal

F1G. 1— Celiomesenteric arteriography
done for pancreatic (black bars) and nonpancreatic (white bars) disease.
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FIG . 2— N um ber of superselective
studies done for pancreatic (black bars)
and nonpancreatic (white bars) disease.
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FTG. 3— Superselective
arteriogram .
Injection into dorsal pancreatic artery.
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hypertension (Fig. 6). In cases of a
very small cancer, superselective
dorsal pancreatic injection may show
a localized encasement of an intrapancreatic artery (Fig. 7).
Angiography is the best technique
for localizing small insulinomas with
their characteristic blush. These tu
mours are even better shown with the
subtraction technique (Fig. 8).

centage of positive tests for cancer
when the patient has the disease. Of
176 angiograms, 163 were true nega
tives (specificity of 92.6%). The spe
cificity is the percentage of negative
tests when the disease is absent. The
positive predictability — the per
centage of patients having the disease
when the test is positive (true plus
false positives) — was 80.3%. The
negative predictability — the per
centage of patients free from the
disease when the test is negative (true
plus false negatives) — was 95.8%.
The results of superselective angio
graphy were even better. During this
period, 32 patients had superselective
arteriographic examination for pan
creatic disease. Twelve were done for
pancreatic cancers, proven later; all
of them were positive (sensitivity
100%). In 20 other patients, 15 were
found on superselective angiography
to have pancreatitis, 1 an insulinoma,
1 an epiploic nodule and in 3 no
abnormality was demonstrated.
The results of the other examina
tions in the 60 patients with cancer
of the pancreas were as follows: An
upper gastrointestinal series was per
formed in 37 (61%) patients; cancer

F in d in g s

Of the 236 patients who underwent
arteriography for suspected pancrea
tic disease, 60 had a pancreatic
malignant neoplasm and 176 had
other diseases of the pancreas. For
all the patients with pancreatic can
cer there was arteriographic and his
tologic proof that the tumour was
malignant. The sites of the tumours
were as follows: 34 (57%) were in
the head of the pancreas, 16 (27%)
in the body arid 10 (17%) in the
tail.
No false-positive arteriographic
diagnoses were made. The diagnosis
of cancer was made by arteriography
in 53 of the 60 patients and this was
in accordance with the operative and
histologic findings. In seven cancer
patients, the diagnosis was missed by
arteriography; that is, there were
seven false-negative diagnoses. Of the
176 angiograms obtained in patients
who did not have cancer, 163 were
interpreted as showing no cancer
(negative) while 13 were thought to
show a malignant tumour (positive);
that is, there were 13 false-positive
diagnoses.
The final results of arteriography
were as follows: 53 out of 60 angio
grams were true positives (sensitivity
88.3%). The sensitivity is the per-

was demonstrated in 13 (sensitivity
35%).
Ultrasonography was carried out
in 10 patients (17%); six tests were
positive for cancer and four were
negative (sensitivity 60%).
Computerized
tomography was
done in 18 patients (30%); 13 scans
were positive for cancer and 5 were
negative (sensitivity 72%).
D isc u ssio n

Computerized
tomography and
ultrasonography were not available
at the beginning of this study, but
even though the number of these
tests performed was small we believe
that they are less sensitive than arte-

F IG . 7— V ery short segm ental encase
m ent (arrow s) of intrapancreatic artery
by sm all cancer (0.9 cm in diam eter)
of head of pancreas.

FIG . 5— Occlusion of splenic vein
(long arrow) beginning n ear hiluin of
spleen (short arrow).

FIG . 4— Selective arteriographic injec
tion into superior mensenteric artery
(bottom arrows). R etrograde opacification
of gastroduodenal and com m on hepatic
arteries due to celiac axis stenosis. G astro
duodenal, hepatic, proxim al superior me
senteric arteries (also proximal splenic
artery not shown on this film) become
encased (arrows) by extensive pancreatic
cancer.

F IG . 6— H epatopetal venous colla
terals mainly by way of gastroepiploic
vein. Arrow indicates direction of flow
through gastroepiploic vein.
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F IG . 8— S ubtraction technique using
sim ultaneous celioinesenteric selective
arteriography. Sm all oval tu m o u r blush
(arrows) in fro n t of first lum bar vertebra
indicates presence of insulinom a.
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riography.
Endoscopic retrograde
cholangiopancreatography was also
not available and so was not used;
however, some reports showed that
high sensitivity and specificity can be
attained with this test.6'7 The results
of upper gastrointestinal series were
very deceptive. The results obtained
with angiography were the best but
to achieve this the following points
must be borne in mind: (a) condi
tions and technique must be meticu
lous and optimal; (b) the equipment
must be adequate and auxiliary tech
niques such as subtraction and stereo
techniques are extremely helpful; (c)
the experience of the angiographer is
important and (d) some conditions
such as arteriosclerosis and other vas
cular disorders, obesity, dyspnea and
intestinal gas will render the exa
mination more difficult and of less
value.
The sensitivity for the superselective
angiographic method has been re
ported to range from 50% to 96%.
The differences are attributed to dif
ferent techniques used and to diffi
culties mentioned. Sometimes the
differentiation between pancreatitis
and neoplasia is impossible even if
each lesion presents a different pat
tern on the arteriogram.

Various improvements have been
made in the standard technique of
celiomesenteric angiography: use of
the oblique projection,8 injection in
the prone position,9 pharmacoangio
graphy (angiography with injection
of vasoactive drugs),10,11 magnifica
tion and superselective injection. The
last is the best improvement.
Summary
Angiography plays a dominant role
in diagnosing pancreatic tumours,
especially when other noninvasive
studies are negative or equivocal. It
gives the surgeon important informa
tion such as the degree of extension
of the tumour, if any, and the vas
cular anatomy of the pancreas and
the liver and it is the best method for
localizing small islet cell tumours. In
our hands superselective arteriogra
phy was the best tool for diagnosing
and evaluating pancreatic cancer.
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SESAP III Critique
ITEM 436
Division of the ureter in its retroperitoneal course is a hazard of operations requiring
mobilization of the peritoneum and mesentery overlying the ureter. When divided
in its proximal three-quarters, end-to-end primary repair is indicated. Mobilization,
excision of damaged wall, spatulation, and reapproximation to provide a watertight
suture line can be expected to produce primary healing. Drainage of the retroperitoneal
space in the early postoperative period is recommended. Unnecessary sacrifice of renal
tissue would militate against nephrectomy. Cutaneous ureterostomy, ureteroneocystostomy, and ureteroureterostomy are alternatives dealing with problems attending loss of
ureter length or immobility of the distal ureter. Cutaneous ureterostomy may lead to
stricture at the skin level and ascending infection, and may ultimately require another
major operation to reestablish urinary continuity. Ureteroneocystostomy may predis
pose to stricture at the anastomotic site and reflux with ascending infection. Anasto
mosis to the contralateral ureter could place the contralateral kidney at unnecessary
risk.

E
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Prosthetic Valve Infections
A. G r ig n o n , m d , frcs [c ], H. S p e n c e r , m d , f r c s ( e d in ), H.G. R obso n , m d , f r c p [ c ],
J.E. M orin , m d , f r c s [c ] and A .R .C . D o b e l l , m d , f r c s [c ], facs

Over a 10-year period, 25 patients
were treated for prosthetic valve
infections: 13 infections were of early
onset (within 2 months of valve
insertion) and 12 of late onset. Of the
latter group 11 patients survived, 6
without reoperation. By contrast, 6 of
the 13 with early infections died,
5 of them being among the group of 9
patients who did not undergo
reoperation. Vegetations were found
on most valves at autopsy or
reoperation; they are a major threat
to these patients. The authors believe
that the mortality for early prosthetic
valve infections can be reduced only
by earlier prosthetic valve removal and
replacement.
Au cours d'une periode de 10 ans,
25 patients furent traites pour une
infection d’une valvule prosthetique:
13 infections etaient d’apparition
precoce (a moins de 2 mois de la
pose de la valvule) et 12 etaient
d'apparition tardive. De ce dernier
groupe 11 patients ont survecu, dont 6
sans reoperation. A I'encontre, 6 des
13 patients atteints d'infections
immediates sont decedes; 5 d'entre-eux
font partie d'un groupe de 9 patients
qui n'ont pas ete reoperes.
A I’autopsie ou a la reoperation, des
vegetations ont ete trouvees sur
la plupart des valvules; elles
represented une menace grave a la
vie de ces patients. Les auteurs
croient que la mortalite due a I’infection

precoce des valvules prosthetiques
ne pourra etre reduite qu'en accelerant
I'enlevement et le remplacement de
la valvule.

Endocarditis due to infected prosthe
tic valves remains the most dreaded
complication of valve replacement.
Saffle and associates,1 in an excellent
paper, reviewed 134 patients with
valve infections in a composite series
from three institutions2-4 and found
that the mortality was 78% in early
(onset within 2 months of prosthetic
valve insertion) and 38% in late
infections; the overall mortality was
56%. The greater gravity of early
onset infections has led us to use
the same classification.
This paper reviews our experience
with prosthetic valve infections over
10 years.
Patients
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To identify patients who had had
prosthetic valve infections, we re
viewed the records of all 545 patients
who had prosthetic valves implanted
between Jan. 1, 1969 and Dec. 31,
1978. Patients with persistent fever
who had the same microorganisms
isolated on more than one blood
culture within 60 days of operation
and who had no other source of
infection were classified as having
early infection of a prosthetic valve.
The valve was assumed to have be
come infected during the operative
or postoperative period. There were
13 such infections (2.4%) and 6 of
them occurred during a single year
(1974). Equal numbers of aortic (307)
and mitral (300) prostheses were im
planted during this period, but more
of the infected valves were in the
mitral (8) than the aortic (4) position.
One patient had undergone replace
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ment of both mitral and aortic valves.
All patients had received antibiotics
prophylactically; those operated upon
before September 1978 received
cloxacillin and those operated upon
after that date received cefazolin.
Each patient was given 500 mg intra
muscularly on call to the operating
room and 500 mg intravenously
thereafter every 6 hours until all
intravenous lines had been withdrawn,
normally within 48 hours.
During the same period late valve
infections developed in 12 patients.
In some instances the infection
occurred several years after operation.
All patients had fever accompanied
by chills and rigor. In two patients
a course of antibiotic therapy had
been started before transfer to our
institution. In both patients antibiotics
were temporarily stopped and blood
samples were taken, but no organisms
were cultured. However, fever prompt
ly recurred and the diagnosis of in
fection of the prosthetic valve was
accepted. Each of these two patients
was treated for 6 weeks with varying
regimens of penicillin G, gentamicin
and cloxacillin and one also received
cephalothin. In the remaining 10
patients with late infections pathogens
were cultured from the blood. One
young woman, who had had three
valves replaced, had two separate
bouts of infection 6 years apart.
Patients were managed jointly by
cardiologists, infectious disease physi
cians and cardiovascular surgeons.
Removal of the prosthesis was advised
when the hemodynamic consequences
of the infection became apparent,
usually in the form of prosthetic valve
insufficiency.
Antibiotic Therapy

Once the diagnosis was established
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a course of intravenously administered
antibiotics was started. The initial
regimen in almost all cases was a
combination of a penicillin or cepha
losporin with an aminoglycoside.
Serum bactericidal activity was mea
sured frequently. Antibiotic dosage
and combinations were adjusted so
that each patient’s serum was con
sistently bactericidal at 1 in 8 dilu
tion or greater against the infecting
microorganism. In two patients
rifampin was added to produce ade
quate serum bactericidal activity. One
patient with early infection caused
by Staphylococcus epidermidis was
reoperated upon after receiving
cloxacillin, cephalothin, gentamicin
and rifampin for 2 weeks and was
cured. A second patient with lateonset Actinohacillus infection was
cured by a 6-week course of antibio
tics including penicillin G. gentamicin
and rifampin.
Results

Predisposing Factors
Possible predisposing factors in
our patients with valve infections are

THE!
LAST!
THING
IS GAS.
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listed in Table I. Two patients, who
were re-explored because of bleeding,
subsequently had sternal infections
and two others had superficial wound
infections before their valves be
came infected. In one of these four
patients both wound and subsequent
blood cultures grew the same or
ganism (S. epidermidis), but in the
other three a different organism was
responsible. The patients with post
operative fever whose cause could
not at first be determined and who
had early infections subsequently had
a pathogen identified by blood cul
ture. Four of the patients with late
infections also had unexplained fever
in the early postoperative period. In
one patient, the fever subsided in 6
days and was attributed to pulmonary
infection. His valve infection de
veloped more than 4 months later.
A second patient had low-grade fever
immediately after operation and was
not treated. He was released from
hospital 1 I days after operation;
valvular infection (a-hemolytic strep
tococcus) developed 10 months later
after a dental extraction undertaken
with inadequate antibiotic prophy
laxis. The third patient in this group

had fever on the fourth and fifth
postoperative days that subsided
spontaneously. Her valve did not be
come infected for 6% months. An
other patient who received penicillin
for unexplained fever postoperatively
did not have prosthetic valve infec
tion until 5 years later. These data
support our belief that it is unlikely
that any late valve infections de
veloped in the early postoperative
period.
A second patient with a late-onset
Table I— Possible Predisposing Factors
Early
Late
infection infection

Factor
Postoperative fever of
unknown cause
Superficial wound
infection
Sternotomy infection
Reoperation for
bleeding
Pneumonia
Diabetes
Dental manipulation
Poor dental hygiene
Trauma
None detected

1OVOL 80 mg tablets work
fast to relieve trapped gas
and painful bloating.
OVOL 80 mg tablets contain
simethicone, a physiologically
inert, non-systemic com
pound with proven in vivo
anti-foaming action.

7

4

2
2

0
0

2
1
1
0
0
0
1

0
0
0
2
1
1
8

OVOL 80 mg
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V O L U M E 24, NO. 6, N O V E M B E R 1981

/

THE CANADIAN JOURNAL OF SURGERY

infection related to dental manipula
tion received no antibiotic prophy
laxis before or after the dental work.
The prosthetic valve had been im
planted 2 V2 years previously. The
valve infection was not diagnosed
until 1 month after the dental pro
cedure.

Table II—Cause of Death in Early Infection
Interval between operation
and diagnosis of infection, d

Survival after
diagnosis, d

Vegetations
on valve

Septic
emboli

3
60
52
16
20
26

10
13
25
65
90
193

Yes
Yes
Yes*
No
Yes
Yes

Yes
Yes
No
No
Yes
No

Mortality
Early infection. — In the group of
patients with prosthetic infection of
early onset, nine were treated with
antibiotics alone and four patients
also underwent reoperation for valve
replacement. Five of the nine patients
who received only antibiotics died
during the course of therapy while
one of the four patients who also
had replacement of the prosthetic
valve died. The reoperations were all
done in the second half o f the 10year period and contributed to the
improved results (six o f seven survived
in the second 5 years compared with
one of six in the first 5 years).
Thus, six patients in the series died
o f early infection (Table II). One
died 10 days after operation because
o f fulminating septicemia due to
Staphylococcus aureus. In two pa
tients, autopsy showed that death was

Cause of death
Septic shock
Septic emboli
Renal failure
Renal failure
Septic emboli
Cerebrovascular
accident

*Valve removed at reoperation 12 d after valve infection was diagnosed.

caused by septic emboli. Two patients
died of renal failure after prolonged
treatment; one had had the infected
valve removed because of obstruction
by vegetations. One patient had ap
parently successful treatment with
antibiotics of S. aureus valve infec
tion, but insufficiency o f the pros
thetic mitral valve soon became ap
parent and subsequently pathogens
were again cultured from the blood.
He received additional courses o f
antibiotics but died of a cerebro
vascular accident 6 months after
treatment was started. Autopsy dis
closed two large paravalvular fistulas
and vegetations on the prosthetic
valve. In retrospect, it would have
been wiser to operate on this patient
again when his valve became insuf
ficient, almost 4 months before he
eventually died.
Late infection. — In this group

Table III Operative Findings in Patients
with Early and Late Infections

OVOL 80 mg

Finding

Antiflatulent Simethicone

Vegetations
Perivalvular abscess
Prosthetic dehiscence
Obstruction

INDICATIONS

OVOL is indicated to relieve bloating,
flatulence and other symptoms
caused by gas retention including
aerophagia and infant colic.

Early
(n = 4)

Late
(n = 5)

3
0
3
1

3
1
5
0

CONTRAINDICATIONS

seven patients were treated with anti
biotics alone and one died o f a cere
bral hemorrhage. A ll five patients
who had prosthetic valve insufficiency
and underwent valve replacement
were cured.
In all,- -nine patients underwent a
second operation, eight for prosthetic
valve insufficiency and one for ob
struction o f a mitral valve by vegeta
tions (Table III).
The microorganisms cultured from
blood samples and deaths related to
these infections are shown in Table
IV. In general, late infection tended
to conform more to the presentation
of subacute infection on nonprosthetic
valves and was usually caused by
microorganisms of relatively low viru
lence.

Discussion
The overall mortality in this series
was 28% (7 o f 25). The risk of death
was considerably lower in the late
infection group, as others have in
dicated.1 Presumably this is related
to the encapsulation o f the fabric
covering o f the prosthetic valve by
invasion o f fibrous tissue, making
the fabric less vulnerable to infection
and presumably more susceptible to
antibiotic treatment. The lower mor
tality in these patients may also be

None reported.
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None reported.
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Staphylococcus aureus
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2
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due in part to the subacute nature of
the infections and less virulent orga
nisms than in the early infections.
Our review has indicated that the
increased hazard of early infections
is primarily related to the vegetations
on the prosthetic valve. Strom and
associates5 recently emphasized the
value of echocardiographic studies in
bacterial endocarditis of nonprosthetic valves. In a group of 32 valves
involved by vegetations, 84% were
identified by echocardiography. We
agree that the discovery of vegetations
by echocardiography constitutes an
indication for prompt valve replace
ment since the vegetations constitute
a significant threat to life.
On the basis of our review we now
plan to reoperate on every patient
with early prosthetic valve infection
within 2 weeks of establishing the
diagnosis. Earlier operations are in
dicated when vegetations are shown

unequivocally by ultrasonography.
Late infections can be managed by
antibiotic therapy with operation
advised for valve dysfunction, persis
tent infection, vegetations as shown
by ultrasonography or embolic man
ifestations.
The serious nature of early pros
thetic valve infections obliges the
surgeon to take rigid precautions to
avoid infection at the primary opera
tion. Not only should antibiotics be
given prophylactically, but the pros
thetic valve should be handled as
little as possible and under no circum
stances should it be allowed to touch
the patient’s skin. This is one of the
reasons for employing an adhesive
plastic skin covering as a barrier.
In addition, all personnel should
realize the vulnerability of prosthetic
valves to infection and take care that
bacteria are not introduced into the
blood stream through any of the

numerous monitoring lines used after
heart surgery. This applies particular
ly to material injected through SwanGanz catheters to measure cardiac
output, and also to the taking of blood
samples from an arterial or venous
line or when such lines are flushed.
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1981 DAVIS & GECK SURGICAL ESSAY AWARD

The 1981 Davis & Geek Surgical Essay Award being presented by Mr. John Ployart (right), marketing manager of
Davis & Geek, to Dr. Richard Reznick (middle) for his paper “Structure and Function of Small Bowel Allografts
in the Dog using Cyclosporin “A”, coauthored by Drs. Craddock. Langer, Gilas and Cullen, while Dr. C. Barber Mueller
(left), coeditor of the Canadian Journal of Surgery, looks on.
The editorial board and the coeditors of the Canadian Journal of Surgery thank Davis & Geek for providing this
award. They extend their congratulations to Dr. Reznick and their thanks to those who participated in the 1981
competition.
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Difficulties in Diagnosing and Treating Renal Angiomyolipoma:
Report of Three Cases and Review of the Literature
G.E.J. St e in h o f f ,

Renal angiomyolipoma is an uncommon
benign tumour that presents
diagnostic and therapeutic problems.
It may be unilateral or bilateral;
in its bilateral form it is usually
associated with tuberous sclerosis. As
a mass lesion of the kidney, it
resembles renal cell carcinoma on
pyelography and angiography, but
computerized axial tomography and
ultrasonography may provide a
definitive diagnosis. This benign tumour
should be treated conservatively
to preserve renal function, but
surgical intervention is necessary
if renal cell carcinoma cannot be
excluded completely.
L’angiomyolipome est une tumeur
benigne rare qui presente des
problemes diagnostiques et
therapeutiques. II peut etre unilateral
ou bilateral; dans sa forme
bilaterale il est habituellement
accompagne d'une sclerose
tubereuse. Sous la forme de masse
renale, il ressemble, a la
pyelographie et a I'angiographie,
a un cancer des cellules renale,
mais la tomographie transverse
axiale avec ordinateur et
I'echographie ultrasonique peuvent
donner un diagnostic definitif.
Cette tumeur benigne doit etre
traitee de facon conservatrice afin
de conserver la fonction renale,
mais une intervention chirurgicale
est necessaire lorsqu'on ne peut
exclure completement la possibility
d'un cancer des cellules renales.

md and

D.E. M oors ,

m d , f r c s [c ]

Renal angiomyolipoma is an uncom 
mon tum our that is difficult to
diagnose and treat because radiologically it resembles renal cell carcinoma
and it often occurs bilaterally.
There are two distinct clinical pat
terns. In one, the tumour may be
associated with tuberous sclerosis and
in such cases it is usually bilateral,
variable in size, multifocal and occurs
with equal frequency in both sexes.
In the other, the tumour occurs
mainly in women in the fifth decade
or older without tuberous sclerosis;
the lesion is unilateral, unifocal and
frequently of large size.
Angiomyolipoma is a benign lesion
and should be treated conservatively
if possible to preserve renal function.
Its differentiation from renal cell car
cinoma may be difficult and if this
is impossible, surgical intervention is
necessary, particularly when the tu 
m our is unilateral.

We present three cases, one unila
teral and two bilateral, to illustrate
the diagnostic and therapeutic pro
blems.
Case Reports

Case 1
A 34-year-old woman was admitted
with pain and tenderness in the left
flank. On physical examination no mass
was found and there were no signs of
tuberous sclerosis.
An intravenous pyelogram showed a
mass in the superior pole of the left
kidney with distortion of the superior
calyx (Fig. 1). The findings on nephro
tomography and retrograde pyelography
supported the diagnosis of renal cyst.
However, ultrasonography demonstrated
a mass lesion with multiple sonolucent
areas and indistinct margins. Angio
graphy revealed abnormal tumour ves
sels, small saccular aneurysms and mul
tiple radiolucent areas (Fig. 2). A diag
nosis of angiomyolipoma was entertained
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Reprint requests to: Dr. D.E. Moors,
Department of urology, Ottawa Civic
Hospital, 1053 Carling Are.,
Ottawa, Out. K IY 4E9

F IG . 1— Case 1. Mass lesion at upper
pole of left kidney.
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F IG . 2— Case 1. Large tu m o u r vessels,
small saccular aneurysm s and m ultiple
radiolucent areas.
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but renal cell carcinoma could not be
excluded.
The age of the patient, the strong
possibility that renal cell carcinoma was
present and a normal contralateral kid
ney persuaded us that radical treatment
was indicated. Therefore, radical thora
coabdominal nephrectomy was perform
ed with resection of para-aortic nodes.
The pathological diagnosis was angiomyolipoma. One lymph node contained
angiomyolipomatous tissue. The impor
tance of lymphatic spread is not known
but will be discussed.
The patient is well, without evidence
of the disease, 5 years after her opera
tion.
Case 2
Ten years previously, this 52-year-old
woman had undergone right nephrectomy
for what was diagnosed preoperatively
as renal cell carcinoma. The pathological
diagnosis was angiomyolipoma. The left
kidney was normal radiologically at
that time.
On this admission she complained of
pain in the left upper quadrant where,
on examination, a large, soft, mobile
mass was noted. An intravenous pyelogram demonstrated a large left kidney
with a deformed collecting system. Poly
cystic disease was suggested. Ultrasono
graphy delineated a large, irregular solid
mass. Angiography showed cystic struc
tures at both poles with irregular col
lections of abnormal vessels throughout
the kidney (Fig. 3).
The patient showed no. signs of tub
erous sclerosis. Despite the widespread
involvement of her kidney by the disease
process, her renal function was quite
adequate (creatinine clearance 60 ml/
min).
The previous diagnosis of angiomyo
lipoma strongly suggested that the ab
normal findings in her remaining left
kidney represented not a renal cell car
cinoma but angiomyolipoma. We opted
for surgical exploration of the kidney
and performed a wedge biopsy. Both
the frozen and fixed sections confirmed
that the mass was an angiomyolipoma.
She is well AV2 years later. Her renal
function is unchanged and she is free
of symptoms or complications related
to the disease.
Case 3
A 54-year-old woman had presented
7 years earlier with severe right abdo
minal pain where a mass was palpable.
Investigation had included intravenous
pyelography and renal angiography. The
findings from the latter study indicated
abnormal vessels throughout the paren
chyma of both kidneys. This bilateral
disease and the nature of the vessels
strongly suggested the presence of bila
teral angiomyolipomas. Her right abdo
minal pain had persisted and was attri
buted to hemorrhage in her right kidney,
so a right nephrectomy was performed.
620

Pathological examination confirmed the
diagnosis of renal angiomyolipoma.
During the following years her renal
function slowly deteriorated. She suf
fered episodes of urinary infection and
left pyelonephritis. Although the infec
tion was adequately treated, it may have
been a factor in the deteriorating renal
function. During this time, she had acne
sebaceum and periungual fibromas. A
diagnosis of tuberous sclerosis was made.
Two years before her present admis
sion she became dialysis-dependent.
Her latest admission was for left abdo
minal pain and the presence of a large
mass in her left abdomen. The pain
had chronic and acute aspects and was
thought to be due to the huge angio
myolipomatous left kidney.
This remaining kidney had negligible
function, so a left nephrectomy was
performed to relieve her symptoms.
Examination of the specimen confirmed
the presence of multiple masses of angio
myolipoma throughout the kidney.
Discussion
Renal angiomyolipomas have been
described as isolated lesions and in
association with tuberous sclerosis.1
They are usually found in mid- to late
adult life although one case has been
reported in an adolescent.2
Renal angiomyolipomas found in
association with tuberous sclerosis are
usually bilateral, small, multifocal and
are distributed equally between the
sexes.3'5
Angiomyolipomas without tuberous
sclerosis are most often unilateral,
unifocal, large in size and found in
women.4'6
Of all cases of tuberous sclerosis
60% to 80% are associated with
angiomyolipoma.7 Tuberous sclerosis
is an inherited disorder characterized
bv autosomal dominant transmission
with incomplete penetrance.5 Females
are affected more frequently than
males.5 The standard features of tu
berous sclerosis are acne sebaceum,
shagreen patches, subungual fibromas,
retinal phakomas, calcified tubers in
the brain, cystic changes in bone and
lung and mental deficiency and epi
lepsy.6
Angiomyolipomas are hamartomas
of mixed mesenchymal origin ana
are made up of varying numbers of
abnormal blood vessels, smooth mus
cle and adipose tissue. Predominance
of the lipomatous or leiomyomatous
tissue may occur resulting in varied
gross and histologic appearances. The
tumours are benign but may display
varied degrees of pleomorphism and
occasionally may be difficult to dis
tinguish from sarcomas or necrotic
renal cell carcinomas.1,6,8 Nuclear
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hyperchromasia and an occasional mi
totic figure may be present.8
The tumour in some cases extends
into perirenal fat as well as regional
lymph nodes, as in our first case.1,9,10
Feriz11 and Kirpcznik12 reported cases
of tuberous sclerosis and renal angio
myolipoma with regional lymph-node
involvement. They described sarco
matous change in the tumour but all
elements in our first case were benign
histologically. There have been no
reports of distant metastatic spread
of renal angiomyolipomas. Those
with sarcomatous change histological
l y ! , 5,9,13-20 jl a v e not metastasized. The
tumour therefore does not behave in
a malignant fashion. Although regio
nal lymph-node involvement suggests
the ability to metastasize, the clinical
course of such cases indicates that
the tumour is benign.
Clinically, the most common fea
tures are pain, mass, hematuria and
fever.4'6,8’14,21"24 Pain (often quite
severe) is frequently accompanied by
massive bleeding and shock.5’21,25
In the absence of tuberous signs the
diagnosis of renal hamartoma is often
first suggested after a plain abdomin
al film of the mass. Radiolucency may
be striking due to the adipose tissue,
but also may indicate hemorrhage or
necrosis. This radiologic feature may
be seen also in renal cell carcinoma,
but less commonly.
Ultrasonography may be valuable,
as the presence of both sonolucent
and nonsonolucent areas suggests the
presence of a hamartoma.
Renal angiography is an essential
examination. Characteristically, angio-

FIG. 3— Case 2. Cystic lesions at both
poles with abnormal vessels throughout.
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myolipomas have saccular aneurysms
and normally tapered vessels and may
display a whorled or sunburst appear
ance in the capillary phase (because
of circumferential peripheral ves
sels).5,19'26 Early venous filling and ar
teriovenous fistulas characteristic of
carcinoma are usually absent.5'27 Both
hamartoma and carcinoma may have
abnormal vessel distribution and fail
to respond to epinephrine.6,27"30 How
ever, one patient has been reported
who did respond to epinephrine.31 A
case of parasitic blood supply in renal
angiomyolipoma has also been de
scribed.32 Although angiography is
helpful and in some cases diagnostic,
it may be impossible to exclude renal
carcinoma from the diagnosis.
Computerized axial tomography
(CAT) was not available for these
cases but it adds another dimension
to the investigation. It can differen
tiate the fatty tissue masses of angio
myolipoma from hemorrhage and ne
crosis seen in renal cell carcinoma.
Pitts and colleagues33 stated that
angiomyolipomas are the only renal
lesions that combine fat-dense areas
on CAT and marked echoes on ultra
sonography. This dense echo pattern
is due to the multiple fat-non-fat
interfaces found in this tumour.
Such diagnostic problems make the
management of patients suspected of
having renal hamartomas quite dif
ficult. It follows that the choice of
treatment will vary as one strives to
preserve renal function when there
is a possibility of misdiagnosing and
inadequately treating a renal cell car
cinoma. Our third patient had recur
rent pyelonephritis and eventual loss
of renal function in her remaining
kidney; a more conservative initial
approach may have obviated or at
least delayed the dialysis dependence.
Unilateral solid renal lesions with
out tuberous sclerosis require surgical
intervention. If there is strong radiologic and sonographic evidence that
the mass is an angiomyolipoma, sur
gical exposure of the lesion and
biopsy with frozen section should be
performed. Conservative surgery such
as local excision or partial nephrec
tomy can follow if angiomyolipoma
is confirmed histologically. Simple
nephrectomy may be necessary if the
lesion is large and involves the mid
portion of the kidney. But if the
diagnostic evidence of hamartoma is
not convincing, radical nephrectomy
should be performed to allow the
patient optimal surgical treatment if
the mass should be a renal cell car
cinoma.
Bilateral solid tumours without

tuberous sclerosis require unilateral
open biopsy. If angiomyolipoma is
found, no further surgery is necessary.
If signs of tuberous sclerosis are
present in unilateral mass lesions,
open biopsy may be advisable, but
with bilateral renal lesions, conserva
tive management without biopsy is
adequate.
If at all possible, renal tissue should
be preserved. Many kidneys are exten
sively involved with angiomyolipomatous elements but maintain ade
quate function (as in our second case)
and conservative management will
prevent the development of renal fail
ure. Conversely, in unilateral mass
lesions in young adult women, inade
quate surgical treatment of a renal
mass that is a renal cell carcinoma
would be equally disastrous. Certain
ly, in the future, the addition of ultra
sonography and CAT to renal angio
graphy will make the diagnosis of
renal angiomyolipoma more exact and
solve such diagnostic and therapeutic
dilemmas.
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Home Study Course
in Immunology
The University of Wisconsin is pleased
to offer a home study course in immu
nology. Physicians can enrol at any
time and study at their own pace.
The course covers basic concepts
about B cells, T cells, neutrophils,
macrophages and complement. The
concepts are utilized to define a
useful clinical approach to patients.
For further information please con
tact: Home Study-CME, University
of Wisconsin, 481 WARF Building,
610 Walnut St., Madison, Wisconsin
53706, or call (608) 263-2853.

tom a: two cases presenting with s p o n tan e 
ous rupture and massive retroperitoneal
hem orrhage. J Urol 1965; 94: 336-41

T H E C A N A D IA N JO U R N A L O F SU R G E R Y

continued on page 625
621

Hypothermia-Induced Gastric Hypercontractiiity
in the Genesis of the Restraint Ulcer
W illiam A. M ersereau ,

The cause of ulcers in restrained
rats is unknown. Experiments were
designed to test the hypothesis
that the lesion results from
hypothermia-induced gastric hypercontractility, which leads to a
compression injury of the mucosa.
Restrained or cervical sectioned rats
in whom miniature gastric balloons
were inserted were studied at body
temperatures of either 37 °C or 27 °C
over an 18-hour period. The development
of hypothermia correlated with the
development of a pattern of vagally
mediated high-amplitude contractions
of the stomach and the formation
of focal hemorrhagic lesions. In
normothermic or vagotomized
hypothermic animals, normal lowamplitude contractions were present
and lesions did not develop. The
authors propose that a mucosal
compression mechanism is responsible
for ulcer formation.

ph d and E. J ohn

H inchey ,

md , m sc, facs , frcs [c ]

vagotomises les contractions normales
de faible amplitude etaient presentes
et les lesions ne sont pas apparues.
Les auteurs proposent la compression
de la muqueuse comme mecanisme
responsable de la formation de I'ulcere.

thermia. An energy-sensitive receptor
system that is stimulated by the
metabolic effects of hypothermia is
proposed as the mechanism respon
sible for the vagally mediated re
sponse.

The mechanism responsible for ulcers Methods
in the restrained rat is unknown. Evi Gastric Balloon and
dence suggests that neither acid hyper
secretion nor barrier dysfunction are Recording System
A miniature gastric balloon was
involved. Studies with a variety of
prostaglandins and H2 receptor block fashioned from condom rubber (Fig.
ing agents confirm that some mecha 1). The finished balloon, containing
nism, apparently unrelated to acid a polyethylene stent with two side
secretion, is responsible for the le holes, was inflated with water, cleared
of air and connected to a pressure
sions.
In 1940, Dalton,1 at McGill Uni transducer (Model P23AC; Statham
versity, reported that many of the Instruments, Hato Rey, Puerto Rico)
effects of restraint or cervical section and to a polygraph (Model 7B; Grass
“stress”, including gastric ulceration, Instruments, Quincy, Mass.). The bal
could be prevented by maintaining loon was placed at zero level and
normal body temperature. Tran and the water allowed to leave the balloon
Gregg2 also observed that hypother until pressure was zero. The resultant
mia was associated with ulceration in balloon was flaccid and contained
La cause de I'ulcere de contrainte
restrained rats. Antoon and Gregg1 approximately 0.1 ml of water. The
chez le rat est inconnue. Des essais
prevented
ulceration by maintaining polygraph was calibrated in centi
ont ete elabores pour verifier
body
temperature.
Goldman and metres of water and was run at a
I'hypothese voulant que cette lesion
Rosoff,4
noting
a
relation
between paper speed of 2.5 mm/min for the
resulte d'une hypercontractilite
contracted
stomachs
and
ulceration
in 18- to 20-hour duration of the experi
gastrique provoquee par une
ment. Contractile activity was quanti
restrained
rats
at
autopsy,
suggested5
hypothermie, hypercontractilite qui
tated by counting the number of
that
gastric
contraction,
secondary
to
entrainerait une atteinte par
contractions in the rat's stomach that
the
absorption
of
bacterial
toxins
compression de la muqueuse. Des
from the bowel, was responsible for had an amplitude of 20 cm H 2O or
rats sous contrainte ou soumis a
mucosal ischemia and ulceration. greater occurring over the first 4
une section cervicale et chez qui on
Watanabe6 and Yano and associates7 hours after the desired body tempera
insera de minuscules ballonnets
demonstrated increased gastric motili ture was reached. This pressure level
gastriques furent etudies a des
ty in rats restrained and partially im was arbitrarily selected because it was
temperatures corporelles de 37°C ou
mersed in water. The role of hypo well above the control amplitude of
27°C au cours d'une periode de
thermia was not assessed. We pos normothermic rats and preliminary
18 heures. L'apparition d'une hypo
tulated that there might be a link studies had suggested a relation to
therm ie coincida avec le developement
between the development of hypo ulcer formation. The first 4 hours
d'une sequence caracteristique de
thermia in the restrained rat, as sug of contractile activity were consi
contractions gastriques de grande
gested by Tran and Gregg,2 and the dered representative of the activity
amplitude et d’origine vagale et la
increase in gastric contractile activity, seen in each animal.
formation de foyers hemorragiques.
as reported by Yano and associates.7 Restraint Model
Chez les animaux maintenus
Therefore, we designed a study to
a temperature normale ou chez
Female Sprague-Dawley rats, weigh
examine the relation between hypo
les animaux hypothermiques
thermia, gastric contractility and ulcer ing 180 to 220 g, were placed in
formation in restrained and cervical individual cages with a wire mesh
sectioned rats. We also examined the bottom and were starved for 24 hours
From the university surgical clinic,
the Montreal General Hospital,
effect of vagotomy on the ulcerative before the study. Under ether anes
McGill University, Montreal, PQ
process. A study of the lesions and thesia, the abdomen was opened
their location relative to the mucosal widely and the nerves to the abdo
Accepted for publication Mar. 2, 1981
folds supports the concept that they minal muscle were cauterized to re
Reprint requests to: Dr. William A.
are
produced by mucosal compression, duce artefacts in pressure records due
Mersereau, Rm. 953, The Montreal
which is secondary to violent gastric to changes in abdominal tension. The
General Hospital, 1650 Cedar Ave.,
muscular activity induced by hypo gastric balloon was inserted into the
Montreal, PQ H3G 1A4
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body of the stomach through a caute
ry hole in the forestomach. The hole
was closed around the catheter with
a cotton tie to hold the balloon in
place and to prevent leakage of gastric
contents. Rats were rejected if their
stomachs were full of fecal material.
The abdominal skin was closed and
the rat restrained on its right side
by taping it to a metal sheet (5.5 X
26 cm) with waterproof electrical
tape, as described by Antoon and
Gregg.3 The animal was then placed
on wire mesh, which was fixed in a
water bath so that part of its right
side and back were in the water. The

water bath temperature was set at
either 26°C or 36°C and the ani
mal’s rectal temperature monitored
periodically to ensure that it was
maintained at 27°C or 37°C.
Cervical Spinal Cord Section Model
Rats prepared as described above
were anesthetized with ether and the
cervical spinal cord was cut at C7
through a longitudinal incision in the
dorsum of the neck. The gastric bal
loon was then placed and the abdo
men closed. The rat was placed on
its right side in a pan that floated
in a water bath set at either 27°C

A

FIG . 1— Steps in balloon construction. (A) PE 60 catheter with side holes
(arrow). (It) Condom rubber disc. (C) Jig for form ing balloon (PE 280). (D) C ondom
rubber is forced into jig with catheter tip and tied in place. (E) Finished balloon
containing 0.1 ml of water.

or 36°C. Rectal temperature was
monitored. One subgroup was sub
jected to bilateral subdiaphragmatic
vagotomy before placement of the
gastric balloon. To study the effect of
varying the rat’s temperature, the rat
was placed in contact with the water
and the water temperature altered.
Another subgroup was submitted to
hypothermia but the gastric balloon
was not inserted. In this way, the
effect of the balloon on ulcer forma
tion was assessed.
Grading of Gastric Lesions
At the end of the experiment the
rats were anesthetized with ether and
given an intravenous injection of 0.1
ml of 50% v/v solution of colloidal
carbon (Pelican) for permanent la
belling of the gastric lesions. Fifteen
minutes after the excess carbon had
been cleared from the blood, the
animals were killed by concussion and
the stomach immediately inflated with
10% formalin in saline administered
with a metal gavage needle. The
inflated stomach was removed and
placed in a fixative for 15 minutes
then opened along the greater curva
ture.
The gastric lesions were scored by
the method of Guth and associates8
with the aid of a dissecting micro
scope (petechial lesions = 1, erosions
less than 1 mm in diameter = 2,
erosions 1 to 2 mm diameter = 3,
erosions 2 to 4 mm = 4, those greater
than 4 mm = 5). Bruise-like lesions
adjacent to the site of the balloon
placement were not included in the
scoring. The stomachs of some rats
were not inflated but were only
flushed with formalin after removal
of the gastric balloon. This preserved
the morphology of the gastric mu
cosal folds so that their relation to
the lesions could be studied. Terminal
femoral artery blood pressure was de
termined in some of the cervical sec
tioned animals in the normothermic
and hypothermic groups.
R esults

FIG . 2— G astric contractile activity in five experim ental groups (right). H ypo
therm ia at 27 °C induces gastric hypercontractility in cervical sectioned or restrained
rats. Vagotomy abolishes this effect. N orm otherm ic anim als dem onstrate low-amplitude
activity.
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Gastric contractile activity increased
above the basal level as the body
temperature fell to below 30°C. This
effect was rapidly reversed by re
warming the rat. Representative re
cordings of the gastric contractile
activity of the various experimental
groups is presented in Fig. 2. The
maintenance of normal body tempe
rature in restrained or cervical sec
tioned rats was accompanied by little,
if any, high-amplitude contractile
activity, but hypothermic restrained
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or cervical sectioned rats demonstrated
a consistent pattern of high-amplitude
gastric contractile activity. This was
prevented by previous bilateral vago
tomy.
Table I shows the relation between
abnormal gastric contractile activity
and the ulcer score. The high motility
values (104 and 157 contractions
respectively with an amplitude of
over 20 cm FTO) in hypothermic
restrained and cervical sectioned rats,
were related to a high ulcer score.
Normothermic restrained and cervical
sectional animals had few, if any,
contractions of this magnitude and an
extremely low ulcer score. Vagotomy
prevented the development of an
abnormal motility pattern in hypo
thermic rats and these rats also had
a low ulcer score.
Cervical sectioned rats subjected
to hypothermia without a gastric bal
loon had a similar degree of ulcera
tion as rats with balloons, indicating
that the balloon was not responsible
for the lesions.
The terminal mean blood pressure
of the hypothermic cervical sectioned
rat was 89.5 ± 3.9 mm Hg; this was
not significantly different from the
mean blood pressure of normothermic
rats, 91.3 ± 5.6 mm Hg.
Morphology of the Gastric Lesions
Two distinct but apparently related
lesions were seen in the glandular
mucosa of the hypothermic restrained
or cervical sectioned rats that demon
strated abnormal gastric contractions.
In the inflated stomach there were
focal hemorrhagic lesions and “cleft
like” lesions. The latter ran at right
angles to the greater curvature (Fig.
3). In the uninflated stomach, the
lesions were seen to lie in close rela
tion to the mucosal folds (Fig. 4).
Histologic sections of the uninflated
stomach demonstrated that some of
the lesions seen along the base of
the mucosal fold consisted of necrotic
mucosal tissue, apparently compressed
on itself by the contractile activity
(Fig. 5). The intimate relationship of
the “cleft-like” lesions and the focal
hemorrhagic lesions suggested that
the hemorrhagic lesion developed
from the “cleft-like” lesion.

Table I— Relation between Hypothermia, Gastric Contractile A ctivity
and Ulcerogenesis in Restrained or Cervical Sectioned Rats
Group
Restraint
Restraint
Cervical section
Cervical section
Cervical section
without balloon
Cervical section
and vagotomy

Rectal
tem perature

No. of
rats

37°C
27°C
37°C
27°C

6
6
9
10

27°C

9

27°C

6

M o tility * Ulcer score!

Term inal blood
pressure, mm Hgt

0.6
19.1
1.7
14.2

91.3 ± 5.6“
89.5 ± 39h

0
104
10.4
157

±
±
±
±

0.3“
3.91’
0.5“
2.31-''

25.8 ± 5.6f
0

0.3 ± 0.2

*No. of contractions, 20 cm H20 in amplitude or higher, occurring in first 4 h of the experiment.
+Mean ± SD.
(a ) was significantly (P < 0 .001 )'lower than (b). The differences between (e ) and (f) and
between (g ) and (h ) w ere not significant.

an essential factor, as reported by
Antoon and Gregg.3 The precise
mechanism by which increased gastric
motor activity induces the lesions is
unknown. Yano and associates7 sug
gested that mucosal rubbing causes
the lesions. Cho and associates9
thought that the lesions might have
an ischemic origin. Our morphologic
studies of the lesions seen in con
tracting stomachs suggest that they
begin as the result of the mucosa
being compressed at sites “where it
is folded upon itself”, such as the
base of the mucosal folds (Fig. 4)
and across the mucosal folds. The

FIG . 5— Compression lesion at base of
mucosal fold (F). N ote convergence of
parallel gastric glands (G) ending in
compressed necrotic lesions with some
extrusion of destroyed tissue into lumen
(L).

FIG. 3— Linearly disposed focal he
morrhagic lesions along long axis of
stomach. “Cleft-like” lesions radiating
(arrows) at right angles. Scale indicates
5 mm.

D iscu ssio n

The results of this study support
the observations of Watanabe4 and
Yano and associates7 that abnormal
gastric contractile activity may play
an etiologic role in the development
of ulcer in the restrained rat and,
further, that hypothermia may be
624

FIG. 4— U ninflated stom ach dem on
strating focal hem orrhagic lesions along
mucosal folds and “cleft-like” lesions
(arrows). Scale indicates 1 mm.
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FIG . 6— Foam rubber model of gastric
mucosa thrown into fold. G astric glands
are simulated by vertical black lines. At
base of fold (arrows) “gastric glands” are
compressed together and distorted (com
pare with Fig. 5).
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mechanism by which this may occur
is illustrated with a foam rubber
model in Fig. 6.
It can be seen that in a mucosal
fold, the mucosa is compressed at
the apex of the fold and at its base.
Futher compression of the apex by
the rhythmic contraction of the ex
ternal musculature would be expected
to intensify the injury and presumably
facilitate bleeding from lesions once
formed.
The virtual absence of restraint
ulceration in the antral region is un
explained. An examination of the
morphology of the rat stomach wall
in this region reveals two factors that
would greatly influence ulcer forma
tion by the mucosal compression me
chanism we propose. First, the ex
ternal gastric muscle layer is thinner
in the antrum of the rat’s stomach;
second, and perhaps of greater im
portance, is that the mucosa is much
thinner. Hence, compression of the
mucosa at the fold sites may be less
severe because there is less tissue to
be compressed.
Our studies with the nonsteroid
anti-inflammatory drugs phenylbuta
zone10 and indomethacin11 suggest that
abnormal gastric contractile activity
and its resultant mucosal compres
sion are probably responsible for the
lesions that occur following the extragastric administration of these
agents in normothermic rats. Those
studies suggested that the lesions and
resultant hemorrhage are initiated in
the absence of acid but that acid
facilitates formation of lesions and
hemorrhage. It was further demon
strated that the blockade of gastric
contractile activity by 16,16-dimethyl
prostaglandin Ez, atropine12 or vago
tomy in acid-perfused rats prevented
ulceration. The above studies thus
support our hypothesis that mucosal
compression may be an initiating
factor in the genesis of focal hemor
rhagic lesions in the rat. The peculiar
focal, hemorrhagic, fold-related char
acteristics of the restraint lesion, as
noted by others, may therefore derive
from the application of physical forces
to the mucosa at specific vulnerable
sites.
The mechanism by which cooling
to 27°C initiates the vagally mediated
contractile response is unknown. In
studies with phenylbutazone13 it was
demonstrated that this agent depres
ses blood glucose and that glucose
feeding or infusion would prevent the
gastric hypercontractile response and
ulceration in the phenylbutazonetreated animal. We postulated that
phenylbutazone, by uncoupling oxida
VOLUME 24, NO. 6, NOVEMBER 1981

tive phosphorylation14 in energy moni
toring receptor cells, was triggering a
glucoprivic (or energy deficit) response
similar to that initiated by insulin
or 2-deoxy-D-glucose administration,
which, through this glucoprivic mech
anism, stimulates feeding in ani
mals,15 hunger contractions in hu
mans16 and vagally mediated gastric
motor and secretory responses in hu
mans and animals. It is possible that
hypothermia at 27°C may so perturb
glucose utilization17 that a glucoprivic
stimulus is evoked in the receptor
cells, which then trigger the vagally
mediated response. A similar situation
may occur in the food-restricted,
exercising rat, where it has been
shown that the rat’s inability to
maintain its body temperature be
cause of food restriction and physical
exercise results in hypothermia and
the development of an identical lesion
to that induced by restraint.18
In conclusion, we propose that the
restraint lesion is produced by mu
cosal compression that is secondary
to the development of violent, vagally
mediated contractile activity. This
response may be triggered by an
energy sensitive receptor system
whose energy synthesis is uncoupled
|
by cooling.
|
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Request for Abstracts

A request for 300-word abstracts of
proposed presentations is made for
the trauma program to be held by
the Canadian Association of General
Surgeons in cooperation with the
Royal College of Physicians and Sur
geons of Canada at its annual meeting
Sept. 13-18, 1982, in Quebec City.
All abstracts should be submitted be
fore Dec. 15, 1981. Subjects in the
following categories will be given
preference: (1) Trauma reviews using
injury severity scoring demonstrating
intercentre matching and evaluation
of treatment protocol; (2) trauma ex
perience in nonteaching centre gen
eral surgical practice; (3) “crash pro
tocols” surgery as part of resuscita
tion; (4) specialty papers on spinal
injury, pelvic fractures and facial
smashes; and (5) nonmedical disci
pline
accident-prevention
studies.
Please submit your abstracts to Dr.
C.M. Burns, Chairman, committee on
trauma, Rm. 160, Old Basic Sciences
Building, 753 McDermot Ave., Win
nipeg, Man. R3E 0T6.

Trauma Care ’82

A national symposium on the system
atic approach to treating critically in
jured patients, sponsored by the John
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Posterior Dislocation of the Clavicle Causing Fatal
Tracheoesophageal Fistula
M ark J. W asylenko , md , fr c s [c J and E dward F. B usse , m d , fr c s [c ]
A 24-year-old man severely injured
in a motor vehicle accident was
found to have, on the right side, a
pneumothorax, extrapleural hematoma,
acromioclavicular dislocation and
fracture of the first three ribs and
of the transverse processes of
C7 and T1. Through a right thoracotomy,
transection of the right main stem
bronchus and a laceration of the left
main stem bronchus were discovered.
These were repaired. Twenty days after
admission, posterior dislocation of
the clavicle at the sternum was noted.
A diagnosis of tracheoesophageal
fistula was made on the 32nd day but
the symptoms had been present
since the 16th day. Severe sepsis
resulted in death without reduction
of the sternoclavicular and
acromioclavicular dislocations.
A t autopsy the medial end of the
clavicle was found to be torn
from its articular disc and locked
behind the manubrium. The fistula
was behind the posterior capsule
between the carina and esophagus.
The authors conclude that continued
pressure from the displaced clavicle
may have led to delayed necrosis
of the esophagus and that reduction
of the dislocated clavicle might
have saved the patient's life.
Un homme de 24 ans gravement blesse
dans un accident d'automobile
a presente du cote droit un
pneumothorax, un hematome
extrapleural, une luxation acromioclaviculaire et des fractures des
trois premieres cotes et des apophyses
transverses de C7 et T1. Lors d'une
thoracotomie droite on decouvrit une
dissection transversale de la
bronche souche droite et une laceration
de la bronche souche gauche.
On effectua la reparation. Vingt jours
apres I’entree du patient a I'hopital
on identifia une luxation posterieure
de la clavicule au niveau du sternum.

Un diagnostic de fistule tracheooesophagienne a ete pose le 32e jour,
bien que les symptomes eurent
ete presents depuis le 16e jour. Une
infection grave entraina la mort
avant qu'on ait reduit les luxations
sternoclaviculaire et acromioclaviculaire. A I’autopsie on observa
que I'extremite interne de la clavicule
etait dechiree de son disque
articulaire et etait coincee derriere
le manubrium. La fistule etait
situee derriere la capsule posterieure
entre I'eperon tracheal et I'oesophage.
Les auteurs concluent qu'une pression
constante exercee par la clavicule
deplacee peut avoir cause une necrose
retardee de I'oesophage et qu'une
reduction de la clavicule disloquee
aurait pu sauver la vie du patient.

Retrosternal dislocation of the clavicle
is known to cause pressure on the
trachea, the esophagus and the great
vessels.1'8 Usually associated with
football, this injury is more often the
result of a blow to the back of the
ipsilateral shoulder than to direct
trauma.9 Early closed or open reduc
tion has resulted in relief of pressure
on the vital intrathoracic structures
and a stable, painless joint.5,7,8
In contrast, tracheoesophageal fis
tula results from violent blunt chest
trauma.1012 Killen and Collins4 found
in their review that 76% of these
lesions were due to motor vehicle
accidents. The injured person was
nearly always the driver, which im
plies that the mechanism of injury is
compression, against the steering
wheel. In the study of Layton and
colleagues,13 5 of the 35 patients
reaching the hospital alive died from
complications of their fistula. We
report the case of a man who died
when a tracheoesophageal fistula com
plicated simultaneous superior dis
location of the clavicle at the acro
mioclavicular joint and posterior dis
location at the sternoclavicular joint.

the man was transferred to the Regina
General Hospital. On admission he was
conscious. He had bruises over the upper
chest, subcutaneous emphysema, de
creased air entry on the right side
and rales in the left chest. The blood
pressure was 100/70 mm Hg, heart rate
88 beats/min and respirations were
36/min. The chest roentgenogram show
ed a right pneumothorax, mediastinal
shift to the left, a right extrapleural
hematoma and right acromioclavicular
dislocation (Fig. I). There were frac
tures of the posterior aspects of the
first three ribs and transverse processes
of Cl and Tl on the right.
On the next day an increasing air
leak and flail chest were noted. A right
posterolateral thoracotomy was done
through the bed of the sixth rib, which
was not resected. The azygous vein was
tiansected. The Carlen’s tube was in the
left main stem bronchus which had a
tear 3 cm long running distally from the
carina. The right main stem bronchus
was totally transected. Repair of the
left main stem bronchus was done over
a 7.5-mm endotracheal tube placed
through the chest (Fig. 2). This tube was
replaced by a transoral 8-mm endo
tracheal tube and the right main stem
bronchus was anastomosed; the air leak
was eliminated. The mediastinal pleura
was closed over the reconstructed
trachea and two chest tubes were insert
ed. Twenty days after the injury, the
orthopedic consultant noted posterior
dislocation of the clavicle at the sternum
(Fig. 3) and an incomplete brachial
plexus palsy involving C5 to Tl, with
right-sided Horner’s syndrome. Reduction
of the clavicle could not be carried out
because of high fever from a right-sided
empyema and consolidated right lower
lobe. The patient’s condition deteriorated
progressively; he required intubation and
mechanical ventilation. Coughing during
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department of surgery, Repina General
Case Report
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A 24-year-old man crashed a car at
Accepted for publication May II, 1981 high speed while trying to elude police.
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FIG. 1—Admission chest roentgeno
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feedings led to the diagnosis of trache
oesophageal fistula on day 32 (Fig. 4),
although this sign had been present for
16 days. On day 41 decompression gas
trostomy. feeding jejunostomy and tra
cheostomy were carried out. Hyperali
mentation was started but the patient
died 55 days after admission of respira
tory failure, septicemia due to Escheri
chia coli, thrombocytopenia and gastric
hemorrhage. Autopsy was carried out.
The medial end of the clavicle was found
to be torn from its articular disc and
locked behind the manubrium; the ante
rior capsule was intact but stripped
from the clavicle; there was a tear 6
mm long in the posterior capsule and
behind the capsule was a 5-mm-long fis
tula between the esophagus and carina.
Laterally the deltoid muscle had been
stripped off the clavicle with a sliver of
bone. There were complete tears of the
clavipectoral fascia and coracoclavicular
ligaments.

of tracheoesophageal fistula develop
3 to 5 days later. The muscularis of
the esophagus and trachea is likely
split at the time of impact." A fistula
forms if the mucosa necroses. Our
patient was noted to cough when
drinking 16 days after injury, but
the diagnosis of tracheoesophageal
fistula was not made for a further
16 days. Antkowiak and colleagues1"
reported a delay in diagnosing such
a fistula for 24 years after a m otor
vehicle accident. Diagnosis is dif
ficult in the severely injured, semi
conscious patient and sputtering may
be erroneously attributed to coexist
ing head injury or incoordination in
swallowing.12
Surgical management of the fistula
is successful if it is carried out in
the first week after injury. After that
time, operation is best delayed to al
low the mediastinitis to subside.4*10,12'13
N utritional replenishment is by hy
peralimentation or feeding jejuno
stomy. The factors determining suc
cess of the repair are the amount of
disruption of esophageal blood supply

Discussion
The symptoms and signs of trauma
tic tracheoesophageal fistula have
been outlined by Lockwood.14 They
include subcutaneous emphysema and
sudden choking a few seconds after
swallowing fluids. Solid food may
be taken well. Some swallowed food
may be coughed up. Most of the
aspiration may be avoided by lying
in a certain position. After ingestion
of fluid, rales may be heard in the
chest (Ono’s sign). Esophagoscopic
examination is usually diagnostic but
bronchoscopic examination frequently
is not. A bronchogram obtained after
a swallow of contrast material is con
clusive.
Layton and associates13 have shown
that traumatic tracheoesophageal fis
tula occurs in young men who sustain
major injuries in motor vehicle acci
dents. R ib fractures are infrequent,
suggesting that elasticity of the chest
wall is an important factor. Injury
to the trachea or bronchi is evident
on first examination but symptoms

and the severity of mediastinal infec
tion." Special problems related to
anesthesia arise intraoperatively.15
Posterior dislocation of the sternal
end of the clavicle occurred in only
0.1% of the injuries to the shoulder
girdle reported by Cave and associ
ates.16 The ratio of anterior to poste
rior dislocations is 20:1.17 The con
currence of acromioclavicular and
sternoclavicular dislocation, as in our
case, is extremely rare.
Continued pressure from persistent
displacement of the clavicle into the
mediastinum may have led to delayed
necrosis of the esophagus in our case.
Early reduction of the dislocation
might have prevented the patient’s
death. Others7 have recognized the
difficulty in diagnosing sternoclavi
cular disruptions with plain roent
genograms. A high index of suspicion
and the use of tomography will lead
to prom pt diagnosis and treatm ent of
tracheoesophageal fistula.
We thank Mr. Frank Borgerink for pre
paring the illustrations.
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Penile Prosthesis for Organic Impotence
G.J. A n k e n m a n ,

L.D. S u l l iv a n , m d , f r c s [c ], J.E. W r ig h t ,
M .G . M c L o u g h l in , m d , f r c s [ c ]

m d , f r c s [ c ],

Only in the past decade have surgeons
been able to offer men with
impotence due to organic disease
procedures that have good success
rates. Between 1976 and 1979 the
authors implanted paired silicone penile
prostheses in 35 such men, in most
cases following cancer surgery.
The procedure described is
technically not difficult. Thirty-three
of 35 patients have a functioning
prosthesis. There were four
complications but these should be
rare if patients are properly selected.
Patient satisfaction is high. No
patient requested removal of the
prosthesis.
Ce n’est que depuis la derniere
decennie que les chirurgiens ont ete
a meme d'offrir aux hommes souffrant
d'impuissance organique des
interventions ayant un bon taux de
succes. Entre 1976 et 1979 les auteurs
ont implante chez 35 hommes
des paires de protheses du penis
en silicone, suite a un chirurgie
anticancereuse dans la plupart des cas.
Techniquement ('intervention decrite
n'est pas difficile. Trente-trois de
ces 35 patients ont des protheses
fonctionnelles. On a enregistre
quatre complications, mais celles-ci
devraient etre rares si les patients
sont choisis soigneusement. Le degre
de satisfaction chez les patients
est eleve. Aucun patient n'a demande
le retrait de la prothese.

The treatment of impotence has long
challenged the medical profession and
only in the last decade have surgical
procedures produced a relatively high
success rate. In this paper we review
From the division of urology,
department of surgery, Vancouver
General Hospital and University of
British Columbia, Vancouver, BC
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combined meeting of the Royal
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our experience with paired penile
prostheses implanted in 35 men be
tween 1976 and 1979. These men
were considered to be impotent as a
result of organic disease.
Patients
The average age of the 35 men
was 56 years. The youngest was a
25-year-old man whose impotence
was secondary to a perineal injury
and the oldest was a man of 69 years
who had been operated on for cancer
of the prostate.
Twenty of the 35 men were im
potent as a result of surgery for
cancer. Most had had radical retro
pubic prostatectomy for cancer of
the prostate. These patients are able
to have orgasms despite lack of eja
culate.
There were two insulin-dependent
diabetics who were able to ejaculate
but not to obtain or sustain an erec
tion.
Indications and Contraindications
A list of the indications for im
plantation of a prosthesis and the
number of men operated upon by
us are shown in Table I. We recog
nize that there is a place for implant
ing a penile prosthesis for psycho
genic impotence following careful
psychiatric assessment, but in this
series we restricted our surgery to
patients with organic problems. The
contraindications were: (a) serious
mental disturbance, (b) any urinary
condition requiring a permanent in
dwelling catheter and (c) extensive
perineal scarring or fistulas.
Prostheses
We have had no experience with
the inflatable penile prosthesis as
originally reported by Scott and asso
ciates1 in 1973 and recently reviewed
by Malloy and associates.2 Although
an inflatable prosthesis might be the
best type, the complication rate is
too high in the hands of an inex
perienced surgeon. The prosthesis we
now use is comparatively inexpensive,
simple to implant and the results are
good.
The Small-Carrion3,4 prosthesis

VO LU M E 24, NO. 6, NO VEM BER 1981

/

m d f r c s [c ] and

was used quite satisfactorily in our
first 24 patients. Complications that
arose probably resulted from poor
patient selection rather than the pros
thesis. We now use the Flexi-Rod
penile prosthesis5,6 (Medical Engi
neering Corp., Racine, Wis.) (Fig. 1).
This prosthesis has a hinge at the
penoscrotal junction that allows the
penis to remain in a downward posi
tion when not required for inter-

Table 1 Causes o f Impotence Amenable to
Operation

Cause

No. o f patients
operated upon

Psychogenic
R esistant to therapy
Vascular
Priapism
Leriche syndrome
Central nervous system
vascular in su fficie n cy
Neurogenic
Spina bifida
M u ltip le sclerosis
P arkinson’ s disease
Tabes dorsalis
Pernicious anemia
P eripheral neuropathy
Diabetes m e llitu s
Traum atic
Pelvic fra ctu re
U rethral rupture
Spinal cord in ju ry
B rain in ju ry
Pelvic irra d ia tio n
Surgical
C astration fo r carcinoma
of prostate
Perineal prostatectom y
or biopsy
Radical prostatectom y
C ystoprostatectom y
Abdom inoperineal resection
Sympathectomy
A o rto ilia c vascular
reconstruction
External sphincterotom y
Penectomy
Metabolic
Renal fa ilu re
Chronic hem odialysis
Hepatic disease
M edicative
A ntihyp erte nsive drugs
Estrogens
A ntiandrogens
Narcotics
T ra n q u illiz e rs
Monoamine oxidase
in h ib ito rs
A ntihista m ines
Other
A lcoholism
P eyronie’s disease

0
3
1
2
0
2
0
0
0
0
0
0
2
4
2
0
2
0
0
21
0
0
15
3

2
0
0
0
1
0

1
0
0
1
0
0
0
0
4
0
4
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course. It also is easier to trim ac
cording to individual needs. It is made
of silicone in several lengths and of
two shaft diameters. Prostheses may
also be custom made.
Operative Technique

Although measurement for the
prosthesis (from the base of the penis
at the dorsum to the mid-glans with
the penis stretched) can be taken in
the office, we prefer to keep all sizes
available in the operating room.
Under general anesthesia, a tourni
quet is placed at the base of the

penis and an erection is produced by
infusing the corpora cavernosa with
saline. Not only does this permit an
accurate measurement (Fig. 2) but the
dilatation also makes it easier to in
sert the prosthesis.
A perineal or ventral approach can
be used but the dorsal incision is
preferred in our centre. Care is taken
to avoid the superficial dorsal penile
vein and neurovascular bundle. Dis
section is carried down to Buck’s
fascia, bilaterally, to expose the tunica
albuginea. An incision 3 cm long is
made into the erectile tissue between
stay sutures. After removal of the
tourniquet, the crus of the corpus
cavernosum is dilated gently with
either Hegar or Pratt dilators. Sub
sequently, the distal penile corpus is
dilated. The penile implant itself is
then inserted with the penis stretched.
The distance from the mid-glans to
the tip of the implant gives a rough
approximation of how much of the
tail piece must be trimmed. The
prosthesis is bent back on itself and
snapped into place. A continuous
suture of 3-0 Dexon is used to close
the tunica albuginea. A small catheter
is left indwelling overnight. Broadspectrum antibiotics are given prophylactically for 4 days postoperatively. In diabetics antibiotics are also
given preoperatively.

Results

The results of operation were ex
cellent. Of the 35 men, 33 (95%)
have a functioning prosthesis and no
patient has requested removal of the
prosthesis. Most patients were able to
leave hospital 5 to 6 days after the
operation.
In one patient, one corpus could
not be dilated and only one prosthe
sis was used; this works quite satis
factorily. If there is any question
about snugness of the prepuce, a cir
cumcision or dorsal slit should be
made at the same time.

Fig. 3a

Fig. lb
FIG . 1— (a) Flcxi-Rod penile prosthe
sis and (b) hinge effect.

FIG . 2— (a) M easurem ent taken during
surgical procedure and (b) Flcxi-Rod
penile prosthesis in place.
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Fig. 3b
F IG . 3— Six weeks after operation.
Penis (a) in norm al position and (b)
elevated.
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ToTreat M any M ixed Infections
W ithout M ultiple A ntibiotics

.. J
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Merck Sharp & Dohme Canada Limited, Trademark Owner
Charles E. Frosst & Co., Registered User

In intra-abdominal and pelvic infections, MEFOXIN
— an effective sin gle agent — provides bactericidal activity against
many mixed aerobic/anaerobic organisms including B. fragilis.
In many cases MEFOXIN* may eliminate the need for combination
antibiotic therapy which could include potentially more toxic agents.
MEFOXIN* is generally w ell tolerated... Data from
108 studies conducted world-wide on 2277 patients with infections at
various sites, 1924 of whom received MEFOXIN* revealed the drug to be
well tolerated by more than 90% of patients.1
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The First C ephamycin D erivative

(CEFOXITIN SO DIUM FOR INJECTION)

For S ingle A ntibiotic Therapy
O f M any M ixed Infections
MEFOXIN* is not active against Pseudomonas spp.,
most strains of enterococci, many strains of
Enterobacter cloacae, and methicillin-resistant
staphylococci.
1. van Winzum, C.: Clinical safety and tolerance o f cefoxitin sodium: an overview,
J Antimicrob Chemother 4 (Suppl B): 91-104, 1978.
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ANTIBIOTIC
ACTION
In vitro studies demonstrate that the bactericidal action ot cefoxitin, a
cephamycin derived from cephamycin C, results from the inhibition of
bacterial cell wall synthesis. Evidence suggests that the methoxy group
in the 7a position is responsible for the resistance of cefoxitin to
degradation by bacterial beta-lactamases.

INDICATIONS AND CLINICAL USES
TREATMENT

The treatment of the following infections when due to susceptible
organisms:
1— Intra-abdominal infections such as peritonitis and intra-abdominal
abscess
2 — Gynecological infections such as endometritis and pelvic cellulitis
3 — Septicemia
4 — Urinary tract infections (including those caused by Serratia marcescens
and Serratia spp.)
5 — Lower respiratory tract infections
6 — Bone and joint infections caused by Staphylococcus aureus
7 — Soft tissue infections such as cellulitis, abscesses and wound
infections
Appropriate culture and susceptibility studies should be performed to
determine the susceptibility of the causative organism(s) to MEFOXIN*.
Therapy may be started while awaiting the results of these tests,
however, modification of the treatment may be required once these
results become available.
Organisms particularly appropriate for therapy with MEFOXIN* are:
Gram positive

Staphylococci, penicillinase producing and non-producing
Streptococci excluding enterococci
Gram negative (beta-lactamase producing and non-producing strains)

E. Coli
Klebsiella species (including K. pneumoniae)
Proteus, indole positive and negative
Haemophilus influenzae
Providencia species
Anaerobes

Bacteroides tragilis
MEFOXIN* may also be appropriate for the treatment of infections
involving susceptible strains of both aerobic and anaerobic bacteria.
Clinical experience has demonstrated that MEFOXIN* can be adminis
tered to patients who are also receiving carbenicillin, gentamicin,
tobramycin, or amikacin (see PRECAUTIONS and ADMINISTRATION).
Intravenous Administration

The intravenous route is preferable for patients with bacteremia, bacterial
septicemia, or other severe or life-threatening infections, or for patients
who may be poor risks because of lowered resistance resulting from
such debilitating conditions as malnutrition, trauma, surgery, diabetes,
heart failure, or malignancy, particularly if shock is present or impending.
PROPHYLACTIC USE

MEFOXIN* may be administered perioperatively (preoperatively, intraoperatively and postoperatively) to patients undergoing vaginal hys
terectomy and abdominal surgery when there is a significant risk of
postoperative infection or where the occurrence of postoperative
infection is considered to be especially serious.
In patients undergoing cesarean section, intraoperative (after clamping
the umbilical cord) and postoperative use of MEFOXIN* may reduce
the incidence of surgery related postoperative infections.
Effective prophylactic use depends on the time of administration.
MEFOXIN* usually should be given one-half to one hour before the
operation. Prophylactic administration should usually be stopped within
12 hours. It has been generally reported that continuing administration
of any antibiotic beyond 24 hours following surgery increases the
possibility of adverse reactions but, in the majority of surgical procedures,
does not reduce the incidence of subsequent infection.
If signs of postsurgical infection should appear, specimens for culture
should be obtained for identification of the causative organism(s) so that
appropriate therapy may be instituted.

CONTRAINDICATIONS
MEFOXIN* is contraindicated in persons who have shown hypersensi
tivity to cefoxitin or to the cephalosporin group of antibiotics.

WARNINGS
Before therapy with MEFOXIN* is instituted, careful inquiry should be
made to determine whether the patient has had previous hypersensitivity
reactions to MEFOXIN*, cephalosporins, penicillins or other drugs.
MEFOXIN* should be given with caution to penicillin-sensitive patients.

'Merck Sharp & Dohme Canada Limited, Trademark Owner
Charles E. Frosst & Co., Registered User

There is some clinical and laboratory evidence of partial cross
allergenicity between cephamycins and the other beta-lactam antibiotics,
penicillins and cephalosporins. Severe reactions (including anaphylaxis)
have been reported with most beta-lactam antibiotics.
Any patient who has demonstrated some form of allergy, particularly to
drugs, should receive antibiotics including MEFOXIN* with caution.
If an allergic reaction to MEFOXIN* occurs, administration of the drug
should be discontinued. Serious hypersensitivity reactions may require
treatment with epinephrine and other emergency measures.

PRECAUTIONS
The total daily dosage should be reduced when MEFOXIN* is adminis
tered to patients with transient or persistent reduction of urinary output
due to renal insufficiency (see DOSAGE and ADMINISTRATION)
because high and prolonged serum antibiotic concentrations can occur
from usual doses.
In patients treated with MEFOXIN* a false-positive reaction to glucose
in the urine may occur with Benedict’s or Fehling's solutions but not with
the use of specific glucose oxidase methods.
Using the Jaffe Method, falsely high creatinine values in serum may
occur if serum concentrations of cefoxitin exceed 100 mcg/mL. Serum
samples from patients treated with MEFOXIN* should not be analyzed
for creatinine if withdrawn within two hours of drug administration.
Increased nephrotoxicity has been reported following concomitant
administration of cephalosporins and aminoglycoside antibiotics.
The safety of MEFOXIN* in the treatment of infections during pregnancy
has not been established. If the administration of MEFOXIN* to pregnant
patients is considered necessary, its use requires that the anticipated
benefits be weighed against possible hazards to the fetus. Reproductive
and teratogenic studies have been performed in mice and rats and have
revealed no evidence of impaired fertility or harm to the fetus due to
MEFOXIN*.
Cefoxitin has been observed in the milk of nursing mothers receiving
the drug.
Prolonged use of MEFOXIN* may result in the overgrowth of nonsusceptible organisms. Repeated evaluation of the patient s condition
is essential and if super-infection occurs during therapy, appropriate
measures should be taken. Should an organism become resistant during
an antibiotic therapy, another antibiotic should be substituted.
In children 3 months of age or older, higher doses of MEFOXIN*
(100 mg/kg/day and above) have been associated with an increased
incidence of eosinophilia and elevated SGOT.
The safety and efficacy of MEFOXIN* for the treatment of infections in
infants from birth to three months of age have not yet been established.

ADVERSE REACTIONS
MEFOXIN* is generally well tolerated. Adverse reactions rarely required
cessation of treatment and usually have been mild and transient.
Local Reactions

Thrombophlebitis has occurred with intravenous administration. Some
degree of pain and tenderness is usually experienced after intramuscular
injections using water. Induration has occasionally been reported.
Allergic

Maculopapular rash, urticaria, pruritus, eosinophilia, fever and other
allergic reactions have been noted.
Gastrointestinal

Diarrhea has been reported rarely.
Blood

Transient leukopenia and neutropenia have been reported. Some
individuals may develop positive direct Coombs tests during therapy
with MEFOXIN*.
Liver Function

Transient elevations in SGOT, SGPT, serum LDH, and serum alkaline
phosphatase have been reported.
Kidney

Elevations in serum creatinine and/or blood urea nitrogen levels have
been observed. The role of MEFOXIN* in changes in renal function tests
is difficult to assess, since factors predisposing to prerenal azotemia or
to impaired renal function have often been present.

TREATMENT OF OVERDOSE
Other than general supportive treatment, no specific antidote is known
MEFOXIN* can be eliminated by dialysis in patients with renal
insufficiency.

DOSAGE AND ADMINISTRATION
TREATMENT DOSAGE

M EFOXIN* may be administered intravenously or intramuscularly when
required. (See monograph for reconstitution directions for each route.)
Adult Dosage

The usual adult dosage is 1 g or 2 g of MEFOXIN* every 6 to 8 hours.
Dosage and route of administration should be determined by severity
of infection, susceptibility of the causative organisms, and condition of
the patient. The usual adult dosages are shown in the table below.

Usual Adult Dosage
Type of Infection

Daily Dosage

Uncomplicated forms*
3-4 grams
of infections such as
pneumonia, urinary tract
infection, soft tissue infection
Moderately severe or
severe infections

6-8 grams

Infections commonly
needing antibiotics in
higher dosage (e.g.
gas gangrene)

12 grams

Frequency and Route

1 gram every 6-8 hours
IV or IM

1 gram every 4 hours
or
2 grams every 6-8 hours IV
2 grams every 4 hours
or
3 grams every 6 hours IV

‘ Including patients in whom bacteremia is absent or unlikely.
Therapy may be started while awaiting the results of susceptibility
testing.
Antibiotic therapy for group A beta-hemolytic streptococcal infections
should be maintained for at least 10 days to guard against the risk of
rheumatic fever or glomerulonephritis. In staphylococcal and other
infections involving a collection of pus, surgical drainage should be
carried out where indicated.
Dosage in Adult Patients with Impaired Renal Function

MEFOXIN* may be used in patients with reduced renal function but
a reduced dosage should be employed and it is advisable to monitor
serum levels in patients with severe impairment.
In adults with renal insufficiency, an initial loading dose of 1 g to 2 g
should be given. After a loading dose, the following recommendations
for maintenance dosage may be used as a guide:
RENAL
FUNCTION

CREATININE
CLEARANCE
mL/min

DOSE

FREQUENCY

every 8-12 hrs
50-30
1-2 g
Mild impairment
every 12-24 hrs
29-10
1-2 g
Moderate impairment
every 12-24 hrs
9-5
0.5-1 g
Severe impairment
every 24-48 hrs
<5
0.5-1 g
Essentially no function
In the patient undergoing hemodialysis, the loading dose of 1-2 g should
be given after each hemodialysis, and the maintenance dose should be
given as indicated in the table above.
Infants and Children

The recommended dosage in children three months of age and older
is 80 to 160 mg/kg of body weight per day divided into four to six equal
doses. The higher dosages should be used for more severe or serious
infections. The total daily dosage should not exceed 12 g.
At this time no recommendation is made for children from birth to three
months of age (see PRECAUTIONS).
At present there is insufficient data to recommend a specific dosage for
children with impaired renal function. However, if the administration of
MEFOXIN* is deemed to be essential the dosage should be modified
consistent with the recommendations for adults (see Table above).
PROPHYLACTIC USE

For prophylactic use, a three-dose regimen of MEFOXIN* is recom
mended as follows:
Vaginal hysterectomy and abdominal surgery

2 g administered intramuscularly or intravenously just prior to surgery
(approximately one-half to one hour before initial incision).
The second and third 2 g doses should be administered at 2-6 hour
intervals after the initial dose.
Cesarean Section

The first dose of 2 g should be administered intravenously as soon as
the umbilical cord has been clamped. The second and third 2 g doses
should be given intravenously or intramuscularly four hours and eight
hours after the first dose.

DOSAGE FORMS
Sterile MEFOXIN* is a dry white to off-white powder supplied in vials
containing cefoxitin sodium as follows:
No. 3356—1 g cefoxitin equivalent in boxes of 10 vials
No. 3357—2 g cefoxitin equivalent in boxes of 10 vials
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Fig. 3 shows the penis 6 weeks
after operation in the norm al and
elevated positions.

Complications
The patients who had sustained a
traum atic injury, especially those with
neurogenic bladders, were the ones
in whom most of our complications
occurred. One patient had a penec
tomy for gangrene; he complained
of dribbling over his scrotum. A
prosthesis was inserted and a scrotoplasty was done; this man then had
a short phallus through which he
could direct his urinary stream. One
patient with a severe perineal injury
had a urethroplasty and perm anent
colostomy. A slough developed and
both prostheses were removed; in
retrospect he was a poor candidate
for the procedure. One patient with
a cauda equina injury required re
moval of both prostheses because of
infection 5 weeks after operation.
Paired prostheses were inserted
into the penis of a paraplegic on
condom drainage who had difficulty
keeping his apparatus on. One
sloughed spontaneously but the other
functions satisfactorily. A nother pa
tient had pain from a prosthesis
protruding under the skin and. on re
moval, it was apparent that the pros
thesis had gone through the septum
into the opposite corpus cavernosum.
After removal of the offending pros
thesis causing the pain, the rem aining
one functioned quite well.

Conclusions
Implantation of paired silicone
penile prostheses for impotence is not
difficult technically. The success rate
is high (95%) in properly selected
patients. Since this paper was pre
pared, 10 other patients have had suc
cessful implants. Patient satisfaction is
high, particularly in those who have
lost their sexual abilities as a result
of operation for cancer.
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Prevention of Severe Intestinal Ischemia following
Reconstruction of the Abdominal Aorta
P.G. K alman , md , K.W. Johnston, md , frcs[c ], facs and I.H. L ipton , md, frcs[c ], facs

Intestinal ischemia should be suspected
in any patient following aortic surgery
who has pain out of keeping with
the operation, postoperative diarrhea
(with or without bleeding) or an
unexplained metabolic acidosis. Ten
such cases of intestinal ischemia
w ere identified during a 10-year period
at the Toronto General and Toronto
W estern hospitals. Six occurred
following repair of a ruptured abdominal
aneurysm, one followed elective
aneurysmectomy and three followed
elective bypass for occlusive disease.
The overall mortality was 70%.
Transmurai bowel infarction was
found in six patients (all died), while
four patients had partial-thickness
injury (one died, three had late
strictures). Potentially preventable
factors in each patient, either single
or multiple, were identified and are
discussed. Emphasis on early diagnosis
is stressed, because once transmural
necrosis has occurred the prognosis
is poor.
Une ischemie intestinale doit etre
soupconne lorsque, suite a une
chirurgie aortique, un patient a des
douleurs beaucoup trop intenses
pour cette operation, une diarrhee
postoperatoire (parfois avec
saignement) ou une acidose
metabolique inexpliquee. Dix de
ces cas d’ischemie intestinale
ont ete identifies au cours d'une
periode de 10 ans aux hopitaux
Toronto General et Toronto Western.
Six sont survenus apres reparation
d'un anevrysme abdominal rupture, un
est survenu apres une anevrysmectomie
non urgente, et trois sont survenus
apres une operation de derivation pour
maladie obliterante. La mortalite
globale fut de 70%. Un infarctus
transmural de I’intestin fut decouvert
chez six patients, (tous les six sont
decedes), alors que quatre patients
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presentaient une lesion de profondeur
partielle (un est decede, trois eurent
un retrecissement tardif). Chez chaque
patient des facteurs simples ou
multiples auraient pu etre prevenus;
ceux-ci sont identifies et discutes.
On insiste sur ('importance d'un
diagnostic precoce car, une fois la
necrose transmurale apparue, le
pronostic est mauvais.

Severe intestinal ischemia is an un
common but serious complication
following abdominal aortic reconstruc
tion. Hagihara and associates1 and
Ernst and associates,2 using colono
scopy routinely after operation, re
ported bowel ischemia in 6% to
7% of patients who underwent major
aortic surgery, but the majority of
the patients had mild, clinically in
significant mucosal damage. As re
ported by Johnson and Nabseth3
severe, clinically manifest intestinal
damage follows only 1% to 2% of
aortic procedures.
In this paper we review our expe
rience with intestinal ischemia follow
ing aortic surgery to identify the
preventable aspects of the problem,
the clinical features that may lead to
an earlier diagnosis and the best
method of treatment.
Method

A review of the case records and
autopsy reports at the Toronto Gen
eral and Toronto Western hospitals
between 1970 and 1979 identified 10
cases of severe intestinal ischemia
that led to death or a major intestinal
complication or that appreciably pro
longed the hospital stay. No attempt
was made to identify patients with
mild transient intestinal ischemia.
Findings
Patients

The patient data are summarized
in Tables I and II. Of the 10 patients
who had severe intestinal ischemia,
6 had undergone repair of a ruptured
abdominal aortic aneurysm, 1 had
had elective aneurysm repair and 3
had had elective bypass grafting for
aortoiliac occlusive disease. There
were seven men and three women
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ranging in age from 52 to 80 years
(mean 66 years). Seven of the 10
patients died; in 5, intestinal ischemia
was the primary cause and in 2 it
was a major contributing factor. Six
patients had transmural bowel necro
sis and all died (Table I, patients 5
to 10). Of the four patients with
partial-thickness bowel injury one
died and strictures subsequently de
veloped in three.
Symptoms and Signs
The time of onset of symptoms
ranged from 24 hours to 21 days
following operation (mean 5.7 days).
There was a correlation between the
onset of symptoms and the degree
of bowel involvement in this series.
Patients with transmural ischemia
had symptoms earlier in the post
operative period (mean 3.3 days,
range from 1 to 10 days). However,
those with partial-thickness injury
experienced symptoms later (mean
9.35 days, range from 3 to 21 days).
Diarrhea was the most frequent pre
senting symptom (in 90% of the
patients) and in six patients there
was blood in the stool. Five patients
presented with signs of peritonitis.
Treatment
At the time of diagnosis five of
the patients were moribund and were
not treated. In four patients a bowel
resection was performed with a proxi
mal defunctioning procedure; two of
these patients survived. One patient,
treated with bowel rest and total
parenteral alimentation for 6 weeks,
recovered.
Cause
The cause of the severe intestinal
ischemia could not always be iden
tified and in some patients more
than one factor was implicated (Table
II).
Site of Involvement
In the majority of patients (7 of
10) the most frequent site of involve
ment was the region supplied by the
inferior mesenteric artery, distal to
the splenic flexure. Four patients had
ischemia of the left colon, in three
it was limited to the rectosigmoid,
one patient had infarction of his
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comitant repair of the mesenteric pathectomy, reduced mesenteric blood
artery. Patients with abdominal aortic flow by 42% to 72%. For these
aneurysms may have mesenteric vas reasons, abnormalities of the superior
cular disease as well and we agree mesenteric artery should be corrected
with Brewster and associates4 that concomitantly with the aortic repair
routine angiography is useful in the unless excellent flow can be main
preoperative assessment of these tained through the inferior mesen
patients, since it provides information teric or the internal iliac arteries.
Sarnoff and Fine7 and Poth and
that is helpful in planning the opera
McClure8 have shown that preopera
tive procedure and detects unexpected
vascular abnormalities that may lead tive preparation of the bowel with
antibiotics reduces the incidence and
to intestinal ischemia.
If superior mesenteric artery steno severity of ischemic bowel injury in
sis is present, limb revascularization laboratory animals, but its clinical
can result in a steal syndrome, as value has been questioned. Smith and
described by Connolly and Stemmer,5 Szilagyi9 recommended bowel prepa
when blood is diverted from the ration for elective cases but Bicks
mesenteric circulation to the limbs. and associates10 were unable to find
In 1966, Kountz and associates6 any appreciable benefit.
Intraoperative prevention. — Pre
demonstrated in dogs that limb re
vascularization accompanied by sym existing insufficiency of the mesen-

entire colon and two patients had
small bowel ischemia.
Discussion

V

v

Prevention
The complication of severe intes
tinal ischemia can often be prevented
by attention to certain details of
management.
Preoperative prevention. — In any
patient having elective aortoiliac re
pair for occlusive disease, the pre
operative angiogram should be care
fully assessed for evidence of mesen
teric vascular insufficiency, in parti
cular a large central anastomotic
artery (meandering mesenteric artery).
This radiologic finding is an indica
tion for celiac and superior mesen
teric angiography and, perhaps, con

Table I— Data on 10 Patients w ith Intestinal Ischemia

► Y

y

!►
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Patient
Age,
no. Sex yr

Reason for operation

Reconstruction
A LCF

Onset of
symptoms
postop, d

Area involved

Management

Degree

Outcome

Rectosigmoid

Partial

Sigmoid colostomy

Recovered

10

Left colon

Partial

Total parenteral
nutrition for
6w k

Recovered

3

Ileum

Partial

Supportive

Died

21

Rectosigmoid

Partial

Transverse
colostomy

Recovered

XCF
< LCF

2

Rectosigmoid

Transm ural

Supportive

Died

A

RCI
< LCI

10

Left colon

Transm ural

Supportive

Died

Ruptured aneurysm

A

RCI
<1X1

2

Duodenum and
proximal jejunum
(thrombosis of SMA)

Transmural

Supportive

Died

Ruptured aneurysm

Tube

(E-E)

3

Entire colon

Transm ural

Colectomy

Died

i

M

59

Aortoiliac occlusive
disease

2

F

52

Aortoiliac occlusive
disease

(EE)
A

3

M

65

Ruptured aneurysm

A

_REI
< LEI

4

M

80

Ruptured aneurysm

A

.REI
< LEI

5

F

68

Aortoiliac occlusive
disease

(E-E)
A

6

M

66

Ruptured aneurysm

7

M

67

8

M

68

.REI
< LCF

9

M

66

Ruptured aneurysm

A

.REI
<LEI

10

F

65

Elective aneurysm

A

REI
<LCI

3

1

Left colon

Transm ural

Left colectomy
and Hartmann
procedure

Died

2

Left colon

Transm ural

Supportive

Died

A = aorta, I = iliac, R = right, L = left, Cl = common iliac, El = external iliac, CF = common fem oral, E-E = end-to-end, SMA — superior
mesenteric artery.

».
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Table II— Patient Data
Patient
no.
i
2
3
4
5
6
7
8
9
10

Hypotension
+
+
+
+

+
+
+
+

+
+
+
+

+
+
+
+
+

+
+
+
+
+

+
+
+
+
+

Internal iliac
perfusion

IMA
Ligated
Ligated
Ligated
Ligated
Patent
Ligated
Ligated
Ligated
Ligated
Ligated

Reduced
Poor
Right and le ft
Right and le ft
Poor
Right and le ft
Right and le ft
Right and le ft
Right and le ft
Left patent

patent
ligated
patent
patent
patent
patent

Embolization

O perative traum a

+ +
—
—
—
—
—
—
—
—
—

—
—
—
—
Thrombosed SMA
—
—

IMA = inferior mesenteric artery, SMA = superior mesenteric artery, + - f - = moderate, + - | —F = severe.
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teric arteries should be suspected if
the inferior mesenteric artery is large,
if there is a thrill in the superior
mesenteric artery or a meandering
artery is present. The colon is sup
plied by three major arteries and
their connections: the superior and
inferior mesenteric arteries and the
middle hemorrhoidal branches of the
internal iliac arteries. The marginal
artery of Drummond lies near the
mesenteric border running along the
entire length of the colon and is fed
by the right, middle and left colic
arteries. Although the marginal artery,
as demonstrated by Steward and
Rankin,11 is missing at the ascending
colon in 51%, at the sigmoid in 20%
and much more often at the rectosig
moid junction, the blood supply is
usually adequate through collaterals
at the level of the second or third
arcades. The central anastomotic
artery is a communication between
the left branch of the middle colic
and the ascending branch of the left
colic arteries and is present in more
than 60% of healthy persons. With
occlusion of the superior mesenteric
or inferior mesenteric artery this
vessel enlarges, elongates, becomes
tortuous and can be identified on
arteriograms as the meandering
mesenteric artery. The important
distal communication in the recto
sigmoid region is between the superior
hemorrhoidal branch of the inferior
mesenteric artery and the middle
hemorrhoidal branch of the internal
iliac artery.
Ligation of the inferior mesenteric
artery is necessary during aneurys
mectomy and is frequently performed
during bypass procedures for occlu
sive disease. Ault and associates12 as
well as Morgan and Griffiths13 have
demonstrated that the distal colon
tolerates this well in most cases, pro
vided a healthy collateral supply is
present. However, if the blood supply
is compromised by occlusive disease
or by damage to the secondary or
tertiary arcade by ligation too distal
from the artery, ischemia may result.
Ernst and colleagues2 stated that liga
tion of the inferior mesenteric artery
would not cause ischemia unless a
meandering mesenteric artery was
present and, although this is generally
true, care must be taken to divide
the vessel close to the aorta since
the major collateral arcade may be
at the level of the primary division
of the inferior mesenteric artery.
During aortic aneurysm resection we
prefer to oversew the inferior mesen
teric artery from within once the
aneurysm has been opened.
636

Similarly, since the internal iliac
arteries may contribute in a major
way to intestinal blood supply if
mesenteric vascular disease is present
and, since the collateral supply in the
rectosigmoid region may be tenuous,
it is important to maintain perfusion
to at least one internal iliac artery.
If the predominant occlusive disease
is in the external iliac arteries, endto-side aortic anastomosis may be
preferable so as to maintain collateral
blood supply.
Traction on the superior mesen
teric artery with retractors while
gaining exposure for the aortic ana
stomosis may damage the vessel,
especially if it is atherosclerotic, or
injure the middle colic artery. The
aorta should be dissected carefully
and with a minimum of manipulation
because atheromatous debris may be
dislodged into the vessels supplying
the colon. In general, we prefer an
end-to-end aortic anastomosis and
simply carry out enough dissection to
permit us to apply a straight vertical
vascular clamp. If necessary, we
complete the dissection after the aorta
is cross-clamped. After the aortic
anastomosis has been completed,
especially if the anastomosis is endto-side, thrombus and atherosclerotic
debris should be flushed from the
aorta and prosthesis. In elective cases,
we use systemic heparinization; this
may be important when moderate
stasis develops intraoperatively. Bicks
and associates10 performed rectal
biopsies on their symptomatic patients
and demonstrated occlusion of small
vessels. This evidence provides some
support for the intraoperative use of
heparin and for keeping the period
of reduced bowel ischemia to a
minimum.
In our series, the most common
factor associated with severe intes
tinal ischemia was intraoperative or
postoperative hypotension. Our cur
rent policy is to monitor arterial
blood pressure with a radial line, urine
output, central venous pressure and,
as indicated, left atrial pressures and
cardiac output with a Swan-Ganz
catheter so as to avoid periods of
hypoperfusion.
Postoperative prevention. — Postoperatively, hemodynamic monitoring
is usually continued for 24 hours
and occasionally for 48 hours if in
dicated. Maintenance of homeostasis
may be of benefit in patients with a
tenuous intestinal blood supply.
Diagnosis
Early diagnosis is essential if these
seriously ill patients are to be saved.
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Intraoperative diagnosis. — Care
ful examination of the colon before
the abdomen is closed is probably the
most important method of diagnosis.
This is particularly important if the
patient is known to be predisposed
to vascular insufficiency or if there
has been a period of intraoperative
hypotension.
The Doppler flowmeter can be
used to detect flow in the small
vessels of the bowel wall if viability
is in question.14 It appears that the
presence of a Doppler signal is reas
surance that the bowel will survive.
Unfortunately, unless the surgeon is
familiar with Doppler techniques, and
in particular with examination of
colonic vessels, failure to detect a
flow signal may lead to unwarranted
intervention.
If the superior mesenteric artery
is stenosed, the decision to carry out
concomitant aorta-superior mesen
teric arterv bypass may be a difficult
one to make Clearly, if the patient
is symptomatic the bypass is indi
cated; however, in the asymptomatic
patient, the decision must be based
on the severity of the stenosis, the
adequacy of collateral circulation,
whether inferior mesenteric and in
ternal iliac blood flow can be main
tained after the bypass procedure and
the appearance of the bowel before
closure.
Postoperative diagnosis. — Patients
with colonic ischemia fall into two
groups — those who present early
with severe acute abdominal and
often systemic symptoms, usually the
result of transmural involvement, and
those who present after 72 hours with
subtle bowel complaints due to partial
thickness damage to the bowel.
Patients with full-thickness involve
ment and ultimate perforation usually
complain of abdominal pain out of
keeping with their operative proce
dure and occasionally have bloody
diarrhea. In less severe cases, abdo
minal tenderness and distension may
be present, but unexplained moderate
leukocytosis or acidosis may be the
only finding. A plain film of the
abdomen may show a localized area
of bowel dilatation. Roentgenography
after a barium enema is usually not
necessary in these patients. Sigmoi
doscopy usually shows mucosal cyano
sis and friability sometimes with
ulceration.
Patients with partial-thickness in
jury (mucosal and sometimes sub
mucosal) may initially be asymptoma
tic and may present late with a
colonic stricture; however, they often
have mild pain, diarrhea with or
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without bleeding, mild local tender
ness and an unexplained leukocytosis.
Diarrhea occurring after 72 hours
may be caused by antibiotic-induced
colitis or ischemic colitis and sig
moidoscopy with biopsy and culture
may be the only accurate method to
distinguish between them. Barium or
Hypaque enema examination may
be useful, but the diagnosis is usually
made by sigmoidoscopy. Colonoscopy
may be useful if the sigmoidoscopy
shows no abnormality and a site of
involvement is suspected above the
sigmoid. Hagihara and associates1
have shown this to be a safe, effective
method.
Treatment
Treatment of patients with severe
intestinal ischemia is difficult. If the
ischemia is recognized intraoperatively following aortic repair, it is essen
tial to ensure an optimal hemodyna
mic status. Revascularization may be
possible by reimplanting the inferior
mesenteric artery, by aorta—superior
mesenteric artery bypass, or, under
rare circumstances, by internal iliac
bypass. If colonic ischemia is sus
pected at operation but its severity
is uncertain, the safest method may
be to plan a second operation 24
hours later. Dextran or heparin given
systemically may minimize extension
of the thrombus and further bowel
necrosis. If the colon is frankly
ischemic, exteriorization is the best
method, but if this is not possible,
resection with exteriorization of the
ends of the bowel will be necessary
after closing the peritoneum over the
graft. Following exteriorization of the
bowel or resection with exterioriza
tion of the ends, the proximal margins
must be observed carefully. Reopera
tion is indicated if there is evidence
of extension of necrosis. None of
our six patients with transmural ne
crosis survived.
Patients who present late (after 72
hours) with partial-thickness involve
ment can usually be managed con
servatively with antibiotics, bowel
rest and, if necessary, total parenteral
nutrition. If the severity of the bowel
damage is uncertain, laparotomy may
be necessary to ensure that full
thickness involvement is not present.
Careful follow-up is necessary to
detect strictures. In our series, three
of the six patients who presented late
survived. In the series of Bicks and
associates10 13 patients presented
early: 9 died, 2 survived after re
section and 2 survived with intact
colon. Six patients presented late and
all survived.
VOLUME 24, NO. 6, NOVEMBER 1981

Summary

CORRESPONDENCE

Bowel ischemia that develops fol
lowing abdominal aortic repair is
serious. In a review of 10 cases we
identified the following contributing
factors that may be preventable:
prolonged intraoperative or postopera
tive hypotension, failure to maintain
perfusion to at least one internal iliac
artery, incorrect ligation of the inferior mesenteric artery, dissemination
of atheromatous debris, operative
trauma, prolonged aortic crossclamping and inadequate heparinization. The diagnosis and management
of this complication have been re
viewed in the hope of improving the
unsatisfactory results.

continued from page 558
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Bon Mot
Patients, generally speaking, are peo

j ple and, like regular people, use

words irregularly because of lack of
comprehension or poor listening and
reading habits or because of attempts
to use words that are beyond them.
Even people who do understand some
times trip over words and unwittingly
produce funny things. The Reverend
W.A. Spooner was reputed to make
such errors in speaking which gave
rise to the term spoonerism (e.g., you
have hissed the mystery lectures).
Typographic errors may also be the
source of amusing variations in
thought. We see them in material
|
j you send us for publication — they
are corrected quickly but we shall
collect them and share them with
you.
What better place is there to pick
up these bon mots than in the doc
|
tor’s office, where long, often tech
nical and unintelligible words are used
to explain mysterious phenomena?
Strange things come out when pa
| tients try to reproduce this profes
sional jargon.
I am interested in collecting these
witticisms and printing them in these
pages from time to time. Here are
a few I have heard in my own office:
“I visited the choirpractor.” (Is this
the singing practitioner?)
“I went to physiotherapy where I
was ultra-violated.”
“The physiotherapist put me in
heat.”
“I was admitted to hospital for
measurement of my 17 feet of stero
ids.” (This would not come out as
well in metric units.)
“The doctor applied a boloney
cast.”
“I was examined with a fine tooth
and comb.”
Next time you hear a bon mot in
your office send it along — irregardless.
J . I . . S h u g a r . m d . f r c s [c ]

Senior associate editor
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Incentive Breathing Devices and Chest Physiotherapy:
a Controlled Trial
J ohn L. O ulton ,

md, frcp [c],*

Incentive breathing devices combined
with standard chest physiotherapy
w ere evaluated in patients who had
undergone coronary artery operations.
Patients were divided into three
groups: those who received only
physiotherapy, those who received
chest physiotherapy and treatment
with a Triflo unit and those who
received chest physiotherapy and
treatm ent with a Spirocare unit.
Chest roentgenograms were obtained
each morning and evening for 4 days
after operation and patients were
scored according to the degrees of
radiologic change in the lungs.
Statistically significant differences
(P = 0.008 to 0.038) were noted
between the patients who had therapy
with the Spirocare device and those
in the other two groups, indicating
that the Spirocare system provides
additional benefits when used as
a supplement to standard postoperative
chest physiotherapy.
Des stimulateurs de la respiration
associes a la physiotherapie thoracique
conventionnelle ont ete evalues chez
des patients qui avaient subi des
operations des coronaires. Les
patients ont ete divises en trois
groupes: ceux qui n'ont re?u que
de la physiotherapie, ceux qui
ont regu de la physiotherapie et des
traitem ents avec un dispositif Triflo,
et ceux qui ont repu de la
physiotherapie thoracique et des
traitem ents avec un appareil Spirocare.

*Clinical associate professor, department
o f anesthesia, University of British
Columbia; assistant director, department
of anesthesia, Vancouver General
Hospital, Vancouver, BC (deceased)
'(Senior physiotherapist, Willow
cardiothoracic unit, Vancouver General
Hospital. Presently, physiotherapy
coordinator. Health Sciences Centre
Hospital, University of British Columbia

G illian M. Hobbs,

Des roentgenogrammes thoraciques
ont ete prises chaque matin et
chaque soir pendant les 4 jours
qui ont suivi I'operation, et les
patients ont ete cotes selon le degre
des changements radiologiques de
I'image pulmonaire.
Des differences statistiquement
significatives (P = 0.008 a 0.038) ont ete
observees entre les patients qui
ont eu un traitement avec le dispositif
Spirocare et ceux des deux autres
groupes; ceci indique que le systeme
Spirocare procure des avantages
additionnels quand il est utilise avec
la physiotherapie thoracique
conventionnelle en postoperatoire.

The development of atelectasis may
be expected in a high percentage of
patients who have undergone cardiac
operation.1"1 This may be as high as
84% ,5 and unpublished data from our
own hospital show an incidence of
65% over a 1-year period in patients
for whom a pump oxygenator had
been used during open-heart oper
ation.
This condition develops partly be
cause of the shallow breathing2,6 that
patients use for comfort after opera
tion. The decrease in vital capacity
and alveolar gas exchange that ac
companies this shallow breathing leads
to alveolar collapse and in some cases
to life-threatening pulmonary com
plications. Less severe complications
in other cases extend hospital stay,
thus increasing costs.
Studies7'10 show that incentive
breathing devices are beneficial when
they are used in fully conscious, extubated patients who are not in severe
pain. But they should supplement, not
replace, the care given by physiother
apists. This study was undertaken to
determine whether incentive breathing

T a b le 1

XDirector, department of diagnostic
radiology, acute care unit, Health Sciences
Centre Hospital, University of
British Columbia

Reprint requests to: Dr. P. Hicken,
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devices add to the benefits of standard
chest physiotherapy.
Patients

All patients 40 to 70 years of age
who were scheduled for coronary
artery bypass grafting at Vancouver
General Hospital on a Monday or
Tuesday were candidates for the
study. Excluded were patients who
had acute respiratory infection, those
who needed to return to the operating
room from the postanesthetic recovery
room, those with total opacity of the
baseline or any postoperative roent
genogram and those who required
intubation beyond noon of the first
postoperative day. Over a 4-month
period, 25 patients met these require
ments. They were assigned at random
to three treatment groups (Table I)
— a control group receiving standard
chest therapy and two others in which
incentive breathing devices were
added to the standard therapy. After
approximately five patients had been
entered into each group it was appar
ent that patients using one of the in
centive breathing devices were faring
better than patients in the other two
groups. Therefore, no other patients
were entered in the control group.
The objective radiologic evaluations
of the patients were not affected by
this change.
Incentive Breathing Devices

Two incentive breathing devices
were tested — the Triflo and the
Spirocare units.
Triflo

The Triflo unit (ChesebroughPonds [Canadal Ltd.. Markham. Ont.)
holds three balls in clear plastic

T r e a t m e n t G ro u p s

S ex
G ro u p
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chambers (Fig. 1). As the patient
inhales through a mouthpiece, first
one, then the second and finally the
third ball is raised in the air stream
passing through the chambers. The
inspiratory flow rate required to raise
the first ball is 600 ml/s, to raise the
second, 900 m l/s and to raise the
third, 1200 ml/s.

men of breathing exercises prescribed
for each patient depended on the pre
operative breathing status. This be
came the postoperative goal.
The physiotherapy staff of the Wil
low cardiothoracic unit supervised all
treatments.

end of 4 days, the score of the Spiro
care group was approximately half
that of the other two groups, and the
differences were statistically signifi
cant (Table II). No significant dif
ferences were found between Triflo
and control scores.

Evaluation

Discussion and Conclusions

Spirocare

Chest roentgenograms were made
each morning and each afternoon on
all 4 study days. These were scored
using the system of Sladen and Jen
kins4 by a radiologist who had no
knowledge of which treatment had
been given. A score of zero indicated
no radiologic abnormalities, 1 in
dicated nonspecific changes, 2 subsegmental atelectasis, 3 segmental
atelectasis and 4 lobar atelectasis.
Each lung was scored separately.
For comparison the total score
for a group was divided by the num
ber of patients in the group and
then multiplied by 100.
The left and right lung scores were
added and the preoperative score sub
tracted from the sum. The Kruskal—
Wallis one-way analysis of variance11
was used to test for statistical sig
nificance in time-of-day (morning
and afternoon) scores. When signifi
cance was found, the Wilcoxon rank
sum test12 was used to make multiple
comparisons between the treatment
regimens.

It is surprising that statistically sig
nificant differences favouring one
group were found in these small
groups, and unexpectedly the patients
who fared best were the oldest (aver
age 60 years). In our experience,
patients in this age range not only
have diminished lung function but
resist doing breathing exercises.
Theoretically, inspiratory exercises
such as those prescribed for the in
centive device groups would add to
the benefits of standard physiother
apy, but the results indicate there was
no benefit from the use of the Triflo
unit, while patients using the Spiro
care unit gained significant advantage.
It is possible that basic differences in
the devices contributed to the dif
ferent responses. The balls in the
Triflo unit rise when a relatively
small volume of air is inspired rapid
ly; it does not require a large volume
as does the Spirocare unit. To reach
a goal on the Spirocare unit, a patient
must — regardless of flow rate -—
inspire a volume approximately equal

The Spirocare unit (Marion Labora
tories, Inc., Kansas City, Mo.) has
two light panels each with 10 colours
on the front of the device (Fig. 1).
The right panel indicates the inspired
air volume goal that has been set
by the physiotherapist. This can be
set for volumes of 250 to 5500 ml
and adjusted so that there is a differ
ence of 125 ml, 250 ml or 500 ml
between each light. As the patient
inhales, the left column is illuminated
from below upwards towards the set
goal.
Treatment

All patients were given standard
chest physiotherapy during the 4 days
after operation according to their
needs. The therapy included en
couraging them to cough and breathe
deeply, postural drainage, vibration
and percussion.
Those patients in the Triflo and
Spirocare groups performed, in addi
tion to the standard physiotherapy,
a prescribed set of inspiratory breath
ing exercises three times daily with the
devices. Physiotherapists showed pa
tients how to use the incentive breath
ing devices the day before operation
and again after operation. The regi-

Results

Results in the three treatment
groups for both lungs are shown in
Figs. 2 and 3. The control and Triflo
groups had approximately the same
number of pulmonary complications
while the Spirocare group had fewer
and less severe complications. At the

Table I I — Statistical Significance of
Spirocare over T riflo and
Control Scores
Postoperative
day
2
3
4

FIG. 1— Spirocare unit (left), Triflo
unit (right).

FIG. 2— Left lung scores following
coronary artery operation.
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Tim e

P value

Morning
Morning
Evening
Morning
Evening

0.038
0.010
0.008
0.010
0.014

FIG. 3— Right lung scores following
coronary artery operation.
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to the preset goal. It is well recognized
that alveolar function returns or is
maintained better when maximal
volumes are inspired. Moreover,
unlike the Spirocare unit, the Triflo
provides no incentive for patients to
hold maximal inspirations for 3 se
conds — a physiologically important
maneuver.
In another recent study comparing
Triflo and Spirocare, Lederer and
associates13 found no clinically sig
nificant differences between groups
of patients who used Triflo, Spiro
care or the Bartlett-Edwards Incen
tive Spirometer. But that study was
not designed to test whether incentive
devices added to the benefits of
standard chest physiotherapy. Rather,
it was carried out to compare the
effects of the three devices used
alone.
The results of this study show that
use of the Spirocare unit adds sig
nificantly to the benefits of therapy
administered by trained physiothera

pists. The lower scores in this group
suggest that patients using the Spiro
care device will have fewer postopera
tive pulmonary complications that
result in prolonged hospital stay.
Patients generally were more motiv
ated by the light and digital counter
systems of the Spirocare unit than
by the three-ball Triflo system. There
was also less difficulty in getting
patients to follow prescribed exercises.
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Leiomyosarcoma in the Mesentery Presenting
as a Uterine Fibroid
P. T h o r n e r ,

md,

W. S t e in b e r g ,

Leiomyosarcoma arising in the
mesentery is a rare neoplasm. The
authors present what they believe
is the first reported case of mesenteric
leiomyosarcoma preoperatively
diagnosed as a uterine fibroid.
The presentation of this lesion is
nonspecific, and clinical, radiologic
and laboratory findings are not helpful
so the diagnosis is usually made at
laparotomy. The pathological findings
including the electron microscopic
findings are illustrated and the
literature on this rare mesenteric
tumour is reviewed briefly. The
most effective treatment is surgical
resection.
From the departments of pathology
and obstetrics and gynecology,
St. Michael’s Hospital and the
University of Toronto, Toronto, Ont.
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Le leiomyosarcome apparaissant dans
le mesentere est un neoplasme rare.
Les auteurs decrivent ce qu'ils
croient etre le premier cas de
leiomyosarcome mesenterique dont le
diagnostic preoperatoire en etait un
de fibrome uterin.
Le tableau clinique de cette lesion
est non specifique, et les observations
cliniques et radiologiques, ainsi
que les resultats de laboratoires,
sont inutiles, de sorte que le diagnostic
est habituellement pose a la
laparotomie. Les constatations
pathologiques, y compris celles de
microscopie electronique, sont
illustrees, et la litterature sur cette
tumeur mesenterique rare est revue
brievement. Le traitement le plus
efficace est la resection chirurgicale.

Primary leiomyosarcomas in the
mesentery are rare tumours; only
seven have been reported.1 The clin
ical presentation is nonspecific and
diagnosis usually is made only at
laparotomy.3 We present such a case
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that was diagnosed clinically as a
uterine leiomyoma. To our knowl
edge,
mesenteric leiomyosarcoma
presenting as a gynecologic tumour
has not previously been reported.
The pathological and electron micro
scopic findings are also discussed.
Case Report
During a routine examination in De
cember 1979, a 46-year-old woman,
gravida 5, para 5. was found to have a
pelvic mass in the posterior aspect of the
uterus about the size of an 8- to 10-week
pregnancy. Adnexae were clear. A clinical
diagnosis of uterine fibroids was made.
Previous examination at the time of a
tubal ligation in 1977 had revealed no
uterine abnormality. Other findings on
physical examination and of laboratory
investigation were normal. Abdominal
ultrasonography showed a solid adnexal
mass, separate from the uterus; it was
thought to be a pedunculated leiomyoma.
Repeat pelvic examination revealed that
the mass had increased in size. Because
of this laparotomy was performed on
Jan. 4, 1980.
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The uterus and adnexae appeared nor
mal. Lying adjacent to the uterus in the
mesentery of the ileum, 15 cm from the
ileocecal junction, was a lobulated mass
stretching the bowel over it. The tumour
to the root of the mesentery and adjacent
bowel were resected. There was no
evidence of tumour spread. Recovery was
smooth and the patient was discharged
on Jan. 15, 1980. Follow-up at 6 months
revealed no evidence of recurrence or
metastatic disease.

Pathological Findings

The surgical specimen consisted of
15 cm of small bowel and attached
mesentery containing a mass that
was well circumscribed, nonencapsulated, tan and lobulated and mea
sured 8.5 X 7.5 X 5 cm (Fig. 1).
The small bowel was stretched over
the mass but distinctly separate from
it. Section of the tumour mass re
vealed soft tan tissue without areas
of cystic degeneration or hemorrhage.
Histologic examination of sections
stained with hematoxylin and eosin
demonstrated solid sheets of spindleshaped cells arranged in interlacing
bundles with cigar-shaped nuclei
(Fig. 2). There was slight cellular
and nuclear pleomorphism but no
giant cells were seen. Rare foci of
necrosis and hemorrhage were evi
dent. A mitotic count in the most
cellular areas found seven mitoses
per 10 high-power fields (10 X 40).
Reticulin staining of sections of the
mass revealed delicate fibre staining
surrounding cells individually or in
small groups. Multiple sections failed
to demonstrate an origin from the
bowel wall.
Tissue processed for electron mi
croscopy was fixed in 4% gluteraldehyde, then in osmic acid and
stained with uranyl acetate and lead
citrate. Most of the cells were elong
ated with fusiform nuclei. Nuclear
membranes were somewhat irregular
with occasional cytoplasmic pseudo
inclusions and prominent single nu
cleoli. Cytoplasmic ultrastructure re-

vealed mitochondria with a tenden
cy to perinuclear grouping and nume
rous ribosomes with only short stacks
of rough endoplasmic reticulum. Well
developed Golgi complex was occa
sionally identified but no secretory
granules were found. A few of the
tumour cells contained small cyto
plasmic areas composed of hapha
zardly arranged microfilaments con
densed in random fashion to form
cytoplasmic dense bodies (Fig. 3).
The plasma membrane showed com
plex interdigitation with neighbouring
cells and moderately developed desmosomes were readily found. Rudi
mentary basement membrane was
found focally around some cells
while collagen fibrils made up other
areas of stroma.
Comment

The light microscopic features cor
respond well with the descriptions in
the literature.3-6 In the absence of
metastatic spread or invasion of con
tiguous structures histologic criteria
must be relied on for prognosis. In
smooth muscle tumours of the mes
entery these criteria are less well
defined than for uterine leiomyo
sarcomas.3,7,8 In our opinion cellularity and the mitotic count obtained in
our case indicate a guarded prog
nosis with a likelihood of metastasis.6'8
Electron microscopic features of
leiomyosarcoma are also well de
scribed in the literature and this case
demonstrates features of smooth
muscle derivation with sparse micro-

filaments and dense body forma
tion.3,5,9,10 The nuclear configuration
and complex interdigitating cell
borders with focal deposits of base
ment membrane and cellular junc
tion attachments have also been de
scribed.9,10
Discussion

In a review of the literature in
1963, Yannopoulos and Stout6 found
seven leiomyosarcomas in the mesen
tery and to our knowledge none have
been reported since.
Mesenteric tumours are far more
likely to be secondary than primary.2
Yannopoulos and Stout6 collected 44
solid primary mesenteric tumours;
16% were of smooth muscle origin.
Fibrous tumours were more com
mon, accounting for 27%.
Up to 50% of patients with me
senteric tumours are asymptomatic.
The symptoms reported are non
specific and include abdominal pain,
weakness, anorexia, weight loss and
change in bowel habit.1,3,6,11 Only
rarely does the patient present with
bowel obstruction or torsion with in
farction.2,11 Physical signs include
ascites and an abdominal mass, which
is often mobile and sometimes fills
the abdomen.1’2,6 Leiomyosarcomas
of gastrointestinal origin have iden
tical signs and symptoms but may
be distinguished by rectal bleeding
and sometimes by perforation of the
bowel and peritonitis.2,12,13 Of re
levance to the gynecologist is that in

«

FIG. 1—Gross appearance showing
lobulated, fleshy tumour mass in small
bowel mesentery.

FIG. 2—Leiomyosarcoma with fre
quent mitotic figures (hematoxylin and
eosin, reduced by 52% from X l25).
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FIG. 3— Cytoplasmic region containing
thin microfilaments, electron dense bodies
and marginal dense plaques along cell
membrane (uranyl acetate and lead citrate
stain, reduced by 56% from X37 000).
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one series of gastrointestinal leiomy
osarcomas, 14% of tumours in fe
males were diagnosed as being of
gynecologic origin.13 Chan and col
leagues14 reported two small bowel
leiomyosarcomas diagnosed as ova
rian carcinomas. No mesenteric leio
myosarcoma diagnosed as being of
gynecologic origin has previously
been reported.
Laboratory tests and radiologic
studies are generally of no value in
preoperative diagnosis.2,414 Although
not a routine procedure, angiography
is helpful in localizing the tumour.4,13,15
Ultrasonography is of proven value
in assessing pelvic masses but sug
gested a solid adnexal mass in our
case; a study of abdominal sarcomas
showed no correlation of echo pat
tern to cell type, nor could other
intra-abdominal masses be conclu
sively eliminated at the time of ultra
sonography.16 Thus, because of non
specific symptoms and often unre
warding investigations the diagnosis
is usually made only at laparotomy.2,4
As for uterine muscle sarcomas,
the most effective treatment is sur
gical resection.1,2,4,6,8,10,13 If the tumour
is easily separated from the bowel,
local resection is feasible, but more
often it is necessary to remove a

segment of bowel. Since many malig
nant tumours grow at the root of the
mesentery, less than one third are
completely resectable.2 If a tumour
is not completely resectable, partial
resection has been shown to increase
survival time since death often results
from the local effects of the tumour
mass and distant metastases occur
late in the course of the disease.2,4,6,13
Radiotherapy and chemotherapy do
not appear to increase survival
time.2,7,13 As numbers are few, sur
vival data for mesenteric leiomyosar
coma are incomplete but survival has
ranged from 12 to more than 29
months.6
The majority of uterine fibroids are
diagnosed correctly. Our case illus
trates well the confusing, nonspecific
presentation of a rare malignant
smooth muscle tumour of the mesen
tery.
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Lincoln Hospital and Trauma
Center, Phoenix, Arizona, will be held
Jan. 17-21, 1982 at the Aiamos Re
sort in Scottsdale, Arizona.
Lincoln Hospital is one of the few
private, nonteaching hospitals in the
nation to develop a trauma centre.
Since its inception in October 1979
the Lincoln Hospital Trauma Center
has treated more than 1800 seriously
injured patients and is recognized as
one of the most innovative trauma
centres in the southwest.
Dr. Robert J. Rankel, associate di
rector of traumatology and associate
medical director of the Lincoln In
stitute of Surgery and Trauma, has
said that “the 1982 symposium is im
portant because the trauma center
concept is relatively new to hospitals”.
Trauma is the leading cause of death
in persons under the age of 44 years.
Dr. Rankel noted that accidents in
volving motor vehicles are the major
cause of trauma.
Dr. Rankel pointed out that trauma
centres in different parts of the counC.

bisacodyl

Dulcolax tablets work overnight
Dulcolax suppositories or
Micro-Enema within one hour

Dulcolax— A family laxative
Available in Tablets 5 mg
Suppositories 10 mg
Suppositories 5 mg for children
Micro-Enema 10 mg/5 ml
FULL PRESCRIBING INFORMATION AVAILABLE ON REQUEST

Boehringer Ingelheim (Canada) Ltd.
W S v 977 Century Drive, Burlington, Ontario L7L 5J8

continued on page 645
VOLUME 24, NO. 6, NOVEMBER 1981

/

THE CANADIAN JOURNAL OF SURGERY

Intra-aortic Balloon Counterpulsation in Septic Shock
D ale M e r c e r , m d , P e t e r D oris , m d , f r c s [c ] and T o m a s A. Sa l e r n o , m d , f r c s [c ]

Mortality in patients in septic shock
remains high (50% to 80%) despite
available treatment, in a 76-year-old
woman with hypodynamic septic shock
intra-aortic balloon counterpulsation
(IABC) successfully improved the hemo
dynamic status to the point at
which the patient could maintain
adequate cardiac output without
assistance. The pertinent literature on
experimental and clinical shock in
which mechanical assistance devices
were used, is reviewed. From the
few clinical reports available it
appears that IABC may be life-saving
in those patients with hypodynamic
septic shock who deteriorate despite
the administration of antibiotics,
steroids and vasopressors. Its value
in hyperdynamic shock remains
doubtful. Since the mortality associated
with septic shock has not decreased
despite modern management, there
is justification in searching for new
modalities of treatment, and the
use of IABC seems most appropriate
and promising.

vasopresseurs. Son interet dans le choc
hyperdynamique demeure douteux.
Puisque la mortalite reliee au choc
septique n’a pas diminue en depit
du traitement moderne, il est justifie
de chercher de nouveaux modes
de traitement. L’emploi de la CDBI
semble des plus appropries et des
plus prometteurs.

Intra-aortic balloon counterpulsation
(IABC) has traditionally been used
in cardiogenic shock secondary to
complicated myocardial infarction,
preinfarction angina and postcardiotomy cardiogenic shock.1 There are
only a few reports on the use of
assisted circulation in patients in
septic shock.'2 The present report
deals with the successful use of IABC
in a patient with septic shock who
did not respond to conventional
medical treatment.
Case Report

Reprint requests to: Dr. T.A. Salerno,
Department of surgery, Queen’s
University, Douglas 3, Kingston General
Hospital, Kingston, Ont. K7L 2V7

A 76-year-old woman was admitted
to the emergency room in a moribund
state. She had a 12-hour history of
severe abdominal pain. Initially the sys
tolic blood pressure was 50 mm Hg,
heart rate was 120 beats/min, respiratory
rate 35/min and temperature 36.8°C.
Examination of the abdomen revealed
evidence of peritonitis. Roentgenograms
showed peritoneal fluid and no free air.
The hemoglobin value was 14.2 g/dl,
hematocrit 42.6%, leukocyte count 4.7
X 109/1 with a shift to the left. Electro
lytes and blood urea nitrogen levels
were normal. Blood culture showed a
growth of Bacteroides fragilis and Esche
richia coli. Ringer’s lactate infusion was
begun and antibiotic therapy consisting
of gentamicin (80 mg q8h), clindamycin
(600 mg q6h) and penicillin (2 million
units q2h) intravenously was started.
Emergency laparotomy revealed gross
fecal peritonitis from perforated sigmoid
diverticulitis due to a small meat bone.
Because her systolic blood pressure re
mained low (50 to 60 mm Hg) intraoperatively, she was started on Levophed
(4 mg/min) therapy, which raised the
systolic pressure to 100 mm Hg. A sig
moid colectomy was performed and a
colostomy and mucous fistula were
created. The abdomen was adequately
lavaged and drained with sump tubes.
Postoperatively, she was ventilated
with a Monaghan respirator and moni
tored by way of an indwelling radial
artery catheter and a flow-directed ther
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La mortalite chez les patients en etat
de choc septique demeure elevee
(50% a 80% ) en depit des traitements
disponibles. Chez une femme de
76 ans en choc septique hypodynamique,
la contre-pulsion diastolique par
ballonnet intra-aortique (CDBI) a
reussi a ameliorer I’etat hemodynamique
jusqu’au moment ou la patiente a pu
maintenir sans aide un debit cardiaque
convenable. On passe en revue
la litterature pertinente a I'emploi
d’appareils mecaniques de secours
dans le choc experimental ou clinique.
Des rapports cliniques disponibles,
il semble que la CDBI puisse-t-etre
vitale chez les malades en choc
septique hypodynamique qui se
deteriorent malgre I'administration
d'antibiotiques, de steroi'des et de
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modilution Swan—Ganz catheter in the
pulmonary artery. Antibiotic therapy
was continued and methylprednisolone
(30 mg/kg) was added to the regimen
and repeated in 6 hours. Even with
increasing doses of Levophed (380 mg/
min) and Isuprel (200 mg/min), the
blood pressure remained at 100/60 mm
Hg, with a cardiac index (Cl) of 3.53
l/m in.m 2. These large doses threatened
to exhaust the hospital’s supply of vaso
pressors in a few hours and her blood
pressure again began to fall. Intra
aortic balloon counterpulsation with an
AVCO model 10 intra-aortic balloon
(AVCO-Roche, Cranbury, Mass.) was
started with a 1:1 mode of counterpul
sation. Over the next 2 days the vaso
pressors were gradually reduced while
her Cl remained at 5.0 l/m in«m 2 (Table
I). There was marked improvement after
initiation of IABC but due to malfunc
tion of the AVCO console, IABC had
to be discontinued temporarily after 50
hours of counterpulsation. This resulted
in immediate drop in her blood pressure
requiring reinstitution of vasopressors.
Her condition stabilized when IABC was
resumed. The counterpulsation was dis
continued after 75 hours (Figs. 1 and
23). Dopamine (10 p.g/min) was required
to maintain hemodynamic stability but
was gradually reduced (Table I). Her
course thereafter was smooth. She is
well 7 months after operation.
Discussion
The mortality in septic shock re
mains high (50% to 80% ) despite
available treatm ent.412 Patients in
septic shock who exhibit myocardial
failure usually die.4,611'13,14 Possible
pathophysiologic mechanisms of car
diac failure include a direct m yocar
dial toxic effect, a circulating myo
cardial depressant factor15 and de
creased coronary perfusion pressure
with resulting subendocardial ische
mia.16 In preparations of isolated per
fused hearts, there is progressive de
terioration in left ventricular function
following an injection of E. coli13,1‘
with rise in left ventricular end-diasto
lic pressure and depressed contractility.
It is known that those with endotoxic
shock who die have m yocardial per
formance curves that have a lower
upslope, lower maximal left ventri
cular stroke work and a lower cardiac
index.5 These indicate either reduced
ventricular compliance or redistribu
tion of coronary blood flow.5 W ith

THE CANADIAN JOURNAL OF SURGERY

643

appropriate treatment, cardiac func
tion improves, indicating that myo
cardial depression in endotoxic shock
is potentially reversible. The increased
metabolic demands created by septic
shock are met in part by a rise in
cardiac output.6'7'1822 The ischemic
and damaged myocardium may not
have sufficient reserve to meet these
demands leading to ultimate cardiac
failure and patient death. The problem
is further compounded by an abnor
mal oxygen transport mechanism,22
commonly found in sepsis.
The literature is conflicting as to
the value of assisted circulation in
experimental septic shock. Dunn and
associates4 and Prager and associates28
reported limited success in dogs made
septic by injection of a preparation
of E. coli. They used a roller pump
capable of delivering pulsatile flow
synchronized with the increase in
diastolic pressure. At 12 hours of
perfusion there was a high incidence
of mesenteric infarction and, at 24
hours, of renal failure. Roberts and
associates24 evaluated the effects of
IABC on dogs made septic with pre
parations of Klebsiella aerogenes. At
24 hours of sepsis, left ventricular
stroke work and myocardial per
formance curves were better preserved
in animals who had IABC. Relatively
less injury was observed in the liver
and small bowel of animals who
received IABC compared with control
animals that did not receive IABC.
They concluded that the early insti
tution of IABC may be important in
treating gram-negative septic shock
in dogs. They speculated that IABC
might allow time for more specific
therapy to be instituted, before ir
reversible cellular destruction de
veloped.
Dunn and associates4 studied the
effects of prolonged assisted circula

tion (24 hours) with a pulsatile assist
pump and membrane oxygenator in
dogs subjected to injections of endo
toxin (E. coli). Survival was notably
prolonged in animals who received
assisted circulation compared with
those who did not. Cardiac output
and blood pressure were higher in
assisted animals; they also tended to
have less metabolic acidosis.
Berger and associates2 described the
first successful clinical use of IABC
in two patients with sepsis, who also
had severe coronary artery disease.
Both had hypodynamic septic shock.
Foster and colleagues1 reported five
patients with septic shock treated

20
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FIG. 1—Demonstrates improvement
of hemodynamic parameters including
blood pressure (BP), central venous
pressure (CVP), pulmonary wedge (PW)
pressure, cardiac index (Cl) and left
ventricular stroke work (LVSW) during
treatment with vasopressors and intra
aortic balloon counterpulsation.
T a b le

with IABC. Three of these, all in
hyperdynamic shock, did not survive.
The two survivors had low-output
shock.
By increasing the diastolic pressure
IABC increases coronary blood flow.
It reduces left ventricular stroke work
by decreasing the impedance of left
ventricular ejection. It has no effect

FIG. 2—Patient’s hemodynamic status
as documented in Table I on left ventri
cular function curves, devised by Ross
and Braunwald.8 Group 1 = normal ven
tricular function; group 2 = mildly sup
pressed left ventricular function; group
3 = markedly depressed ventricular func
tion. Patient’s ventricular function im
proved from markedly depressed to
normal function upon treatment with
IABC. Numbers 1 to 8 represent plotting
of pulmonary capillary wedge pressure
(PCWP) against left ventricular stroke
work index (LVSWI) at various time
intervals.
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on systemic peripheral resistance.2
Also, IABC can reduce the discre
pancy between oxygen supply and
demand in both the ischemic and the
septic heart.1 As a result of reduced
myocardial workload, the metabolic
demands are diminished and, with
increasing coronary perfusion, oxy
genation is improved in the ischemic
subendocardial regions.
Hypodynamic septic shock is usu
ally considered as the late phase of
septic shock. With volume loading it
may be converted, at least tempo
rarily, to the hyperdynamic state or
it may become evident that volume
loading may not lead to increased
cardiac output. Our patient demon
strated the inability to convert from
a hypodynamic to hyperdynamic state
with volume loading. This indicates
some degree of myocardial depres
sion. Vasopressors had some effect in
increasing the Cl but the doses were
extremely high and could not be
maintained. However, IABC was suc
cessful in increasing the Cl and left
ventricular stroke work. During the
75 hours of IABC the hemodynamic
status improved and, when support
was withdrawn, the patient was able
to maintain a similar Cl and left
ventricular stroke work.
Insertion of foreign material, such
as the intra-aortic balloon, into the
vascular system in a patient with
sepsis may appear dangerous.2 But.
with adequate antibiotic coverage and
use of balloon support for as short
a period as possible, its use is feasible.
No complications resulted from in
sertion of the balloon into the right
femoral artery of our patient, despite
the Dacron graft which was sutured
to the side of that vessel. Percu
taneous insertion of the balloon may
minimize risks and greatly extend its
use. The materials are now commer
cially available.
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try face different circumstances be
cause of geographic characteristics,
population densities and field delivery
systems: “The major goal of the sym
posium is to provide an exchange of
knowledge and techniques. Physicians
will have an opportunity to examine
current methods with the all-im
portant goal of reducing the time be
tween injury and treatment.”
Featured speakers at the sympo
sium will include noted physicians
and surgeons in the field of trauma
care as well as staff members of the
Lincoln Hospital Trauma Center.
Prior to the conference, on Jan.
15-16. Lincoln Hospital will be the
site of an advanced trauma life sup
port course offered by the American
College of Surgeons. Further informa
tion on this course and the symposium
can be obtained from: Paul Halver
son. Symposium chairman, “Trauma
Care ’82”, John C. Lincoln Hospital
and Trauma Center, 9211 North Sec
ond St., Phoenix, Arizona 85020.
Telephone: (602) 943-3641.

Prize for Vascular Surgery

The Liebig Foundation announces an
annual competitive prize of $5000.
for the best essay on a problem in
vascular surgery. The investigative
work shall be: original and unpub
lished; performed by a house officer
in the United States, Canada or Mexi
co, and written in English; presented
at the International Cardiovascular
Society meeting in June 1982; and
published in the Archives of Surgery.
Essays must be submitted before
Dec. 31, 1981 and sent to: Dr. Ri
chard J. Turner, Award committee
secretary, 103 Bauer Dr., Oakland,
New Jersey 07436. Telephone: (201)
237-6126.

D el G u e r c io

LR: A bnorm al vascular tone, defective
oxygen transport and myocardial failure
in hum an septic shock. A n n Surg 1967;
165: 504-17
23. P rager R, K ir sh M M , D u n n E, N is h iy a m a
R, S traker J, L ee R, S loan H : The
benefits of corticosteroids in endotoxic
shock. A n n Thorac Surg 1975; 19: 142-52
24. R oberts A J, H oover E L , A lo n so D R ,
C o m b es JR , D in e e n P, G ay WA j r , S u b 
ra m a n ia n V A :
Prolonged intraaortic bal
loon pum ping in Klebsiella-induced hypo
dynam ic shock: cardiopulm onary, hem ato
logical, m etabolic, and pathological observa
tions. A n n Thorac Surg 1979; 28: 73-86
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NOTICES

American Association
for Hand Surgery

The American Association for Hand
Surgery will sponsor the second
Rocky Mountain Hand Symposium
in Vail, Colorado, Feb. 13-20. 1982.
For further information please con
tact: Dr. Ronald Tegtmeier, 9950
West 80th Ave., Arvada, Colorado
80005. Telephone: (303) 424-1174.
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Narcotic
analgesia
can be
shadowed by
respiratory
depression

nuBnin
Nalbuphine HC1 Injection

Casts new light
on narcotic analgesia
Provides the same analgesic efficacy as
meperidine or morphine
Nubain, a new injectable analgesic, has an onset, a
peak of action, and analgesic effectiveness similar to
those of meperidine or morphine. Nubain generally
provides longer analgesia (3-6 hours) than
meperidine (2-4 hours), helping to reduce the
amount of narcotic required.

With a greater margin of safety
Unlike other narcotics which can cause undesirable
respiratory depression even at moderate doses1, the
respiratory depressant effect of Nubain is limited and
does not increase appreciably beyond a peak effect
equivalent to that produced by 20 mg/70 kg of
morphine1. Therapeutic doses of nalbuphine have
been associated with hemodynamic stability, and
clinical studies of the hemodynamic effects of
Nubain in patients with coronary artery disease and
acute myocardial infarction demonstrated that
nalbuphine HC1 produced no major untoward clinical
or cardiocirculatory effects2,3.

As an adjunct, to supplement surgical
anesthesia, Nubain provides
hemodynamic stability, good
postoperative analgesia and limits
postoperative respiratory depression
A recent study showed that nalbuphine is an effective
supplement to balanced anesthesia. Post-operative
recovery time may be reduced due to limited
respiratory depression and good post-operative

Significantly fewer side effects
Nubain has a lower incidence of reported side effects
than other narcotics or pentazocine6, causing
significantly less nausea and vomiting than
meperidine or morphine7. Psychotomimetic effects
have rarely been reported1. The incidence of
constipation is less than 1%6.

&ido Laboratories
7000 Park Avenue
u ra v r i v
m u im t a i, r . v
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Su b sid iary of E .I . Dupont de N em ours C o . (In c .)

Prescribing information on page 648

nuBnin
NUBAIN INJECTION
(Nalbuphine Hydrochloride) Analgesic
ACTION
Nubain (nalbuphine hydrochloride) is a synthetic narcotic
agonist-antagonist analgesic for parenteral use, related
chemically to the narcotic oxymorphone and to the
narcotic antagonist naloxone. Nabulphine has an
analgesic (agonist action) potency equivalent to that of
morphine on a milligram basis, and an antagonist activity
(reversal of major effects o f opioid drugs) about
one-fourth that of nalorphine and ten times that of
pentazocine. The analgesic effect of 10 mg of nalbuphine
is about equal to that of 10 mg o f morphine sulfate. The
onset of action begins within 2 to 3 minutes after
intravenous administration, and within 15 minutes
following subcutaneous or intramuscular injection. The
plasma half life of nalbuphine is five hours and the
duration o f action has ranged from three to six hours.
At the usual dose of 10 mg, nalbuphine produces
respiratory depression equivalent to that of equianalgesic
doses of morphine. At much higher doses, above 30 mg
i.v. (which produces a respiratory depressant activity
equivalent to 20 mg of morphine i.v.), the respiratory
depressant effect of nalbuphine does not appear to
increase appreciably. Nalbuphine may precipitate
abstinence, when administered to individuals taking
narcotics chronically or produce withdrawal symptoms
when discontinued abruptly after prolonged use. It is
reported to have an abuse potential comparable to that of
pentazocine. The mechanism of action of nalbuphine has
not yet been established.
INDICATIONS AND CLINICAL USE
NUBAIN (nalbuphine hydrochloride) is indicated for the
relief of moderate to severe pain.
Clinical studies indicate that it can also be used for
preoperative analgesia, as a supplement to surgical
anesthesia, and for obstetrical analgesia during labor.
CONTRAINDICATIONS
NUBAIN (nalbuphine hydrochloride) should not be
administered to patients who are hypersensitive to the
drug or to its inactive ingredients (see section on
‘AVAILABILITY’).
WARNINGS
In patients physically dependent on opiate drugs,
NUBAIN (nalbuphine hydrochloride) should not be given
prior to detoxication since withdrawal symptoms are
likely to be produced.
Drug Dependence:
On the basis of behavioural, substitution and direct
addiction studies in humans. NUBAIN has been shown to
have low abuse potential which approximates that of
pentazocine. Psychological and physical dependence and
tolerance may follow the abuse or misuse o f nalbuphine.
Therefore, caution should be observed in prescribing it
for emotionally unstable patients or for individuals with a
history o f narcotic abuse. Such patients should be closely
supervised, since increases in dosage or frequency of
administration in susceptible individuals might result in
physical dependence.
Abrupt discontinuation of NUBAIN following prolonged
use has been followed by symptoms of narcotic
withdrawal, such as abdominal cramps, nausea and
vomiting, rhinorrhea, lacrimation, restlessness, anxiety,
elevated temperature and piloerection.
Use in Ambulatory Patients:
NUBAIN may impair the mental or physical abilities
required for the performance of potentially dangerous
tasks such as driving a car or operating machinery.
Therefore, NUBAIN should be administered with caution
to ambulatory patients, who should be warned to avoid
such hazards until recovered from the effects o f the drug.

Interaction With Other Central Nervous System
Depressants:
Although NUBAIN possesses narcotic antagonist
activity, there is evidence that in non-dependent patients
it may not antagonize the analgesic effect of narcotic
analgesics. Patients receiving narcotic analgesic, general
anesthetics, phenothiazines or other tranquilizers,
sedatives, hypnotics, or other CNS depressants (including
alcohol) concomitantly with NUBAIN may exhibit an
additive effect. When such combined therapy is
contemplated, the dose of one or both agents should
be reduced.
Use in Children:
Because clinical experience in children under the age of
12 years is limited, the administration of NUBAIN in this
age group is not recommended.
Use in Pregnancy:
Safe use o f NUBAIN in pregnancy (other than labor) has
not been established. Although animal reproductive
studies have not revealed teratogenic or embryotoxic
effects, NUBAIN should only be administered to
pregnant women when, in the judgement of the
physician, the potential benefits outweigh the possible
hazards.
Use in Labor and Delivery:
Since NUBAIN can produce respiratory depression in the
neonate, it should be administered with caution to women
delivering premature infants.
Head Injury and Increased Intracranial Pressure:
The possible respiratory depressant effects and the
potential o f potent analgesics to elevate cerebrospinal
fluid pressure (resulting from vasodilation following CO 2
retention) may be markedly exaggerated in the presence
o f head injury, intracranial lesions, or a pre-existing
increase in intracranial pressure. Furthermore, potent
analgesics can produce effects which may obscure the
clinical course o f patients with head injuries. Therefore
NUBAIN should be administered in these circumstances
only when essential, and with extreme caution.
PRECAUTIONS
Impaired Respiration:
Caution should be observed when administering
NUBAIN (nalbuphine hydrochloride) to patients with
impaired respiration, or who are receiving other
medications which produce respiratory depression. In the
presence of bronchial asthma, uremia, severe infection,
cyanosis, or respiratory obstruction, NUBAIN should be
administered only with great caution and in reduced
doses. Respiratory depression induced by NUBAIN can
be reversed by the administration of naloxone
hydrochloride.
Impaired Renal or Hepatic Function:
Because NUBAIN is metabolized in the liver and
excreted by the kidneys, patients with renal or liver
dysfunction may show an exaggerated response to
customary doses. Therefore, in these individuals
NUBAIN should be used with caution and administered
in reduced amounts.
Myocardial Infarction:
As with all potent analgesics, NUBAIN should be used
with caution in patients with myocardial infarction who
have nausea or vomiting. Hemodynamic studies in
patients with severe arteriosclerotic heart changes reveal
that NUBAIN has circulatory effects similar to those of
morphine, i.e ., a minimal decrease in oxygen
consumption, cardiac index, left ventricular end-diastolic
pressure and cardiac work.
Management of Narcotic Withdrawal Symptoms:
If NUBAIN is inadvertently administered to a patient
physically dependent on narcotics and unduly
troublesome narcotic withdrawal symptoms develop,
these symptoms may be controlled by the slow
intravenous administration of small increments of
morphine, until relief occurs.

ADVERSE REACTIONS
In clinical trials with NUBAIN (nalbuphine
hydrochloride) the most frequently reported side effects
were: sedation (36%) of 1066 patients treated), sweating
or clamminess (9%), nausea or vomiting (6%), dizziness
or vertigo (5%), dry mouth (4%) and headache (3%).
Other adverse reactions which may occur:
Central Nervous System: nervousness, crying,
depression, restlessness, euphoria, hostility, confusion,
faintness, floating, unusual dreams, numbness, feeling of
heaviness, and psychotomimetic effects such as
hallucinations, feeling of unreality and dysphoria.
Cardiovascular: Hypertension, hypotension,
bradycardia, tachycardia.
Gastrointestinal: Cramps, dyspepsia, bitter taste.
Respiration: Depression, dyspnea, asthma.
Dermatological: Itching, burning, urticaria.
Miscellaneous: Speech difficulty, urinary urgency,
blurred vision, flushing and warmth.
SYMPTOMS AND TREATMENT
OF OVERDOSAGE
Symptoms:
These are expected to be similar to those of other drugs of
this class. (The administration of single I.M. doses of
72 mg of NUBAIN to eight normal subjects has been
reported to have resulted primarily in symptoms of
sleepiness and mild dysphoria.)
Treatment:
NARCAN (naloxone hydrochloride) administered
intravenously is a specific antidote for NUBAIN. Since
the duration of action of NUBAIN may exceed that of
NARCAN, the patient should be kept under continued
surveillance and repeated doses of NARCAN should be
administered as necessary. Oxygen, intravenous fluids,
vasopressors and other supportive measures should be
employed as indicated.
DOSAGE AND ADMINISTRATION
The usual recommended dose of NUBAIN (nalbuphine
hydrochloride) is 10 mg for a 70 kg individual
administered subcutaneously, intramuscularly or
intravenously. This dose may be repeated every 3 to 6
hours as required. The recommended dosage range is 10
mg to 20 mg, with a maximum single dose of 20 mg and a
maximum total daily dose of 160 mg. Dosage should be
adjusted according to the severity of the pain, physical
status of the patient, and other medications which the
patient may be receiving. (See Interaction with Other
Central Nervous System Depressants under
WARNINGS’.)
Patients who have been taking narcotics chronically for
pain under medical supervision may experience
withdrawal symptoms upon the administration of
NUBAIN. If NUBAIN is administered to these patients
as an analgesic, it should be introduced gradually.
NUBAIN should not be used as a substitute for other
narcotics or for withdrawal purposes in individuals
dependent on these drugs.
AVAILABILITY
NUBAIN (nalbuphine hydrochloride) is supplied in glass
ampoules of 1 ml and 2 ml, and in multiple-dose vials of
10 ml containg 10 mg of nalbuphine hydrochloride per
ml. Each ml also contains 0.1% sodium chloride, 0.94%
sodium citrate, 1.26% citric acid anhydrous, 0.1%
sodium metabisulfite and 0.2% of a 9/1 mixture of
methylparaben and propylparaben as preservatives.
STORE AT CONTROLLED ROOM TEMPERATURE
(15° TO 30°C). PROTECT FROM EXCESSIVE LIGHT.
NUBAIN (nalbuphine hydrochloride) is a Schedule G
(Controlled) drug.

Endo Laboratories
7000 Park Avenue,
Montreal, P.Q H3N 1X1
Subsidiary of E .I. Dupont de Nemours Co. (Inc.)
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Cardioplegic Rearrest:
Clinical Experience with 12 Patients
T omas A. Salerno, md , frcs[c ],* M ichael A. C hiong, md , ph d, FRCP[c],t Ian R. N eilson, m sc and
Edward J.P. Charrette , md, facs, frcs [c ]*

Myocardial damage due to ischemic
arrest occurs during aortic unclamping
and early reoxygenation (reperfusion
injury). Thus, surgeons may be
reluctant to reinfuse cardioplegic
agents if a second period of aortic
css-clamping is required at the
end of cardiopulmonary bypass.
Because of technical difficulties,
12 patients underwent two consecutive
periods of cardioplegic arrest with
an intervening period of reperfusion
of the heart. All survived without
complications. Myocardial biopsy
specimens from three patients revealed
some cellular edema. Serial enzyme
levels measured postoperatively
compared favourably with those of
12 other patients who had sustained
a single period of multidose
cardioplegic arrest. Postoperative
hemodynamic measurements were
similar to preoperative values.
Although cardioplegic rearrest may
appear safe in the human heart,
further studies assessing hemo
dynamics, morphology and metabolism
are necessary in order to delineate
fully the changes that occur with this
method of myocardial preservation.
Des dommages myocardiques dus a
un arret ischemique surviennent durant
le declampage aortique et le debut
de la reoxygenation (lesions de
reperfusion). En consequence, le
chirurgien peut hesiter a reperfuser
des agents cardioplegiques quand,
a la fin de la circulation extracorporelle, une deuxieme periode de
clampage est necessaire. Du a des
difficultes techniques 12 patients ont
subi deux periodes consecutives
d'arret cardioplegique avec une
periode intermediaire de reperfusion
cardiaque. Tous ont survecu sans

complications. La biopsie du myocarde
de trois patients a revele un
certain degre d'oedeme cellulaire.
Des determinations seriees des taux
enzymatiques pratiquees apres
I’operation se sont comparees
avantageusement avec celles de
12 autres patients qui n'avaient subi
qu’une seule periode d'arret
cardioplegique a doses multiples.
Les mesures hemodynamiques
postoperatoires ont ete semblables aux
valeurs preoperatoires. Bien que
I'arret cardioplegique repete puisse
paraltre sur pour le coeur humain,
d'autres etudes portant sur les
facteurs hemodynamiques, la
morphologie et le metabolisme sont
necessaires pour permettre de
determiner pleinement les changements
qui surviennent avec cette methode
de protection du myocarde.

Injury to the myocardium during
ischemic arrest occurs in the period
o f reperfusion after release of aortic
clamps.1’2 To our knowledge the ef
fects of a second period of cardio
plegic arrest after reperfusion of the
myocardium are unknown. This re
port deals with a group of patients
who, due to technical difficulties
intraoperatively, sustained two con 
secutive periods of cardioplegic arrest
with an intervening period of reper
fusion of the myocardium.

Patients

Reprint requests to: Dr. T.A.
Salerno, Department of surgery, Queen’s
University, Douglas 3, Kingston General
Hospital, Kingston, Ont. K7L 2V7

Twelve patients had a second pe
riod o f aortic cross-clamping and sus
tained a second period of cardioplegic
arrest after reperfusion. Coronary
artery bypass grafting was carried out
in six, left ventricular aneurysmec
tomy and bypass grafting in one,
valvular surgery in four and ascend
ing aortic aneurysmectomy in one
patient. In the patients who had coro
nary artery bypass grafting, after
cross-clamping for a mean period of
58 ± 15 minutes ( ± SEM) under
cardioplegic arrest and 26 ± 15
minutes of reperfusion of the myo
cardium, the distal circumflex-saphe
nous vein anastomosis had disrupted
in three and occluded in two, and
the aorta had a linear tear due to
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the exclusion clamp in one patient.
The aorta was reclamped and 5 m l/
kg of cardioplegic solution (con
taining 500 ml lactated Ringer’s solu
tion, 10 mmol potassium chloride,
12.5 mmol sodium bicarbonate, 12
ml 2% lidocaine, 17 ml 50% dex
trose and 125 mg Solu-Medrol at
pH 7.7 and 4 °C ), as in the first
arrest, was reinfused to allow cor
rection o f the problem. Mean re
clamping time was 25 ± 10 minutes.
Normothermic cardiopulmonary by
pass was used in all these patients.
In the group of patients who under
went valve repair there were two
mitral valve replacements, three aortic
valve replacements and one resection
of an ascending aortic aneurysm in
which a composite graft was used.
In the two patients who had mitral
valve replacement, malfunction of
the prosthesis became apparent (left
atrial pressure was greater than 30
mm Hg for no other apparent reason
and the patient could not be weaned
from cardiopulmonary bypass). Hy
pothermic (28 °C ) cardiopulmonary
bypass was re-established, the aorta
was reclamped and cardioplegic solu
tion was reinfused. The valve was
visualized and rotated to a suitable
position in order to avoid the heavy
calcification of the posterior leaflet
anulus. Cross-clamping times were 45
and 48 minutes during the first car
dioplegic arrest with 10 and 17 min
utes of myocardial reperfusion. The
second cross-clamping period lasted
10 and 11 minutes respectively.
In two patients who had aortic
valve replacement, after 65 and 75
minutes o f clamping and 15 and 17
minutes of reperfusion of the myo
cardium, a high left ventricle to aorta
gradient (greater than 60 mm H g)
was suggestive o f prosthetic malfunc
tion. The aorta was reclamped and,
with a second period of cardioplegic
arrest, the prosthesis was rotated to
a suitable position to avoid the cal
cified anulus. The third patient who
underwent aortic valve replacement
had a severe hemorrhage 4 hours
after the operation due to a tear in
the aorta proximal to the suture line.
After cannulation o f the femoral
artery and cardioplegic arrest, the
aorta was repaired. The mean re-
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clamping period for these three pa
tients was 22 ± 10 minutes.
In the patient who underwent re
pair of an ascending aortic aneurysm,
the left coronary ostium—Dacron graft
had become disrupted at the site of
the anastomosis, necessitating a se
cond 40-minute period of cardioplegic
arrest. The aorta had already been
clamped for 78 minutes with 15
minutes of reperfusion.
A full-thickness left ventricular
biopsy was performed in the three
patients with reclamping periods
longer than 30 minutes.
For comparison a control group
of 12 patients who underwent elective
aortic cross-clamping and a single
period of multidose cardioplegic ar
rest was evaluated. Of the 12, 8
had coronary artery bypass grafting.
2 had aortic valve replacement and
2 mitral valve replacement. Cross
clamping time for the group was 60
± 24 minutes. Cardioplegic solution
was infused in a volume of 5 ml/kg
and reinfused after 20 minutes in a
volume of 2.5 ml/kg; preoperative
(pulmonary wedge pressure) and
postoperative (left atrial pressure)
hemodynamic status was determined,
electrocardiograms were obtained and
the creatine phosphokinase activity
was measured on days 1 and 2 after
operation. The occurrence of arrhyth
mias was recorded. All patients have
been followed up for more than 7
months after operation.
Results

There were no deaths in the two
groups of patients. All were weaned
from cardiopulmonary bypass without
the use of vasopressors. Postoperative
left atrial pressure compared favour
ably with preoperative wedge pres
sure (Table I). An ST-segment ab
normality was seen on the electro

cardiogram of two patients sustaining
a single cardioplegic arrest and one
patient sustaining two consecutive
cardioplegic arrests. Premature ventri
cular beats occurred in three patients
of each group and were treated suc
cessfully with lidocaine. Serial cre
atine phosphokinase activity on days
1 and 2 after operation was similar
in both groups (single arrest, 80 ±
7 IU/1 on day 1 and 72 ± 5 IU/1
on day 2; cardioplegic rearrest, 82
± 6 IU/1 on day 1 and 78 ± 9 IU/1
on day 2; P > 0.05, analysis of
variance).
Light microscopy of the biopsy
specimens revealed mild cellular
edema but no other abnormality. At
14-month follow-up all patients were
well.
Discussion

Much remains to be learned about
cardioplegic arrest, a method of myo
cardial preservation now favoured by
most cardiac surgeons. The relative
merits of each ingredient in the solu
tion3 and the safe period of aortic
clamping4 are of great clinical im
portance and will undoubtedly be
clarified in the future. Multidose car
dioplegic infusions given while the
aorta is clamped counteract the ad
verse effects of noncoronary collateral
flow, allow for a safe prolonged
interval of aortic clamping and
appear to be more effective in pre
serving myocardial function than
single injections of cardioplegic solu
tion.5 Periods of 60 to 120 minutes
of cardioplegic arrest are well toler
ated by these techniques.4'7
It is known that cellular injury
after ischemic arrest (reperfusion in
jury) occurs during the period of
early reoxygenation of the myocar
dium.1'2 Intermittent perfusion of the
ischemic normothermic myocardium

Table 1- Hemodynamic Measurements

Procedure
Single cardioplegic arrest
Coronary arte ry bypass grafting
Aortic valve replacement
M itral valve replacement
Cardioplegic rearrest
Coronary artery bypass grafting
Aneurysm of ascending aorta and
coronary artery bypass grafting
Aortic valve replacement
Mitral valve replacement

Preoperative pulmonary wedge
pressure, mm Hg
(no. of patients)

Postoperative left atrial
pressure, mm Hg
(no. of patients)

8 12 (8)

8-12 (7 )
15 (1)
12 15 (2)
12 15 (2)

12 15 (2)
12 15 (1)
20 (1)
8 12 (4)
12-15 (2)

8 12 (4)
15 (2)

17 (1)
12 15 (3)
12 15 (2)

14 (1)
12 15 (3)
15 (2)

appears to add to the deleterious
effect upon the heart.8,9 The addition
of hypothermia (or cardioplegia, or
both) attenuates but does not eli
minate the reperfusion injury under
similar conditions.10 Because of this,
surgeons may be reluctant to reinsti
tute cardioplegia if, at the end of
cardiopulmonary bypass, a period of
reperfusion of the myocardium has
occurred. Technical difficulties such
as disruption of a saphenous vein to
coronary artery anastomosis or mal
function of a valve prosthesis can
easily be dealt with if cardioplegic
arrest can be safely re-established.
Although the options of inducing ven
tricular fibrillation or anoxic arrest,
or both, for a short time are avail
able, they may lead to myocardial
damage.11,12
It was with hesitation that we
reinfused cardioplegic solution after
a period of reperfusion in our first
two cases. However, it became ap
parent that the effects of a second
cardioplegic infusion were similar, at
least clinically, to the first, that com
plete arrest was achieved and that,
at unclamping, the heart immediately
and spontaneously resumed sinus
rhythm. All our patients were
weaned from cardiopulmonary bypass
without the use of vasopressors and
demonstrated no evidence of myo
cardial damage postoperatively when
compared to a similar group of pa
tients sustaining a single period of
multidose cardioplegic arrest. All
patients were well 14 months after the
operation.
This preliminary study in 12 human
hearts suggests that a second period
of cardioplegic arrest after reperfu
sion of the myocardium (cardioplegic
rearrest) is well tolerated. Further
animal work using hemodynamic,
metabolic and morphologic studies,
currently under way in our laboratory,
will be necessary to delineate fully
the effects of cardioplegic rearrest
on myocardial function. It is con
ceivable that a second infusion of
cardioplegic solution after the first
arrest and reperfusion may modify
the damage that is known to occur
during ischemic arrest and reper
fusion.
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Les faux anevrysmes de la sous-claviere
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Un homme de 18 ans, polytraumatise a la suite d’un accident d’autornobile, est admis en urgence en juillet
1979. II presente une commotion
cerebrale, un tableau de polyfractures
des membres et une fracture de la
premiere cote droite. Les lesions necessitent un sejour hospitalier de 2
mois. Ni l’examen clinique ni la radiographie thoracique ne laissent suspecter une lesion vasculaire de l’artere
sous-claviere.
Un mois apres sa sortie, le patient
est rehospitalise pour l’apparition recente d’une masse cervicale droite
avec sensibilite douloureuse et engourdissements du membre superieur droit
qui reste discretement oedematie.
Parallelement, un enrouement recent
s’est installe. L’examen clinique permet d’observer un syndrome de Clau
de Bernard-Horner droit, une masse
pulsatile sus-claviculaire et latero-cervicale droite avec expansion a la pal
pation et souffle systolique de grade
3/6 a 1’auscultation. La perception
du pouls radial et humeral est diminuee a droite par rapport au cote
gauche. Le reste de l’examen neurologique du membre est normal. Les
radiographies des poumons (fig. 1)
montrent un cal de fracture recent
sur Fare posterieur de la premiere
cote droite et une opacite arrondie,
homogene de 10 cm, cervico-thora
cique, refoulant la trachee vers la
gauche.
La gerbe aortique realisee alors

permet d’opacifier cette masse et de
Fidentifier comme etant un faux ane
vrysme de Fartere sous-claviere droite
qui refoule Fartere carotide droite
vers la gauche (fig. 2).
L’intervention a lieu le 12 novembre 1979. Le malade est intube par
sonde de Carlens. On realise une
sternotomie mediane partielle jusqu’au troisieme espace inter-costal,
branchee cranialement sur une inci
sion horizontale transverse supra-claviculaire droite et caudalement sur
une sternotomie transverse droite
vers le troisieme espace inter-costal
droit. Cette voie d’abord est encore
elargie par une cleidectomie interne.
Le tronc arteriel brachiocephalique
est controle, ainsi que Fartere axillaire. Le scalene anterieur et le sternocleidomastoi'dien adherent au sac
anevrysmal. Ils sont sectionnees apres
dissection difficile du pneumogastrique et du nerf phrenique. La dissec
tion de la veine jugulaire et de la
veine sous-claviere est rendue laborieuse en raison des rapports contactes avec la masse anevrysmale.
Apres heparinisation et clampage
proximal et distal de Fanevrysme, on
ouvre le sac. II existe une laceration
de Fartere sous-claviere droite de 30
mm qui est fermee par un surjet continu de Prolene 4-0. Le debit de
l’artere axillaire etant juge insuffisant,
un pontage axillaire en termino-lateral par tube de Dacron tricote de 6
mm est realise.
En fin d’intervention, le bras est
chaud, les pouls sont perqus, il n’exis-

Les demandes de tires-d-part doivent
etre adressees an Dr Y. Glock,
Professeur adjoint, Departement de
chirurgie cardio-vasculaire et thoracique,
Centre Hospitalier Universitaire
de Sherbrooke, 3000, l i e ave Nord,
Sherbrooke, PQ JIH 5N4

FIG. 1—Observation 1. Radiograpliie
thoracique montrant I’opacite anevrysmale (fleches).

FIG. 2—Observation 1. Gerbe aortique
montrant I’opacification de la masse
anevrysmale (fleches).
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Les auteurs rapportent deux
observations de faux anevrysme
de I’artere sous-claviere droit, I’un
par plaie penetrante cervicale,
I'autre par traumatisme ferine
thoracique. Tous deux ont ete traites
chirurgicalement.
Ils soulignent I'importance d'un
diagnostic precoce fonde sur
I'aortographie et d'une cure
chirurgicale rendue difficile par le
trajet cervico-thoracique de Fartere
sous-claviere. Voie d'abord large
et chirurgie reconstructrice s'imposent.
The authors describe two cases of
false aneurysm of the right subclavian
artery. One was due to a penetrating
cervical injury and the other to blunt
thoracic trauma. Both patients were
treated surgically.
Early diagnosis by aortography and
surgical treatment are important.
The operation is difficult because
of the cervicothoracic course of the
subclavian artery. Because of this
a wide approach should be made and
reconstruction is mandatory.

Dans l'histoire naturelle des plaies
vasculaires, le faux anevrysme resulte
toujours de l’organisation d’un hematome autour de vaisseau blesse. La
localisation sous-claviere apres trau
matisme ferme ou ouvert est rare.
L’indication operatoire est indiscutable, le diagnostic et la voie d'abord
reposent sur des donnees arteriographiques. Nous rapportons deux obser
vations de faux anevrysmes d’artere
sous-claviere droite.

Observation 1

Du service de chirurgie generate et
chirurgie cardio-vasculaire et thoracique,
Centre Hospitalier Universitaire
de Sherbrooke, Sherbrooke, PQ
*Professeur de chirurgie generate,
Universite de Sherbrooke
•Projesseur adjoint de chirurgie
cardio-vasculaire et thoracique,
Universite de Sherbrooke
tResident IV de chirurgie cardiovasculaire et thoracique,
Universite de Sherbrooke
Accepte pour publication le 23 avril, 1981
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te pas de trouble neurologique au
niveau du membre. Le patient sort
au 14e jour et va bien. Revu a 12
mois, la revascularisation du membre
est excellente, le pontage est fonctionnel.
Observation 2

Une femme de 20 ans est admise
en urgence, dans un etat d'ebriete et
avec hypotension arterielle, pour plaie
par balle (calibre 22) tiree a bout
portant. II n’existe qu’un orifice d’entree situe 30 mm au-dessus du ster
num et 15 mm a gauche du cartilage
thyroide. Radiologiquement, la balle
est enfouie au-dessus de l’articulation
gleno-humerale (fig. 3). L’examen
montre une paralysie isolee basse du
membre superieur droit et un hematome important para-cervical droit.
Les pouls radial et humeral sont diminues a droite. L'oesophagogramme et
la laryngoscopie realises en urgence
sont normaux.
L’exploration chirurgicale s’impose
en urgence devant l’hematome qui
devient compressif. On pratique une
cervicotomie anterieure transverse
sus-sternale emportant l’orifice d’entree. Une dechirure complete de l’artere carotide primitive droite est
trouvee au sein de l’hematome.
La veine jugulaire interne droite
est intacte. Devant l'impossibilite
d’une reparation, la ligature carotidienne s’avere necessaire. L’explora
tion de la region sous-claviculaire
semble normale.
Les suite operatoires sont simples
et, cicatrisee, la malade debute son
protocole de reeducation pour le defi
cit plexulaire.
L’installation d’un syndrome de
Claude Bernard-Horner et un enrouement evoquant une atteinte du nerf
recurrent et un thrill sus-claviculaire
droit avec un souffle systolo-diastolique continue de grade 4/6 evoquant
une fistule arterio-veineuse font decouvrir a l’examen, Les radiographies
pulmonaires montrent un refoulement
tracheo-bronchique vers la gauche par
une opacite homogene droite sousclaviculaire (fig. 4).
La gerbe aortique realisee alors
montre une vascularisation normale
a gauche. A droite, il existe une dila
tation anevrysmale de l’artere sousclaviere apres le depart de l’artere
vertebrale, associee a une stenose
significative distale ainsi qu’un retour
veineux precoce vers les veines du
cou evoquant une fistule arterioveineuse. Le tronc thyro-lyngo-facial
est refoule par l’anevrysme.
11 s’agit done d’un faux anevrysme
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de l’artere sous-claviere droite avec
stenose significative et fistule arterioveineuse. L’intervention est menee
par sternotomie mediane branchee
cranialement sur l'incision de la pre
miere intervention, prolongee vers le
sillon deltopectoral en croisant la clavicule a son tiers moyen. II y a reali
sation d'une cleidectomie interne avec
dissection du tronc arteriel et de la
carotide primitive droite, dissection
de l'origine de l'artere sous-claviere
droite et reperage du nerf phrenique.
La dissection de l’artere sous-claviere
droite, distale et du sac anevrysmal
est alors faite. Le clampage est realise
apres heparinisation. A l’ouverture du
sac, on constate une dechirure longitudinale de l’artere sous-claviere droi
te dans le carrefour comprenant le
tronc thyro-cervical, l’artere verte
brate et l’artere mammaire interne.
Ces vaisseaux sont ligatures, l’artere

vertebrale, dechiree a sa base, ne peut
etre conservee. Les veines periarterielles sont turgescentes et un thrill
est palpe signant la fistule arterioveineuse. L'artere sous-claviere droite
est resequee au niveau du sac ane
vrysmal et un pontage est realise
grace a un greffon veineux saphene
inverse, monte en termino-terminal
entre les deux segments de la sousclaviere proximate, distal a l’anevrysme. La presence d’adherences inflammatoires au niveau des lesions
plexulaires fait refuser par le neurochirurgien une exploration qui serait
delabrante. Les suites operatoires sont
simples au plan vasculaire et les pouls
humeral et radial droits sont bien
perqus. Revue a 6 mois, la patiente
va bien sur le plan vasculaire et suit
son programme de rehabilitation pour
son atteinte plexulaire.
Discussion

F IG . 3— O bservation 2. R adiographic
tho raciq u e: la balle est visible (flcche) audessus de I’a rtieu latio n gleno-hum erale.

F IG . 4— O bservation 2. C liches en
so u stractio n de la gerbe ao rtique m o n tra n t
I’anevrysm e de la sous-claviere (fleches).
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Les plaies de l’artere sous-claviere
sont rares, tant en pratique civile1,2
qu’en pratique de guerre ou elles
sont estimees a moins de 0,85% des
plaies vasculaires.3,4 Perry et collegues5 estiment entre 1% et 7% l’incidence des plaies de l'artere sous-cla
viere par rapport aux plaies des vais
seaux au niveau des extremites. Des
lors, les faux anevrysmes de l’artere
sous-claviere apparaissent comme
exceptionnels.612 Le type de blessures
qui leur donnent naissance entraine
le plus souvent un deces rapide par
exsanguination* s’il n’est pas repare
en urgence.
Les faux anevrysmes de l’artere
sous-claviere resultent initialement
soit simplement d’une plaie arterielle
par projectile (observation 2), soit
d’un mecanisme plus complexe en
cas de traumatisme ferme thoracoscapulaire (observation 1).
La premiere cote et la clavicule
protegeant l’artere sous-claviere, un
traumatisme violent est toujours ne
cessaire. Ce traumatisme est soit di
rect sur le moignon de l’epaule induisant une forme aigue de “syndrome
de la traversee thoraco-brachiale,”
l’artere sous-claviere etant cisaillee
sur une berge du canal cervico-thoracique.9'11,12 Ou encore, le traumatisme
est indirect et il s’agit d’un impact
a grande vitesse avec deceleration
entrainant une avulsion du vaisseau
par le coup de belier, lie a l’inertie
de la colonne sanguine et de la masse
cardiaque. Une hyperextension du
rachis peut etre associee.9'1112
La frequence des traumatismes associes s’explique done:
• Thoraco-vasculaires: ils concer-
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nent l’isthme aortique ou le tronc
supra-aortique, le tronc arteriel brachio-cephalique,9’10 ou l’arbre bronchique.5,12
• Cranio-encephaliques: ces traumatismes sont retrouves dans un
quart des cas de lesion des troncs
supra-aortique par Kieffer et collegues.9
• Nerveux peripheriques: le plexus
brachial est plus sensible aux elon
gations que 1’artere sous-claviere et,
une fois sur deux, a l’atteinte de cette
artere s’associe une atteinte plexulaire.4,13
En matiere de traumatisme thoracique, la fracture de la premiere cote
est frequente8"12 et associee aux lesions
vasculaires.
Le pseudo-anevrysme de l’artere
sous-claviere survient quand une plaie
vasculaire ou une contusion vasculaire echappe au diagnostic. II s’ensuit
un delai variable de quelques semaines7,u a quelques annees7,8 au terme
duquel il est diagnostique de faqon
retrospective. La decouverte du faux
anevrysme de l’artere sous-claviere
est parfois fortuite devant une opacite mediastinale.6 Cependant un cer
tain nombre de signes sont parfois
retrouves: il ne s’agit pas tant d'une
insuffisance circulatoire distale du
membre, car le pouls radial peut etre
perqu s’il n’y a pas de stenose," que
d’une symptomatologie liee a la masse
anevrysmale; celle-ci est soit palpable
au cou, pulsatile et expansive dans
la region retro-claviculaire, soit thoraco-mediastinale. Elle engendrera alors
une pathologie de compression,7,14
nerveuse (syndrome de Claude Bernard-Horner, syndrome recurrentiel),
veineuse (oedeme du membre) et tracheo-bronchique
(dyspnee).
Nous
avons observe une telle symptomato
logie dans nos deux observations.
Sont considerees par certains comme
"signe d’alarme” la fracture de la
premiere cote et la paralysie du plexus
brachial.9'11,14'1* En cas de stenose as
sociee au faux anevrysme de I'artere
sous-claviere. peuvent bien sur voir
des deficits circulatoires avec eventuel “vol sous-clavier” si I’artere vertebrale est distale au faux anevrysme
et a la stenose.8
A l’examen, le faux anevrysme,
parfois palpable au creux sus-claviculaire, sera battant et expansif. Il
engendrera souvent un souffle systolique. Dans notre deuxieme obser
vation, le souffle etait systo-diastolique, evocateur d’une fistule arterioveineuse. Celle-ci fut authentifiee radiologiquement et a l'intervention.
L’unanimite est faite sur l'examen
diagnostic qui est la gerbe aortique

realisee par la technique de Seldinger.
L’image du faux anevrysme ne pose
aucun probleme d’interpretation. Il
est important de le situer sur I’artere
sous-claviere par rapport a son origine
et a I’artere vertebrate d’une part et
d’autre part, par rapport aux regions
anatomiques traversees, thoracique,
retro-claviculaire et prescalenique. Le
bilan negatif d’une opacite mediasti
nale superieure doit faire envisager
un examen arteriographique pour
eviter certaines decouvertes operatoires fortuites.6
Une fois le diagnostic pose, l'indication chirurgicale est formelle. De
principe, la voie d’abord doit etre
large afin de realiser un bon controle proximal et distal. En raison
des adherences, le controle des collaterales posterieurs est difficile par
voie peri-sacculaire et le controle
endo-sacculaire peut etre hemorragique, necessitant l’artifice d’une hemostase provisoire par sonde de Fogarty.6
Le sac est parfois laisse en place
apres ligature et pontage.8
Une voie mixte cervico-thoracique
s’impose. L’artere sous-claviere droite
est parfaitement controlee par une
sternotomie mediane sur laquelle est
cranialement branchee une cervicotomie sous-claviculaire.611,17 Une cleidectomie interne donne un jour avantageux pour un prejudice fonctionnel
et esthetique minimum.9,18 L’artere
sous-claviere gauche, moins souvent
atteinte que la droite est controlee
proximalement par une thoracotomie
postero-laterale dans le quatrieme
espace intercostal.19
La ligature isolee doit etre proscrite
et une reconstruction s'impose toujours.7,9,11
Le caractere traumatique de ce
faux anevrysme de I’artere sous-cla
viere en fait une formation sacciforme parfois peliculisee par un col
let qui correspond a la plaie arterielle
initiale. Un traitement conservateur
a pu etre realise avec suture simple.7,10
Resection greffe, mise a plat greffe
et pontage se partagent les indica
tions. La prothese synthetique repond
plus volontier a la portion proximale
de I’artere, la greffe veineuse saphene
inversee a ses segments distaux.7"9,11
Le pronostic circulatoire de ces
lesions vasculaires est bon apres trai
tement chirurgical, le pronostic fonc
tionnel du membre etant lie aux le
sions nerveuses definitives, associees
dans la moitie des cas.
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BOOK REVIEWS

ATLAS OF TOPOGRAPHICAL AND
APPLIED HUMAN ANATOM Y. Vol
ume I. Head and Neck. 2nd revised ed.
Eduard Pernkopf. Edited by Helmut
Ferner. Translated from German by
Harry Monsen. 308 pp. Illust. Urban
& Schwarzenberg, Inc., Baltimore; The
Macmillan Company of Canada Li
mited, Toronto, 1980. $122.50. ISBN
0-8067-1552-9.

The appearance of the second revised
edition of volume I of this atlas is an
important event in medical education.
The size of the atlas permits ample room
for the large yet detailed illustrations
with their many labels and the excellent
quality of the paper adds to the fineness
of reproduction. The illustrations them
selves are of a very high quality with
respect to artistry, detail and subtlety of
colouring and shading. The in-situ dissec
tions of the brain are remarkable. It is
difficult to single out one illustration
or group of illustrations over others,
when all of them are so excellent ana
tomically and artistically. Moreover,
there are excellent roentgenograms and
arteriograms in the appropriate places.
Some of the illustrations are noteworthy
for the unusual dissection used or unusual
isolation of one set of structures relative
to the skull. The anatomy of the eye and
ear, the oral cavity and the larynx is very
well presented.
This volume is valuable not only for
the physician and general surgeon, but
also for the otolaryngologist, the oral
surgeon, the maxillofacial surgeon and
residents training in these fields. It is a
necessary addition to any well provided
anatomical library or larger biomedical
library.
K.R. D onnelly,

md

Associate professor.
Department of anatomy,
University of British Columbia,
Vancouver. BC

of “basic" is not one normally under
stood by most physicians.
The volume is divided into four sec
tions.
The first section, dealing with specific
conditions, includes discussion and details
of cardiac arrest, management of cardiac
failure, acute poisoning and insect bites,
status epilepticus, head injuries, chest
injuries, burns, complications of spinal
and epidural anesthesia, pre-eclampsia
and eclampsia and neonatal resuscitation.
Section two covers the practical aspects
of ventilation, intravenous anesthetics,
neuromuscular blocking agents and the
pathophysiology of respiratory failure.
Section three discusses the heart and
circulation in health and disease, includ
ing the physiology of the heart and
circulation, shock and its treatment,
blood transfusions and blood substitutes.
The final section consists mainly of a
discussion of the mathematics of acidbase balance, and interpretation and
elaboration of the SI units used in
measurements relating to resuscitation.
The authors give a thorough overview
of most of the problems involving emer
gency care and, in so doing, the book
becomes a more advan'ed reference.
In view of the varied and large
amount of material present and the
detail given it is difficult to assess the
audience to whom this volume is
directed. It seems too detailed for under
graduate nursing education, but it would
fulfil a need in the postgraduate training
of housestaff interested in anesthesia and
intensive care.
This volume presents, in a very ex
pansive fashion, the problems of acute
or primary care and basic requirements
for resuscitation. In covering such a
wide spectrum, both in content and
detail, the authors have produced a
book that has value as a ready reference
in any emergency department but that
also could be useful for postgraduate
students in anesthesia and intensive care.
C.U. H en d er so n ,

BASIC RESUSCITATION AND
MARY CARE. F. Wilson and
Park. 339 pp. Illust. University
Press, Baltimore, 1980. $24.95.
0-85200-316-1.

PRI
W.G.
Park
ISBN

In their introduction the authors state
that “basic” is meant to include the first
hour following the start of treatment of
any stated emergency and that all equip
ment discussed is readily available in
most centres. One might argue, having
reviewed the book, that this definition
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m d , f r c p [c ]

Chief of anesthesia,
The Charles A. Janeway Child
Health Care Centre.
St. John’s, Nfld.
CURRENT SURGICAL PRACTICE
VOLUME 2. From Lectures Given at
the Royal College of Surgeons of
England. Edited on behalf of the
Royal College of Surgeons of England
by John Hadfield and Michael Hobsley. 378 pp. Illust. Edward Arnold
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(Publishers) Ltd., London, 1978. Price
not stated, paperbound. ISBN 0-71314322-3.

When this book appeared on my desk
1 felt a certain annoyance at having to
set aside time to read it and write a
review. The initial annoyance soon gave
way to tolerance and finally to enjoy
ment. This book reads well and quickly.
Its authors are experts in their respec
tive fields and their changing literary
styles stimulate interest and foster at
tention.
The text is organized into chapters
relating to the different surgical sub
specialties. Each chapter describes one
or two topics of current interest. Also
included are sections common to all
subspecialties on medical communica
tions, the biochemical problems of sur
gery relating to fluid and electrolyte
management and acid-base balance, and
on cryotherapy. The chapter on cryother
apy describes its use for skin lesions as
well as its application to anal conditions
such as hemorrhoids and fistula-in-ano.
The section on urology is extensive
and informative. Two topics are dis
cussed: carcinoma of the bladder and
prostatectomy. The section provides
insight into the approach to illness in
the former and a more technical dis
cussion of the latter. For the general
surgeon the details will fade but the
main thrust of surgical therapy will
remain.
The orthopedic section deals with
tumours of bone and surgery of the
hip. The discussion of tumours begins
with a classification that is easy to under
stand and remember. Diagnosis and
management follow. The descriptions are
quite straightforward and will provide
residents with a quick review before
examinations. The subsection on surgery
of the hip covers the spectrum of
diseases from childhood disorders to
fractures in the elderly and total hip re
placement. It is concise. More discussion
on the complications of surgical treat
ment might have been included, as well
as some of the functional problems that
are encountered after total hip replace
ment.
The neurologic segment discussing the
broad spectrum of space-occupying le
sions is interesting. Its emphasis is on
cerebral edema and the discussion of
this condition is worth reading.
The chapters on gunshot wounds and
on burns are useful and are good re
views for the expert as well as for the
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general surgeon who is called upon to
deal with these injuries occasionally.
For the general surgeon, the book is
a pleasure. Several chapters touch upon
the common problems of general sur
gery. Its vascular component is divided
into varicose veins, aneurysms and a
section on the management of ischemic
lower limbs. The management of vari
cose veins is discussed by a surgeon
who has wide experience in treating
them. He is an advocate of the combined
approach of sclerotherapy and operation,
but prefers the former. This chapter is
one of the better ones written on the
management of varicose veins. The sec
tions on aneurysms and ischemic lower
limbs are straightforward.
Gastrointestinal problems are repre
sented by a wide range of topics: anal
conditions such as hemorrhoids, fissures,
fistula-in-ano and rectal prolapse; gastric
conditions such as postgastrectomy syn
dromes and recurrent ulceration follow
ing initial operation; pharyngoesophageal
carcinoma and intestinal stomas and
fistulas. The discussion on hemorrhoids
presents a description of their etiology,
an aspect not emphasized in residency
training and often dismissed by the
practising surgeon. It is worthwhile re
viewing. The treatment of fissures, and
abscesses is fairly standard and conforms
to general knowledge and its application
in current usage. The well illustrated
chapter on prolapse of the rectum con
firms that no single treatment works
especially well, although preference is
given to the Ivalon rectoplexy procedure.
The postoperative management of the
colostomy and ileostomy sites including
an evaluation of ostomy appliances is
covered in the chapter on intestinal
stomas and fistulas.
After reading the discussion on pha
ryngoesophageal carcinoma, I can only
be happy that it does not occur more
often. The outcome is dismal.
Discussion of the postgastrectomy
syndrome with the variants of the
dumping syndrome is detailed. It is a
good summary on the current thinking.
A good review is provided of recurrent
ulcer following initial operation.
By and large the authors take their
own advice on medical communications,
that is, be brief, precise and informative.
After reading the book one is inclined
to go over it again. It has didactic value,
not only for students and residents but
even more so for the practising surgeon.
It is a good review of the more common
aspects of surgical practice. Its concepts
are current and treatment is based on
experience. I would recommend this
book to the practising surgeon and to
residents as great help in organizing
their thoughts before fellowship exa
minations.

FUNDAMENTAL TECHNIQUES OF
PLASTIC SURGERY AND THEIR
SURGICAL APPLICATIONS. 7th ed.
Ian A. McGregor. 336 pp. Illust.
Churchill
Livingstone, Edinburgh;
Academic Press Canada Limited, Don
Mills, Ont., 1980. $26.25 (Can.), paperbound. ISBN 0-443-01828-6.

Department of surgery.
Grace General Hospital,
Ottawa, Ont.

The 7th edition of this book comes on
the 20th anniversary of the first. This
time it appears in a new format —
smaller dimensions (14 X 21.5 cm)
and soft cover. This should help keep
the cost reasonable and at the same
time make it more transportable and
therefore more likely to be carried by
students and trainees.
As stated in the foreword, this book
is not written for specialists in plastic
surgery. The content lies somewhere
between an extensive collection of notes
on plastic surgery and a definitive text
book written for the specialist. The
material is greater in scope and depth
than that usually found in the section
devoted to plastic surgery in standard
surgical textbooks. 1 have, for many
years, recommended this book to medi
cal students spending an elective period
on the plastic surgery service. I have
also recommended it for residents in
general practice, general surgery, ortho
pedic surgery and other surgical speci
alties, who rotate through the plastic
surgery service at the resident level.
I believe that this latest edition will
continue to serve these groups well.
Further, the book is written so that it
will be of value to general practitioners
and general and orthopedic surgeons
who find themselves in a situation in
which they are required to practise
plastic surgery in a limited way.
The first part of the book deals with
the general topics of wound healing,
wound care, incisions and principles of
skin grafting and skin flaps. There is a
revised section on skin flaps including
a new chapter devoted to muscle and
myocutaneous flaps. These sections are
not definitive but are timely and con
cisely written.
The second section, as in previous
editions, is devoted to the surgical ap
plication of plastic surgery principles
in areas of general, orthopedic, hand and
maxillofacial surgery.
McGregor has again, masterfully,
made the book easy to read. It is orga
nized well and flows easily without the
chopped up characteristic of books that
attempt to classify and categorize.
The author has admittedly left out
references and eponyms. In some sec
tions there is a lot of detail concerning
technique. Although this is tedious to
those involved in plastic surgery every
day it is helpful for the trainee and
occasional operator. The book lacks
sections on congenital malformations,
burns, microsurgery and cosmetic sur
gery.
The author, who has an international
reputation as a leading practitioner and
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teacher in plastic surgery, has again
demonstrated his talents as an expert
author. I highly recommend this book
to those embarking upon plastic surgery
and to those surgeons who are occa
sionally called upon to use some of
the techniques practised in plad'-c
surgery and who require an update on
the principles and techniques involved.
D.C.

B i r d s e l l , m d , f r c s [ c ], FACS

Chief,
Division of plastic surgery.
Foothills Hospital,
Calgary, Alta.
INFLAMMATORY BOWEL DISEASE.
2nd ed. Edited by Joseph B. Kirsner
and Roy G. Shorter. 693 pp. Illust.
Lea & Febiger, Philadelphia, 1980.
$88.75 (Can.). ISBN 0-8121-0698-9.

This second edition easily maintains
the standards of excellence established
by the first. Like no other text, the
book provides a wealth of practical and
theoretical knowledge to physicians and
surgeons who grapple with the difficult
diagnostic and therapeutic decisions
CARDIOPLEGIC R E A R R E S T
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inherent in the care of patients with
inflammatory bowel disease.
The first seven chapters dealing with
etiology, pathophysiology and epide
miology are lucid. They contain current
working hypotheses and are well sup
plied with references. Although there
is some unnecessary repetition from
chapter to chapter concerning the struc
ture and function of the gut-associated
lymphoid tissue, the current concepts
of the potential role of immune pheno
mena in inflammatory bowel disease
are nicely described.
The sections that follow, describing
the clinical, roentgenographic and en
doscopic features of inflammatory bowel
disease illustrate the authors’ breadth
and depth of experience. As the editors
point out in their preface, research con
tinues to throw light on many unsolved
questions in inflammatory bowel disease.
Unfortunately the authors fall victim to
this continuing expansion of knowledge
resulting in the only important error in
the text. The recent identification of
Clostridium difficile as a pathogen in
the antibiotic-related form of pseudo
membranous colitis makes the text’s
description of this entity incomplete if
not misleading. But this is a small price
to pay for an otherwise detailed com
pilation of the clinical features of in
flammatory bowel disease.
The final chapters dealing with the
management and prognosis are extremely
well done. Although each author allows
his own bias to be known regarding
management, objectivity is maintained.
Opposing views are documented and
adequate references are provided in each
chapter. Thus, one gains not only spe
cific recommendations for treatment but
also a broad overview of very complex
and often controversial clinical pro
blems.
The technical aspects of this book
are not found wanting. The organization
is quite good. Each chapter may be
read in isolation from the others with
out detracting from the overall thrust
of the text. The illustrations are clear
and the photographic reproductions are
first rate.
Although this second edition is ex
pensive, its clarity and comprehensive
style easily justify the price. The addi
tions made to the first edition are suf
ficient that individuals who purchased
and enjoyed that volume will want to
update their libraries with the second
edition.
W il l ia m

T. D e p e w ,

b sc , m d , f r c p [c ]

Assistant professor of medicine.
Division of gastroenterology,
Queen’s University,
Kingston, Ont.
OPHTHALMOLOGY. The Essentials.
David Miller. 290 pp. Illust. Houghton
Mifflin Professional Publishers, Bos
ton; The Macmillan Company of
Canada, Toronto, 1979. $22.50, paperbound. ISBN 0-89289-325-7.
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Aimed directly at the medical student
who must rotate through various de
partments in medicine and surgery, this
text attempts to present what the author
considers to be essential ophthalmologic
material for all future physicians “to
help the physician-in-training develop a
foundation for understanding ophthal
mology".
The book first reviews briefly the
structure and function of the eye, then
presents the various methods used in the
clinical evaluation of the ocular system.
Following this are single chapters de
voted to the most common ocular prob
lems such as refractive errors, corneal
disease, cataract, strabismus, glaucoma,
uveitis and retinal disease.
Some students will appreciate the nar
rative approach that the author uses,
but I believe the majority of medical
students will find the information pre
sented too superficial.
In attempting to present as much of
the essential facts of ophthalmology as
possible, the author has placed too much
emphasis on clinical ophthalmology with
out an appropriate balance of basic sci
ence. Although there are several chap
ters on the anatomy and physiology of
the eye, these chapters lack depth and
so the students will not gain an under
standing of the basics of ophthalmology
upon which their future clinical experi
ences can be built.
This book as it is currently written
will not replace the standard texts re
commended for medical students.
M artin B. K aback,

md , frcs [c ]

Department of ophthalmology.
The Sir Mortimer B. Davis-Jewish
General Hospital.
Montreal. PQ
SURGERY FOR THE COMPLICA
TIONS OF MYOCARDIAL IN
FARCTION. Edited by John M.
Moran and Lawrence L. Michaelis.
465 pp. Illust. Grune & Stratton, Inc.,
New York, 1980. $46. ISBN 0-80891278-X.

This book was compiled from papers
delivered at a symposium held by North
western University in Evanston, Illinois,
June 24 and 25, 1980. It comprises
discussions of the pathophysiology, treat
ment and complications of coronary
artery disease; most of the topics are
presented by current leaders or innova
tors in the field.
The book opens with an excellent
discussion of the morphologic features
in complications of coronary artery
disease such as papillary muscle dys
function or rupture, acquired ventricular
septal defect, cardiogenic shock and
myocardial rupture. There is some over
lap in the next chapter on diagnosis
and medical approaches to the complica
tions of infarction. Although interesting,
the chapter on sustaining factors in
atherosclerosis could have been omitted.
Mechanisms and diagnosis of periopera
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tive myocardial damage are then dis
cussed. The chapter by Bernardine Bulkley on the morphologic consequences
of myocardial revascularization, which
appears later in the text, might have
been better placed here.
There follows a section that details
the types of myocardial protection —
discussion of acellular perfusion by
Levitsky and colleagues, cold potassium
cardioplegia and intermittent aortic
cross-clamping. A chapter by the editors
and their colleagues on oxygenated car
dioplegia in rats could have been
omitted. As in other areas, it is unfor
tunate that the discussion of myocardial
protection that must have occurred at
the symposium was not included.
The technique of myocardial revascu
larization is then presented by John
Ochsner. The line drawings are excel
lent. Some surgeons do not place grafts
through the transverse sinus and cer
tainly other anastomotic techniques are
in use.
The remainder of the text consists
generally of two or more chapters dis
cussing the surgery applicable to each
of the complications of myocardial
infarction. Treatment of mitral regur
gitation, both by valve repair and anuloplasty as well as by valve replacement,
is presented, again, however, without
discussion. A chapter by Planz and
Kouchoukos covers surgery for com
bined coronary artery disease, ventri
cular aneurysm and valvular disease.
Acquired ventricular septal defects are
covered in several chapters, which con
tain excellent illustrations. The role of
surgery for acute myocardial infarction
and for patients in cardiogenic shock is
presented by Buckley, Gay and Keon.
The staff of the Texas Heart Institute
and the Cleveland Clinic then present
their results with surgical treatment for
ventricular aneurysm. Moran, in another
chapter considers cardiac rupture and
unusual types of ventricular aneurysm.
A separate chapter on the characteris
tics of embolization from ventricular
aneurysms emphasizes the rarity of this
problem. I agree with the authors that
an embolectomy should be done when
limb viability is in question. Intra-aortic
balloon support has been used when the
patient’s status is critical and might
improve the results presented by those
favouring conservative therapy.
The emerging fields of surgery for
the prevention of sudden cardiac death
and for treating recurrent sustained
ventricular tachycardias are then dis
cussed. With recurrent tachycardia the
poor results with standard aneurysm
resection and revascularization, the need
for careful mapping of the endocardium,
if necessary under hyperthermic con
ditions, and the value of endocardial
resection are all emphasized. The im
portance of sudden cardiac death is
heightened by the knowledge that this
usually occurs in patients who do not
have end-stage myocardial disease and
who can often be: identified by careful
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preoperative electrical and pharmacol
ogic testing as to their suitability for
surgery.
Mechanical support devices including
the intra-aortic balloon, as it is generally
used, and the newer percutaneous me
thod are described in several chapters.
The authors from Northwestern Uni
versity describe a new method of bal
loon insertion without a graft which will
speed the insertion but requires primary
arterial repair at removal. Ventricular
assist devices are considered and their
current and future uses outlined. Finally,
cardiac transplantation in patients with

end-stage myocardial disease who are on
the balloon pump is discussed and the
current status of cardiac transplantation
at Stanford University outlined. Pro
blems of infection, graft atherosclerosis
and malignant conditions in long-term
survivors are emphasized.
Apart from the reservations men
tioned, this text can be recommended.
It should be most useful for residents
in cardiovascular surgery. Internists and
cardiologists may find the text useful
for its descriptions of the various options
available for surgical treatment. Dis
cussions of the various topics presented

might have made the text more useful
for the practising cardiac surgeon. Most
of the information present has appeared
in the recent cardiovascular literature.
One of the best points of the text is
the extensive bibliography after each
chapter which is current almost to the
day of publication.
Jo h n

M.

R o t h s c h il d ,

m d

,

c m

,

f r c s [c ]

Department of cardiovascular
and thoracic surgery,
Calgary Associate Clinic,
214-6th Ave. SW,
Calgary, Alta.
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GENERAL SURGEON: ONT.

CLINICAL FELLOWSHIP
PROFESSOR AND CHAIRMAN

General surgeon fo r fu ll-tim e ju n io r faculty
position. M ust have strong academic interest
and demonstrated ca pa b ility in independent
research, preferably in Gl tra ct area. Contact:
Dr. H.W. Beattie, Professor and Chairman,
Department of Surgery, McMaster University,
1200 Main St. W., Hamilton, Ont. L8N 3Z5.
— S81-018

Ewart Angus Surgical Intensive Care U nit,
W ellesley Hospital, Toronto. Available Ju ly 1,
1982 fo r a period of one year in a m u lti
d iscip lin a ry acute surgical u nit w ith 600
adm issions per year. Duties w ill include
patient care and c lin ic a l research in a strong
academic and teaching unit w ith all types of
patient population excepting cardiac surgery.
Reply to: Dr. D.P. Jones, Director, Surgical
ICU, Suite 219, E.K. Jones Building, 160
Wellesley St. E., Toronto, Ont. M4Y 1J3. (416)
966-6656
—S81-019

ONTARIO
Department of Surgery, Faculty of M ed
icin e , U nive rsity of Toronto. Q u a lific a tio n s :
MD. Royal College fe llo w s h ip or equivalent.
D uties: Leadership of a u niv e rs ity departm ent
w ith d ivision s in several a ffilia te d teaching
hospitals, research a c tiv itie s in u n iv e rs ity
laboratories and association w ith several
com m unity hospitals. The chairm an w ill also
be C hief of Service at an a ffilia te d h osp ita l.
Address enquiries to: Dean Frederick H. Lowy,
Faculty of Medicine, University of Toronto,
Toronto, Ont. M5S 1A8. Position available
July 1, 1982.
— S81-020

Interested In A Change Invo lvin g Regular Office Hours,
No Evening Work And E xcellent Fringe Benefits?

ORTHOPEDIC SURGEON: USA

Due to expansion of services and pending retirements vacancies
have developed in the following areas:

UNIT MEDICAL/OFFICER

A physician with a broad know ledge of fam ily or industrial
medicine. The role is an advisory one involving assessment of
disabilities in dealing with industrial injury claims.

TREATMENT
MEDICAL/OFFICER
This physician w ill supervise the activities of a treatm ent team
involved in the re h a b ilita tio n of
Rehabilitation C enter in Edmonton.

in ju red

w orkers

at

our

Live the good life in Hampton, a pros
perous, clean, safe, fam ily-o rien te d com m u
n ity . There are 13 000 residents in Franklin
County. Iowa, and no orthopedic surgeon in
th is county or in three of the fo u r surround
ing counties. Q uality recreational, educational,
social, re lig io u s, c iv ic , and fraternal fa c ilitie s
and o pportunities abound here, and e xistin g
medical fa c ilitie s and personnel are outstand
ing. For fu rth e r inform ation on the potential
fo r an orthopedic surgery practice in Hampton,
contact: Duane Kelch, President, Medi-Search
Ltd., c /o Hampton Chamber of Commerce,
Hampton, IA 50441 — or te l. c o lle c t: Gary
Petersen, Franklin General Hospital Adminis
trator, (515) 456-4721.
— S81-023

O ur organization offers:
— Com petitive Salaries with recognition considered for specialities
useful to the Board.
— Four weeks h olidays in your firs t year of service.
— An em ployer paid Blue Cross, Dental and Visioncare plan.
— An excellent Pension Plan.
— An excellent Staff Development Program aimed at im proving
your skills.
— Moving cost subsidy.
Applicants must:
— Be eligible for licensing in Alberta
— Have a background in family or industrial medicine practice.
Please direct your application and curriculum vitae to:
Mr. M ilt Webster
The Director of Personnel
WORKERS' COMPENSATION BOARD
Box 2415, Edm onton, Alberta
T5J 2S5
For fu rth e r inform ation call: Karen G ill, Staff R ecruitm ent O fficer
(403) 427-1285.
Suitable applicants w ill be invited for personal interviews at our
expense.
— S81-022
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HEAD, DEPARTMENT OF SURGERY
Dalhousie U nive rsity, School of M edicine.
A p p lica tion s are invited fo r the p o s itio n of
Head of the Department of Surgery. This is
a m ajor p osition w ith in the Faculty o f M edicine
and the individual w ill a dm inister a dep a rt
ment of 14 fu ll-tim e and 41 part-tim e fa c u lty ,
located in 6 teaching hospitals a ffilia te d w ith
D alhousie U nive rsity. The departm ent con
tains the subspe cialities of cardiac, th o ra cic,
orthopedic, p la s tic and p e d ia tric surgery as
w e ll as general surgery. Fu lly accredited
residency tra inin g programs are present in
m ost su bspecialties. The successful applicant
w ill be responsible for developing and ad
m in is te rin g all aspects of patient care, under
graduate teaching, residency tra in in g and
research in surgery and its su bspecialty
d iv is io n s in those hospitals served by D al
housie U nive rsity. Salary and term s n egotia
ble. A p p lica tion s w ith cu rricu lum vitae should
be addressed to: Brian Chandler, M D , FRCP(C),
Chairman, Search Committee, Department of
Surgery, c /o The Office of the Dean of M ed
icine, Dalhousie University, Halifax, NS B3H
4H7.
— S81-021
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Zinacef

Dosage and administration: Adults: the intramuscular dose is 750
mg three times daily and the intravenous dose is 750 mg or 1.5 g
three times daily.
For most infections the usual recommended dosage is 750 mg every
8 hours (2.25 g/day) and may be administered either l/M or l/V.
For severe or life-threatening infections, the higher dose is sug
gested. For infections of the lower respiratory tract, caused by gram
CEFUROXIME SODIUM INJECTION
negative organisms, the higher dose may also be required Anti
biotic therapy for infections caused by B-hemolytic streptococci
Prescribing Information:
should be continued for at least 10 days.
There is insufficient evidence for recommending the use of ZINACEF
Indications and Clinical uses: ZINACEF may be indicated for the in children or in nursing mothers.
treatment of the following infections when caused by susceptible
organisms: lower respiratory tract, urinary tract and soft tissue Dosage in adults with impaired renal function: ZINACEF may be
used for patients with impaired renal function but a reduced dosage
infections.
Appropriate culture and susceptibility studies should be performed must be employed and serum levels of cefuroxime may need to be
to determine the susceptibility of the causative organism to monitored. The following Table shows the dosage recommendations.
ZINACEF Therapy may be started while awaiting the results of these Serum creatinine Glomerular filtration rate Dose of ZINACEF
tests, however, modification of the treatment may be required once
(mL/min)*
(mg/mL)
(mg)
these results become available.
50011 d
2.0 - 3 5
2 0 -5 0
Clinical studies have shown ZINACEF to be effective against infec
500 b i d
3 .5 -6 .0
1 0 -2 0
tions caused by sensitive strains of:
> 6 .0
< 10
500 q.d
Gram positive cocci Staphylococcus aureus
T o r more precise calculations, whenever possible, the glomerular
Streptococci (excluding S. faecalis)
filtration rate should be used.
Gram negative rods - Hemophilus influenzae
Patients on dialysis should receive an additional dose of 500 mg at
Escherichia coli
the end of dialysis.
Proteus mirabilis
Klebsiella spp.
Preparation of solutions: For intramuscular use Add 3 2 mL of
Water for Injection to a vial containing 750 mg of ZINACEF and
Contraindications: Hypersensitivity to cephalosporins.
shake gently to produce an opaque suspension. The total volume
Warnings: Before therapy with ZINACEF is instituted, careful inquiry obtained is approximately 3.7 mL.
should be made concerning previous hypersensitivity reactions to For intravenous use: When a single bolus injection is prepared. 750
cephalosporins, penicillins or other drugs. ZINACEF should be given mg of ZINACEF is dissolved in 7 mL of Water for Injection, which pro
vides a volume of approximately 7.5 mL. Reconstitution of 1.5 g of
only with caution to penicillin-sensitive patients
There is some clinical and laboratory evidence of partial cross- ZINACEF is done by adding 19 mL of Water for Injection, thereby ob
allergemcity of the cephalosporins and penicillins. Patients have taining an approximate volume of 20 mL.
been reported to have had severe reactions (including anaphylaxis) For short intravenous infusion, 1.5 g of ZINACEF is dissolved in
to both types of drugs
49 mL of Water for Injection, resulting in an approximate volume of
Any patient who has demonstrated some form of allergy, particularly 50 mL
to drugs, should receive antibiotics, including ZINACEF. with cau
tion. If an allergic reaction to ZINACEF occurs, administration of the Administration: Intramuscular: ZINACEF should be injected into a
drug should be discontinued. Serious acute hypersensitivity reac large muscle m ass to minimize pain. As the preparation is in
tions may require treatment with epinephrine and other emergency suspension form, a 21 gauge needle should be used
measures.
Intravenous: ZINACEF may be administered intravenously either by
Precautions: The safety of ZINACEF in the treatment of infections a bolus injection or by a short intravenous infusion over a period of
during pregnancy has not been established. If the administration of approximately 30 minutes.
ZINACEF is considered to be necessary, its use requires that the po For continuous intravenous infusions, a solution of ZINACEF (1.5 g
tential benefits be weighed against possible hazards to the patient dissolved in 19 mL of Water for Injection) may be added to a suitable
and to the fetus. Animal studies have shown ZINACEF to affect bone bottle containing an appropriate intravenous infusion fluid in the
amount calculated to give the desired antibiotic dose.
calcification in the fetus and to show maternal toxicity in the rabbit
The safety of ZINACEF for the treatment of infections in infants, Compatibility: Reconstituted primary solutions of ZINACEF may be
further diluted with Sodium Chloride Injection B.P. 0.9% w/v, 5%
children and nursing mothers, has not been established.
Prolonged use of ZINACEF may result in the overgrowth of non- w/v Dextrose Injection B.P. or Compound Sodium Lactate Injection
susceptible organisms. Careful observation of the patient is there B.P. (Hartmann's Solution).
fore essential, and if superinfection should occur during therapy, NOTE: The pH of 2.74% w/v Sodium Bicarbonate Injection B P con
appropriate measures should be taken. Should an organism become siderably affects the colour of the solution, therefore, this solution is
resistant during antibiotic therapy, another antibiotic should be not recommended for the dilution of ZINACEF. However, if required,
substituted.
for patients receiving Sodium Bicarbonate Injection by infusion, the
Patients with renal or hepatic impairment should be carefully ZINACEF may be introduced into the tube of the set
monitored during therapy with ZINACEF. Patients with impaired NOTE ZINACEF should not be mixed with aminoglycoside antibiotics
renal function should be placed on the special dosage recom (e g gentamicin sulfate, tobramycin sulfate, amikacin sulfate) be
mended under DOSAGE AND ADMINISTRATION, because normal cause of potential interaction.
doses in these individuals are likely to produce excessive serum
Stability: The dry powder in vials should be stored below 25°C and
concentrations.
Studies suggest that the concurrent use of potent diuretics, such as protected from light.
furosemide and ethacrynic acid, may increase the risk of renal tox Suspensions of ZINACEF for intramuscular injection and aqueous
solutions for intravenous injection retain their potency for 6 hours if
icity with cephalosporins.
ZINACEF may interfere with Benedict s and Fehlmg’s tests for kept below 25CC. and for 48 hours if refrigerated. More dilute solu
glycosuria. It may cause false negative reactions in the ferricyamde tions. i.e. 1.5 g in 50 mL Water for Injection, retain their potency for
test, and possibly, may cause an erroneously high reading in the at least 12 hours if kept below 25°C. and for 36 hours when re
frigerated. Some increase in the intensity of colour may occur on
alkaline picrate test for creatinine.
storage.
Adverse reactions: The following reactions have been observed
Dosage forms: ZINACEF is available for intramuscular or direct in
during treatment with ZINACEF.
Hypersensitivity: rash and eosinophilia. Anaphylaxis, pruritus and travenous injection in 18 mL vials containing cefuroxime sodium
powder equivalent to 750 mg of cefuroxime. in packs of five.
drug fever have also been observed with cephalosporin therapy.
For intravenous injection, 30 mL vials contain cefuroxime sodium
Local reactions: thrombophlebitis, stiffness at the site of injection powder equivalent to 1.5 g of cefuroxime, in individual packs
and inflammatory reactions at the site of injection. Some degree of For intravenous infusion, ZINACEF is available in 75 mL vials con
pain, after intramuscular injections when using water as the di taining cefuroxime sodium powder equivalent to 1.5 got cefuroxime
luent, has been observed.
in individual packs.
Blood: increased erythrocyte sedimentation rate and decreased
PAAB
hemoglobin. Some patients developed a positive direct Coombs test. Product Monograph available on request.

Renal: increases in BUN and serum creatinine.
Hepatic: transient increases in serum bilirubin, transaminases and
alkaline phosphatase
Others: drowsiness, loose stools, faint feeling, sweating, palpita
tions and Candida intertrigo.
Symptoms and treatment of overdose: Other than general suppor
tive treatment, no specific antidote is known. Excessive serum
levels of cefuroxime can be reduced by dialysis. For treatment of
hypersensitivity reactions, see WARNINGS.
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Anewchoicein —
firstchoicehospitalantibiotics.

Zinacef is a new third generation injectable
cephalosporin with advantages that
make it an excellent first choice antibiotic.

Unlike most penicillins and cephalosporins which
are inactivated by 6-lactamase producing pathogens
Zinacef has a novei structure (the addition of an
a methoximino group)1which helps protect the betalactam ring against destruction.

Lower individual dosage (750 mg) and longer half-life
(70 minutes)1than other third generation cephalosporins
• Convenient eight-hour dosage interval for a low
usual daily dose of 2.25 g.1
t • Therapeutically effective levels throughout body
tissu e s.1

J

# # #

Range of M.I.C.'s
for most common pathogens.

CONH
NOCH
CHz0C0NH
Time from dose (hours).

Zinacef has a broad range of activity
and excellent pharmacokinetics:
• Rapidly absorbed and not meta
bolised, yielding high levels
(91-96% ) of active unchanged
antibiotic in the urine.1

From Glaxo Laboratories

Reference 2

Zinacef has a high intrinsic activity against the
range of Gram-positive and Gram
negative pathogens responsible for
the vast majority of hospital
infections.1Up to 9 2 % of isolated
pathogens were effectively treated
by Zinacef.3

We started cephalosporin research. And we’ve never stopped.

The Silkworm rsTlie Chemist:

The Silkw orm s
product: Silk
1. Strength-G ood
2. “H and"-V ery good
3. Tying characteristics Very good
4. Tissue reaction—
Moderately high
5. Knot security-Very good
6. Tissue drag-G ood
7. “ Brooming” tendency—High
8. Product variability-Moderately high
9. C ost—Competitive

The Chemist's
product: SURGILON
Silicone-treated braided nylon
1. Strength-Superior+
2. “ Hand”-V e ry good
3. Tying characteristics—Very good
4. Tissue reaction—Very low
5. Knot security-Very good
6. Tissue drag-S uperiort
7. “ Brooming” tendency-Low
8. Product variability—Very low
9. Cost-Com petitive

Conclusion:
Silk is good...
SURGILON is better.

vs.

SURGILON
other braided nylons:
SURGILON is the only
silicone-treated nylon...
SURGILON is stronger
during and after surgeryt
SURGILON provides great knot
security... minimizes complications
SURGILON is available in both
black and white

DAVIS+GECK
Cyanamid Canada Inc.
Atria North, 2255 Sheppard Ave. E„ Suite E440
Willowdale, Ontario M2J 4Y5
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A tradition of innovation.
SU RG ILON is a registered trade mark of Cyanamid Canada Inc.
t Data on file, Davis & Geek, Toronto,
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